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ABSTRACT 
The introduction of human papillomavirus (HPV) vaccination has caused some parents to 
report concern that their daughters may change their sexual behaviour following 
vaccination.  This concern consistently relates to vaccination acceptance, but had not been 
investigated in detail.  Accordingly, five studies addressed the thesis objective: to explore 
parents’ concern about adolescent sexual behaviour following HPV vaccination in the 
context of the UK immunisation programme and to examine whether such concerns were 
justifiable. 
 
The first study examined discussions of risky sexual behaviour and HPV vaccination in 
news articles published over five years in British newspapers.  The second study 
investigated mothers’ concern about their daughters engaging in risky sexual behaviour 
after vaccination by questioning a sample of mothers.  The third study explored whether 
adolescents would interpret vaccination consent from parents as carte blanche approval for 
sexual activity, by surveying 162 girls.  The fourth study prospectively investigated the 
impact of HPV vaccination and a fifth study compared differences between vaccinated girls 
and girls who had not been offered the vaccine. 
 
Concern about the impact of HPV vaccination on sexual behaviour was raised and 
countered in the media.  A minority of mothers were apprehensive about girls’ sexual 
behaviour following vaccination, however these concerns did not relate to vaccine 
acceptance.  Before the vaccination programme was introduced, some adolescents would 
infer implicit consent to sexual activity if their parents were to consent to vaccination but 
most would also take positive messages.  Once the HPV immunisation programme was 
underway, girls’ sexual behaviour did not become more negative following vaccination, 
despite perceptions of risk lowering.  Parents’ concerns may have resulted in reluctance to 
discuss sex with their daughters in the context of HPV vaccination so that implicit 
messages of approval for sexual activity are not conveyed.  Risk perceptions were pertinent 
in HPV vaccination acceptability and when exploring behaviour change.  These findings 
may help reduce resistance to HPV vaccination.  Implications for theory and practice are 
discussed.
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Chapter 1 - Background 
CERVICAL CANCER AND HUMAN PAPILLOMAVIRUS (HPV) 
Incidence and mortality 
Each year around 2,300 women in England are newly diagnosed with cancer of the cervix 
and in 2008 759 women died as a result of the disease (The Information Centre, 2009b).  
Worldwide incidence of the disease in 2002 was estimated at 493,000, with 274,000 deaths 
attributable to the disease (Ferlay et al., 2004). 
Causes 
Human papillomavirus  
It has been estimated that 5.2% of all cancers worldwide are caused by human 
papillomavirus (HPV; de Sanjose et al., 2007; Parkin, 2006).  There are over 130 types of 
HPV which can be classified as low- and high-risk: low-risk types cause benign warts 
(predominantly types 6 and 11 in the case of condyloma acuminata), high-risk types are 
carcinogenic agents.  Around 15 oncogenic HPV types have been identified.  High-risk 
HPV types are responsible for over 99% of the two main types of cervical cancers 
(squamous cell carcinoma and adenocarcinoma; Walboomers et al., 1999) with types 16 
and 18 involved in 70% of all cervical cancers (Parkin & Bray, 2006).  More recent data 
has suggested that this may be even higher with 76% of squamous cell carcinomas and 82% 
of adenocarcinomas being caused by types 16 and 18 (Howell-Jones et al., 2010).  HPV 
types have also been associated with the development of cancers of the vulva, vagina, anal 
canal, perianal skin and penis, and possible associations have been noted with cancers of 
the skin, oral cavity and upper aerodigestive tract (Parkin, 2006).  The virus is very 
common; 80% of sexually active individuals will be exposed to HPV in their lifetime 
(Monsonego, 2007, p.190) and at any time point, 10.4% of females worldwide have 
cervical HPV infections (de Sanjose et al., 2007).  Infection often occurs soon after sexual 
debut; a study of sexually naïve women found 38% to be infected with one HPV type 
within one year of sexual debut (Winer et al., 2003). 
 
HPV is normally spread by skin-to-skin contact and transmission of the virus to the cervix 
is usually via sexual contact but not necessarily penetrative sexual intercourse.  Consistent 
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condom use offers some protection from HPV infection (Winer et al., 2006).  In the case of 
cervical cancer the virus penetrates cervical epithelial tissue cells causing the cells to 
mutate as the virus replicates its DNA in the cell’s nucleus, starting the process of dysplasia 
or cervical intraepithelial neoplasia (CIN).  Full integration of the virus does not occur in 
low-risk HPV types and hence the cells remain benign.  Initial infection with HPV can be 
latent and can remain so for many years; latent HPV is not infectious and is asymptomatic.  
In 80-90% of cases, the individual’s immune system spontaneously rids the body of the 
virus or HPV DNA can no longer be detected (Stanley, 2006).  Persistent infection with 
HPV can cause mild dysplasia (CIN1), potentially progressing to higher grade CIN disease 
(CIN2 and CIN3), which if left untreated, may develop into cancer of the cervix (Stanley, 
2008).  The duration of the process of infection with HPV to the development of CIN3 is 
not completely clear.  Cross sectional data give estimates anywhere between 7-15 years but 
prospective cohorts have found it can be as little as four months (Bosch & de Sanjose, 
2003; Winer et al., 2005). 
 
Risk factors 
A number of factors have been established to increase a woman’s chance of becoming 
infected with HPV and developing high-grade CIN disease. 
 
Risk factors for infection 
Factors which increase a woman’s chance of becoming infected with HPV tend to relate to 
her sexual history or the sexual history of her partner.  These risk factors include having 
many sexual partners (sometimes identified as more than six), a history of previous 
miscarriage, earlier sexual debut, and an increased risk that her partner is an HPV carrier 
(Deacon et al., 2000; Kjaer et al., 2001). 
 
Risk factors for developing high-grade CIN disease 
Infection with HPV is necessary for the development of high-grade CIN disease and 
cervical cancer; however epidemiological studies and have identified a number of other 
factors that increase the risk of an HPV infected woman developing the disease.  These 
factors include her sexual lifestyle, co-infections, health behaviours and demographic 
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factors.  Women who have a younger sexual debut, a younger first full-term pregnancy, 
have used oral contraceptives for longer than five years and started a new sexual 
relationship more than six years ago are more likely to develop high-grade disease (de 
Gonzalez & Green, 2007; Deacon et al., 2000; Moreno et al., 2002).  There is also a 
positive correlation between risk of high-grade disease and both the number of sexual 
partners a woman has and her parity.  The sexual lifestyle of a woman’s male partner (for 
example number of his sexual partners, number of prostitutes as sexual partners, and being 
a carrier of a high-risk HPV type) can increase the likelihood that she develops 
CIN3/cervical cancer (Bosch et al., 1996).  Women with a circumcised male partner are 
less likely to develop cervical cancer (and be infected with HPV;  Castellsague et al., 2002).  
Pooled analysis of international epidemiological studies have found co-infection with 
chlamydia trachomatis to be associated with squamous cell cervical carcinoma, but not 
adenocarcinoma (Smith et al., 2004a).  Herpes simplex virus-2 is associated with both 
histological types (Smith et al., 2002) and human immunodeficiency virus infection (HIV) 
increases the risk of high-grade disease (Palefsky, 2006).  Immunosuppression in its own 
right increases the risk of HPV-related lesions and detection of HPV (Palefsky & Holly, 
2003).  Research is investigating at what stage of the development of cervical cancer, HIV 
and immunosuppression are involved, and what role they play at each stage.  Smoking also 
increases a woman’s risk of developing high-grade disease (Appleby et al., 2006; de 
Gonzalez & Green, 2007).  Finally, geographical location and socio-economic status (SES) 
are associated with development of the disease independently of other lifestyle factors (de 
Gonzalez & Green, 2007; Quinn et al., 2001). 
 
Prevention 
Cervical screening 
Organised cervical screening programmes operating call-and-recall systems with systematic 
follow-up are available in some developed countries, such as Finland, Iceland and some 
developing South American countries (Sankaranarayanan et al., 2001).  Less effective 
unorganised programmes are available to women in other developed countries such as the 
USA.  Screening programmes of any kind are much rarer in developing countries, 
particularly those in Sub-Saharan Africa and India, where the burden of disease is greatest. 
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Since 1988, the National Health Service (NHS) cervical cancer screening programme has 
operated a call-and-recall system inviting women registered with a GP to attend cervical 
screening every 3-5 years.  The age that women are first invited varies across the UK: in 
England first invitations are sent at age 25 whereas in Wales, Northern Ireland and Scotland 
first invitations are sent at age 20.  Women are no longer invited for screening after age 64 
if they have had three consecutive negative results (age 65 in Northern Ireland and 60 in 
Scotland).  The programme aims to detect and treat any abnormal changes in cells in the 
cervix before they develop into high-grade disease, and can reduce the incidence of cervical 
cancer by up to 73% (Sasieni et al., 2003).  During the procedure a nurse or doctor takes a 
sample of cells from the cervix, which is prepared using liquid based cytology for analysis 
in a laboratory1.  A sample prepared for liquid based cytology is preserved in fluid 
immediately after it has been taken.  It is then sent to a laboratory where it is transferred to 
a slide for examination under a microscope. 
 
Women receive their results in writing within four to six weeks of their appointment 
(depending on their geographical location).  Cases of mild dyskaryosis or more advanced 
abnormalities are further examined by colposcopy and treated according to the results of 
this investigation.  HPV-DNA can be detected in cellular specimens taken from the cervix.  
In order to reduce the number of referrals for colposcopy, the NHS in England are 
evaluating testing of borderline and mild dyskaryotic cervical screening samples for HPV-
DNA.  If HPV-DNA is not detected, the woman is unlikely to develop cervical cancer and 
she will be returned to 3-5 year screening.  Women with samples showing evidence of 
HPV-DNA will be referred for colposcopy. 
 
In 2008/2009, 79% of eligible women in England were less than five years since their last 
cervical screening appointment (73% in Scotland in 2008, 71% in Northern Ireland in 2004; 
                                            
1 Before liquid based cytology was introduced in the UK, the sample would have been immediately smeared 
onto a slide after it had been taken and sent to the laboratory in this form.  As a result, in the UK, cervical 
cancer screening is commonly known as a ‘smear test’, although the procedure of smearing the sample on to a 
microscope slide is no longer used. 
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Cervical Screening Wales, 2010; Information Services, 2009; Public Health Agency for 
Northern Ireland, 2006; The Health and Social Care Information Centre, 2009).  However, 
coverage rates have fallen in the last 10 years in England, with young women being less 
likely to attend (The Health and Social Care Information Centre, 2009).  In 2009 66% of 
25-29 year olds had attended screening in the last five years compared with 78% in 1999. 
 
Prophylactic vaccination 
Two, highly effective, virus-like particle (VLP) prophylactic HPV vaccines that protect 
against the two most common high-risk HPV types (16 and 18) have recently been 
developed (known commercially as Gardasil® and Cervarix®).  Gardasil® also protects 
against HPV types that cause 90% of genital warts (types 6 and 11), making it a 
quadrivalent vaccine as opposed to a bivalent vaccine.  There is evidence that both vaccines 
offer some cross-protection against HPV types not specifically targeted by the vaccine 
(Brown et al., 2009; Paavonen et al., 2009; Wheeler et al., 2009), but it is unknown how 
long this protection lasts for or whether the protection will be clinically meaningful 
(Franceschi, 2009).  Second generation HPV vaccines will target more HPV types and are 
currently being evaluated.  The quadrivalent and bivalent vaccines in use today have proved 
safe and are close to 100% effective; preventing up to 70% of cervical cancers if given to 
individuals naïve to infection (this is normally equivalent to never having sexual contact; 
Rambout et al., 2007).  The bivalent vaccine has shown poorer efficacy in intention to treat 
analysis (The FUTURE I/II study group, 2010).  Both vaccines are administered three times 
over a six month period and are known to offer greater than 98% protection against HPV 
types 16 and 18 over five to seven years.  It is likely that protection will extend well beyond 
this, although data are not currently available (De Carvalh et al., 2009; Villa et al., 2006).  
 
The UK HPV immunisation programme 
The NHS in Great Britain and Northern Ireland recommends and offers a number of 
immunisations to all children (the childhood immunisation schedule).  The vaccinations are 
provided without financial cost at the point of receipt.  In September 2008, the HPV 
vaccine was included in the UK childhood immunisation schedule and it is the UK HPV 
immunisation programme that is the focus of this thesis.  The routine HPV immunisation 
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programme offers the vaccine to all girls in school year 8 (12-13 years old) and in most 
cases is administered in schools.  Ordinarily the girl’s parents or guardians must ‘opt-in’ to 
vaccination2.  A one-off, two-year ‘catch-up’ programme to include all girls not included in 
the main programme and who were born after 1st September 1990 (2nd July 1990 in 
Northern Ireland) was also introduced in September 2008.  In the first year of the ‘catch-up’ 
programme girls born between 1st September 1990 and 31st August 1991 (school year 13) 
were offered the vaccine.  In the second year of the programme, girls born between 1st 
September 1991 and 31st August 1995 were offered the vaccination.  Girls in the ‘catch-up’ 
cohort were offered the vaccine either in their educational establishment or through their 
GP; dependent on their local primary care trust (PCT) and whether they continued into 
post-16 further education.  Initially, the government planned a phased roll-out of the ‘catch 
up’ programme that offered the HPV vaccine to a different school year group each 
academic year.  This schedule was amended at the end of the first year of the immunisation 
programme so that all girls due to be offered the vaccine as part of the ‘catch-up’ 
programme would do so in the second year of the programme. 
 
The UK government chose to use the bivalent vaccine (Cervarix®) in its immunisation 
programme and is not offering the vaccine to boys, which has caused considerable 
discussion.  The quadrivalent vaccine is licensed for use in males in over 40 countries, 
including the UK, and the US Food and Drug Administration (FDA) has recommended the 
quadrivalent vaccine for genital wart prevention (European Centre for Disease Prevention 
and Control (ECDC), 2010; Koulova et al., 2008).  It has been estimated that inclusion of 
males into the UK immunisation programme is not cost effective for the reduction of 
cervical cancer if over 75% of eligible females are fully vaccinated (Kim & Goldie, 2009).  
However, others argue that excluding males from the programme strengthens societal 
beliefs that sexual health is the woman’s responsibility (Szarewski, 2008).  As the focus of 
the UK HPV immunisation programme has been on cervical cancer prevention, HPV 
                                            
2
 Girls under the age of 16 in England and Wales have the legal right to confidential healthcare without 
parental consent if they are considered to be competent in understanding the information given to them, 
including the risks and alternatives, and can make a balanced decision; termed ‘Gillick competent’.  Similar 
premises are used in Scotland (HMSO Stationery Office, 1991).  However, the application of Gillick 
competence is contentious as there is no appropriate legal framework in the UK for determining ‘mental 
capacity’ in children. 
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vaccination in males and HPV vaccination for the prevention of genital warts has not been 
addressed in this thesis, because beliefs about these issues are unlikely to reflect the 
experiences of parents and girls involved in the British programme. 
 
Uptake of the HPV vaccine 
To maximise the efficacy of the programme, uptake of the vaccine needs to be high; 80% 
vaccination coverage would result in a 63% reduction in cases of invasive cervical cancer 
and 70% coverage would result in a 55% reduction (Cuzick et al., 2010).  In the first year 
of the routine HPV immunisation programme in England, 80.1% of girls born between 1st 
September 1995 and 31st August 1996 (school year 8) received all three doses of the 
vaccine (Department of Health, 2010).  Uptake was higher for the first two doses (86% 
received doses one and two).  Uptake varies across the country, being highest in Poole PCT 
(98.9% received three doses) and lowest in Luton PCT (44.1%)3.  Preliminary data for 
uptake in the other countries of the UK show that since September 2008 89.4% of 12-13 
year olds in Scotland had received two doses of the vaccine, 78.8% of 13-14 year old girls 
had received two doses in Northern Ireland, and 79% of 12-13 year old Welsh girls had 
completed the full programme (NHS National Services Scotland, 2008; Northern Ireland 
Executive, 2009; National Public Health Services for Wales, 2009).  Uptake of the HPV 
vaccine in the first year of the ‘catch-up programme’ was considerably lower, with 31.8% 
of girls born between 1st September 1990 and 31st August 1991 receiving all three doses.  
Just over 54% received the first two doses of the vaccine. 
 
In the USA the vaccine is not being delivered in schools.  In 2008, 37.2% of eligible 13–17 
year old Americans had initiated the three dose vaccination series and 17.9% had 
completed it (Centers for disease control, 2009).  In Australia the vaccine is being delivered 
in schools.  In the first year of this programme between 75 and 80% of 11-12 year old girls 
received the vaccine, varying by state and territory (Shefer et al., 2008).  In Canada, one 
study has suggested that uptake of the HPV vaccine has been lower than for other vaccines 
offered during adolescence.  Ogilivie et al. (2010) reported that 65% of 11-12 year olds in 
                                            
3 Bassetlaw PCT in the East Midlands reported three-dose uptake as .03% but this is likely to be due reporting 
or implementation differences by the PCT rather than decisions of parents not to vaccinate. 
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British Colombia had received the HPV vaccine, compared with 88% and 87% who had 
received the Hepatitis B vaccine and Meningitis C vaccine respectively. 
 
The HPV vaccination in the UK in context 
Accompanying the introduction of the HPV vaccine, the Department of Health in England 
dedicated resources to raising awareness of the vaccine to parents and girls themselves and 
promoting its use.  Television and radio advertisements were broadcast, leaflets were 
distributed, and poster advertisements were displayed in prominent places such as bus 
stops.  Girls were also encouraged to set up text message reminders for each vaccination 
dose.  Similar campaigns were launched in Scotland, Wales and Northern Ireland. 
 
In August 2008, one month prior to the introduction of the HPV vaccine in the UK, a 
reality television personality, Jade Goody, received a diagnosis of cervical cancer live on 
television.  A television programme documented Jade’s life in the following months, 
filming her learning that the cancer had metastasised and covering events right up until her 
death in March 2009.  Newspapers, magazines and other television programmes also 
covered this news story.  Jade Goody was a highly visible individual to young women and 
her experience with cervical cancer was credited as the cause of an increase in cervical 
cancer screening attendance in 2008/2009, especially in younger age groups (The 
Information Centre, 2010a).  Her death was likely to have had a similar influence on HPV 
vaccination uptake, although figures were not available to confirm this. 
 
In contrast, in September 2009 a 14-year old girl from Coventry died after receiving the 
HPV vaccine (The Guardian, 2010).  Considerable media coverage raised the profile of this 
event and the immunisation programme was temporarily suspended in Coventry Teaching 
PCT.  Post-mortem examinations revealed that the girl had died from a malignant tumour in 
her chest and that the HPV vaccine had not contributed to her death.  This event is likely to 
have caused temporary or permanent concern about the vaccine and had the potential to 
affect vaccination uptake negatively. 
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Experience of childhood immunisation in the UK 
Given that the HPV vaccination has only recently been introduced, it is instructive to look 
at the experience of vaccines that are more established in the childhood immunisation 
programme, and the broader context of vaccination in the UK, to help understand problems 
that may be encountered with the introduction of a new vaccine.  Presently, a programme of 
11 vaccines is offered to children as part of the UK childhood immunisation schedule that 
provides protection from 11 illnesses (some of these are combined vaccines). The vaccines 
include: diphtheria, tetanus, acellular pertussis/inactivated polio vaccine/Haemophilus 
influenzae type b, DTaP/IPV/Hib; pneumococcal conjugate, PCV; meningitis C, MenC; 
measles, mumps and rubella, MMR and also now HPV.  Table 1.1 shows the uptake of 
these vaccines by 2 years of age.  Children are offered a booster dose of the tetanus, 
diphtheria and polio vaccine when they are age 13-18 and uptake of this booster dose 
would be a useful age-appropriate comparison with HPV uptake, however percentage 
uptake is not currently reported by the Health Protection Agency due to reporting issues 
and because it has been difficult to determine an accurate denominator as the vaccine can 
be received at any age between age 13 and 18.  As can be seen from Table 1.1, on the 
whole, uptake of these vaccines has been high, although MMR vaccination uptake is much 
lower. 
 
In 1998, a study was published in The Lancet that investigated chronic enterocolitis and 
regressive developmental disorder.  Although the authors did not link autism and the 
combined MMR vaccine in this paper, this interpretation was made by others, including in 
the media.  The study was subsequently discredited, and retracted by the journal in 2010.  
The media’s persistent and sometimes frenzied response to this study was significant in 
raising panic in parents.  In presenting a so-called, balanced argument, with the opinions of 
anti-vaccination groups as well as the medical establishments, parents were led to believe 
that there was uncertainty in the scientific community about the safety of the vaccine 
(Speers & Lewis, 2004).  There was a substantial fall in uptake of the MMR vaccine 
following the publication of this study: prior to its publication around 92% of 2 year olds 
were receiving the MMR vaccine; media coverage peaked in 2002, and in 2003/2004 only 
80% received the vaccine.  Over 10 years later still only 85% of infants have received the 
vaccine, short of the 90% uptake needed to ensure herd immunity.  This contrasts with 
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uptake of other childhood immunisations which are consistently above 90% (Health 
Protection Agency, 2010).  A similar case was seen with pertussis (whooping cough) 
vaccination in the UK (and internationally) in the late 1970s.  Following suggestions that 
the vaccine caused brain damage, uptake of this particular vaccine fell from around 80% to 
31% (Health Protection Agency, 2010) while uptake of other vaccines remained constant 
(around 80%).  Both instances illustrate the substantial impact that single issues, when 
given sustained media coverage, can have on the uptake of specific vaccines, with this 
effect being enduring. 
 
 
Table 1.1 - Completed primary courses at two years of age in England 2008/2009 (Health Protection 
Agency, 2010; The Information Centre, 2009a) 
 
 Diphtheria, tetanus, 
acellular 
pertussis/inactivated 
polio 
vaccine/Haemophilus 
influenzae type b 
(DTaP/IPV/Hib) 
Measles, mumps 
and rubella  
(MMR) 
Meningitis C  
(Men C) 
Pneumococcal 
conjugate           
(PCV) 
Uptake 94% 85% 92% 91% 
 
 
The role of health psychology in understanding HPV vaccination uptake 
Health psychologists have been involved in evaluating the psychosocial issues related to 
cervical cancer prevention for a number of years.  Research in this area has improved 
understanding of women’s experiences of participating in the different areas of cervical 
cancer prevention.  Such research has previously focused on HPV testing, cervical cancer 
screening and biobehavioural factors involved in preventing HPV infection and the 
development of high-grade disease (see Waller et al., 2004).  More recently, psychosocial 
research has examined parents’, non-parent adults’, healthcare professionals’ and girls’ 
attitudes and beliefs about HPV vaccination and vaccination uptake, and some of this 
research has been considered in more detail in a review of the literature in Chapter 2.  Not 
all eligible young women are taking up the opportunity to receive the vaccine.  In the UK 
specifically, previous events such as the MMR controversy, have raised a general distrust 
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of vaccinations and the introduction of a newly developed vaccine, especially one relating 
to a sexually transmitted infection, is likely to prove contentious.  Specific groups of 
individuals may remain unaware of, or have chosen not to, access vaccination health 
services based on their personal beliefs.  The health psychologists’ toolkit for improving the 
level of acceptance of cervical cancer vaccination is large.  Health psychologists can use 
scientific methodologies and theory to identify who is less likely to receive the HPV 
vaccine, investigate the reasons why, and implement interventions to increase its adoption 
or facilitate more informed decision making.  In this thesis a number of these tools have 
been used to help inform the wider picture of cervical cancer vaccination uptake and shall 
be considered in more detail in subsequent chapters. 
 
SUMMARY OF CHAPTER 1 
Cervical cancer affects over 2,000 women in England every year.  Most cases of cervical 
cancer are caused by the highly prevalent HPV.  Two vaccines have been developed to 
prevent infection with the two oncogenic types responsible for most cervical cancers and, 
along with a national cervical cancer screening programme, the HPV vaccine now forms 
part of the UK government’s cervical cancer prevention strategy.  The vaccine is most 
effective if received prior to infection with one of the virus types (usually equivalent to 
sexual debut) and as a result is now being offered to girls when they are in school-year 8.  
A two-year ‘catch-up’ programme is also making the vaccine available to all girls born 
after 1st September 1990 (2nd July 1990 in Northern Ireland).  In the first year of the 
vaccination programme uptake was high in the main programme, but far fewer girls in the 
‘catch-up’ programme received the vaccine.  Health psychology research will be useful in 
determining personal vaccination choices and why some girls are not receiving this vaccine 
in particular.  Such understanding will help in the design of interventions that may improve 
HPV vaccination uptake.  Chapter 2 reviews the recent empirical literature that has 
explored vaccination receipt in children, focusing on the children themselves and their 
parents and highlights factors that are likely to affect HPV vaccination receipt in the British 
immunisation programme.
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Chapter 2 - A literature review of factors associated with non-receipt of 
vaccines recommended in the UK childhood immunisation schedule and 
reasons that individuals give for not receiving these vaccines. 
 
INTRODUCTION 
To maximise the efficacy of HPV immunisation it is essential that uptake is high.  As 
detailed in Chapter 1, uptake of the HPV vaccine is suboptimal in some age groups and in 
some countries generally.  It is important to understand why this may be, and this was the 
main rationale for this review.  Since the HPV vaccine has been developed and introduced 
there have been a large number of studies examining vaccination uptake under various 
conditions, however given the novelty of the vaccine we may also be able to use research 
considering other, more established early childhood vaccinations to enhance our 
understanding of non-receipt of vaccinations.  There were three main questions that this 
review sought to answer: 
1. What factors are associated with the non-receipt of vaccines recommended in the UK 
childhood immunisation schedule? 
2. What factors are associated with parents’/girls’ intentions to not receive the HPV 
vaccine? 
3. What are the reasons that parents/girls give to explain why they have not received a 
vaccine recommended in the UK childhood immunisation schedule (intention not to receive 
or actual non-receipt for HPV vaccination)? 
 
At the outset it was important to consider the definition of vaccination non-receipt.  The 
literature uses a variety of terms to define when an individual has not received a vaccine: 
suboptimal compliance, incomplete immunisation, under-immunisation, not being up-to-
date with vaccinations, not having received any vaccinations, delayed vaccination and not 
intending to receive/consent to a vaccination.  Each of these terms has also been measured 
in a number of ways such as intention to receive a vaccine, completion of a treatment 
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regimen, initiation of a treatment regimen or delaying a recommended vaccine.  The 
literature also distinguishes between unvaccinated children and under-vaccinated children.  
Under-vaccinated children are those who have received at least one vaccine previously, but 
are not fully immunised.  This may be the result of deliberate non-receipt of one specific 
vaccine or because of practical barriers that prevent intentions to vaccinate being translated 
into behaviour.  Generally, under-immunised children come from more socio-economically 
deprived backgrounds (Smith et al., 2004b).  Unvaccinated children have not received any 
vaccinations; this may be because of total failure to engage with healthcare or an active 
decision by parents to not allow their child to be vaccinated at all.  Unvaccinated children 
tend to come from more affluent, well educated families (Smith et al., 2004b).  The term 
vaccination non-receipt is used in this review to encompass all variations on this term, but 
distinctions between measurement differences were highlighted where necessary. 
 
This review considered the role that individual-level factors play in influencing vaccination, 
however organised resistance to, and non-receipt of, vaccinations can also be highly 
influential and need to be acknowledged.  Organised anti-vaccination groups cannot be 
assumed to be representative of the opinions of parents but explorations of their stances and 
beliefs has helped understanding of the anti-vaccination positions that parents are exposed 
to.  Hobson-West (2007) identified two differing anti-vaccination group orientations: 
reformists and radicalists.  Reformist groups are often led by parents who have a personal 
belief that a vaccine has caused damage to their child and are more likely to be supportive 
of vaccination in general.  Radical groups are concerned with issues such as alternative 
health, personal empowerment and perceptions of unreasonable power held by 
pharmaceutical companies.  For example, vaccination non-receipt is seen by radicalists as 
an expression of the legal right not to vaccinate their children and is perceived as personally 
empowering.  Anti-vaccination groups tend to be small and are often run by one or two 
parents, but have the potential to reach large audiences.  Anti-vaccination stances have been 
evident since the early days of vaccination, but in the last 15 years, campaign groups 
opposing vaccination have again become prominent (Hobson-West, 2007). 
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Psychological theories relevant to vaccination decision-making 
Social cognition theories of health behaviour attempt to explain why individuals choose to 
adopt certain health behaviours and are useful in helping to explain vaccination decision-
making.  They are used extensively in health psychology with many of the concepts 
overlapping between theories.  Three prominent theories are discussed below. 
 
The Health Belief Model (HBM, Becker et al., 1977; Rosenstock, 1966) proposes that 
behaviour is informed by threat perceptions and behavioural evaluations (see Figure 2.1).  
It is principally an expectancy-value model and was first used to explain preventative 
behaviour.  Threat perceptions consist of perceptions of susceptibility and severity which 
are modified by sociodemographic factors and psychological characteristics (e.g. peer 
pressure).  Behavioural evaluations are estimations of the benefits and barriers to engaging 
in a behaviour.  Cues to action (triggers that inspire behaviour such as media campaigns) 
and the individual’s motivation to be healthful also determine behaviour. 
 
The model has been used to examine a variety of behaviours.  Abraham and Sheeran (2005) 
grouped them into preventative health (e.g. breast self examination, Norman & Brain, 
2005), sick role behaviours (e.g. insulin use in diabetic patients, Bond et al., 1992) and 
clinic use (e.g. preventive physician visits, Norman & Conner, 1993).  Cues to action and 
health motivation have been understudied empirically within the model, to the extent that 
Harrison, Mullen and Green (1992) did not include these concepts in their meta-analysis of 
the utility of the HBM.  Harrison et al. found significant but small correlations between the 
HBM components and behaviour (.15 for susceptibility, .08 for severity, .13 for benefits, -
.21 for barriers).  The model has been criticised for lacking specificity on how it should be 
operationalised, and although Becker suggested that the benefits component should be 
weighted against the barriers component, a formula describing how this should occur has 
not been developed (Abraham & Sheeran, 2005).  This has resulted in researchers using 
different interpretations of the model (a validated questionnaire does not exit) which has 
weakened its evidence base and the coherence and consistency of the model (Harrison et 
al., 1992).  The model also ignores social, cultural and emotional aspects of behaviour 
decisions.  In an attempt to update the model and improve its predictive utility, Rosenstock 
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et al. (1988) added ‘self-efficacy’, but again did not specify how it interacted with beliefs.  
Research has suggested that beliefs may indirectly affect self-efficacy which may then 
determine action (Schwarzer, 1992). 
 
 
Figure 2.1 - Health Belief Model.  Adapted from Abraham and Sheeran (2005) 
 
 
 
 
Protection Motivation Theory (PMT, Figure 2.2) was first developed by Rogers (1975; 
1983).  It attempts to explain individuals’ behavioural responses to fear messages.  The 
theory proposes that individuals appraise both the threat and the coping method available to 
them to deal with the threat.  These appraisals inform intentions (protection motivation) 
which directly affect behaviour.  Threat evaluations consider the individual’s perceived 
vulnerability to the threat, how severe they believe the threat is, and the level of fear 
aroused by the threat.  Coping evaluations take into account how effective the individual 
believes the response to be (response efficacy), their belief in their ability to engage in that 
response and their perceived costs of the response.  The theory has been used widely to 
explain behaviours, with two recent examples being exercise in coronary artery disease 
patients (Tulloch et al., 2009) and sun protective behaviours (Prentice-Dunn et al., 2009). 
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Milne, Sheeran and Orbell (2000) in their meta-analysis of studies that have used PMT 
found the theory to modestly predict behaviour.  Intentions to engage in a behaviour were 
correlated with threat and coping appraisals (vulnerability=.16, severity=.10, fear=.20, self-
efficacy=.33, response efficacy=.29 and response costs=-.34).  The model showed generally 
weaker associations with current behaviour (vulnerability=.13, severity=.10, fear=.26, self-
efficacy=.36, response efficacy=.17, response costs=-.32 and intention=.82) and was even 
less predictive of future behaviour (vulnerability=.12, severity=.07, fear=-.04, self-
efficacy=.22, response efficacy=.09, response costs=-.25 and intention=.40), although these 
correlations are on the whole higher than those reported for the HBM.  Coping appraisals 
had a greater predictive ability than threat appraisals.  Although the model has received 
some empirical support, some researchers have suggested that threat appraisals are only 
influential when the subject is novel to the individual and others have questioned the 
stability of the constructs over time (Boer & Seydel, 1995), although this is likely to be a 
criticism of all social cognition model constructs. 
 
 
Figure 2.2 - Protection Motivation Theory adapted from Boer and Seydel (1995) 
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The Theory of Planned Behaviour (TPB, Ajzen, 1985; Ajzen, 1988; Ajzen, 1991), an 
extension of the Theory of Reasoned Action (TRA, Ajzen & Fishbein, 1980; Fishbein & 
Ajzen, 1975), was also developed as an attempt to predict behaviour (Figure 2.3).  The 
model proposes that intentions are the most proximal determinants of behaviour.  Intentions 
are themselves informed by salient attitudes (beliefs about the behaviour), subjective norms 
and perceived behavioural control (PBC, how much control the individual believes they 
have over enacting the behaviour).  PBC is similar to Bandura’s construct of self-efficacy 
(1982) and is itself also a direct determinant of behaviour.  These three determinants of 
intention each are influenced by additional constructs.  Attitudes are informed by 
behavioural beliefs (belief that performing the behaviour could lead to some consequence) 
and evaluations of the consequences.  Subjective norms are determined by normative 
beliefs (whether the individual believes that significant others would want them to adopt 
the behaviour multiplied by their motivation to comply with this individual’s beliefs).  PBC 
is determined by the individual’s evaluation of their external and internal resources, for 
example opportunities and skills.  Other determinants of behaviour such as demographics 
affect behaviour through the TPB components.  Since its development, researchers have 
suggested adding a number of different constructs to the model, such as anticipated regret 
(Richard & van der Pligt, 1991), self-identity (Sparks & Shepherd, 1992), moral norms 
(Sparks, 1994) or past behaviour (Bentler & Speckart, 1979).  Researchers have also 
replaced intentions with self-predictions in some studies (Sheppard et al., 1988), while 
others have suggested that attitudes inform desires which then determine intention 
(Bagozzi, 1992). 
 
The model has been used widely to predict behaviour, such as studies investigating condom 
use (Gredig et al., 2007), pain relief use during childbirth (Williams et al., 2008) and 
smoking cessation (Rise et al., 2008).  Armitage and Conner’s meta-analysis of studies that 
have used the TPB found the model to account for 27% of variance in behaviour and 39% 
of variance in intention (Armitage & Conner, 2001).  Correlations between the constructs 
ranged from .34 (subjective norm-intention) to .63 (combination of attitude, subjective 
norm and PBC on intention).  The strongest individual correlation was for control beliefs 
informing PBC (.52).  Subjective norm was found to be the weakest construct but the 
authors suggest that this was due to poor measurement.  The model was most accurate 
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when behaviour was measured objectively.  Finally the theory has been criticised as the 
ordering of beliefs and the direction of causality is not specified (Schwarzer, 1992). 
 
Figure 2.3 - Theory of Planned Behaviour adapted from Conner and Sparks (1995) 
 
 
 
Rarely has research compared the efficacy of the models in explaining behaviour.  Bish et 
al. (2000) found both the TPB and HBM to be equally poor in predicting future cervical 
screening attendance, however the TPB was superior in predicting behavioural intentions.  
The model-specific meta-analyses reported in this section suggest that the TPB and PMT 
are more strongly associated with behaviour and behavioural intentions than the HBM.  The 
HBM is likely to be the weakest of the three social cognition models, although comparisons 
between meta-analyses are purely descriptive. 
 
Social cognition models such as the ones described above have been criticised for assuming 
that behavioural decision making is rational and logical, however the concepts are useful to 
help understand behaviour.  The theoretical concepts from these models were used in this 
review to draw together some of the factors identified to be important in determining 
vaccination non-receipt to see how the factors fit with theories of health psychology and the 
pathways of association that they propose. 
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This systematic review of the literature was designed to answer the three research questions 
outlined at the beginning of this chapter: 
1 What factors are associated with the non-receipt of vaccines recommended 
in the UK childhood immunisation schedule? 
2 What factors are associated with parents’/girls’ intentions to not receive the 
HPV vaccine? 
3 What are the reasons that parents/girls give to explain why they have not 
received a vaccine recommended in the UK childhood immunisation 
schedule (intention not to receive or actual non-receipt for HPV 
vaccination)? 
 
METHOD 
This systematic review followed the Cochrane guidelines for conducting systematic 
reviews (Higgins & Green, 2009). 
 
Inclusion criteria (Table 2.1) 
Falagas & Zarkadoulia (2008) published a systematic review of factors associated with 
suboptimal compliance of childhood immunisations in developed countries.  This review 
sought to add to their findings (which will be discussed) by including all articles published 
after 31st January 2005 (Falagas et al.’s last search date).  Articles were included if they 
statistically examined the factors associated with non-receipt of vaccinations that are 
currently part of the UK childhood immunisation schedule4 in children/adolescents (for 
review question 1 and 2) or reported the reasons for non-receipt of vaccinations currently 
part of the childhood immunisation schedule in children/adolescents (for review question 
3).  Although the vaccines of interest were ones included in the UK schedule, studies were 
included if they were conducted outside of the UK if they focused on these vaccines.  
Articles were included if their participants were parents of children under the age of 18 (or 
                                            
4
 DTaP/IPV/Hib (diphtheria, tetanus, acellular pertussis/inactivated polio vaccine/Haemophilus influenzae 
type b), PCV (pneumococcal cojugate), MenC (meningitis C), MMR (measles, mumps and rubella), HPV 
(human papillomavirus). 
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parents of daughters under the age of 18 for HPV) or children/adolescents under the age of 
18 (or girls under the age of 18 for HPV).  Articles were included if some of their 
participants were outside of these inclusion criteria so long as the desired participants were 
also in the sample.  For example a sample may have examined girls and women up to the 
age of 26 or HPV vaccine analysis may have used parents of sons and daughters, or some 
of the sample may have responded about a hypothetical child.  Legal guardians were 
considered to be parents.  Articles that examined intentions not to receive vaccinations were 
excluded apart from those that considered HPV vaccination5.  Papers reporting the findings 
of qualitative studies must have detailed the reasons for vaccination non-receipt in 
participants who had previously not received the vaccine (or intended not to for HPV 
vaccination).  Articles were excluded if they were not published in English, not published 
in peer review journals, were conference abstracts or editorials, if the participants had 
underlying health conditions, if they only reported the results of an intervention aimed to 
reduce vaccination non-receipt or studies that were conducted in developing countries.  
Reviews were also excluded from the main review but were discussed at the end of this 
review. 
 
This review only reported the univariate findings of the included studies as its aim was to 
solely identify the factors that have been shown to be associated with vaccination non-
receipt.  Multi-variable analyses were defined as those analyses that had included more than 
one independent variable in the statistical model at the same time.  In these models the 
statistical results would have been adjusted for all independent variables that were in the 
model.  Studies that employed multiple-variable tests will each have adjusted for different 
factors making comparisons between studies difficult, impossible or unhelpful.  Theories of 
social cognition from health psychology may be useful to help illustrate the pathways 
through which the factors identified in this review work to affect vaccination non-receipt 
and they shall be used in the discussion section for this purpose. 
                                            
5
 As HPV vaccination has only recently become available much of the research in this area has only 
considered intentions not to receive the vaccine.  It is established that intentions do not always reflect 
behaviour (Sheeran, 2002) and so their use in predicting vaccination non-receipt is not optimal.  Intentions 
were not assessed for more established vaccines in the childhood immunisation schedule as they have been 
available for a sufficient length of time for research to consider actual vaccination non-receipt. 
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Table 2.1: Inclusion and exclusion criteria 
 
 Inclusion criteria Exclusion criteria 
Focus Statistical associations with non-receipt of a 
vaccine in the UK childhood immunisation 
schedule or reported reasons for not receiving 
a vaccine in the childhood immunisation 
schedule. 
Reported an evaluation of an intervention 
only. 
For qualitative studies: 
Parents who have not refused 
vaccination/intend to refuse the HPV 
vaccination 
Outcome Actual vaccination non-receipt 
Intention to refuse the HPV vaccine 
Reasons given for actual vaccination non-
receipt or intention to refuse the HPV vaccine 
Intention to receive any vaccine (other than 
HPV) 
Only reported multi-variable analysis 
Article type Primary research article in peer reviewed 
journals. 
Editorial, review, conference abstract 
Participants Conducted in developed countries 
For all childhood vaccines: 
Parents of children under the age of 18 
Children under the age of 18 
For HPV vaccine: 
Parents of daughters under the age of 18 
Girls under the age of 18 
Children sampled primarily because of an 
underlying health condition 
For HPV vaccine: 
Parents of sons only 
Only parents of daughters who are over the 
age of 18 or their age not reported. 
 
Search strategy 
The following databases were searched for this review: Embase, Medline, Web of 
Knowledge, Cumulative Index to Nursing and Allied Health Literature, Psyc Info, 
Cochrane Database of Systematic Reviews (CDSR) and Health Management Information 
Consortium.  Following a basic search using key words from the review questions, five 
categories of terms were chosen to be used in the database searches based on the MeSH 
terms from the articles retrieved.  These categories were broadly: 1) intention or patient 
acceptance of health care, 2) adolescence or infancy, 3) immunisation, 4) demographics and 
5) predictors.  The terms in these categories were adapted to meet the unique thesaurus or 
subject headings for each database and truncations and wildcards used (see Appendix 1 for 
the detailed search terms used).  The search was pre-tested and refined to ensure that 
relevant articles were retrieved.  The search was restricted to articles published post-
January 2005 and yielded 989 articles.  The reference lists of the reviews identified in the 
main search were also searched to identify any articles that should also have been included; 
this yielded 47 extra articles.  The last search was conducted on 17th May 2010.  See Table 
2.2 for the number of articles excluded and the reasons for exclusion and Appendix 1 for 
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the number of articles downloaded from each database and Appendix 2 for a reference list 
of the final articles included in the review. 
 
Table 2.2: Number of articles excluded and reasons for exclusion. 
 
Reason for exclusion Frequency (original N=989) 
Did not examine the predictors of vaccination acceptance/off-topic 274 
Did not examine parents who have decided against vaccination 1 
Was an evaluation of an intervention 7 
Examined a vaccine that is not in the UK childhood immunisation schedule 250 
Examined intentions to refuse a vaccine (not HPV) 3 
Was not peer reviewed 9 
Did not examine parents/girls as participants 56 
Was not conducted in a developed country 125 
Sample participants primarily because of an underlying health condition 13 
Qualitative study not looking at those who have refused a vaccine (or intend to) 3 
Duplicate 154 
Published pre-2005 22 
Reported data repeated from another article included in the review 1 
Review/editorial that considered <3 studies 8 
Paper arising from data in this thesis 2 
Reported multi-variable findings only 9 
Not enough information provided to locate the article 1 
 
Data extraction 
A standardised data extraction form was used to extract the information for review (see 
Appendix 3 for an example of a completed data extraction form).  Each article was given a 
unique ID number.  The author, title, year of publication was extracted.  In the methods 
section, the following information was extracted: definition of non-receipt, vaccine of 
interest, whether the study was powered to detect a small, medium or large effect size, 
whether the study was prospective, whether validated measures were used, the 
measurement of vaccination non-receipt and intention, whether piloting occurred and how 
qualitative data were analysed.  Information about the participants that was extracted 
included: the child’s gender, average age of the child, who the respondent was, sample size, 
recruitment site, response rate, country of study.  From the results, I extracted the average 
socioeconomic status of the sample, the most common ethnicity, the factors that were 
considered to be associated with non-receipt, univariate findings, non-significant findings 
and qualitative findings. 
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Assessing the methodological quality within studies 
Methodological limitations allow bias to be introduced into results.  The greater the bias the 
less confident we can be that the results are accurate and could be replicated.  By assessing 
the quality of the methodology of studies included in reviews we can judge whether our 
conclusions are likely to reliable and we can place greater weight on the findings of studies 
that are considered to be methodologically stronger in informing our conclusions.  A 
number of tools are available to aid assessment of methodological quality, for example 
Scottish Intercollegiate Guidelines Network, SIGN; Oxford Centre for Evidence-Based 
Medicine, OCEBM; the National Service Framework, NSF, and US Preventive Services 
Task Force (Atkins et al., 2001; Ball et al., 2009; Petrie et al., 1995; Turner-Stokes et al., 
2006).  The NSF tool is recommended for psychometric studies (NHS Plus & The Clinical 
Effectiveness Forum, 2009), but it was deemed not to be rigorous enough for the present 
review.  Atkins et al. (2004) note that no tool is appropriate for use with every target group 
and every review will value certain methodological aspects more than others.  As a result, 
guidelines recommended by the Cochrane Handbook for Systematic Reviews of 
Interventions (Higgins & Green, 2009) and existing quality assessment tools including the 
NSF, were adapted and used for this review based on informed judgment.  For this review, 
methodological quality was assessed by taking into consideration the quality of six aspects 
of study methodology: study design, response rate, study power (for quantitative studies), 
piloting, how the outcome was measured and the quality of qualitative analysis conducted 
(for qualitative studies). 
• Study design:  For this review prospective studies were considered the most 
appropriate choice for considering the predictors of vaccination acceptance.  Prospective 
studies are more informative about causation.  Furthermore recall bias is likely to hinder the 
reliability of retrospective studies.  A score of 1 for methodological quality was assigned to 
prospective studies and 0 for all other designs. 
• Response rate:  Low response rates provide more opportunity for the introduction of 
bias as non-responders may differ from responders.  If a large proportion of a population is 
not included in a study we cannot be certain that the results are generalisable to that 
population or to similar populations.  Response rates greater than 50% were assigned a 
score of 1 and those below 50% scored 0.  Studies that used all patient records from a 
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particular population (and so response rates were not applicable) were also given a score of 
1. 
• Power:  In order for studies to be able to detect significant differences between 
groups they must be powered sufficiently.  The level of power that was considered 
appropriate for the types of studies in this review was determined by looking at the effect 
sizes reported by a selection of studies used in Falagas and Zarkadoulia’s (2008) review.  
Effect sizes in these studies were often small, especially for attitudinal variables, it was 
likely that this would be the case for studies in the present review.  Assuming 80% power 
and an alpha of .05, 395 participants would be needed to detect a small effect size, 55 
participants needed to detect a medium effect size and 25 participants needed to detect a 
large effect size.  As a consequence, studies with >395 participants were given a score of 1 
and studies not powered to detect small effect sizes scored 0.  The total sample size 
reported was used when assessing power, rather than sample size reported for the different 
tests as sample sizes varied between statistical tests in the same article. 
• Piloting:  Piloting ensures that a study is as methodologically strong as is possible 
and helps ensure that the results represent what researchers intended to investigate.  Studies 
that piloted their methodology prior to the main study were assigned a score of 1, and those 
that did not were given a score of 0. 
• Measurement of the outcome:  Investigations of vaccination acceptance tend to use 
either self-report or review of medical records (Falagas & Zarkadoulia, 2008).  Self-report 
is subject to recall bias and often requires individuals to remember which vaccinations were 
received years previously.  There are a number of vaccinations in the childhood 
immunisation schedule, making parent recall even more difficult.  Medical records, 
although not perfect (Harrington et al., 1995; Jefferies et al., 1991; Salmon et al., 2005; Wei 
et al., 2009), are documented statements of vaccination receipt made at the time of 
vaccination and are likely to be more accurate, and therefore introduce less error into the 
results.  Studies using objective measures of vaccination receipt were given a score of 1 and 
studies using self-reported measures were given a score of 0.  For studies in which intention 
to vaccinate was the outcome, studies that reported an intention measure that was judged 
appropriate were given a score of 1.  Studies that did not report the intention measure used 
or that used a measure that was considered inappropriate were given a score of 0.  
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Inappropriate intention measures were ones which were not specific enough to ensure that 
measurement did not contain a high degree of error. 
• Quality of the qualitative analysis: qualitative analysis is inherently subjective, but 
techniques can be employed to improve the methodological rigour and ensure that 
interpretations are warranted.  Such techniques include using multiple raters to analyse the 
data (and reporting concordance between raters), using a coding frame to ensure 
consistency throughout analysis, and using a formal analytic method (such as discourse or 
framework analysis).  Studies that had employed such techniques were given a score of 1 
and all others were given a score of 0. 
 
Study quality was determined by summing the quality scores and categorised using 
definitions recommended by the Cochrane Handbook for Systematic Reviews of 
Interventions (Higgins & Green, 2009): 
• High: All or most of the quality indicators were met, and if they were not, the 
conclusions of the study were thought very unlikely to alter (score of 4 or 5).  
Methodologically strong. 
• Moderate: Some of the quality indicators were met and where they were not, or 
were not adequately described, the conclusions of the study were thought unlikely to alter 
(score of 2 or 3).  Methodologically strong in some areas. 
• Low: Few or none of the study indicators were met, or were not adequately 
described and the conclusions of the study were thought likely or very likely to alter (score 
of 0 or 1).  Methodologically weak. 
 
Reporting and interpretation of findings 
This review did not take into account results when the direction of findings or the details of 
findings were not reported.  Often studies grouped all early childhood vaccinations together 
(DTaP/IPV/Hib, PCV, MenC, MMR) for this reason these vaccinations were grouped 
together for the purpose of this review, unless an individual vaccine was specified.  HPV 
was not included in this group as it was the main focus of this thesis.  The ID number for 
each study that considered each factor was provided in brackets in the results section.  In 
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the tables, the study ID number has been formatted according to the quality of that study: 
underlining indicates high quality, bold indicates medium quality and no formatting 
denotes low study quality.  Assessments of the methodological quality within studies were 
used in part to draw conclusions about the strength of the evidence across studies.  The 
following interpretations were made following the approach and definitions used by the 
Cochrane handbook (Higgins & Green, 2009): 
• Low risk of bias: Most information is from studies at low risk of bias (high quality).  
Plausible bias unlikely to seriously alter the results. 
• Unclear risk of bias: Most information is from studies at low or unclear risk of bias 
(moderate quality).  Plausible bias that raises some doubt about the results. 
• High risk of bias: The proportion of information from studies at high risk of bias is 
sufficient to affect the interpretation of results (low quality).  Plausible bias that seriously 
weakens confidence in the results. 
 
RESULTS 
The results were discussed by each review question separately, followed by a discussion of 
existing reviews of the literature. 
 
Description of the studies 
In total 88, empirical studies were included in this review (n=64 for review question 1, 
n=36 for review question 2, n=33 for review question 3) and there were 10 existing 
reviews.  A minority of studies reported both qualitative and quantitative findings.  Of the 
studies considered for review question 1, 39 explored vaccination receipt, 16 looked at 
vaccination completion and nine examined delayed vaccination; a minority of studies 
considered more than one definition of vaccination non-receipt or actual non-receipt and 
intentions.  HPV vaccination was the vaccine of interest in 56 studies, other childhood 
vaccinations were considered in 32 studies and one study examined both types of vaccines.  
Most of the studies were of medium quality (n=54 quantitative studies and n=22 qualitative 
studies); there were a small number of low quality studies (n=13 quantitative studies and 
n=11 qualitative studies) and even fewer high quality studies (n=5 quantitative studies and 
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n=0 qualitative studies).  Studies were performed in 17 countries; the majority came from 
the USA (n=50), 19 were conducted in the UK, three in Italy, two from Australia and The 
Netherlands, and a single study was performed in the remaining countries (Belgium, 
Canada, Denmark, Finland, Germany, Greece, Israel, Japan, Spain, Sweden, Switzerland 
and New Zealand). 
 
Participants were recruited from schools, medical centres (either in person or their medical 
records used), national samples (whole year cohorts and random samples), community 
centres and from previous studies and nurseries.  Snowballing sampling was also used for 
qualitative studies.  Vaccination receipt was measured by self-report in most cases but some 
studies used objective measures such as medical records and others validated a proportion 
of self-reported vaccination statuses using medical records. 
 
Description of the populations studied 
Often an age range for the target child was provided rather than a mean age.  The mean for 
these age ranges was taken, and along with studies that provided an actual mean age, the 
mode age was calculated.  The most common age of the target child was 11 years.  Varying 
measures of family socio-economic status (SES) were used.  For measures of highest level 
of parental education the most common academic achievement was a high school education 
or greater (n=12), for measures of wealth the most common outcome was being privately 
insured for healthcare (n=3).  Often a range of incomes were provided when reporting SES, 
making it difficult to estimate the most common income, a crude estimate was that most 
participants earned over $50,000 per year.  In around one third of cases, ethnicity was not 
reported (n=32) and in over half of the studies that did report ethnicity the most common 
ethnic group was white (n=35).  Most studies were conducted with mothers and fathers 
(n=45).  Twenty-one studies investigated the child/adolescent themselves and 23 studies 
looked at just mothers.  A number of studies looked at both adolescents/children and 
parents and no study investigated fathers only. 
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Review question 1:  What factors are associated with the non-receipt of vaccines 
recommended in the UK childhood immunisation schedule? 
 
Demographic characteristics (Table 2.3) 
Associations between ethnicity and receipt of both childhood vaccines and HPV were 
considered in 21 studies conducted in a number of countries, with 16 reporting significant 
findings.  Minority groups were most likely to have refused vaccinations in some studies 
(8, 102, 26, 37, 32, 54, 63, 86, 107, 63, 106; see Appendix 2 for reference list of included 
articles) but not all (12, 30, 92, 42, 78), and most were of medium quality indicating an 
unclear risk of bias for the overall finding.  There was an unclear risk of bias for the six 
non-significant studies (42, 45, 59, 75, 87, 93).  This evidence suggests that ethnic minority 
groups are possibly more likely to have refused vaccination. 
 
Various forms of SES were considered including income, postcode level data and 
attendance at a state versus public school in 16 studies.  Positive, negative and non-
significant relationships were found for both childhood vaccines and HPV specifically; all 
of these relationships had an unclear risk of bias.  Three studies found less deprived 
participants to be more likely to be unvaccinated (26, 30, 102), eight medium quality 
studies found more deprived participants to be more likely to be unvaccinated (8, 12, 22, 
26, 47, 63, 102, 113) and five studies reported non-significant findings (54, 87, 92, 93, 
105).  The evidence for SES is unclear. 
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Table 2.3: Demographic findings for research question 1 (n=low quality, n=medium quality and n=high quality) 
Factor (if yes/no, 
yes=high) 
Positive association 
(high factor = more 
likely unvaccinated) 
Negative association (low 
factor = more likely 
unvaccinated) 
Direction cannot be assigned Non-significant 
result 
Ethnicity   Ethnic minority school: 8, 102; non-Hispanic: 12, 30, 92; non-
white: 26, 37, 47;  Maori/New Zealand European: 32; Do not 
live in Northern Ireland: 42; Moroccan: 54; Black: 63, 86, 107; 
Asian: 63; Unknown/other ethnicity: 63; Hispanic: 63, 86; not 
Black: 78, ethnic minority: 106 
42, 45, 59, 75, 87, 93 
SES 26, 30, 102 8, 12, 22, 26, 47, 63, 102, 
113 
 54, 87, 92, 93, 105 
Education 26, 42, 46, 103 12, 31, 45, 47, 62, 63, 
106, 113 
 36, 59, 62, 92, 93, 
105 
Child age 62, 63, 89 12, 73, 75, 78, 79, 93, 108  45, 54, 78, 84, 86, 93 
Parent age 12, 26, 42, 46, 62 28, 42, 47, 105, 106  10, 42, 36, 45, 59, 92, 
93, 103, 106 
Was child the first 
born? 
 10, 36, 44, 47  26 
Religion 
  
 92, 103 
Marital status 
  
Not married: 26; Single parent: 31, 42, 62 92, 93 
Parents' employment   Mother returned to work within 12 weeks of birth: 6; Mother 
working: 36; Mother self-employed: 42; Mother unemployed: 
42, Parents not employed: 93 
 
Child's gender 
  
Male: 42; Female: 62 26, 31, 37, 44, 54, 
106, 108 
Parents' gender 
  
Mother: 107 75, 93 
No. children in family 103, 106, 113   26, 59, 93 
Family make-up 
 
 Traditional family set-up: 103 45 
Native speaker of 
country? 
 31, 93  42 
Native to the country 
of study? 
 54, 106  62, 92, 103 
Region of residence 
  
Live in rural location: 113, 93 75, 87, 93, 106 
Relationship of 
guardian to child 
  
 92 
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The evidence was similarly unclear for degree of education, child’s age and parent’s age.  
For degree of education, the evidence had an unclear risk of bias and positive (26, 42, 46, 
103), negative (12, 31, 45, 47, 62, 63, 106, 113) and non-significant (36, 59, 62, 92, 93, 
105) results were reported for studies conducted in numerous countries that considered 
childhood vaccinations and HPV vaccination.  Child’s age showed positive (62, 63, 89), 
negative (12, 73, 75, 78, 79, 93, 108) and non-significant (45, 54, 78, 84, 86, 93) 
associations with vaccination non-receipt and all of these relationships had an unclear risk 
of bias.  These studies considered both HPV and childhood vaccinations generally, and 
were mainly conducted in the USA.  Evidence for parent’s age had an unclear risk of bias, 
considered both childhood vaccines and HPV vaccination and studies were conducted in a 
number of countries.  Positive (12, 26, 42, 46, 62, 62), negative (28, 42, 47, 105, 106) and 
non-significant (36, 45, 59, 92, 93, 103, 106, 10, 42) associations were reported between 
parents’ age and vaccination non-receipt.  Religion was not associated with vaccination 
non-receipt in two studies (92, 103; n=1 medium quality and n=1 low quality). 
 
Children who were not the first born in their family appeared to be more likely to be 
unvaccinated for childhood vaccinations (10, 36, 44, 47, all medium quality studies), 
although one non-significant finding was reported (26).  Parental employment in most 
studies was shown to be associated with non-receipt of childhood vaccinations (6, 36, 42), 
but parental unemployment was only associated with HPV vaccination non-receipt in one 
study of medium quality (93); the level of bias for these findings was unclear.  Being an 
unmarried or single parent appeared to be associated with non-receipt of childhood 
vaccinations (26, 31, 42, 62), although there was an unclear risk of bias for this finding.  
Marital status was not associated with HPV vaccination receipt in two American studies of 
medium and low quality (92, 93). 
 
The evidence suggested no role for the child’s gender as the majority of studies showed no 
associations between child’s gender and childhood vaccination non-receipt (26, 31, 37, 44, 
54, 106, 108) and this had an unclear risk of bias.  One study of high quality found males to 
be more likely to be unvaccinated (42) and one study of medium quality reported the 
opposite (62).  One medium quality study found the gender of the parent to be associated 
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with receipt of childhood vaccines (107) and two medium quality studies found the gender 
of the parent to not be associated with receipt of the HPV vaccine (75, 93), suggesting that 
the evidence for the role of parents’ gender is uncertain.  One American study (low study 
quality) did not find there to be an association between the relationship of the primary 
caregiver to the target child (e.g. foster mother, grandmother) and HPV vaccination receipt 
(92).  One Canadian HPV vaccination study (medium quality) found children from 
traditional family set-ups to be more likely to be unvaccinated (103), but another study (45, 
medium quality) found family cohesion not to be related to receipt. 
 
Three medium quality studies showed a positive relationship between number of children in 
the household and likelihood of childhood vaccine and HPV vaccine non-receipt (103, 106, 
113), although three medium quality studies found no association for childhood vaccination 
(26, 59, 93), meaning that the evidence for this factor is uncertain.  The significant studies 
were conducted in Canada, Belgium and Greece, whereas the non-significant studies were 
performed in the UK and USA, although this does not provide a clear explanation for the 
difference in findings. 
 
Participants who spoke a language that was not the official language of the country where 
they lived were at an increased likelihood of not receiving either the HPV vaccine or 
childhood vaccines in two studies of medium quality (31, 93), but not in one high quality 
British study exploring MMR vaccination receipt (42).  Not being born in the country that 
the study was conducted in was also shown to increase the likelihood that childhood 
vaccines were not received in two medium quality studies (54, 106) but not in three studies 
(n=1 low quality) exploring both childhood vaccines and HPV vaccine receipt (62, 92, 
103).  The evidence for the role of country of origin and mother tongue was unclear. 
Two medium quality studies investigating childhood vaccines and the HPV vaccine found 
that participants who lived in rural locations were less likely to be vaccinated (113, 93) but 
four studies similarly of unclear bias found non-significant results (75, 87, 93, 106), 
meaning that definite conclusions cannot be drawn. 
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Summary of demographic findings 
All the findings for demographic characteristics were of medium quality had an unclear risk 
of bias and no factor had an indisputable relationship with vaccination non-receipt.  The 
findings were more conclusive for childhood vaccinations than for HPV vaccination.  Some 
evidence suggested that minority ethnic groups may be at a greater risk of being 
unvaccinated with all vaccines, as are children with unmarried or single parents (although 
not for HPV vaccination).  Children of employed parents may be less likely to receive 
childhood vaccinations as may non-first born children.  It is likely that there is no 
relationship between the gender of a child and their vaccination status for childhood 
vaccinations. 
 
Practical factors (Table 2.4) 
Four studies reported significant findings concerning the type of clinic that a child was 
recruited from and had an unclear risk of bias (3, 12, 46, 113); however there was no 
consistency in the definitions used to describe each clinic, or in which clinic vaccination 
non-receipt was highest.  There is likely to be a relationship between clinic type and 
vaccination status but more research is needed. 
 
Need for more information showed positive relationships with non-receipt of childhood and 
HPV vaccination in these studies (23, 65, 106), but and also negative (10, 23) and non-
significant relationships (23, 106) for childhood vaccines.  All of these findings had an 
unclear or plausible risk of bias and the evidence for the role of this factor is unclear.  Two 
studies have considered the amount of information sought and its association with HPV 
vaccinations and childhood vaccinations.  Both found that children were more likely to be 
unvaccinated if more information had been sought (46, 74, n=1 of low quality and n=1 of 
medium quality). 
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Table 2.4: Practical factors for research question 1 (n=low quality, n=medium quality and n=high quality) 
Factor (if yes/no, 
yes=high) 
Positive association 
(high factor = more 
likely unvaccinated) 
Negative association (low 
factor = more likely 
unvaccinated) 
Direction cannot be assigned Non-significant 
result 
Clinic type 
 
 Non-school-based clinic: 3; Not paediatrician: 12; non-
physician 46;  nurse: 46; CAM: 46, vaccination-only clinic, 
non-well-baby clinic: 113 
 
Need more information 
about vaccine? 
23, 65, 106 10, 23  23, 106 
Format of the 
information 
46, 74 46, 47, 79, 87  23, 46 
Usefulness of 
information gained 
 
46, 47, 74, 79  46, 74, 79 
Amount of information 
sought 
46, 74    
Length of time registered 
at clinic 
 12   
Easy access to the clinic? 
 106, 108  87, 92, 93 
Child unwell? 47, 78, 86   36 
Health insurance status 
  
Having public health insurance: 37; 86.  Not being insured: 37, 
89, 105; Not private health insurance: 47, 78; do not believe 
vaccine is covered under insurance: 75; Not having public 
insurance: 78 
63, 93, 106 
Was there a vaccine 
shortage? 
37    
Vaccination experience 
  
106: Unfriendly staff 89 
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Six studies considered the format of the information that participants reported using.  Often 
only one study considered each format and on no occasion did two studies explore the same 
format and report the same finding, meaning that the evidence is uncertain.  The studies 
were all of medium or low quality indicating that in addition to the weak evidence the risk 
of bias was unclear or plausible.  Children were found to be more likely not to have 
received childhood vaccines or the HPV vaccine if their parents gained information from 
professional organisations, pharmaceutical companies, charities, religious leaders, 
friends/family, the internet, information evenings, government or the media (46, 74).  
Children were also more likely to be unvaccinated if their parents had not used the media 
for information, as well as if they had used healthcare professionals, leaflets or their child’s 
school (46, 47, 79, 87).  Finally non-significant results were reported for whether a parent 
had used the government for information, healthcare professionals or pharmacists (46, 23). 
 
Four studies explored the usefulness of the vaccine information used by participants and its 
association with HPV vaccines and childhood vaccines.  Negative and non-significant 
findings were reported, suggesting that parents who find information useful are unlikely to 
refuse vaccination.  Participants who perceived the information gained from information 
sheets, pharmaceutical companies, charities, professional organisations, the government or 
healthcare professionals to be less useful were more likely to have children who were not 
vaccinated (74, 79, 46, 47).  Non-significant effects were also reported for information 
sheets, as well as for the usefulness of the media, religious leaders and friends/family (46, 
74).  Again, each information format was considered once by one study meaning that 
definite conclusions cannot be made. 
 
One medium quality HPV vaccination study conducted in the USA reported that 
adolescents who had been registered at the study clinic for a short period of time were more 
likely to be unvaccinated than those who had been registered for a longer period of time 
(12).  One study examined the impact of a vaccination shortage on childhood vaccination 
receipt and reported both non-significant and significant findings (37).  Two medium 
quality studies considering childhood vaccines found participants to have not received the 
vaccine if they did not have easy access to a vaccination clinic (106, 108), but three studies 
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reported non-significant findings (one of low quality, two of medium quality, 87, 92, 93).  
This evidence suggests that parents who have easy access to clinics are unlikely to have not 
accepted a vaccine for their child, but the evidence is unclear when access is more 
problematic. 
 
The health of the child at the time of vaccination was considered in four studies, including 
the reason that the child was attending the clinic and the child having allergies.  Three 
American studies, all of medium quality, found poor health to be related to non-receipt of 
childhood and HPV vaccines (47, 78, 86) but one medium quality Japanese study found no 
relationship for measles vaccination (36).  This evidence suggests a potential role for poor 
health.  Past vaccination experience including pain at last vaccination and perceiving 
vaccination staff to be unfriendly were found to be both associated (106) and not associated 
(89) with childhood and HPV vaccination receipt in two medium quality studies, limiting 
conclusions from being drawn. 
 
Not having health insurance (or being unsure of health insurance status) increased the risk 
of being unvaccinated for childhood and HPV vaccines in seven studies and this finding 
had an unclear risk of bias (37, 86, 89, 105, 47, 78, 75).  Three medium quality studies 
reported non-significant findings for health insurance (63, 93, 106).  The evidence suggests 
that those without health insurance are probably more likely to have not received a vaccine. 
 
Summary of practical factor findings 
No high quality study considered relationships between practical factors and vaccination 
non-receipt.  No one factor showed a conclusive relationship with vaccination non-receipt 
and all findings had an unclear risk of bias.  A number of factors were only considered in a 
few studies.  Clinic type does appear to relate to vaccination receipt but a lack of 
consistency in defining clinic types means that this finding cannot be expanded.  There is a 
potential relationship between a need for more information and HPV vaccination, although 
weak evidence suggests that children are more likely to be unvaccinated if more 
information has been sought.  It is possible that a child with sub-optimal health at the time 
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of a clinic visit may be more likely to remain unvaccinated.  Finally, children without or 
perceived to be without health insurance are more likely to have not received a vaccine. 
 
Lifestyle choices, past behaviour and past health outcomes (Table 2.5) 
There is consistent evidence that parents who choose more ‘alternative lifestyles’ (use 
complementary and alternative medicine or send their child to an anthroposophic school for 
example) are more likely to have children who are unvaccinated with childhood vaccines 
(10, 46, 54, 62), although the risk of bias for this finding was unclear.  Positive (36), 
negative (108) and non-significant associations (31) have been found between whether a 
child went to nursery school and childhood vaccination receipt.  Consequently, the 
evidence for this factor is uncertain and all of the studies were of unclear risk of bias.  The 
majority of the evidence suggests that children who have not previously received 
recommended vaccines or who have ever had a vaccine deferred are less likely to have 
received HPV vaccination and other childhood vaccines (10, 37, 43, 62, 93, 102, 103), 
although four non-significant findings were reported (n=1 of low quality, n=3 of medium 
quality).  The risk of bias for these findings was unclear.  Mothers who are smokers have 
been shown to be more likely to have children who have not received the MMR vaccine 
(42, high quality study), although non-significant findings were reported in one low quality 
study examining HPV vaccination and smoking (87).  More high quality evidence is 
needed before definitive conclusions can be made about the role of smoking.  One low 
quality HPV vaccination study found children whose parents had not spoken to others 
about the vaccine were more likely to be unvaccinated (73) but one medium quality study 
reported non-significant associations for MMR vaccination (10); again more research is 
needed here.  Children who have fewer clinic visits appear to be less likely to receive 
childhood and HPV vaccines in the USA (37, 47, 87, 92, 109) although this finding has an 
unclear risk of bias. 
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Table 2.5: Lifestyle choices, past behaviour and past health outcome (n=low quality, n=medium quality and n=high quality) 
Factor (if yes/no, yes=high) Positive association (high factor = 
more likely unvaccinated) 
Negative association (low factor = more 
likely unvaccinated) Non-significant result 
Age that mother had her first child 62  10, 42 
Child went to nursery? 36 108 31 
Have an alternative lifestyle? 10, 46, 54, 62   
Received previous vaccines? 
 10, 37, 43, 62, 93, 102, 103 62, 92, 93, 105 
Is respondent a smoker? 42 
 
87 
Have spoken to others about the vaccine? 
 
73 10 
Number of clinic visits 
 
37, 47, 87, 92, 109 
 
History of cervical screening? 
 12 86, 87, 92, 93 
History of abnormal cervical screening? 
89 12 45, 87, 89, 103 
History of STI? 
 12, 45 75, 12, 89 
Experience of cancer? 
  
75, 92, 93, 103 
Child has boyfriend/girlfriend? 
  45 
Number of sexual partners 
  89 
Age of first sex 
  45, 89 
Have ever had sex? 
  86 
Ever pregnant? 89  93 
Use condoms? 89   
Political stance 
  
92, 45 
Talk to child about sex? 
 
73 45 
Mother had post-natal depression? 39 
  
Monitor child? 
 45  
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A history of cervical screening or future cervical screening attendance intentions seemed 
not to be associated with HPV vaccination receipt (86, 87, 92, 93).  An association was 
only shown in one study (12) but bias in this finding was unclear or plausible.  Similarly, 
relationships between having a history of abnormal cervical screening results and HPV 
vaccination were not apparent (45, 87, 89, 103, n=1 low quality study, n=3 of medium 
quality), although positive and negative relationships have been shown in two single studies 
that were of medium quality (12, 89).  Parents without a history of STIs or genital warts 
specifically have been shown to be more likely to have children who have not received the 
HPV vaccine (12, 45) but non-significant associations have also been reported (75, 12, 89) 
and all findings had an unclear risk of bias and the evidence for a previous STI diagnosis is 
uncertain.  A history of cervical cancer (including area-level incidence of cervical cancer) 
has consistently been shown to not be associated with HPV vaccination receipt in four 
studies (n=1 of low quality, n=3 of medium quality) conducted in the USA and Canada.  
Age of first sex (45, 89), having had sex (86), number of sexual partners (89) and whether 
the girl has a boyfriend (45) all show non-significant relationships with HPV vaccination 
receipt in medium quality studies.  The teenage pregnancy rate of the county the participant 
resides in has not been found to be associated with HPV vaccination receipt (93) but girls 
who themselves have ever been pregnant are less likely to have received the HPV vaccine 
(89).  This latter study also found that girls who use condoms are less likely to have 
received the HPV vaccine.  Both of these studies were of medium quality and conducted in 
the USA.  Taken as a whole this evidence suggests that there is no role for a girl’s previous 
sexual behaviour.  One low quality study has shown that parents who have not spoken to 
their child about sex are more likely to have a child who has not received the HPV vaccine 
(73) but one medium quality study found no relationship (45), suggesting that the evidence 
is uncertain. 
 
A number of factors were considered by single studies only so general conclusions cannot 
be drawn.  One high quality study looking at childhood vaccines found children whose 
mother suffered from post-natal depression were more likely to be unvaccinated (39).  A 
parent’s political stance has been shown not to be associated with HPV vaccination receipt 
in two studies (45, 92; one low quality and one high quality).  Parents who monitor their 
child to a lesser extent are more likely to have a child who has not received the HPV 
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vaccine (45, medium quality) but this study found family cohesion to not be associated with 
vaccination receipt. 
 
Summary of lifestyle choices, past behaviour and past health outcome findings 
There seems to be consistent evidence that parents who choose alternative lifestyles are 
more likely to refuse childhood vaccinations for their children.  Children who have not 
received all of their previously recommended vaccines and children who have seen a doctor 
least frequently are more likely to be unvaccinated with childhood and HPV vaccinations.  
History of cervical screening, history of abnormal cervical screening results and a history of 
cervical cancer appear not to be associated with HPV vaccination receipt.  This was also the 
case for the girls’ previous sexual behaviour.  All findings had an unclear risk of bias. 
 
Vaccination-related attitudes (Table 2.6) 
General concerns about vaccinations have been considered in a number of studies, all of 
which found that greater concern was associated with non-receipt of both the HPV vaccine 
and childhood vaccines.  General concerns have included: concern about the need for 
booster doses, having a generally negative opinion about the vaccines and being concerned 
about family health in the context of vaccination.  The four studies that have considered 
general concerns were of low or medium quality (10, 73, 74, 103).   
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Table 2.6: Vaccine-related attitudes for research question 1 (n=low quality, n=medium quality and n=high quality) 
Factor (if yes/no, yes=high) Positive association (high factor = 
more likely unvaccinated) 
Negative association (low factor = more 
likely unvaccinated) 
Non-significant result 
General concerns 10, 73, 74, 103   
Efficacy concerns 10, 46, 75, 92  26 
Safety concerns 23, 26, 36, 46, 73, 74, 79, 105  23, 92, 105, 106 
Concern about sexual behaviour after 
vaccination 
74, 103  73 
Concern about certain foods 10   
Believe vaccines to be important?  92, 105, 106 23, 46, 92, 106 
Not sure that the decision to vaccinate was 
the right one 
10   
The earlier the parent became concerned 
about vaccines in the child's life 
10   
Authorities should have responsibility for 
vaccination 
 10  
Exposed to conflicting opinions 65, 106  23 
Fear of needles 45  89 
Influenced by research 23   
Vaccine should be  given to males 
 
 74 
Distrust 46, 73, 106  46, 106 
Disagree with mandatory vaccination 79   
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Specific vaccine efficacy concerns have also been shown to be related to both childhood 
vaccines and HPV vaccination in four studies (n=1 low quality and n=3 medium quality) 
although non-significant results for childhood vaccines were reported in one medium 
quality American study.  The evidence suggests a probable role for vaccine efficacy 
concerns.  The evidence for concern about safety is less clear, but is likely to follow the 
same pattern as vaccine efficacy concerns and general concerns.  Eight studies have found 
concern about childhood and HPV vaccination safety to be associated with non-receipt 
(n=3 studies were of low quality and the rest were of medium quality; 23, 26, 36, 46, 73, 
74, 79, 105), but non-significant findings have been reported in four studies (n=2 of which 
were low quality and n=2 were of medium quality; 23, 92, 105, 106). 
 
Concern about sexual behaviour following HPV vaccination has been found to be 
associated with non-receipt in two studies (n=1 British study of low quality and n=1 
Canadian study of medium quality; 74, 103) but one American study showed non-
significant results (low quality; 73).  This issue was specific to HPV vaccination and not 
considered by studies looking at childhood vaccinations generally.  Parents’ concern about 
feeding their children certain foods has been found to be associated with MMR vaccination 
acceptance in one medium quality British study (10).  For all of these factors there is no 
evidence that parents with less concern are less likely to vaccinate. 
 
Beliefs about the importance of vaccinations have shown negative and non-significant 
associations with childhood and HPV vaccination non-receipt, so the evidence for this 
factor is uncertain.  Three studies (n=1 low quality and n=2 medium quality) reported that 
parents who thought vaccines were unimportant were less likely to vaccinate their child 
(92, 105, 106) and four studies (n=2 of low quality and n=2 of medium quality) reported 
non-significant findings (23, 46, 92, 106).  There is no evidence that those who think 
vaccines are important are more likely to refuse vaccination. 
 
Parents who have been exposed to conflicting opinions regarding vaccinations have been 
found to be less likely to vaccinate their child with childhood and HPV vaccines (65, 106) 
but these studies have an unclear risk of bias and non-significant findings have also been 
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reported for MMR vaccination (23).  Fear of needles has been considered by two studies, 
both of medium quality that looked at HPV vaccination.  One found that fear of needles 
reduced the likelihood that the HPV vaccine had been received (45) and one found non-
significant associations (89), meaning that definitive conclusions cannot be drawn. 
 
There was inconsistent evidence regarding trust.  Various forms of trust have been 
considered including distrust of pharmaceutical companies and vaccination authorities.  
Greater distrust has been shown to be associated with a reduced likelihood that a child has 
received childhood vaccines or the HPV vaccine in studies that had an unclear risk of bias 
(46, 73, 106) but non-significant findings have also been reported in two medium quality 
studies exploring childhood vaccinations (46, 106).  There was no evidence that greater 
trust results in greater likelihood of vaccination non-receipt. 
 
Certain attitudes were considered by single studies only.  Parents who believe that the HPV 
vaccination should be given to males are more likely to have vaccinated their child (74, low 
quality).  Parents who report being influenced by research are less likely to have vaccinated 
their child against MMR (23, low quality).  Parents who do not believe that the authorities 
should have responsibility for vaccination are less likely to have vaccinated their child 
against MMR (10, medium quality) and parents who disagree with mandatory vaccination 
are less likely to have had their daughter receive the HPV vaccine (79, medium quality).  
One British study of medium quality has shown that parents who were unsure whether their 
previous decision to vaccinate their child was the right one are more likely to have a child 
who has not received the MMR vaccine (10). 
 
Summary of vaccine-related attitudes 
No study that considered vaccine-related attitudes was of high quality and all findings show 
an unclear risk of bias.  Many of the individual attitudes were considered by a small 
number of studies so the evidence for each was weak and unclear.  There appeared to be 
consistent evidence that general concern about vaccination and concern about the efficacy 
of vaccinations are related to non-receipt of HPV vaccines and childhood vaccines.  There 
was weak support for an association between concern about sexual behaviour following 
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HPV vaccination and HPV vaccination receipt and this concern was specific to HPV 
vaccination.  A vaccine given to adolescents to protect from an STI is a novel event and 
was not explored in detail by any of these studies.  There was also a possible role for 
vaccination safety. 
 
Social cognition model concepts and knowledge (Table 2.7) 
Perceived severity has shown both negative (10, 103) and non-significant associations with 
non-receipt of HPV vaccination and childhood vaccinations (75, 89, 105).  All findings 
have an unclear risk of bias and the varying findings limit definitive conclusions from being 
drawn.  The negative associations were reported in British and Canadian studies whereas all 
of the non-significant findings were reported in American studies, suggesting that the effect 
may be cultural. 
 
Subjective norm beliefs have on the whole been found to be associated with childhood 
vaccine and HPV vaccination non-receipt (lower subjective norm, more likely to be 
unvaccinated; 10, 23, 73, 75, 89; two low quality and three medium quality studies).  One 
study reported non-significant findings for MMR vaccination and subjective norms (23).  
One study considered comparative norms and found that those who did not believe that 
they were similar to their peers were more likely to have refused MMR vaccination for 
their child (10, medium quality British study). 
 
Many studies have considered vaccination knowledge and both negative and non-
significant findings have been reported.  Six studies (n=2 of low quality and n=4 of 
medium quality; 36, 73, 79, 87, 49, 105) found low knowledge to be associated with 
vaccination non-receipt (both childhood vaccines and HPV vaccination) and five studies 
(n=2 of low quality and n=3 of medium quality) reported non-significant associations for 
knowledge (87, 89, 92, 103, 105).  There is no evidence that high knowledge is associated 
with a greater likelihood of vaccination non-receipt. 
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Table 2.7: Social cognition model beliefs and knowledge for research question 1 (n=low quality, n=medium quality and n=high quality) 
Factor (if yes/no, yes=low) Positive association (high factor = 
more likely unvaccinated) 
Negative association (low factor = more 
likely unvaccinated) 
Non-significant result 
Perceived severity  10, 103 75, 89, 105 
Intention  
 89 
Perceived susceptibility  73, 75 
 
Normative beliefs  10, 23, 73, 75, 89 23 
Self-efficacy  
 89 
Comparative norm (I am similar to my 
peers) 
 10  
Fear of disease   92 
Barriers 75  89 
Benefits  46, 73 89 
Knowledge  36, 73, 79, 87, 49, 105 87, 89, 92, 103, 105 
Perceived risk of negative effects of 
vaccination 
23   
Anticipated regret if child became more 
sexually active 
75   
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A number of factors were considered by one study only so definitive conclusions cannot be 
drawn.  Intention to receive the HPV vaccine and self-efficacy were not associated with 
vaccination receipt in one medium quality study from the USA (89).  Fear of disease also 
showed non-significant associations with HPV vaccination in a low quality study 
performed in the USA (92).  Parents who would anticipate regret if their child became more 
sexually active following HPV vaccination were more likely to have refused HPV 
vaccination for their child (75), and finally parents who perceive their child to be at risk of 
the negative effects of vaccination were more likely to have not vaccinated their child 
against MMR (23). 
 
Summary of social cognition model concepts and knowledge 
A number of social cognition model components have been considered by only one study.  
No study exploring social cognition model components was of high quality, causing 
concern about the risk of bias in the findings.  There was weak evidence that perceptions of 
susceptibility are associated with HPV vaccination receipt.  Normative beliefs have fairly 
consistently been found to be associated with vaccination non-receipt although the evidence 
is of unclear/plausible risk of bias. 
 
Summary of the findings of review question 1 
The evidence for studies helping to answer review question 1 was mostly of medium 
quality and findings were of an unclear risk of bias.  Often only one study had considered 
each factor, limiting definitive conclusions.  Studies of high quality were only used to 
investigate the influence of some demographic factors.  Rarely was the evidence consistent 
so conclusions are generally tentative.  For demographic factors clearer evidence was 
available for childhood vaccination receipt compared with HPV vaccination.  Ethnic 
minority groups appeared at a greater risk of being unvaccinated against all vaccinations.  
Childhood vaccinations were less likely to have been received if the child was being raised 
by a single parent or unmarried parents, if their parents were employed and if the child was 
not the first born in the family.  There appears to be no role for the gender of the child in 
influencing vaccination receipt.  The type of clinic that the parent/child was recruited from 
appears to be related to vaccination receipt but a lack of consistency in defining clinic types 
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restricts more detailed conclusions from being drawn.  Having a need for more information 
appears to be related to HPV vaccination although this conclusion may be rather simplistic 
as weak evidence suggested that children are more likely to be unvaccinated if more 
information was sought.  The health of the child at the time of their vaccination 
appointment may influence vaccination receipt and health insurance status may also affect 
vaccination receipt.  Children who had not previously received all of their recommended 
vaccinations and those who saw their doctor less frequently were more likely to be 
unvaccinated, as were children of parents who use complementary and alternative 
medicine.  Parents’ history of cervical screening, history of abnormal cervical screening 
results and a history of cervical cancer were not associated with HPV vaccination receipt, 
neither was a girl’s sexual behaviour.  General concerns about vaccination and concern 
about the efficacy of vaccinations were fairly consistently associated with vaccination 
receipt and there was weak support for concern about sexual behaviour following HPV 
vaccination and HPV vaccination receipt, with this concern being specific to HPV 
vaccination.  Up until the development of an STI vaccine designed for receipt in 
adolescence, this issue has not been of concern and may require further investigation.  
Finally, of the social cognition model components that were considered in these studies, 
perceived susceptibility and subjective norms seemed most consistently associated with 
vaccination receipt. 
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Review question 2: What factors are associated with parents’/girls’ intentions to refuse 
the HPV vaccine? 
 
Demographic characteristics (Table 2.8) 
Eleven studies explored associations between ethnicity and HPV vaccination intentions 
with eight reporting significant findings.  Most of the studies were of medium quality but 
one significant and one non-significant study were of high quality.  Five studies found 
intentions to refuse the HPV vaccine to be higher for the vaccination of non-Hispanic 
White children (12, 13, 30, 56, 96) but four studies found intentions to refuse to be higher 
in other ethnic minority groups (13, 26, 34, 96). 
 
Five studies considered the role of SES.  These studies measured SES at a postcode level, 
using income and using school type.  Two studies with an unclear or plausible risk of bias 
found those with higher SES more likely to not intend to vaccinate against HPV (73, 96), 
one study of medium quality found the opposite (34) and one study of medium quality 
found that parents with a middling income had higher intentions to refuse (96).  Non-
significant results were reported in three studies (one of low quality, 15 and two of medium 
quality, 33, 35).  The evidence for the role of SES is uncertain. 
 
Degree of education appeared not be associated with HPV vaccination intentions.  Five 
studies (showing an unclear risk of bias) reported non-significant results (15, 35, 34, 41, 
82), although one study found more educated individuals had higher intentions to refuse 
(13) and two studies found less educated individuals were more likely to intend to refuse 
HPV vaccination (45, 96). 
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Table 2.8: Demographic factors for research question 2 (n=low quality, n=medium quality and n=high quality) 
Factor (if yes/no, yes=high) 
Positive association (high 
factor = more likely 
unvaccinated) 
Negative association (low 
factor = more likely 
unvaccinated) 
Direction cannot be assigned Non-significant result 
Ethnicity   Ethnic minority school: 34; 
Black: 13; non-Hispanic/Latino: 
12, 13, 30, 56, 96; Asian: 13, 34 
non-white: 26, 96 
33, 41, 45, 82 
SES 73 34 Did not go to a state school: 96, 
Middling income: 96 
15, 33, 35 
Education 13 45, 96  15, 35, 34, 41, 82 
Child age  17, 33  34, 45, 96 
Parent age 41 28  13, 15, 33, 45, 58, 82, 96 
Employment    82 
Religion 
  
Other Christian: 13; Other 
religion: 13; Born-
again/evangelical: 13; Muslim: 
34, 91; Hindu/Sikh: 34, Other: 
82, Protestant: 96 
41 
Practicing a religion? 13, 91, 98 
 
 41 
Marital status 
  
Household with <2 parents in it: 
41 
33, 82 
Child's gender 
  
Male: 58 
 
Parents' gender 
  
Male: 41 35, 58, 96 
Number of children in the household 
  
 41 
Native speaker of country of study? 
 34   
Native of country of study? 
  
 35 
Region of residence 
  
Live in British Columbia/Yukon 
Territory: 41 
35 
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There was inconsistent evidence for the impact of child’s age on HPV vaccination 
intentions as three studies reported non-significant findings (34, 45, 96) and two studies 
showed that intentions to refuse were higher for younger children (17, 33).  All of these 
studies were of medium quality indicating an unclear risk of bias for these results.  The 
findings were more consistent for parents’ age and intentions with seven studies (one of 
low quality, six of medium quality) reporting that parents’ age was not related to intentions 
(13, 15, 33, 45, 58, 82, 93).  However, two studies, both of high quality found that older 
parents and younger parents were more likely to intend not to vaccinate a child against 
HPV (41, 28).  The evidence for the role of parents’ gender was unclear.  One high quality 
study found fathers had higher intentions to refuse (41) but three medium quality studies 
reported null findings (36, 58, 96).  Regarding marital status the evidence was also unclear, 
one high quality study reported that single parents were more likely to intend to refuse to 
vaccinate against HPV (41), but two medium quality studies reported null findings for the 
effect of marital status on intention (33, 82). 
 
Five studies reported significant associations between religion and intention but there was 
very little consistency in the religious beliefs that were associated with higher intentions to 
refuse (13, 34, 91, 82, 96, all medium quality).  One high quality study found null findings 
for religion (41).  There appeared to be more evidence for the degree of religiosity in those 
who identified themselves as having a religion as three studies (one of low quality and two 
of medium quality) found that those who were more engaged with their religion had higher 
intentions to refuse (13, 91, 98).  One high quality study reported null findings (41). 
 
A number of demographic factors were considered by just one study.  A medium quality 
study found vaccination intentions to refuse were higher if the target child was male (58).  
Parents who were not native speakers of the country where the study was conducted had 
higher intentions to refuse (34, medium quality), but non-significant findings were reported 
for whether the respondent was born in the country that they reside (35, medium quality).  
Mothers’ employment was not shown to be related to vaccination intentions in one medium 
quality study (82).  Number of children in the household was not found to be associated 
with intention in a high quality study (41).  Region of residence in the USA was found to be 
                                                              CHAPTER 2 – A REVIEW OF THE LITERATURE 
 70 
related to intention in this same high quality study (41) but living in a rural location in 
Australia specifically was not associated with intention (35, medium quality). 
 
Summary for demographic factors 
A number of studies considered the role of demographic factors in affecting HPV 
vaccination intentions.  Mainly the findings were of unclear risk of bias, although two high 
quality studies explored demographic factors.  A number of factors were considered by 
single studies only, restricting generalisations.  Non-Hispanic and ethnic minority 
individuals appeared to have higher intentions to refuse.  Parents’ age and education 
seemed not to be associated with intention.  Although there was inconsistent evidence for 
the role of religion, those who are practising a religion to a greater extent may be less likely 
to intend to vaccinate a child. 
 
Practical factors (Table 2.9) 
Only three distinct practical factors were explored when considering HPV vaccination 
intentions and each factor was investigated by one study only.  One high quality American 
study found higher intentions to refuse in those without health insurance (85).  One study 
manipulated what they told participants that the HPV vaccine protected against.  This 
medium quality study found that intentions to refuse were higher if the vaccine was 
described as protecting against HPV solely (and not specifically cervical cancer or genital 
warts) or as protecting against genital warts (and not cervical cancer, 76).  Finally, 
information use by respondents (including the media, friends/family, leaflets and the 
internet) was not associated with vaccination intentions in a British study of medium 
quality (33). 
 
Summary for practical factors 
Only three studies have considered practical factors associated with intention so generalised 
conclusions could not be drawn.  All of the studies were of medium quality. 
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Table 2.9: Practical factors for research question 2 (n=low quality, n=medium quality and n=high quality) 
Factor (if yes/no, yes=high) 
Positive association (high 
factor = more likely 
unvaccinated) 
Negative association (low 
factor = more likely 
unvaccinated) 
Direction cannot be assigned Non-significant result 
Format of information 
  
 33 
Health insurance status 
 
 
No insurance: 85  
Type of vaccine 
 
 
Protects solely against HPV 
(and not specifically cervical 
cancer or genital warts): 76; 
Protects solely against genital 
warts (and not cervical cancer): 
76 
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Lifestyle choices, past behaviour and past health outcome findings (Table 2.10) 
There was consistent support that intentions to refuse vaccination against HPV were higher 
when the target child had not received all of their previously recommended vaccinations or 
had delayed a previously recommended vaccine (15, 41, 51, 77, 81), although this finding 
was of unclear risk of bias.  However, in a similar vein having had a bad vaccination 
experience previously was not associated with vaccination intentions in one British study of 
medium quality (77).  Mothers who are not willing to have the HPV vaccine themselves 
seemed to have higher intentions to refuse to vaccinate a daughter against HPV, although 
only two medium quality studies explored this (51, 82). 
 
Not having a history of attending for cervical screening, or not intending to do so was 
associated with higher intentions to refuse vaccination in two medium quality studies (26, 
91), and null findings were reported in one medium quality British study (33).   Intentions 
to refuse were higher in those with a history of abnormal cervical screening results in one 
high quality study, but not in one medium quality study.  A similar pattern was seen for 
having experienced cancer (including knowing someone who has been diagnosed with 
cancer), one high quality study reported null findings (41) and one medium quality study 
found that those who have not experienced cancer have higher intentions to refuse HPV 
vaccination (82).  As a result, the evidence for previous cancer and cervical cancer 
prevention experience was uncertain. 
 
The political orientation of the parent was considered in three studies.  Two medium quality 
studies found conservatives in the USA to have higher intentions to refuse HPV vaccination 
for their daughters (13, 96), but one low quality British study reported null findings (98).  
More evidence is needed here in order to draw more definite conclusions.
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Table 2.10: Lifestyle choices, past behaviour and past health outcome for research question 2 (n=low quality, n=medium quality and n=high quality) 
Factor (if yes/no, yes=high) Positive association (high 
factor = more likely 
unvaccinated) 
Negative association (low 
factor = more likely 
unvaccinated) 
Direction cannot be assigned Non-significant result 
Bad previous vaccination experience? 
 
  77 
Received previous vaccines? 
 
15, 41, 51, 77, 81   
Mother willing to have the vaccine? 
 
51, 82  
 
History of cervical screening? 
 26, 91  33 
History of abnormal cervical screening? 
 26  45 
Experience of cancer? 
 82  41 
Political stance? 
  
Conservative: 13, 96 98 
Talk to child about sex? 
 
73, 82  45 
Have spoken to others about the vaccine? 
  
Want to involve child in the 
decision: 81 
 
Spoken to daughter about cervical screening? 
 
26  
 
History of STI? 
 45   
Ever pregnant? 85    
Use condoms? 
 
85   
Child has boyfriend/girlfriend? 
 
  45 
Number of sexual partners 85 
 
 
 
Age of first sex 
 
  45 
Monitor child  45   
Greater family cohesion    45 
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Parents who have not spoken to their daughter about cervical screening were found to have 
higher intentions to refuse to vaccinate in a high quality study (26).  Parents who have not 
spoken to their child about sex or who did not feel comfortable talking to their children 
about sex were more likely to intend refuse vaccination (73, 82, one study of low quality 
and one study of medium quality) although one study reported null findings for this factor 
(45).  Again, more evidence is required here in order to draw definitive conclusions. 
 
A number of factors were considered by single studies only, meaning that definitive 
conclusions could not be made about their role in vaccination intentions.  Not having a 
history of STI infection was found to be associated with higher refusal intentions in a 
medium quality study (45) and ever being pregnant was related to girls having higher 
intentions refuse the HPV vaccine themselves (85, high quality).  Lower condom use was 
also associated with higher refusal intentions in this same high quality study as was having 
a higher number of sexual partners.  There was no relationship for age of sexual debut in 
one medium quality study (45).  Intentions were not related to whether the target child had 
a boyfriend in this same American study.  Further findings from this study were that 
intentions to refuse were higher if a parent monitored their child to a lesser extent and null 
findings for the role of family cohesion.  Finally, parents who wanted to involve their child 
in the decision to receive the HPV vaccine had higher intentions to refuse (81). 
 
Summary for lifestyle choices, past behaviour and past health outcomes 
A large number of factors were considered by only one study which limits the ability to 
draw definitive conclusions about the importance of this factor.  High, medium and low 
quality studies explored lifestyle choices, past behaviour and past health outcomes although 
the findings overall showed an unclear risk of bias.  Only previous vaccination receipt was 
consistently associated with HPV vaccination refusal intentions. 
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Vaccine-related attitudes (Table 2.11) 
Having general concerns about vaccinations or the HPV vaccine was consistently 
associated with higher vaccination refusal intentions in five studies, although this finding 
was of unclear risk of bias (15, 73, 77, 82, 94).  The types of general concerns explored 
included length of time that the vaccine has been on the market for, dislike of vaccinations 
generally and concern that there are already too many vaccinations in the immunisation 
schedule.  Two medium quality studies reported that greater concern about the efficacy of 
the vaccine was associated with higher refusal intentions (15, 94).  Respondents with 
greater concerns about safety had consistently higher refusal intentions in seven studies 
with an unclear risk of bias (15, 58, 73, 77, 82, 91, 94), although one study reported null 
findings (58).  Concern about sexual behaviour following HPV vaccination was often 
related to refusal intentions (15, 41, 58, 82, 91, 96) in studies from a number of countries, 
although this finding had an unclear risk of bias and one low quality study reported null 
findings (73).  However, weak evidence suggested that there is not a role for how liberal a 
parents’ sexual values are (two studies of medium quality reported null findings, 45, 58, 
and one study of low quality reported significant results, 15).  Similarly to the evidence 
reported for review question 1, these factors were only assessed in studies exploring HPV 
vaccination.  Parents who disagreed that vaccinations were important held higher refusal 
intentions in one low, one medium and one high quality study (41, 73, 77), suggesting that 
beliefs about importance are relevant to vaccination intentions.  A greater concern about 
needles was associated with higher refusal intentions in two medium quality studies (34, 
45).  Distrust of governments or pharmaceutical companies was explored in two studies 
(one low quality and one medium quality study) that found greater distrust associated with 
higher refusal intentions (73, 77). 
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Table 2.11: Vaccine-related attitudes for research question 2 (n=low quality, n=medium quality and n=high quality) 
Factor (if yes/no, yes=high) 
Positive association (high 
factor = more likely 
unvaccinated) 
Negative association (low 
factor = more likely 
unvaccinated) 
Direction cannot be assigned Non-significant result 
General concerns 15, 73, 77, 82, 94 
 
  
Efficacy concerns 15, 94    
Safety concerns 15, 58, 73, 77, 82, 91, 94   58 
Concern about sexual behaviour after 
vaccination 15, 41, 58, 82, 91, 96   73 
More liberal sexual values  15  45, 58 
Believe vaccines are important?  41, 73, 77   
Fear of needles 34, 45    
Distrust 73, 77    
Vaccine should be given to males? 
 
81   
Not sure that the decision to vaccinate was the 
right one    77 
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Two factors were only considered by single studies.  Parents who were uncertain whether 
their previous decision to vaccinate a child was the right one were no more or less likely to 
intend to vaccinate their child (77, medium quality) and Dutch parents who did not believe 
that the HPV vaccine should be given to males held higher refusal intentions (81, low 
quality). 
 
Summary for vaccine-related attitudes 
Studies of low, medium and high quality considered vaccine-related attitudes although on 
the whole the conclusions drawn had an unclear risk of bias.  A number of attitudes were 
found to be consistently associated with higher refusal intentions including general 
concerns about vaccination, concerns about efficacy and parents questioning the 
importance of vaccinations.  Concern about sexual behaviour after vaccination was 
associated with higher refusal intentions and was specific to HPV vaccination only.  
Similarly to the findings reported in review question 1, it is highly likely that this novel 
issue is relevant to HPV vaccination decision making.  There was weaker support for the 
role of fear of needles and trust. 
 
Social cognition model concepts and knowledge (Table 2.12) 
Subjective norm beliefs were shown to be associated with vaccination intentions with five 
studies reporting that those with lower subjective norm beliefs had higher refusal intentions 
(15, 41, 82, 85, 91, findings unlikely to change), although one study reported null findings 
(41, high quality).  One study explored descriptive norms, finding that those who thought 
others would not vaccinate had higher refusal intentions themselves (82, medium quality).  
Knowledge was fairly consistently associated with vaccination refusal intentions and this 
finding had an unclear risk of bias or was unlikely to change (41, 58, 82, 85), although one 
low quality British study reported null findings for knowledge (15). 
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Table 2.12: Social cognition model beliefs and knowledge for research question 2 (n=low quality, n=medium quality and n=high quality) 
Factor (if yes/no, yes=high) 
Positive association (high 
factor = more likely 
unvaccinated) 
Negative association (low 
factor = more likely 
unvaccinated) 
Direction cannot be assigned Non-significant result 
Perceived severity  15, 82, 85  34 
Perceived susceptibility  34, 41, 58, 82, 91  
 
Subjective norm  15, 41, 82, 85, 91  41 
Descriptive norm  82   
Worry about disease 15    
Barriers 15, 34, 85, 94 
 
  
Benefits  15, 34, 73, 82   
Knowledge  41, 58, 82, 85  15 
Self-efficacy 
 
41   
Consideration of future consequences 
 
97   
Need for internal consistency 
 
100   
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Individuals with lower perceptions of risk were shown to have higher refusal intentions to 
vaccinate in four medium quality and one high quality study (34, 41, 58, 82, 91), with every 
study being performed in a different country.  Consistent findings were reported for 
benefits and barriers.  Four studies of varying quality reported that individuals who 
perceive more barriers are more likely to have higher refusal intentions (15, 34, 85, 94) and 
similarly four studies showed that those who believed there were fewer benefits to 
vaccination were less likely to intend to vaccinate (41, 58, 82, 85, n=2 studies of low 
quality and n=2 studies of medium quality), although one low quality study reported non-
significant findings (15). 
 
The evidence was less clear for perceptions of severity with three studies finding lower 
perceptions of severity to be associated with higher refusal intentions (unclear risk of bias, 
15, 82, 85) but null findings reported in one study (medium quality, 34).  Three factors 
were considered by single studies.  Having lower self-efficacy was related to higher refusal 
intentions in a high quality study (41), as was having lower consideration for future 
consequences (97, low quality study) and having a low need for internal consistency (100, 
low quality study). 
 
Summary for social cognition model concepts and knowledge 
The quality of the evidence for social cognition model concepts and knowledge was greater 
than for other categories.  A number of studies were of high quality allowing some certainty 
that the conclusions drawn would not change.  However, the majority of conclusions had an 
unclear risk of bias.  Subjective norm beliefs and knowledge showed consistent and reliable 
associations with refusal intentions and perceptions of risk and barriers and benefits were 
also related to refusal intentions, although these conclusions were weaker. 
 
Summary of the findings of review question 2 
The evidence used to help to answer review question 2 was mainly of medium quality 
causing some concern about the risk of bias of conclusions drawn.  Conclusions cannot be 
made about the role of practical factors in vaccination refusal intentions because too few 
studies considered these factors.  Methodologically stronger studies reported findings for 
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social cognition model components and knowledge so more definite conclusions can be 
drawn for these factors.  Individuals who are not from Hispanic ethnicities and those from 
ethnic minorities seem more likely to intend refuse vaccination.  Parents’ age and education 
appear unlikely to be related to intentions.  Having previously not received other 
vaccinations or having delayed a vaccination in the past may be associated with vaccination 
refusal intentions.  General concerns about vaccinations, concerns about vaccine efficacy 
specifically and concerns about sexual behaviour following HPV vaccination receipt were 
all associated with intentions.  Concern about sexual behaviour was specific to HPV 
vaccination only and as it was also deemed influential in review question 1, it is likely to 
play an important role in HPV vaccination decision making.  There was a possible role for 
fear of needles and lack of trust.  Subjective norm beliefs and knowledge were strongly 
associated with refusal intentions and there are potential relationships for perceptions of 
risk and perceptions of the barriers and benefits of vaccination. 
 
Review question 3: What are the reasons that parents/girls give to explain why they have 
not received a vaccine recommended in the UK childhood immunisation schedule 
(intention to not receive or actual non-receipt for HPV vaccine)? 
 
Description of the studies 
The studies included in the review that helped answer review question 3 used a variety of 
methods to elicit parents/girls reasons to explain why they had not received a recommended 
vaccine (or would intend to do so).  Some studies were purely qualitative and employed 
focus groups or interviews.  Other studies asked participants to answer an open response 
question in a questionnaire as well as assessing actual non-receipt or intention to not 
receive a vaccine. 
 
Demographic factors (Table 2.13) 
Nine studies found respondents to report that the child’s age would prevent them from 
vaccinating a child or has already prevented them, or has caused them to delay vaccination 
(4, 8, 14, 17, 40, 93, 99, 103, 111).  The risk of bias for this finding was unclear; however 
the number of studies reporting this finding suggests that age is important.  In most cases it 
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was deemed that the child was too young to receive the vaccine, but in one study girls 
believed they were too old to receive the HPV vaccine.  Religious values were cited as a 
reason for preventing HPV and MMR vaccination (intention, receipt and completion) in 
four studies all conducted in the USA, although this finding had an unclear or plausible risk 
of bias (17, 29, 46, 92).  Parents in two medium quality studies reported that their living 
situation caused them to delay vaccination or had prevented them from vaccinating their 
child with childhood vaccines (40, 52).  Problematic living situations included having a 
transient lifestyle, living abroad or not having a permanent place to live.
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Table 2.13: Factors for research question 3 (n=low quality, n=medium quality and n=high quality) 
Factor Study 
Child’s age 4, 8, 14, 17, 40, 93, 99, 103, 111 
Religion 17, 29, 46, 92 
Living arrangements 40, 52 
Want to get vaccine at GP and not in school 32 
Need more information about vaccine 4, 8, 17, 24, 40, 45, 56, 67, 71, 72, 80, 89, 92, 93, 99, 103, 111 
Gained information from the media 29 
Easy access to the clinic 26, 40, 89 
Child unwell 8, 26, 29, 36, 40, 52 
Cost/health insurance 17, 26, 89, 92, 107, 111 
Bad previous vaccination experience 29 
General practical difficulties 8, 36, 40, 87, 89, 92, 107, 111 
Forgot 26, 36, 40, 89 
Preference for complementary and alternative medicine 29, 40 
Want to involve daughter in the decision 17 
Ever pregnant? 67, 87 
History of HPV infection 87 
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Table 2.13: Factors for research question 3 continued … 
Factor Study 
Moral/ethical values 46, 107 
General concerns 8, 13, 14, 40, 67, 71, 80, 81, 93, 99, 103, 107 
Efficacy concerns 26, 36, 46, 87, 95, 107 
Safety concerns 13, 14, 17, 19, 24, 26, 29, 36, 40, 46, 53, 67, 71, 81, 87, 92, 93, 95, 99, 103, 107, 110, 111 
Concern about sexual behaviour after vaccination 4, 8, 13, 53, 72, 80, 81, 92, 93, 95, 103 
Importance of vaccination 8, 14, 29, 32, 36, 40, 45, 52, 67, 99, 103, 107 
Fear of needles 8, 17, 45, 67 
Distrust 25, 40, 92, 103 
Undecided 36 
Perceived severity 46 
Perceived susceptibility 8, 13, 14, 17, 19, 24, 40, 45, 46, 51, 56, 64, 67, 80, 87, 92, 93, 99, 103, 107, 110 
Subjective norm 29, 67, 80, 87, 92, 93, 103 
Benefits 40, 107 
Perceived risk of negative effects of vaccination 51 
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Practical factors (Table 2.13) 
An often reported factor that would or has prevented HPV vaccination was a need for more 
information about the vaccine (4, 8, 17, 24, 40, 45, 56, 67, 71, 72, 80, 89, 92, 93, 99, 103, 
111; plausible or unclear risk of bias).  The specific information requested included needing 
to know more about the side-effects and safety of the vaccine, the prevalence of HPV and 
the benefits of receipt, the immunisation schedules specifically and one study found 
participants reported that they did not know that more than one dose was required.  One 
study found that parents stated that their use of the media for information about MMR 
vaccination had caused them to refuse vaccination for their child (29). 
 
Having concerns about cost or lack of health insurance would or has prevented HPV 
vaccination or use of childhood vaccines in six studies, although this finding had an unclear 
risk of bias (17, 26, 89, 92, 107, 111).  Six studies found parents to have prevented or 
delayed HPV vaccination or childhood vaccinations because of their child’s health status.  
The child being unwell at the time the vaccine was due, the child having already had the 
disease that the vaccine was designed to prevent and contraindications were all cited, 
although the risk of bias was unclear (8, 26, 29, 36, 40, 52).  Participants said that 
forgetting to get the vaccine had prevented or delayed vaccination receipt (both childhood 
vaccines and HPV vaccination) in four studies of medium quality (26, 36, 40, 89).  In 
studies from the USA, some respondents found difficulty of access to the vaccination clinic 
had caused them to delay vaccination or had prevented them from receiving vaccines (HPV 
and childhood vaccines).  Access problems included transportation issues and being unable 
to get an appointment (26, 40, 80; unclear risk of bias). 
 
General practical difficulties associated with the process of receiving childhood vaccines or 
the HPV vaccine have been reported to have prevented or delayed vaccination receipt in 
eight studies (8, 36, 40, 87, 89, 92, 107, 111; unclear risk of bias).  Practical difficulties 
included needing to receive vaccines in a particular order, feeling overwhelmed by the 
number of vaccines required, having to arrange supervision of other children whilst the 
target child receives the vaccine, the vaccine not being available or not offered, not having 
enough time and not knowing where to go to get the vaccine. 
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Two studies highlighted issues that were not reported in any other study.  A study from 
New Zealand found parents to have refused tetanus vaccination offered in school because 
they preferred to receive it from their GP (32, medium quality).  Parents in another low 
quality American study said that a previous bad vaccination experience had prevented them 
from giving their child the MMR vaccine (29). 
 
Lifestyle choices, past behaviour and past health outcomes (Table 2.13) 
Respondents rarely reported that their lifestyle choices, past behaviour and past health 
outcomes had affected their vaccination decisions and all studies that did find participants 
to cite these factors were from the USA.  A preference for or use of complementary and 
alternative medicine had caused parents in two studies (n=1 low quality and n=1 high 
quality) to delay or refuse childhood vaccinations (29, 40).  Another two studies found 
adolescent girls to say that they had refused the HPV vaccine, or failed to complete the 
schedule because they had become pregnant (67, 87, plausible or unclear risk of bias).  One 
medium quality study found that parents who did not intend to vaccinate their daughter 
against HPV made this decision because they wanted to involve their daughter in the 
decision (rather than making it for her; 17).  Finally, in one low quality study girls said that 
they had not received the HPV vaccine because they had already been infected with HPV 
(87). 
 
Vaccine-related attitudes (Table 2.13) 
The most frequently discussed attitude that had prevented or would prevent HPV 
vaccination or childhood vaccination was having safety concerns about vaccination (13, 14, 
17, 19, 24, 26, 29, 36, 40, 46, 53, 67, 71, 81, 87, 92, 93, 95, 99, 103, 107, 110, 111; unclear 
risk of bias).  Safety concerns cited included fear of side effects, believing that vaccines are 
dangerous, fear of contracting the disease through vaccination, concern about overloading 
the immune system and preferring to wait to see whether problems arise with the vaccine. 
 
General concerns preventing vaccination or causing respondents not to intend to vaccinate 
(HPV vaccine and childhood vaccines) was cited in studies that were performed in a 
number of countries (8, 13, 14, 40, 67, 71, 80, 81, 93, 99, 103, 107; unclear risk of bias).  
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Concerns expressed included worry about the vaccine being offered as part of a study, 
concern about the adjuvant, unease about the trauma of the vaccination process and concern 
about the novelty of the vaccine.  Respondents reported that efficacy concerns had 
prevented or would prevent HPV vaccination or the use of childhood vaccines in six studies 
(26, 36, 46, 87, 95, 107; unclear risk of bias).  Concern about sexual behaviour was 
reported by some parents to have prevented (or would prevent) them from letting their child 
receive the HPV vaccine (4, 8, 13, 53, 72, 80, 81, 92, 93, 95, 103; unclear risk of bias).  The 
specific concerns associated with this included worry that consent condones sexual activity, 
believing that the vaccine will encourage sexual promiscuity and concern about girls 
reaching sexual debut earlier as a result of the vaccine.  Similarly to the findings of review 
questions 1 and 2 such, concerns were only raised in studies exploring HPV vaccination. 
 
In many studies respondents stated that their belief that vaccinations are not important had 
or would cause them to not receive childhood vaccines or HPV vaccination (8, 14, 29, 32, 
36, 40, 45, 52, 67, 99, 103, 107; unclear risk of bias).  Some believed that alternative 
methods of preventing infection/disease were sufficient.  Trust was reported to have caused 
respondents to have delayed or refused childhood vaccines or HPV vaccination in studies 
from the USA and Canada (25, 40, 92, 103; plausible or unclear risk of bias).  Participants 
reported distrust of medical communities and the information they provide, sources of 
information generally, the government, and others believed that vaccination is a ploy for 
pharmaceutical companies to make money.  A fear of needles or parents believing that their 
child was scared of needles had prevented HPV vaccination (or intention to receive the 
vaccine) in four studies of medium quality (8, 17, 45, 67).  In the USA parents stated that 
they had refused childhood vaccines for their child because of their moral or ethical values 
(46, 107; both medium quality).  These values included opposition to the use of aborted cell 
lines, use of foetal tissue or blood, animal testing and opposition to vaccination mandates. 
 
Social cognition model concepts (Table 2.13) 
Perceptions of susceptibility were the most commonly raised social cognition model belief 
that had prevented respondents from vaccinating their child against childhood vaccines or 
HPV vaccines (or from intending to do so for HPV vaccination); this finding had an unclear 
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risk of bias (8, 13, 14, 17, 19, 24, 40, 45, 46, 51, 56, 64, 67, 80, 87, 92, 93, 99, 103, 107, 
110).  Respondents stated the following susceptibility concerns as being important: not 
believing that their child is at risk of infection or will not be for some time, not believing 
that the child is sexually active, having only had one sexual partner, being already married 
or not believing in sex before marriage.  One study of low quality found parents to report 
that their belief that their child was at risk of the negative effects of HPV vaccination 
caused them to decline to allow their child to receive the vaccine (51). 
 
Normative beliefs were also raised as having prevented HPV or MMR vaccination in seven 
studies (29, 67, 80, 87, 92, 93, 103; unclear risk of bias).  Normative beliefs that were 
influential included reporting that friends, family or their doctor discouraged the vaccine’s 
use, the doctor not offering the vaccine to the respondent or wanting to get the opinion of a 
healthcare professional first. 
 
In two American studies of medium quality participants reported that low perceived 
benefits of childhood vaccination had caused them to either delay or refuse vaccination for 
their child (40, 107).  Low perceptions of severity were cited as a reason for failing to 
complete the childhood vaccination schedule in one American study (46, medium quality). 
 
Summary of the findings of review question 3 
The qualitative literature has highlighted a number of factors that are influential in causing 
parents and adolescents to have delayed, refused or failed to complete vaccination 
schedules for HPV vaccines and childhood vaccines and also caused individuals to fail to 
intend to vaccinate against HPV.  All of the findings were of an unclear risk of bias 
meaning that we should be cautious about the validity of the findings.  The demographic 
factor that was most consistently associated with non-receipt was the child’s age, with the 
preference, on the whole for older children to be vaccinated.  Knowledge deficits were 
frequently stated as another cause of vaccination non-receipt, as were financial concerns 
and general practical difficulties.  Lifestyle choices, health behaviours and past health 
outcomes were less frequently raised as affecting vaccination decisions.  Concerns about 
vaccination, including general, safety and efficacy concerns, were a major cause of 
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vaccination non-receipt both for HPV vaccines and childhood vaccines.  Concerns about 
sexual behaviour following HPV vaccination was a concern specific to HPV vaccination 
and was regularly reported to have affected non-receipt of the HPV vaccine.  The fact that 
this factor was deemed influential in quantitative and qualitative research, suggests that it is 
an important issue influencing vaccination decision making and requires further enquiry.  
Believing that vaccines were not important appeared to be influential also.  Perceptions of 
invulnerability seemed to influence parents’ and adolescents’ vaccination decisions or 
intentions, as did normative beliefs. 
 
Discussion of the findings of existing reviews 
The literature search identified ten reviews that had considered reasons for vaccination non-
receipt.  Three were systematic reviews and the remaining articles were summaries of 
available literature (9, 20, 38, 50, 69, 70, 88, 101, 112, 114). 
 
The present review updated a systematic review exploring reasons for vaccination non-
receipt in studies conducted before 2005 (Falagas & Zarkadoulia, 2008).  This review of 39 
studies concluded that vaccination non-receipt was affected by parental-childhood 
characteristics and healthcare structure/professional characteristics.  Some of their findings 
concur with the present review: demographic parental-childhood characteristics associated 
with non-receipt were being of a non-white ethnicity, late birth order and having an 
unmarried mother.  However, they also found non-receipt to be associated with not having 
a religion, the child being older, the mother being younger, where the child lived and 
having a larger family size.  Socio-economic factors within this category that were not 
highlighted as influential in the present review included having a low SES, low income, 
having to pay for immunisations, having less educated parents, not having health insurance 
and attending a state school.  Attitudinal factors within parental-childhood characteristics 
that concurred with the present review included negative beliefs towards vaccinations and 
fear of side effects; but they also noted a role for parents' perceptions of controlling health 
and their sense of responsibility.  Other important parental-childhood factors reflected the 
practical factor findings and lifestyle choice, health behaviour and health outcome findings 
for the present review: non-receipt was related to having a lack of knowledge, not 
                                                              CHAPTER 2 – A REVIEW OF THE LITERATURE 
 89 
remembering appointments, the schedule of the vaccination, the immunisation status of the 
child, sick child delays and well-child visit delays, lack of childcare for other siblings, time 
constraints and having received conflicting information.  Healthcare structure/professional 
characteristics reported to be influential included having a private healthcare provider, 
inadequate support from healthcare providers, inadequate support from the social 
environment, lack of healthcare structure, doubts about the healthcare provider's 
knowledge, accessibility problems, having had previous negative interactions with 
healthcare providers, long waiting times in clinics, previous traumatic vaccination 
experiences, physicians being reluctant to administer vaccination and not receiving 
reminders to have the vaccine.  These factors did not come out of the present review.  In 
contrast to the present review, the review was limited as it did not consider the quality of 
the evidence for each factor and did not examine whether studies were powered to detect 
effects. 
 
The other reviews identified in the literature search were of varying quality and only two 
were systematic reviews.  Others were much more unsystematic in their approach, did not 
describe how the review was conducted and did not elaborate on their results (for example, 
one reported that ‘ethnicity’ was associated with vaccination non-receipt without specifying 
details).  There was not a great deal of consistency between reviews in the influence of 
demographic factors on vaccination non-receipt.  Being an older child was the only factor 
reported by a number of reviews to be influential but one review did report that younger 
children were more likely to remain unvaccinated.  Practical issues that were often reported 
in the reviews to be important included the child’s health (previous negative vaccination 
experience, sick at the time of vaccination or too little contact with physicians), forgetting 
appointments and problems with childcare for other children and lack of access to 
healthcare.  Fear of side effects/concern about safety was the only vaccine-related attitude 
to regularly be cited as influential in the reviews.  A number of social cognition model 
components were also reported to be related to vaccination non-receipt; perceived 
susceptibility, severity and efficacy, subjective norms, low knowledge and negative 
vaccination beliefs were frequently suggested as being related to vaccination non-receipt. 
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One theory-informed review described the literature associated with parental immunisation 
decision making and developed a model to summarise the process (Sturm et al., 2005).  The 
model highlights the importance of: social-environmental factors (cultural attitudes, social 
norms, media coverage); parent-specific/personal factors (cognitive heuristics, health 
beliefs), interface with health care (provider attitudes, access to healthcare), institutional 
policies, physical environment (incidence of vaccine-preventable diseases).  Personal 
factors were described as the most important factors in influencing vaccination receipt; 
social-environmental factors shape parental beliefs, as do provider attitudes.  The strength 
of the influence of provider attitudes is dependent on parents' trust in authorities.  Provider 
systems, such as reminder systems, influence the salience of immunisation in the parents' 
competing concerns and priorities, and institutional policies may enhance the perceived 
importance of immunisation or increase parental resistance to vaccination.  Similarly to the 
present review, the authors assert that the academic literature provides evidence supporting 
the importance of norms, including provider attitudes, the importance of susceptibility, 
benefits and barriers and competing health claims (e.g. getting child to school), but also 
suggested that the media, perceived severity, self-efficacy, omission bias, protected values 
(values that are not amenable to change) and framing also play a role, which did not come 
out of the present review.  The authors acknowledged that there are some inconsistencies in 
the relative importance of the various concepts due to methodological differences between 
studies. 
 
Differences between these reviews and the present review may be explained by their 
considering studies published before 2005, prior to the influx of studies exploring the HPV 
vaccine.  The HPV vaccine may be perceived differently from existing vaccinations 
because of a variety of factors.  The vaccine is given to older girls who are more likely to 
be involved in the decision making process than young children receiving existing 
vaccines.  It is also likely that peer pressure and social peer norms will be an important 
influence on older girls’ vaccination decisions.  The HPV vaccine is generally being 
delivered in schools in the UK.  This means that nurses come to the girls, rather than the 
girls having to seek out vaccination and so accessibility issues may be less important in 
informing vaccination uptake.  Finally, the novelty of the vaccine is likely to be influential 
in informing parents’/girls’ vaccination decision and its relationship to sexual behaviour 
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has been shown to be pertinent to parents’ making decisions about whether to vaccinate 
their daughter against HPV. 
 
DISCUSSION 
The present review aimed to identify the factors that are associated with the non-receipt of 
vaccines recommended in the UK childhood immunisation schedule or intentions to refuse 
HPV vaccination and within both of these contexts to report the reasons that participants 
give to explain why they have refused a vaccine in the past or intend to refuse the HPV 
vaccine in the future.  The review benefited from taking a systematic approach, exploring 
the methodological quality of the evidence and the findings of the review were triangulated 
to other reviews to increase the reliability of the results.  Eighty-eight empirical studies 
were included in the review and the factors identified could be classified into five 
categories: demographic characteristics; practical factors; lifestyle choices, past behaviour 
and past health outcomes; vaccination-related attitudes and social cognition model concepts 
and knowledge.  A larger number of studies considered the HPV vaccine as opposed to 
early childhood vaccinations.  This is likely to reflect the proliferation of interest in HPV 
vaccination in recent years rather than a particularly reduced interest in early childhood 
vaccination uptake. 
 
Demographic factors 
This review demonstrated very little consistency in the role of demographic factors in 
influencing vaccination non-receipt.  The non-significant findings may be more reliable.  
The child’s gender was not associated with actual vaccination non-receipt and parents’ age 
and parents’ education were not related to vaccination intentions.  Studies exploring 
vaccination intentions found lower intentions in non-Hispanic and ethnic minority groups, 
but studies exploring actual vaccination non-receipt suggested that only ethnic minority 
groups are more likely to have not received a vaccination.  The finding of lower intentions 
in non-Hispanic groups is confusing given that minority groups also had lower intentions.  
It may be that comparisons are not appropriate due to the varying definitions of ethnicity.  
The finding that individuals from ethnic minority groups are more likely to have not 
received a vaccination is concerning as in UK populations they already suffer poorer health 
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(Cooper, 2002).  Although it is difficult to compare findings for ethnic groups between 
countries due to the prevalence of different ethnicities and the variety of ways that ethnicity 
is classified, it is likely that the poorer health experienced by ethnic minorities in the UK is 
reflective of the experience of ethnic minorities in other countries.  Studies of actual non-
receipt of early childhood vaccinations found children of single or unmarried parents; of 
employed mothers and who were not the first born in their family were more likely to have 
not received a vaccine.  Vaccination coordinators should pay special consideration to 
ensuring that children from these types of families come to receive their recommended 
vaccines by exploring the factors that are preventing these groups particularly from doing 
so.  
 
Practical factors 
There was not a great deal of consistency between the findings of each review question in 
the role for practical factors affecting vaccination non-receipt.  Practical factors were not 
strongly associated with vaccination intentions.  This is unsurprising as daily events and 
hassles are often unpredictable and cannot be factored into vaccination intentions.  In 
reality though, a parent with the strongest beliefs about their child’s susceptibility to a 
vaccine preventable infection may delay vaccination if their bus were not to turn up to take 
them to the vaccination appointment and this could not be anticipated.  The reviews and 
studies considering actual vaccination non-receipt both highlighted the importance of the 
child’s health (illness at the time of vaccination, having reacted badly to vaccines in the 
past and allergies) in influencing vaccination non-receipt.  Decisions about postponing 
vaccination because of illness may not be simple for parents.  The NHS immunisation 
website recommends not vaccinating a child when he is ill, but also states that vaccination 
need not be prevented because of a cold or cough, which are both likely to be interpreted as 
‘illness’ by a parent (NHS Choices, 2010).  Vaccination non-receipt because of child illness 
may be an example of appropriate non-receipt or may reflect parents making a personal, 
although uninformed, decision for their child.  Lack of access to healthcare, including not 
having health insurance and having transportation problems were associated with 
vaccination non-receipt in both existing reviews and in actual non-receipt in the present 
review.  The review also highlighted that parents who have problems finding childcare for 
other children whilst the target child is being vaccinated were also more likely to have not 
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had their child vaccinated.  These factors appear to relate to poverty and so should be 
considered by governments if vaccination non-receipt is to be reduced.  Finally, the review 
raised the issue of forgetting appointments as being important in affecting vaccination non-
receipt.  Putting systems in place to remind parents that appointments are due has been 
shown to improve childhood vaccination, particularly telephone call reminders from 
surgeries (Jacobson & Szilagyi, 2005). 
 
Lifestyle choices, past health behaviours and health outcomes 
Few lifestyle choice, past health behaviour and health outcome factors were shown to be 
strongly associated with vaccination non-receipt.  These factors were not considered in any 
of the existing reviews and were not raised in the qualitative studies.  Children who had not 
previously received all of their recommended vaccinations or who had previously had a 
vaccination delayed were more likely to have refused vaccination or parents’ intentions to 
refuse a vaccine were higher.  This suggests that parents may use their previous vaccination 
decisions as a heuristic to help them decide about future vaccines, especially novel ones.  
This self-identity of being a ‘vaccination refuser’ may be difficult to counter and perhaps 
the greatest efforts to encourage vaccination should occur with the first vaccines that 
children are offered with the intention of this impacting on future vaccination decisions.  
Having a preference for, or previous use of, complementary and alternative medicine was 
associated with greater actual vaccination non-receipt.  For HPV vaccination receipt 
previous history of cervical cancer screening, history of abnormal cervical screening results 
and history/experience of cervical cancer were consistently not related to vaccination 
receipt.  This was also the case for the girls’ sexual behaviour.  It is useful to know that 
there is no need to measure these factors when exploring reasons for vaccination non-
receipt in the future. 
 
Vaccine-related attitudes 
Vaccination-related attitudes were considered separately from social cognition model 
concepts as there were a variety of attitudes identified that needed special consideration 
rather than being grouped under the heading ‘attitudes’ in models such as the TPB.  
However, many of these attitudes could be grouped with the unspecific measurement of 
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benefits and barriers reported in a number of studies.  Concerns were consistently identified 
in all aspects of this review to relate to vaccination non-receipt including general concerns, 
concerns about safety, concerns about efficacy and concerns about the effect of the HPV 
vaccination on the sexual behaviour of adolescents.  These concerns were evident in a 
number of countries and frequently cited.  Concern about sexual behaviour was only raised 
in studies investigating non-receipt of HPV vaccination and not all childhood vaccinations 
suggesting that it is a specific concern to this particular vaccine.  It is an issue that has only 
been raised since the development of this particular vaccine6.  It was deemed to be 
influential in both qualitative and quantitative studies, suggesting that it is a novel issue that 
deserves further enquiry.  Studies that investigated HPV vaccination intentions also found 
participants who did not believe vaccinations to be important were more likely to intend to 
refuse the vaccine highlighted, the importance of fear of needles and lack of trust in 
vaccination authorities/pharmaceutical companies.  The fact that these three issues were not 
found to be associated with vaccination non-receipt in other aspects of this review suggests 
that they may only be important in informing vaccination intentions but are not significant 
enough reasons to actually refuse vaccination. 
 
Social cognition model factors and knowledge 
Perceptions of susceptibility were highlighted in every aspect of this review to be 
associated with vaccination non-receipt (actual non-receipt, intentions to refuse, qualitative 
reasons for non-receipt and in the findings of previous reviews) although the strength of the 
evidence was weaker for actual non-receipt as few studies had considered this factor.  
Perceptions of susceptibility or invulnerability are suggested by both the HBM (Becker et 
al., 1977; Rosenstock, 1966) and PMT (Rogers, 1975; 1983) to be important in determining 
whether a behaviour is engaged in and this appears to be the case for vaccination.  
Normative beliefs, considered in the TPB (Ajzen, 1985; Ajzen, 1988; Ajzen, 1991), 
emerged from all aspects of the review to influence vaccination uptake.  Barriers versus 
benefits or negative vaccination beliefs were identified as being associated with intentions 
                                            
6
  Previously vaccination against Hepatitis b (an STI) for adolescents has been trialed in one Scottish city.  
However, this pilot implementation was not accompanied with the mass media advertising and commentary 
that has been the case for HPV vaccination.  This is likely to mean that parents offered Hepatitis b vaccination 
for their children were less likely to be engaged with the vaccination programme and the sexually transmitted 
nature of the vaccine than those parents offered HPV vaccination for their daughters. 
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not to receive a vaccination (although this was not the case for actual vaccination non-
receipt).  These beliefs or attitudes are theorised to determine behaviour in a number of 
social cognition models, although this may not actually be the case for vaccination.  
Perceived severity and self-efficacy were highlighted in the review of existing reviews to 
be influential in informing vaccination non-receipt but this was not the case for the present 
review.  Perceptions of severity were considered in a number of studies for the present 
review and the lack of evidence that it is important suggests that it is no longer prominent 
in vaccination non-receipt.  Few studies reported findings for self-efficacy and so its lack of 
influence in the present review was due to a failure of studies to measure the construct 
rather than it not being important. 
 
Intentions to refuse vaccinations and the summary of existing reviews found lower 
knowledge to be associated with non-receipt, but this was not the case when participants 
reported the reason for their non-receipt/intention to refuse vaccination or when examining 
actual vaccination non-receipt.  This discrepancy may be because knowledge is considered 
important when thinking about vaccination hypothetically, but in reality lack of knowledge 
or having high knowledge does not prevent vaccination.  The existing reviews are likely to 
have considered studies that were conducted prior to the introduction of the HPV vaccine 
and if this were the case the reviews are more likely to have explored studies considering 
existing early childhood vaccinations than HPV.  It is possible that knowledge of these 
vaccines was more variable than knowledge of a new vaccine where only a rare minority 
have any prior understanding (HPV vaccination) and this would have allowed for greater 
variability in the data and made significant effects easier to detect (i.e. there is a greater 
likelihood that some participants had high knowledge as well as others having low 
knowledge).  The implication of this is that HPV vaccination knowledge may become a 
more influential factor on vaccination non-receipt as the vaccine becomes more established 
and there are more opportunities to gain knowledge.  Perceptions of low knowledge and a 
desire for more information were found to be influential in actual vaccination receipt and in 
the reasons given to explain vaccination non-receipt suggesting that perceptions of low 
knowledge are more associated with vaccination than actual knowledge.  Parents who 
sought more information were less likely to have vaccinated their children but this was 
most likely because these parents have an existing uncertainty about a particular vaccine 
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and so have sought more information than the average parent who does not share these 
concerns, rather than it being that greater knowledge per se equaling greater non-receipt. 
 
How might these factors work together to affect vaccination non-receipt? 
As multiple-variable studies were not considered in this review it may be important to 
contemplate how the factors identified to be important in this review collectively influence 
vaccination non-receipt and the pathways through which they work.  The social cognition 
models described in the introduction and Sturm et al’s (2005) model of parental vaccination 
decision making (described in the summary of reviews) provide a useful structure to work 
with, with the addition of other factors identified to be influential in this review.  Using the 
evidence described in this review a model to explain vaccination non-receipt has been 
proposed.  As illustrated in Figure 2.4 demographic factors may influence social cognition 
model variables of barriers/benefits or attitudes (from the HBM and TPB respectively), 
perceived susceptibility/vulnerability (from the HBM and PMT) as proposed in the HBM 
and normative beliefs (from TPB).  The practical factors would most likely affect the 
relationship between intentions and behaviour, although intuitively perceived/actual low 
knowledge within this factor may also affect perceived susceptibility and 
barriers/benefits/attitudes independently (not included in the diagram).  There was no 
evidence in this review for the role of the factors that the TPB suggests informs subjective 
norms.  Social cognition model factors inform vaccination intentions, as do lifestyle choice, 
past health behaviour and health outcome factors.  There was not evidence in the present 
review to suggest that the social cognition model components impact on 
behaviour/intentions through self-efficacy as proposed by the HBM.  Although there was 
no support for the role of intentions in the present review, in accordance with the TPB and 
PMT, intentions are likely to inform behaviour. 
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Figure 2.4: Proposed model to explain vaccination non-receipt using the evidence from this review. 
 
A relevant systematic review was published after the final search was conducted, but the 
topic and findings were pertinent to the present review and so are briefly discussed below 
(Brown et al., 2010).  The review considered the factors that are related to whether parents 
allow their child to receive the first dose of combination vaccinations offered in childhood 
in developed countries and included studies published from 1987-2008.  The majority of 
the 31 empirical studies considered in the review were conducted in the UK and Ireland, 
sampled mothers and used unrepresentative samples.  In agreement with the present review 
they found the methodological quality of the studies to be mediocre, calling into question 
the reliability of the findings and criticised the use of non-objective measures of 
vaccination receipt and retrospective methods.  Similarly to the present review, parental 
attitudes about the safety and efficacy of combination vaccines were consistently associated 
with vaccination receipt and the authors also highlighted the importance of mistrust of 
government and healthcare professionals.  There appeared to be a role for knowledge, 
source of information and satisfaction with information provision.  Contrary to the present 
review they found that perceptions of disease severity were associated with uptake and their 
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qualitative findings suggested that parents dislike risking their child’s health solely so that 
herd immunity is achieved.  The authors found vaccine refusers to generally have lower 
incomes and levels of educational attainment and for the child to not be their first born.  
However, the review considered parental intentions to vaccinate their child against existing 
vaccines in addition to actual vaccination decisions, unlike the present review. 
 
Limitations 
The limitation that is of primary importance is the mediocre quality of the evidence to 
support the findings of this review.  The majority of findings had an unclear risk of bias, for 
a number it was plausible that the finding was biased and in very few cases could it be 
certain that the findings were unlikely to change had the studies been replicated.  The 
criteria used to judge the quality of the individual studies were stringent but included 
important methodological techniques that should ideally be used.  A systematic review 
examining the measures used in 79 studies exploring HPV vaccine acceptability echoes the 
concerns of this review (Allen et al., 2010).  The authors concluded that these studies are 
limited by being cross-sectional in design and failing to report reliability or validity 
statistics.  Future research should consider performing prospective studies, that use 
objective measures of vaccination receipt, that have piloted their study, that report their 
methodology for qualitative analysis, that are sufficiently powered to detect small effect 
sizes and should dedicate considerable effort to ensure a high response rate. 
 
The methodologies used by the studies considered in the review employed a variety of 
definitions of vaccination non-receipt which could have caused findings to vary.  However 
on no occasion did the definition of vaccination non-receipt explain differences in findings 
(for example when significant and non-significant results were reported).  In most cases 
vaccination status was elicited through self-report which as discussed in the methods 
section is liable to bias, although objective measures such as medical records are not perfect 
themselves, they are created with the intention of being a documentation of healthcare 
receipt (Harrington et al., 1995; Jefferies et al., 1991; Salmon et al., 2005; Wei et al., 2009).  
It is likely that there is a degree of measurement error in most of the studies considered in 
this review. 
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The populations considered in the studies included in this review were fairly homogenous 
and mainly used American participants, although the studies were performed in a large 
number of countries.  The research was conducted with participants who were reasonably 
wealthy, with an average education and were predominantly white, suggesting that the 
findings are not a true reflection of whole populations.  Ethnicity was not often reported 
and given that ethnicity appeared to be an important factor in vaccination non-receipt this is 
a limitation of current research.  This can be easily rectified in future research.  Fathers only 
were not considered in any study.  This may reflect the fact that mothers are traditionally 
the primary caregiver for children and so are likely to be bringing them to clinics for 
vaccination, where recruitment for studies often occurred.  However, this neglects that 
fathers will likely be involved in the vaccination decision making process and their 
opinions need considering.  A crude estimate of the most common age of child was 11 
years.  This is likely a reflection of the large number of HPV studies included in the review 
raising the average age as few of the early childhood vaccination studies used participants 
who were that distal from vaccination receipt. 
 
This review explored some studies that examined vaccination completion.  Completion is 
likely to vary by vaccine type and number of doses needed and this level of detail was not 
considered in this review.  As a consequence the findings of this review relating to 
vaccination completion specifically are unlikely to provide the level of detail needed to 
comprehensively understand vaccination completion; although this was not an aim of this 
review. 
 
The findings of the review have a number of restrictions.  Firstly, the approach was limited 
because effect sizes were not taken into consideration when interpreting the findings.  For 
this reason we cannot know the importance of each factor in informing vaccination non-
receipt.  Similarly, the number of participants in each study was not considered.  It is 
possible that evidence for a factor suggesting a positive relationship may have been based 
on a small cumulative sample size and that the one study reporting non-significant findings 
for this factor was ignored even though it could have been based on a very large study.  It 
may have been the case that the factors outlined in the proposed model to explain 
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vaccination non-receipt all made very small contributions to vaccination decision making, 
whereas factors that were not found to significantly relate to vaccination decision making 
had large effect sizes but were not powered sufficiently for them to be detected.  It may 
have been more appropriate for a meta-analysis to have been performed instead of a 
systematic review as such reviews do take into consideration effect size and sample size.  A 
meta-analysis was not conducted as means and standard deviations were not consistently 
reported in the articles included in the review.  Given the time limited nature of this review 
(conducted as part of a PhD) it was not feasible to contact all of the authors of the articles 
that were included in the review.  However, it must be acknowledged that the findings may 
have changed had a meta-analysis been performed. 
 
The review considered univariate results only; because of this the complex relationships 
between factors that are associated with vaccination compliance were not explored.  The 
grey and unpublished literature was not formally sought out during the literature search 
meaning that publication bias may have influenced the findings of the review.  
Additionally, I did not contact the authors of the studies to obtain missing data because, as 
described above, the review was time limited and had to be completed quickly.  It would 
have taken a considerable amount of time to contact all the authors of studies that reported 
multi-variable findings and for them to respond with the relevant information.  However, 
this does mean that data were not included in the review that had the potential to be 
publically accessible, which limits the accuracy of the findings of the studies. 
 
The studies considered were limited to childhood vaccination programmes in developed 
countries and to studies published in English language journals.  It is likely that relevant 
articles that were not published in English but were conducted in developed countries were 
omitted from this review.  Vaccination non-receipt in developing countries is likely to 
differ from developed countries because of socio-economic and cultural variations between 
individuals and healthcare systems.  The total sample sizes reported were used to assess 
quality and it is likely that the actual sample sizes used for some statistical tests may have 
been smaller than those used in this review for power calculations.  As a result some quality 
assessment points may have been awarded unjustifiably.  This review did not assess studies 
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that examined parents of sons7 only or boys only, nor did it assess studies that asked adults 
to respond for a hypothetical child.  Parents’ acceptance of the vaccine for a son could be 
different from acceptance for a daughter especially considering that males will not 
necessarily benefit from receiving a vaccine primarily targeting cervical cancer.  
Furthermore, hypothetical responses (for a son or in adults without children) will be less 
useful in explaining how parents will respond and may even confuse the picture for studies 
examining parents of vaccine-eligible daughters.  The review did not consider hypothetical 
STI vaccines other than the HPV vaccine.  Acceptance of other STI vaccines is likely to 
differ as the HPV vaccine is being promoted as a vaccine against cervical cancer whereas 
STI vaccines will primarily be endorsed for their benefits against STIs.  HPV vaccines have 
also received a lot of media and advertising attention since their licensing (2007) that other 
undeveloped STI vaccines have not, and this will have influenced knowledge and 
acceptance of the HPV vaccine and allowed individuals to have formed opinions. Finally, 
only one coder extracted the data, meaning that data extraction could have been coder-
biased.  However, I did double enter the extracted data which would have reduced the 
likelihood of basic errors in data extraction occurring. 
 
Conclusions 
This review identified a number of factors that are potentially important in influencing 
vaccination non-receipt, although the quality of the evidence overall provided an unclear 
risk of bias so the findings should be interpreted with caution.  Social cognition model 
factors of subjective norm, perceived susceptibility and benefits versus barriers or attitudes 
(particularly specific and general concerns) seem to influence non-receipt, as do practical 
factors, lifestyle choices, past health behaviours and health outcomes, and some 
demographic characteristics.  A model to explain vaccination non-receipt using the current 
evidence was proposed that was adapted from social cognition models and an existing 
model of parental vaccination decision making.  Future research should consider using 
more objective measures of vaccination receipt, it should consistently report ethnicity and 
                                            
7
 It has never been intended that males should receive the HPV vaccine as part of the UK childhood 
immunisation schedule. 
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should consider examining fathers only, individuals of a low SES and more heterogeneous 
populations that are not solely white. 
 
OBJECTIVES FOR THIS THESIS 
The HPV vaccination for the prevention of cervical cancer has the potential to reduce 
incidence of cervical cancer.  However, as identified in Chapter 1, a significant minority of 
girls in the main UK HPV vaccination programme did not receive the HPV vaccine during 
the first year of the programme, and the majority of girls who were eligible for vaccination 
as part of the ‘catch-up’ programme remained unvaccinated.  This literature review 
identified the possibility that concern about girls’ sexual behaviour following HPV 
vaccination may influence parents’ HPV vaccination decisions and, with the addition of 
other known predictors of HPV vaccination uptake, could explain why some girls are not 
receiving the HPV vaccine.  Given the relationship between HPV infection and sexual 
activity this issue is specific to HPV vaccination (unlike other communicable diseases that 
vaccines prevent) and has not been considered in the wider vaccination literature.  As a 
result, this aspect of HPV vaccination decision making and parental unease about a 
vaccination relating to sexual behaviour being offered in early adolescence, has not been 
considered in detail in previous research, although both quantitative and qualitative 
research have shown it to be important in influencing vaccination decision making.  As the 
case with the MMR vaccine has highlighted, single issues can override parents’ beliefs 
about the benefits of vaccination and determine vaccination choices.  The media played a 
role in the MMR controversy and it is highly likely that the development of a cancer 
preventing vaccine will receive substantial news coverage.  As a result, it will be important 
to monitor media coverage of the vaccine.  With a greater understanding of parents’ 
concern about girls’ sexual behaviour following HPV vaccination, it may be possible to 
alleviate these apprehensions by appropriately engaging with parents to reassure or address 
their anxieties.  This can be achieved by speaking to parents themselves as we will be able 
to understand their concerns more clearly.  It will also be important to investigate what 
effect adolescent girls believe the vaccine will have on their sexual behaviour and for 
sexual behaviour to be monitored when the vaccine has been received or offered. 
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Accordingly, the objective of this thesis was to explore parents’ concerns about sexual 
behaviour in their daughters following HPV vaccination in the context of the UK HPV 
immunisation programme and examine whether these concerns were justifiable.  The thesis 
had four specific aims: 
1. To explore whether the issue of girls engaging in increased risky sexual 
behaviour following HPV vaccination is being addressed in the UK national 
press. 
2. To establish the degree of concern that parents feel about HPV vaccination and 
sexual behaviour. 
3. To establish girls’ views on HPV vaccination and sexual behaviour. 
4. To examine the effect of participation in the HPV immunisation programme on 
sexual behaviour in older girls participating in the ‘catch-up’ programme.
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Chapter 3 – The theoretical and empirical evidence for adolescents 
engaging in risky sexual behaviour following HPV vaccination. 
The review of the literature in Chapter 2 revealed that parents have shown concern about 
their children’s sexual behaviour following HPV vaccination.  These concerns fall into two 
groups.  Firstly parents have expressed apprehension that girls will engage in more risky 
sexual behaviour following HPV vaccination because they believe that they have a reduced 
risk of catching an STI after receiving the vaccine; for example increasingly engaging in 
unprotected sex or having sex more often, at an earlier age and with a greater number of 
partners (for example, Marlow et al., 2007a; Ogilvie et al., 2007; Woodhall et al., 2007).  
The second type of concern expressed by parents is concern that HPV vaccination consent 
implicitly confers ‘carte blanche’ approval for sexual activity in their daughters (for 
example, Bair et al., 2008; Constantine & Jerman, 2007; Waller et al., 2006).  The 
prevalence and specific nature of these concerns are discussed in detail in Chapter 5 and 
Chapter 6.  Theoretical understanding of risk and evidence from similar contexts can be 
useful in attempting to predict and understand girls’ sexual behaviour, and specific to this 
situation, theories of risk perception from health psychology and economics may help 
investigate parents’ concerns.  It cannot be known whether sexual behaviour has actually 
changed until the vaccination programme is established.  However, it would not be 
unreasonable to consider that protection from an STI may lower risk perceptions and 
ultimately influence the adoption of safe sexual behaviours.  Alternatively, it could be the 
case that HPV vaccination results in increased perceptions of risk, leading to the adoption 
of safer sexual behaviour.  Short et al. (2010) interviewed older adult women about their 
attitudes to their receiving the HPV vaccine.  Some women thought that they might engage 
in safer sexual behaviour as HPV vaccination would act as reminder of the risks of having 
sex: “... like letting you know it’s a caution out there.  So I would use a condom just in 
case”.  In the absence of evidence of actual behaviour change of any kind following HPV 
vaccination, the theoretical background of the concern about risky behaviours expressed by 
parents was examined in this chapter. 
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PERCEIVED RISK 
Perceived risk is an individual’s ‘perceived probability that harm will occur if no action is 
taken’ and is also known as perceived likelihood, perceived susceptibility and perceived 
vulnerability (Weinstein, 2000).  Many academic disciplines have considered risk 
perceptions and identified a number of factors that are important in predicting perceived 
risk.  Economic theories of risk compensation (Wilde, 1976) suggest that perceived risk is 
predicted by past experience and the causal attributions that have been afforded to past 
outcomes.  The economic interpretations of perceived risk will be discussed in more detail 
below.  Psychological theories emphasise the importance of both experiential and rational 
systems in the construction of risk perceptions (Reventlow et al., 2001).  Heuristics such as 
optimistic biases (Weinstein, 1987) and affect such as dread (Fischhoff et al., 1978) both 
influence perceptions of risk.  The anthropologic Cultural Theory (Douglas & Wildavsky, 
1982) proposes that cultural adherence and social norms affect risk perceptions, and the 
Social Amplification of Risk Framework (Kasperson et al., 1988) suggests that the way a 
risk event is communicated amplifies or attenuates the receiver’s risk perceptions. 
 
THEORIES OF RISK PERCEPTION AND BEHAVIOUR CHANGE FROM 
HEALTH PSYCHOLOGY 
Perceptions of risk are identified as contributing components of many theories of health 
behaviour and are deemed to be the “motivational engine” behind many health protective 
behaviours (Robb et al., 2007).  Social cognition models including the Health Belief Model 
(Becker, 1974; Rosenstock, 1966), Protection Motivation Theory (Rogers, 1983) and 
Health Action Process Approach (Schwarzer, 1992; Schwarzer, 2001) all posit that 
perceived vulnerability or susceptibility to an illness predict behavioural intentions and 
behavioural intentions themselves are associated with actual behaviour (Conner & Sparks, 
2005).  Behaviour motivation theories solely specify that perceptions of personal risk 
predict behaviour (Brewer et al., 2004).  Risk-reappraisal theories (also termed adaptive 
accuracy; Renner et al., 2008) suggest that when actions are taken that are thought to 
effectively control or increase risk, individuals’ perceptions of risk adapt to reflect this 
change (Brewer et al., 2004).  Figure 3.1 is a diagrammatical representation of how these 
theories work together to help explain risky health behaviour following an illness-
prevention intervention.  In the context of HPV vaccination the theories would suggest that 
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HPV vaccination (the intervention) causes girls to perceive their risk of an STI to have 
lowered; these reduced risk perceptions predict the girls’ subsequent behaviour resulting in 
them engaging in riskier sexual behaviour. 
 
Figure 3.1 - The relationship between risk perceptions and behaviour 
 
 
 
Evidence for the theory 
Although there is a wealth of research investigating the role of risk perceptions in 
explaining behaviour, research examining the notion that risk perceptions change in 
response to an intervention and then predicting future behaviour is limited.  There is 
evidence that after the adoption of an illness prevention intervention, individuals’ 
perceptions of risk reduce but it is unknown whether this will be the case with HPV 
vaccination.  Brewer, Cuite, Herrington and Weinstein (2007b) studied Lyme disease 
protective behaviours following Lyme disease vaccination (a vaccine that reduces but does 
not eliminate the risk of disease).  They found perceptions of risk to have lowered in the 
vaccinated group (below the levels of the unvaccinated group; risk-reappraisal).  
Individuals who had been vaccinated (a group that had been shown to have lowered risk 
perceptions) were found to perform two of five Lyme disease protective behaviours less 
often than before their vaccination (using tick repellent and wearing light-coloured 
clothing; behaviour motivation). 
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ECONOMIC THEORIES OF RISK PERCEPTION AND BEHAVIOUR CHANGE 
Risk compensation, a term first coined by Wilde (1976), grew out of economic theories and 
encompasses both risk-reappraisal and behaviour motivation theories but also attempts to 
explain the flux in risk perceptions and behaviour.  It has mainly been investigated in the 
field of safety, specifically traffic safety. 
 
Inherent in risk compensation theories is the premise that individuals attempt to maximise 
the benefits and minimise the personal risks of engaging in an activity.  In order to acquire 
benefits of an activity, individuals accept a certain level of personal risk.  If personal risk is 
perceived to have changed, individuals will adjust their activity to readdress the benefits-
risk balance (this is risk-compensation).  Various versions of risk compensation have been 
proposed including Peltzman’s (1975) Economic Model of Human Behaviour and Human 
Behaviour Feedback Theory (Evans, 1985).  Three varying models of risk compensation 
will be introduced below: Risk Homeostasis (Wilde, 1982), Danger Compensation (O'Neill, 
1977) and Risk Thermostat (Adams, 1985; Adams, 1988).  A summary of the evidence for 
these theories has been provided. 
 
Risk Homeostasis (Wilde, 1982) 
Wilde (1982) proposed a physiologically-based version of risk compensation based on 
driving behaviour which he termed Risk Homeostasis (Figure 3.2).  The theory proposes 
that individuals have a target level of risk that they base on a balance between the perceived 
costs and benefits of action or inaction.  An individual’s evaluation of what costs they are 
willing to accept and what benefits they desire is defined by the level of physiological 
arousal that they perceive to be optimal (Simonet & Wilde, 1997).  Perceptions of risk arise 
from the individual’s evaluation of previous action and their knowledge of others’ 
experiences (Wilde, 2002).  Individuals attempt to maintain physiological and 
psychological equilibrium between perceived risk and target risk: if their perceived risk in a 
situation exceeds their target level of risk they will act to reduce their risk and if their 
perceived risk is lower than their target level of risk they will increase their risk through 
more dangerous actions. 
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Wilde argues that safety interventions, such as the implementation of seatbelts will not 
ultimately result in fewer accidents; although seatbelts may cause an immediate decrease in 
mortality from road accidents, after a lag-time (where new risk information is fed-back and 
interpreted, such as media reports that the roads are now safer), the number of negative 
events will return to normal as individuals may now perceive that they can now drive more 
quickly to compensate for the safety provided by seatbelts (the evidence for this is 
discussed in the next section).  Only safety strategies that influence the target level of risk 
will ultimately reduce the number of occurrences of an undesired outcome because it will 
mean that individuals are unwilling to accept a higher level of risk (Simonet & Wilde, 
1997). 
 
This theory has been criticised for assuming that individuals are able to rationally adjust 
their behaviour on a moment-by-moment basis (Robertson & Pless, 2002) and for 
suggesting that Risk Homeostasis occurs for all behaviours and in all situations (O'Neill & 
Williams, 1998). 
 
 
Figure 3.2 - Risk Homeostasis in driving behaviour (Wilde, 1982) 
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Danger Compensation (O'Neill, 1977) 
Danger Compensation theory approaches risk compensation from a theoretically distinct 
standpoint: expectancy theories.  O’Neill supposes that individuals are rational beings with 
stable goals.  They adjust their behaviour in an attempt to maximise the extent that 
outcomes reflect these goals and minimise risk (the motivation for behaviour is the 
maximisation of goals, rather than maintaining target risk).  Safety changes to an 
environment will not result in improved safety rates because after an undefined period of 
time accident rates will return to a ‘normal’ level due to individuals adjusting their 
behaviour to compensate exactly for the safety changes in their environment that have 
allowed them to further maximise their goals. 
 
The theory was designed to explain driving behaviour, but it is proposed that it could be 
applied to any regularly performed behaviour enacted to achieve a goal at the risk of a rare 
event.  O’Neill concedes that aspects of Danger Compensation may not always hold true in 
reality, such as individuals being accurate at estimating their own risk or being rational and 
that his approach is theoretical rather than descriptive. 
 
Risk Thermostat (Adams, 1985; Adams, 1988) 
Adams’ ‘Risk Thermostat’ (Figure 3.3) attempts to simplify Wilde’s original model and 
proposes that risk compensation is conceptual (rather than operational as Wilde suggests).  
Similarly to Wilde, Adams suggests that everyone takes risks to a varying degree.  
Decisions to engage in a risky behaviour are based on a balancing act between perceived 
danger (perceptions of risk) and the individual’s target level of risk (propensity to take 
risk).  Personal propensity to take risks is based on the rewards the individual perceives will 
result from engaging in a particular behaviour.  The perceived danger associated with 
engaging in a behaviour is influenced by prior experience (their own and others’) of 
negative outcomes that have resulted from engaging in that behaviour (“accidents”).  
“Accidents”/rewards are further predicted by the consequences of engaging in the current 
behaviour.  The example of having a suntan may make this theory clearer.  An individual’s 
sunbathing behaviour can be determined by their propensity to take risk and their perceived 
danger.  This individual’s propensity to take risks, for example staying in the sun, is 
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explained by their experience of the rewards that they perceive from having a suntan, such 
as thinking others look attractive or being previously told that they look healthy when they 
had a suntan.  Their perceived danger is based on their experience of being sunburnt or 
seeing another person with sunburn (or “accidents”).  The balance between the individual’s 
desire to avoid sunburn and desire to look attractive or healthy will determine their 
sunbathing behaviour and the outcomes of their chosen behaviour will predict their future 
propensity to take risks and perceived danger. 
 
Figure 3.3 - Risk Thermostat (Adams, 1985; Adams, 1988) 
 
 
Risk Homeostasis and Danger Compensation are more rigid versions of risk compensation 
than Adams’ Risk Thermostat.  They may be more useful in helping to understand changes 
or stability in population behaviour following the implementation of a risk 
reducing/increasing strategy, rather than explaining individual responses to such schemes.  
Many authors interpret risk compensation theories in general terms; accepting that 
individuals offset their perceived reduction in risk rather than making changes that 
completely compensate for reductions in risk (for example, Brewer et al., 2007b; Pinkerton, 
2001).  Adopting such an interpretation of risk compensation allows the use of the theory in 
general terms (as opposed to specific and more restrictive theories of risk compensation).  
Taking this approach appears to be a more intuitive and overarching attempt to explain 
human risk taking, especially in the field of health behaviours. 
 
A general interpretation of risk compensation can be applied to HPV vaccination and risky 
sexual behaviour.  An adolescent girl could be motivated to not use condoms because of the 
embarrassment of discussing using them with her partner, but thinks she should use them to 
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avoid catching an STI.  If following HPV vaccination, this girl perceives her risk of STIs to 
have been reduced, she can permit herself to engage in more unprotected sex without 
exceeding her risk threshold. 
 
Evidence for risk compensation 
No studies have examined risk compensation specifically in relation to HPV vaccination.  
Much of the evidence for the theory’s development came from observational studies of 
traffic accidents following the implementation of enforced safety measures, such as 
wearing seat belts, although this research did not measure risk perceptions directly.  Adams 
(2000, p.125) reported that the implementation of seat belt laws had no effect on total 
fatalities; although car occupants were less likely to die, pedestrians and cyclists were more 
at risk due to increases in risky driving by motorists.  However other data has questioned 
such findings (Ferguson et al., 1995; Kahane, 1994; Kahane, 1996; Lund & Zador, 1984; 
Lund & Ferguson, 1995; O'Neill & Lund, 1993; Zador & Ciccone, 1993).  Some studies 
have partially supported the theory, but the idea that original levels of risk are always 
restored is not consistently evident in the data.  Peterson, Hoffer and Millner (1995) 
reported that there was an increase in the number of insurance claims following the 
adoption of airbags by drivers, but the increase did not diminish over time (as would be 
expected with restoration of original risk levels) and in the HIV prevention literature 
increases in condom use appeared to have coincided with an increase in the number of acts 
of intercourse but this overall rise did not increase HIV/STI risk (Pinkerton, 2001). 
 
A more recent examination of risk compensation tested the theory more comprehensively 
by examining the role of risk perceptions.  Brewer, Cuite, Herrington and Weinstein’s 
(2007b) Lyme disease experiments provide partial support for risk compensation.  As 
explained in the section exploring psychological theory of risk, Brewer et al. reported that 
risk perceptions reduced after vaccination and vaccinated individuals performed certain 
Lyme disease protective behaviours less frequently.  Their data also showed that vaccinated 
individuals who perceived greater reductions in risk reduced the frequency with which they 
performed four Lyme disease protective behaviours more than vaccinated individuals who 
had smaller reductions in perceived risk.  Furthermore, individuals who over time engaged 
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in fewer Lyme disease protective behaviours perceived their risk to have increased.  
However the notion of original levels of risk being restored was not supported by their data; 
more rigid interpretations of the theory would predict that vaccinated individuals (who 
should have had a perceived reduction in risk) who engaged in fewer protective behaviours 
(and so should have had a perceived increase in risk) would show no change in risk 
perceptions, but this interaction was not confirmed by the data. 
 
It appears then that partial support for the theory is evident, namely that safety interventions 
can result in individuals increasing their risky behaviour.  However, the notion of original 
levels of risk being restored is not often supported by the data.  This further supports a more 
general interpretation of the theory.  There are also methodological problems with most 
existing risk compensation studies as they have not assessed perceived risk, arguably the 
most important aspect of the theory. 
 
Limitations of applying risk compensation theories to the context of HPV vaccination 
There is reason to believe that risk compensation will not be evident in the context of HPV 
vaccination.  Theoretical caveats to the idea that girls will engage in risky sexual behaviour 
following HPV vaccination are described by Hedlund (2000).  Hedlund suggests that risk 
compensation will only occur under certain conditions: those in which the protective 
behaviour is perceived to be effective, when the protective behaviour is visible, when the 
individual is motivated to change their current behaviour, and when the individual has 
control over their current behaviour.  It is unknown whether adolescent girls will remember 
that they have received the vaccine when engaging in sexual activity, whether they are 
motivated to engage in sexual behaviours more frequently or without protection, and 
whether they believe that they have self-efficacy in their sexual behaviours.  Nor is it 
known how effective girls perceive the vaccine to be (and the impact of this on their risk 
perceptions) and this in itself is dependent on a complex interplay of a multitude of factors 
identified at the beginning of this chapter.  Unlike other health behaviours such as exercise 
and dental hygiene, risky sexual behaviours are dependent on the behaviour of two people 
and consequently the interaction of two individuals’ perceptions of risk must be taken into 
account.  The beliefs of others who are equally affected by the risk behaviour are not 
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considered by theories of risk compensation, although they are likely to be hugely 
important in the context of sexual behaviour.  Even if the criteria for risk compensation 
were fulfilled in girls who receive the HPV vaccine, boys are currently not offered the 
vaccine in the UK and so their risk perceptions may not change in accordance with the 
theories unless they see the girl as a less risky partner. 
 
Evidence of behaviour change in other STI reduction interventions 
As there is not yet any evidence of the effect of HPV vaccination on behaviour change, it is 
important to consider whether there is any evidence of behavioural alterations following 
other STI reduction interventions.  Some research, although not specifically testing risk 
compensation has shown undesirable changes in behaviour following such interventions.  
These studies have not examined whether risk perceptions mediate behaviour change or 
whether original levels of risk are ultimately restored and were designed to establish the 
efficacy of the intervention in STI reduction rather than exploring the effect of the 
intervention on changes in sexual behaviour.  Nevertheless they do provide an indication of 
how individuals respond to sexual health interventions that reduce the risk of STI 
acquisition.  
 
Circumcision has been used as an intervention to reduce HIV and STI transmission.  It has 
been shown to reduce HIV transmission in South Africa, Kenya and Uganda by up to 60% 
(Auvert et al., 2005; Bailey et al., 2007; Gray et al., 2007).  Auvert et al. (2005) reported 
that following circumcision, males had more sexual partners than non-circumcised males 
(although no differences were found for condom usage).  Similarly, Gray et al. (2007) 
found that six months after circumcision males reported more inconsistent condom use and 
were less likely to use condoms than non-circumcised males, although these differences 
were not present at 12 or 24 month follow-up and the authors did not make it clear whether 
condom use differed from baseline reports.  Bartholow et al. (2005) studied male 
participants in an HIV vaccine trial who reported having sex with men and although they 
found an overall decrease in instances of unprotected anal sex, those who believed that they 
were allocated to the experimental arm (although they were blind to their allocation) 
reported an increase in their instances of unprotected anal sex.  However two trials of male 
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circumcision found no differences in sexual behaviour between circumcised and non-
circumcised males (Agot et al., 2007; Wawer et al., 2009) and another found in absolute 
terms, males to report more consistent condom use, a reduction in instances of unprotected 
sex and to make fewer reports of two or more partners in the previous six months than 
before their circumcision (Bailey et al., 2007).  The participants in these studies knew that 
they were involved in HIV risk reduction trials although none of the authors explicitly 
stated whether participants knew how much their risk had been reduced by. 
 
Finally, there is some weak evidence that sexually transmitted infection vaccinations 
already in use do not negatively influence sexual behaviour.  Ogilvie, Anderson, Marra 
McNeil and Pielak et al. (2010) reported that increases in the average age of sexual debut 
for adolescents in British Columbia, detailed in Saewyc, Taylor, Homma and Ogilvie 
(2008), occurred at the same time that Hepatitis B vaccination for 11 year olds was 
introduced into a school-based immunisation programme.  However, the original authors 
did not suggest that the introduction of the programme influenced the improvements in 
sexual behaviour nor was the vaccine considered in any of their primary analysis. 
 
Limitations of applying evidence from existing STI reduction interventions to the context of 
HPV vaccination 
Methodological issues may limit the relevance of evidence from existing STI reduction 
interventions to the context of HPV vaccination.  Firstly, the studies described mainly used 
male populations, most of which were from Africa.  Cultural and gender differences may 
restrict the relevance of these studies to British girls receiving the HPV vaccination.  
Furthermore, some of the interventions were much more invasive than HPV vaccination 
and the participants’ involvement in a substantial clinical trial is likely to have influenced 
not only the attitudes and behaviours of the participants, but of their sexual partners also. 
 
Secondly, in comparison to HIV, knowledge about HPV is low, especially its link to sexual 
behaviour.  Prior to the development of the vaccine the percentage of young women who 
knew that HPV was the cause of cervical cancer was sometimes reported to be as low as 
8% (Klug et al., 2008) and the UK government are promoting the vaccine as a cervical 
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cancer prevention method rather than as protecting against an STI.  Consequently, girls 
may not even associate the vaccine with sex, although the HPV vaccination information 
leaflet aimed at older girls does reference the sexually transmitted nature of HPV.  Even if 
knowledge improves, there is a complex interplay of factors that affect sexual behaviour 
that shall be discussed in detail in Chapter 7.  For example, fear of pregnancy or other STIs 
(that the vaccine does not protect against) are commonly reported reasons for remaining 
abstinent in young women (Blinn-Pike, 1999; Morrison-Beedy et al., 2008).  Finally, risk 
theories ignore the emotional aspects of initiating a sexual relationship with another person. 
 
SUMMARY OF CHAPTER 3 
Until the HPV vaccination programme is established it will remain unknown whether 
parents are right to be concerned that their daughters are likely to engage in more risky 
sexual behaviour following HPV vaccination.  Theories of risk perception from health 
psychology and economics and evidence from comparable contexts to HPV vaccination can 
help predict whether behaviour change is likely.  Although the importance of perceived risk 
in health behaviour research is recognised, there is very little health psychology research 
examining alterations in perceived risk and subsequent behaviour change.  General 
interpretations of economic theories provide a useful structure to examine such events but 
again little research has employed the constructs appropriately.  There are also other 
theoretical caveats that limit the theory’s relevance to HPV vaccination.  Some evidence 
from STI reduction interventions suggest that sexual behaviour may change but their 
relevance to the HPV vaccine is questionable.  Taking these caveats into account it appears 
unlikely that girls will engage in more risky sexual behaviour following HPV vaccination, 
but given mothers’ concerns it is important to investigate further.  Risk compensatory 
behaviour is only likely if certain criteria are fulfilled: the intervention needs to be visible 
and perceived to be effective, the individual must have control over their behaviour and be 
motivated to change.  In addition for behaviour change to be likely, young women are 
going to have to misinterpret the protection afforded by the vaccine to include all STIs and 
is more likely to cause young women to reduce their condom usage or increase their 
number of sexual partners if they are sexually active prior to vaccination (rather than 
virgins initiating sexual relationships). 
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Even though behaviour change will be unlikely in most girls, theoretically behaviour 
change is possible in a minority of cases.  Risk theories may not prove applicable to HPV 
vaccination, but their constructs and proposed pathways will be useful in determining what 
should be measured and how analysis should be conducted.  Even if no girls change their 
behaviour following vaccination, as detailed in Chapter 2, some parents would withhold 
consent to HPV vaccination for this reason.  Demonstrating that behaviour does not change 
may help alter these parents’ beliefs.
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Chapter 4 – An analysis of newspaper articles about the HPV vaccine and 
risky sexual behaviour 
BACKGROUND8 
Chapter 2 identified that parental concern about risky sexual behaviour in girls following 
HPV vaccination has been addressed in the academic literature.  Given the newsworthiness 
of the development of a vaccine to prevent a cancer, the HPV vaccine has received 
significant coverage by the mass media and the issue of adolescent sexual behaviour in the 
context of the vaccine was mentioned.  The public consider the media to be a useful source 
of information about HPV and it has the potential to affect perceptions of health issues 
(Lupton, 1998; Pitts et al., 2007).  News articles often try to provide a ‘balanced’ discussion 
of current affairs (even if the alternative view is only endorsed by a minority), in an attempt 
to indicate that competing arguments exist (Hargreaves et al., 2003) and commentary 
articles can also assert controversial opinion to stimulate debate.  Both types of article 
provide opportunities for anti-vaccination groups and beliefs to be represented.  Experience 
in the UK of other vaccines, notably those against pertussis and MMR, shows that media 
reporting of vaccine safety issues can hugely influence public perceptions and vaccine 
uptake (Griffith, 1981; Hackett, 2008).  The sexually transmitted nature of HPV will likely 
generate significant media coverage and public debate, and coupled with the unease that 
has accompanied the use of previous vaccines, this may affect parents’ vaccination 
decisions. 
 
Little is known about the content of the British media coverage that the HPV vaccine has 
received.  Quilliam (2006) reviewed 11 HPV vaccination stories in British newspapers and 
British news websites after the announcement that the vaccine had been developed.  Five of 
these reports were predominantly positive, and stories that criticised the vaccine tended to 
                                            
8
 This study was conducted between December 2007 and June 2008.  Literature available during this period 
which contributed to the rationale for this study has been presented in the introduction.  Literature published 
after analysis had been performed has been introduced in the discussion section.  A version of this chapter has 
been published in the Journal of Health Communication (Appendix 5). 
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have only a single sentence of negative commentary.  Only one article was completely 
disparaging.  Greene and Davies (2008) reporting a preliminary analysis found British print 
and electronic media coverage about the HPV vaccine to be dominated by articles detailing 
a moral panic regarding vaccination against an STI but the stories did not reflect traditional 
anti-vaccination discourse.  Systematic analyses of newspaper and television news stories 
about HPV in the American media have been conducted although are limited by reviewing 
articles published over a short period of time (Ache & Wallace, 2008; Anhang et al., 2004a; 
Calloway et al., 2006), and either prior to the vaccine being recommended for use by the 
American government or not long afterwards.  These studies found that information 
provided about HPV was not always accurate, often failing to include the basic facts that 
women generally want to know, such as information about transmission (Anhang et al., 
2004a; Calloway et al., 2006), and they mainly quoted vaccine manufacturers or scientists 
(Calloway et al., 2006).  One analysis of HPV vaccination videos posted on the internet 
found that the content was mainly positive (Ache & Wallace, 2008), although a proportion 
of these videos are likely to have been funded or created by the pharmaceutical industry.  
Calloway et al (2006) found 24% (n=6) of the American articles they analysed discussed 
parental concerns about adolescent sexual behaviour following vaccination, however the 
specific details of such discussions have not been evaluated in the scientific literature. 
 
As has been the case with other vaccines previously, British media coverage of the HPV 
vaccine is likely to influence public awareness of the immunisation programme and 
perceptions of whether others are choosing to receive the vaccine or providing consent for 
their daughters to do so.  Previous examinations of newspaper coverage of the HPV vaccine 
have mainly considered the American press.  The findings of international studies, although 
useful to our general understanding of such issues, are likely to have been dependent on 
culture-specific beliefs and the unique immunisation programmes of these countries so their 
findings are less relevant to the discussions that are being reported in the UK.  British 
analyses of media coverage have reported incomplete findings or have taken an 
unsystematic approach to their analysis.  No study has explored in detail the impact that the 
sexually transmitted nature of this particular vaccine has had on media coverage.  Public 
discussions of girls engaging in risky sexual behaviour may shape parents’ beliefs about the 
matter.  It is important to establish the nature of such stories to identify whether these issues 
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are likely to become barriers to parents consenting to HPV vaccination, particularly as 
health psychology theory suggests that potential barriers determine vaccination uptake 
(Becker et al., 1977; Rosenstock, 1966). 
 
The present study sought to address aim one of this thesis: 
1. To explore whether the issue of girls engaging in increased risky sexual behaviour 
following HPV vaccination is being addressed in the UK national press. 
 
British newspaper stories about the HPV vaccine published in the most highly read main 
national daily and Sunday papers were examined.  Stories discussing the issue of girls 
engaging in risky sexual behaviour following HPV vaccination were analysed 
quantitatively and qualitatively.  Articles were considered that were published over a five 
year period, going beyond the time that the vaccine was first licensed to provide a more up-
to-date analysis than previously published research.  Five study-specific research questions 
were posed: 
1. How frequently is the HPV vaccine reported on in the news press? 
2. What proportion of articles on the HPV vaccine mention risky sexual behaviour 
following vaccination? 
3.  Has the proportion of articles being published that discuss risky sexual behaviour 
following HPV vaccination changed over time? 
4. What is the tone9 of articles mentioning risky sexual behaviour following HPV 
vaccination? 
5. What is the content of articles mentioning risky sexual behaviour following 
vaccination? 
 
As the American press has discussed parents’ concern about adolescents engaging in more 
risky sexual behaviour following HPV vaccination, it was hypothesised that this issue 
would also be discussed publicly in the British press.  Given the findings of previous 
                                            
9
 Tone was defined as ‘supportive’ (generally encouraging of the vaccine), ‘neutral/balanced’ (stating no or 
mixed opinions about the vaccine) or ‘opposed’ (generally critical of the vaccine). 
                                                                          CHAPTER 4 – NEWSPAPER ANALYSIS 
 120 
literature about the vaccine generally, it was also expected that these reports would mostly 
be positive.  Findings about the frequency of articles published and the content of these 
articles were not predicted. 
 
METHODS 
This study was retrospective, employing descriptive quantitative and qualitative methods to 
examine newspaper stories relating to the HPV vaccine and risky sexual behaviour.  Ethical 
approval was not required for this study.   The electronic database NexisUK was used to 
obtain the stories for analysis (Reed Elsevier Ltd, 2008).  NexisUK is an online database of 
articles from over 12,500 international, national and regional news sources worldwide. 
Filters can be applied to the database so that searches are specific to a country, date or by 
newspaper type or name.  It is used in a similar way to other literature databases such as 
Medline: the user searches for key words and any instance of their use in an article that is 
published in a newspaper within the search filters is shown in the results.  The whole article 
that uses that key word can then be downloaded in full.  The most highly read daily (N=11) 
and Sunday (N=10) newspapers in the UK were searched (based on Guardian circulation 
figures from December 2007; Guardian News and Media Limited, 2008a; Guardian News 
and Media Limited, 2008b; Table 4.1) over a five year period (February 2003 to February 
2008).  The search terms included “HPV OR human papillomavirus”; “cervical AND 
cancer”; “STD OR sexually transmitted disease AND vaccine” as well as common 
misspellings of these terms. 
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Table 4.1 - Newspapers evaluated in the study 
 
No. of articles that were predominantly… Newspaper name grouped by newspaper 
type 
No. of 
included 
articles  Supportive 
Neutral 
/balanced Opposed 
Tabloid newspapers     
The Sun 4 1 3 0 
The Mirror 4 1 3 0 
The Daily Star 0 0 0 0 
The Daily Record 3 2 1 0 
News of the World 1 1 0 0 
Sunday Mirror 1 0 1 0 
The People 0 0 0 0 
The Daily Star Sunday 0 0 0 0 
Middle-market newspapers     
The Daily Mail 24 4 21 1 
The Daily Express 5 1 4 0 
The Sunday Mail 0 0 0 0 
The Sunday Express 2 0 1 1 
Broadsheet newspapers     
The Daily Telegraph 13 3 8 2 
The Times 7 4 3 0 
The Financial Times 7 1 5 1 
The Guardian 6 2 5 0 
The Independent 4 1 4 0 
The Sunday Times 3 0 3 0 
The Sunday Telegraph 1 0 1 0 
The Observer 2 0 2 0 
The Independent on Sunday 1 0 1 0 
Total 92 21 66 5 
 
After reading the stories identified by the search to gain familiarity with them, inclusion 
and exclusion criteria were applied that had been developed through discussions with 
colleagues.  All stories that in any way addressed the issue of girls engaging in risky sexual 
behaviour following HPV vaccination were included.  Articles were included both if they 
suggested that sexual behaviour would change following vaccination, but also if they 
explicitly stated that is would not or made reference to the argument.  Stories were 
excluded if they were duplicates, focused on the finances of pharmaceutical companies or if 
less than 100 words of the story related to the HPV vaccine.  One story was removed 
because it was a biography of an immunologist.  All other article types were included (e.g. 
letters, editorials) to achieve a more comprehensive understanding of the topic by accessing 
both news and comment.  The inclusion criteria were applied to all the articles identified by 
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the author of this thesis and another rater read 20% of the stories to validate this process.  
The kappa was good (.73; Cohen, 1960) and percentage agreement was high (92%). 
 
Analysis  
For each article a number of characteristics were noted: the date of publication, type and 
name of newspaper, type of article, political stance and readership of the newspaper 
(according to the Newspaper Marketing Agency), whether a major news event about HPV 
occurred in the month the article was published and the percentage of words in the article 
that referred to risky sexual behaviour.  For the quantitative analysis the number of articles 
published per month was plotted, the predominant topic of each story was established and 
the number of times each topic arose overall was summed. 
 
Framework analysis was used to qualitatively organise the news articles and identify the 
categories that were arising from the data; it is a non-linear analytical method (Spencer et 
al., 2003).  The categories that were identified were interpreted descriptively using methods 
employed in the analysis aspect of content analysis.  Content analysis first emerged in the 
early 20th century from the human sciences.  It allows the analyst to determine the 
frequency that categories occur as well as their content and context and is often used to 
analyse newspaper articles (Weber, 1990).  Content analysis ultimately results in a counting 
exercise, which can make results less open to interpretation than other qualitative methods 
(Weber, 1990).  This method was deemed most appropriate for analysis as there were a 
large number of articles to be examined and it was not the intention of the present study to 
explore implicit meaning within the articles, but to consider the overt messages that parents 
are being exposed to.  The category counting associated with content analysis was also 
particularly useful for this longitudinal study as it could reveal change over time. 
 
Framework analysis consists of five stages (Ritchie & Spencer, 2000, p.178) and these were 
adhered to in the present study (see Appendix 4 for an example of the framework analysis).  
The first stage is familiarisation.  The analyst reads through the data, making notes on 
topics that arise.  Secondly, a thematic framework is identified based on the notes made 
during familiarisation.  This initial framework is large but is refined by the analyst 
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conceptualising the issues more comprehensibly and involves subjective judgements of the 
importance of the categories.  Next the analyst indexes the original data by matching it to 
the categories in the thematic framework.  The fourth stage is charting: each case is 
assigned one row and each category assigned a column, permitting comparisons between 
categories and cases.  Examples of each category from each case are placed in the chart.  
The main characteristics of each case were also charted (date of publication, article type, 
newspaper name and type, readership and political stance of the newspaper, whether a 
major news event about HPV occurred in the month the article was published and whether 
the percentage of words referring to risky sexual behaviour in the article was above the 
median percentage for all included articles).  Similarities were identified between initial 
categories; these categories were grouped together and labelled.  The framework was then 
revised to ensure that it was appropriate for the data.  The conceptual framework was 
constructed using Microsoft Office Excel (Microsoft Corporation, 2003).  The final stage is 
mapping and a content analysis approach was taken here.  The charted categories were 
examined to explore the content of the text within each category, when the categories 
occurred, their context and frequency of occurrence.  This qualitative method draws 
meaning from the original data at all stages of analysis and the data is systematically 
processed.  Throughout this whole process, personal memos were kept to remind the 
analyst of categories that were arising and links between categories.  The raw data was 
regularly returned to to ensure that the data was being analysed in an appropriate context.  
Similarities within categories were examined, but data was also respected for its uniqueness 
and outliers were noted.  The tone of each article was rated as either ‘supportive’ (generally 
encouraging of the vaccine), ‘neutral/balanced’ (stating no or mixed opinions about the 
vaccine) or ‘opposed’ (generally critical of the vaccine).  This analysis was verified by 
other colleagues to ensure that it was warranted. 
 
Functionally this method was intuitive: the coding was flexible and allowed easy retrieval 
of information both within and between cases.  The process of charting was transparent 
allowing others to judge the reliability of the interpretation of the data.  Code and retrieve 
methods such as framework analysis have been criticised for analysing the data outside of 
the context that it was written but the method does allow for more abstract interpretation of 
the data (Ritchie & Spencer, 2000). 
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The framework analysis revealed a number of themes that were present in the articles that 
did not relate to risky sexual behaviour.  These additional themes did not relate to the aims 
of this chapter so have not been discussed in the results.  A list of these other themes and 
their sub-themes can be found in Appendix 4. 
 
My role in this study 
The study was conceptualised and designed by myself in collaboration with my PhD 
supervisors Professor Jane Wardle and Dr Jo Waller.  Professor Wardle, Dr Waller and my 
third supervisor Professor Judith Stephenson discussed the analysis of data with me to 
verify my interpretations and aided in the writing of this study for publication.  Dr Waller 
performed one of the inter-rater assessments to validate the included studies and I 
performed the other.  I performed all other aspects of this study described in the method 
section unaided.   
 
RESULTS 
 
Characteristics of the articles included 
The initial search identified 539 stories: 81 were duplicates, 35 were financial articles, 84 
contained fewer than 100 words about the HPV vaccine, 1 was a biography of an 
immunologist and 120 did not mention the HPV vaccine.  Of the remaining 218 articles, 
42% (n=92) referred to risky sexual behaviour (see Figure 4.1 for a plot of the annual 
figures).  These 92 stories were included in the main analysis (Table 4.1).  Articles came 
from daily and Sunday papers and from a mixture of ‘tabloid’ newspapers (focus on 
sensational stories and gossip), ‘middle-market’ newspapers (entertainment and some 
serious news coverage) and ‘broadsheet’ newspapers (more intellectual and in-depth in 
content).  Three of the eight tabloid papers and one of the four middle market papers that 
were searched did not mention the issue of risky sexual behaviour following HPV 
vaccination at all, but it was referred to at least once in all of the broadsheet papers that 
were searched.  No articles were published in 2008 that mentioned the issue of risky sexual 
behaviour following HPV vaccination so the remaining analysis only considered articles 
published between 2003 and 2007. 
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Quantitative analysis 
The notion of increased risky sexual behaviour following HPV vaccination was not 
mentioned prior to December 2004, however, following this month the number of stories 
published per year increased steadily.  Figure 4.1 shows five peaks in the number of articles 
published per month, corresponding to vaccine-related events: 
• October 2005 – Successful trials of Gardasil®. 
• August 2006 – Statement that the UK government was considering adding the 
vaccine to the childhood immunisation programme. 
• September 2006 – Gardasil® licensed for use in Europe. 
• June 2007 – Announcement that the vaccine is to be given to schoolgirls in the UK. 
• October 2007 – Announcement that a ‘catch-up’ programme for 14-18 year olds 
will take place in the UK. 
 
The proportion of articles about the HPV vaccine (total N=218) mentioning the idea of girls 
engaging in risky sexual behaviours following vaccination increased over time, from 0% in 
2003 to 13% in 2004, 29% in 2005, 34% in 2006 and 58% in 2007 (Figure 4.1).  In articles 
that mentioned the HPV vaccine, sexual behaviour was increasingly discussed during two 
months when vaccine-related events occurred.  In August 2006, when the UK government 
announced that it was considering adding the HPV vaccine to the childhood immunisation 
programme, 100% of stories about the vaccine mentioned sexual behaviour. This figure 
was 81% for articles published in June 2007 when the government confirmed that the 
vaccine would be given to school girls.   
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Figure 4.1 – Number of stories that mention girls engaging in risky sexual behaviour following HPV 
vaccination
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Only 5% of the 92 articles included in the final analysis were predominantly opposed to the 
vaccine (72% were neutral/balanced and 23% supportive).  As a proportion of the number 
of articles mentioning risky sexual behaviour published per year, the number that were 
predominantly positive in tone decreased from 2005-2007 whereas the number of 
neutral/balanced articles fluctuated but remained fairly high (Table 4.2).  Predominantly 
negative articles were only published in 2007 when the school immunisation programme 
was announced. 
 
The Daily Mail and The Times published the highest number of predominantly supportive 
articles (both n=4; Table 4.1) and The Sunday Express and The Daily Telegraph published 
the highest number of predominantly negative articles (both n=2).  The issue of girls 
engaging in risky sexual behaviour following vaccination was usually considered briefly 
and was the predominant theme of only 14% (n=13) of the stories.  Unsurprisingly most 
1. October 2005 – 
Successful trials of 
Gardasil® 
 
2. August 2006 – 
Statement that the UK 
government was 
considering adding the 
vaccine to the 
childhood 
immunisation schedule 
 
3. September 2006 – 
Gardasil® licensed for 
use in Europe 
 
4. June 2007 – 
Announcement that the 
vaccine is to be given 
to schoolgirls 
 
5. October 2007 – 
Announcement that a 
catch-up programme 
for 14-18 year olds 
will take place 
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stories focused on explaining the vaccine and cervical cancer (35%) or the introduction of 
the vaccine (34%).  Other themes arising from the stories included the pharmaceutical 
industry (4%), vaccination safety (3%), vaccination schemes in other countries (2%), STI 
rates (2%), calls to vaccinate boys (1%), the NHS (1%), personal experiences of cancer 
(1%), and sex before marriage (1%). 
 
Table 4.2 – The tone of the articles published each year 
 
Year 
Number of articles 
mentioning risky 
sexual behaviour 
Positive 
n (%a) 
Neutral/balanced  
n (%a) 
Negative 
n (%a) 
2003 0 0 (0) 0 (0) 0 (0) 
2004 1 0 (0) 1 (100) 0 (0) 
2005 12 5 (42) 7 (58) 0 (0) 
2006 29 4 (21) 22 (79) 0 (0) 
2007 50 12 (20) 36 (70) 5 (10) 
Total 92 21 (23) 66 (72) 5 (5) 
a
 Of annual articles mentioning the vaccine 
 
Qualitative analysis 
Discussions of adolescent sexual behaviour following HPV vaccination fell into three broad 
groups, although often the three types of discussion occurred within the same news story: 
1. News stories proposing that girls will engage in risky sexual behaviour following HPV 
vaccination (mentioned in 60 of 92 articles). 
2. Counter-arguments that girls will not engage in risky sexual behaviour after HPV 
vaccination (mentioned in 23 of 92 articles). 
3. Parents’ view of girls engaging in risky sexual behaviour following vaccination 
(mentioned in 12 of 92 articles). 
 
Table 4.3 provides a summary of the content categories and the distribution of these 
categories by tone and newspaper type. 
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Table 4.3 – Content categories by tone and newspaper type 
 
Total 
n (%) 
1. Behaviour will 
change 
n (%) 
2. Behaviour will 
not change 
n (%) 
3. Parents’ views 
n (%) 
Total 92 (100) 60 (65) 23 (25) 12 (13) 
Newspaper type     
Tabloid 13 (12) 12 (20) 5 (22) 3 (25) 
Middle market 33 (30) 29 (48) 5 (22) 2 (17) 
Broadsheet 46 (42) 19 (32) 13 (57) 7 (58) 
Tone     
Supportive 19 (23) 13 (22) 6 (26) 2 (17) 
Neutral 66 (72) 42 (70) 17 (74) 9 (75) 
Opposed 5 (5) 5 (8) 0 (0) 1 (8) 
 
News stories proposing that girls will engage in risky sexual behaviour 
Just under two thirds of all of the stories (56/92) provided some suggestion that the vaccine 
might encourage girls to engage in risky sexual behaviours, mentioning negative outcomes 
including teenage pregnancy, infertility, reduced condom use, increased STI rates, more 
promiscuity, and sex at a younger age.  These claims were never substantiated with 
objective evidence.  ‘Groups’ rather than individuals were referenced as criticising the 
vaccine on these grounds, and only four individuals were named and quoted, coming from 
religious and conservative family groups. 
 
Critics said the jab, designed to be given before girls become sexually active, may promote 
sexual promiscuity (The Mirror 21/06/2007) 
 
 
Conservative groups, including the influential Family Research Council (FRC), voiced 
strong concerns that immunising young girls against HPV may lead to sexual promiscuity 
(Daily Mail 16/04/2007) 
 
A few stories (4/92) suggested why girls’ sexual behaviour might change, such as girls 
believing that they are protected following vaccination and having reduced incentives to 
practise safe sex.  One article merely stated that the vaccine will “trigger” unsafe sexual 
behaviour, without specific explanations.  The language of the articles that raised the 
argument that girls will engage in risky sexual behaviour was sometimes emotive in nature 
and individuals were described as being fearful, panicked and anxious about the idea of the 
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HPV vaccine (19/92).  Fear discourses were used to describe the possible changes in 
behaviour and their negative outcomes, making these changes and outcomes seem 
inevitable and out of control.   
 
…if you vaccinate young women against a sexually transmitted disease, you are giving 
them a green light to become sexually active, plunging them into a dark, grown-up world 
for which they are not ready (Guardian 19/06/2007) 
 
The proposal has alarmed some religious groups, which have argued that vaccinating girls 
will encourage them to start having sex at a younger age (The Express 24/04/2007) 
 
Counter-arguments 
Counter-arguments to the suggestion that girls will engage in risky sexual behaviours after 
HPV vaccination were not common (23/92) but several claims were made.  Often these 
claims were made in articles that had also proposed that risky sexual behaviour will occur 
(15/23), suggesting that authors were attempting to provide a balanced discussion. 
 
A popular rebuttal (7/92) was that the vaccine does not protect against other problems 
relating to unprotected sex and therefore there should be no change in sexual behaviour.  
Individual doctors or unspecified ‘supporters of the vaccine’ were quoted as being 
proponents of such views.  Some of these articles (2/92) suggested that parents will attempt 
to reduce the likelihood of their daughters engaging in increased risky sexual behaviour by 
reminding them about pregnancy.  Others (3/92) suggested that schoolgirls are already 
apprehensive about other STIs and this would prevent them from adopting more high-risk 
sexual behaviour. 
 
Some stories (7/92) emphasised the lack of any evidence to support the argument that girls 
will engage in risky sexual behaviours following vaccination.  Two of these stories quoted 
charities with an interest in the successful implementation of the immunisation programme 
as proponents of such views, such as Cancer Research UK.  Spokespersons were quoted as 
stating that there was no evidence to support the critics’ claims and provided comparisons 
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with other vaccines that are also related to sex (such as the rubella vaccine), noting that 
these vaccines did not cause any adverse effects on sexual behaviour.  In addition, one 
feature article presented evidence suggesting that the vaccine will have the opposite effect 
on sexual behaviour due to the positive consequences of sex education. 
 
Seven articles vaguely proposed that girls will not engage in risky sexual behaviours, but 
did not back-up these claims.  The idea that girls will increase their risky sexual health 
behaviour after receiving the HPV vaccine was simply rejected and named experts were 
quoted in four of these articles. 
 
Professor Henry Kitchener … dismissed protests that such a vaccine programme would 
encourage sexual promiscuity (Daily Mail 31/03/2006) 
 
Parents’ views 
Twelve articles, all published since June 2006, considered parents’ views about the effect 
of the HPV vaccine on girls’ sexual behaviour.  Two of these stories stated that parents ‘in 
general’ were concerned about adolescent sexual behaviours following vaccination. 
 
The move will be controversial with some parents, who fear the jabs will encourage 
unprotected sex (The Observer, 24/12/2007) 
 
However, most articles reported positive attitudes among parents (10/92).  Most of these 
stories (8/10) provided evidence from specific studies conducted by Cancer Research UK 
(e.g. Marlow, 2007a) and researchers at the University of Manchester (e.g. Brabin et al., 
2006) and gave numerical findings.  These stories were often printed in broadsheet 
newspapers, and probably corresponded to press releases relating to the publication of the 
specific research findings. 
 
In January this year, Cancer Research UK found that …only 12 per cent [of mothers] 
thought it might encourage promiscuous behaviour (The Daily Telegraph, 27/10/2007) 
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One news story described the opinions of individual mothers (Daily Mail 22/06/2007).  
Some of these mothers acknowledged the sexually transmitted nature of HPV, but stated 
that they did not believe that vaccination would result in risky sexual behaviour in their 
daughters.  However, these women’s views were countered by other aspects of the article 
which asserted that mothers in general were expressing “grave concerns” about the 
vaccine.  Additionally, one mother was quoted as being “realistic” in believing that the 
vaccine will raise issues surrounding sex when her daughter is older. 
 
DISCUSSION 
As the HPV immunisation programme has been rolled-out across the UK, the media are 
likely to have played an important role in shaping public debate about the vaccine, in 
particular, whether or not they focused on the issue that the vaccine might have an adverse 
impact on adolescent sexual behaviour.  In the present study UK national newspaper stories 
addressing this issue were examined and the types of views proposed were assessed, as well 
as the content of the arguments.  As was hypothesised, media coverage of the vaccine grew 
substantially since the announcement of its development, and the issue of girls engaging in 
risky sexual behaviours following vaccination was a minor, but increasing theme over the 
five years studied. 
 
The increasing media coverage of the HPV vaccine appears to be a feature of news 
reporting both in the UK and the USA (Kelly et al., 2009) reflecting the public’s interest in 
this topic, but only a minority (42%) of articles identified by the original search in the 
present study considered the issue of girls engaging in risky sexual behaviours following 
vaccination and it was the predominant theme of only 14% of articles.  However, the issue 
continued to be discussed over the search period and the presence of this constant discourse 
over many years is likely to have had an impact on readers (Menashe & Siegel, 1998).  
Other studies have also reported that such discussions are occurring in the media and to a 
similar extent.  Descriptive studies of American news articles on the internet and American 
and Canadian newspaper articles have found discussions of concern about vaccination 
recipients increasingly engaging in risky sexual behaviour to occur in 20-38% of articles 
reviewed, but the specific details of these discussions were not reported (Abdelmutti & 
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Hoffman-Goetz, 2009; Calloway et al., 2006; Habel et al., 2009).  Hilton, Hunt, Langan, 
Bedford and Petticrew (2010) after the present study was performed conducted an analysis 
of British newspaper articles that discussed the HPV vaccine between January 2005 and 
December 2008 (slightly extending the coverage of the search in the present study).  Using 
similar methods to the ones described in the present study they identified 344 articles that 
mentioned the HPV vaccine.  Their content analysis found 48% of articles made reference 
to the vaccine encouraging risky sexual behaviour suggesting that that the debate is 
continuing to be discussed, perhaps increasingly so.  Wallace and Ache (2009) analysed 
evening news broadcasts about the vaccine on five American networks and reported that 
references to moral concerns were much more frequent (85% of broadcasts referred to 
moral or political issues), although the nature of these concerns were not detailed and a 
proportion of these will likely have not considered sexual behaviour at all.  
 
Although in the present study the issue of risky sexual behaviour following HPV 
vaccination was increasingly discussed in news articles, it was usually covered briefly and 
where endorsed, this was often based on the opinions of unspecified opposition groups, 
religious groups and conservative family groups and this appears to mirror the findings of 
Hilton et al. (2010) and an unsystematic analysis of UK news articles (Quilliam, 2006).  
Articles that were predominantly negative in tone were published when the UK government 
announced that the HPV vaccine was to be introduced into the childhood immunisation 
programme and it was in these months that the percentage of articles mentioning risky 
sexual behaviour as a proportion of all articles discussing the vaccine was highest (80-
100%).  Similarly discussions of risky sexual behaviour and HPV vaccination in the 
American media reduced after the government recommended the vaccine for use (Habel et 
al., 2009).  The number of articles that were predominantly positive in tone decreased over 
time, but this is likely to be due to the initial excitement surrounding the development of a 
cancer-preventing vaccine subsiding.  It seems that most parents who read newspapers will 
at some point have been made aware of opposition towards vaccinating schoolgirls and to 
the idea that the HPV vaccine could encourage risky sexual behaviour, however in 
agreement with the null hypothesis most articles were neutral/balanced in tone. 
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Over a quarter of articles in the present study detailed a variety of counter-arguments 
suggesting why behaviour change is unlikely to occur, a small number of which were 
supported by named ‘experts’.  Many of these discussions were presented alongside 
arguments suggesting that behaviour change will occur.  This was also the case in Hilton et 
al’s (2010) analysis.  This finding of neutrality of reporting is comparable to a recent 
analysis of YouTube coverage of the vaccine (Ache & Wallace, 2008) and another analysis 
of Canadian and American newspaper articles (Abdelmutti & Hoffman-Goetz, 2009).  
These studies as a whole suggest that as the HPV vaccine news story progresses articles 
appear to be becoming more likely to be neutral in tone, reflecting attempts to keep 
journalism balanced that have been reported in other media analysis (Hargreaves et al., 
2003).  Journalists use balanced reporting to present more entertaining stories and be fair to 
all sides, however, these practises have been considered inappropriate when reporting 
science as personal opinion is considered to be less valid than scientific findings (Offit, 
2008).  Offit argues that there is a difference between balance and perspective, and by 
presenting both arguments equally readers cannot gain true perspective on the issue.  It is 
not the role of the media to educate the public about health interventions, nor to solely 
represent the position of public health officials (Habel et al., 2009).  However, vaccination 
programme managers need to remain aware of how they can use the media to influence 
public opinion and be prepared to ensure that powerful anti-vaccination sentiments 
represented in the press are countered (Leask et al., 2009). 
 
The qualitative differences between the arguments presented might influence the extent to 
which parents are influenced by them.  Discussions in the articles that were more 
oppositional in tone often included emotional language, citing individuals from 
organisations who claim to be protecting the best interests of children, whereas supporting 
arguments were more rational and endorsed by science.  Epstein (1991) suggests that 
emotional information is less effortful to process than rational information.  The use of the 
differing emotional or rational discussions about the vaccine may influence how readers 
respond to the information they have received.  If emotional information is easier to process 
and so more likely to be remembered it may be that the oppositional positions that used 
some emotion-based language will have been easier for parents to understand rather than 
‘rational’ scientific arguments.  It is also possible that parents who lack trust in the 
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government and science may be more inclined to agree with those who oppose the 
immunisation programme.  Lack of trust in the government has been found to predict HPV 
vaccine acceptability (Marlow et al., 2007b) and has yet to fully recover from the MMR 
debacle.  Trust in vaccination authorities comes in various guises: believing that authorities 
are withholding safety data, lack of confidence in the knowledge needed to justify not 
vaccinating a child or believing oneself to be a responsible parent for not implicitly trusting 
what authorities recommend.  It may therefore be beneficial for communication 
interventions to use information about the HPV vaccine as a way of trying to build parents’ 
trust in immunisation more generally.  Parents need to be armed with communication tools 
to help them discuss the HPV vaccine and sex with their daughters to ensure that they 
understand that safe sexual behaviours are still necessary to prevent other STIs and 
pregnancy so that parents feel comfortable consenting to vaccination. 
 
A small number of articles discussed parents’ views about the vaccine and only a minority 
of these were negative and this was also the finding of Hilton et al. (2010).  Articles that 
reported positive attitudes among parents referenced scientific studies, often citing 
statistics.  These articles will have given their readers the opportunity to hear normative 
beliefs as they cited statistics about ‘other parents’.  Descriptive norms are associated with 
intention to perform health-related behaviours (Rivis & Sheeran, 2003) and intentions in 
turn relate to actual behaviour (Conner & Sparks, 2005).  With this in mind, news stories 
that included statistics stating that most parents are not concerned about adolescent sexual 
behaviour following vaccination may have decreased the number of readers themselves 
worrying about this issue; consequently more parents may intend for their daughter to 
receive the vaccine.  However, these stories were published infrequently and most appeared 
in broadsheet newspapers, whose readers are more likely to be from higher social classes 
than readers of tabloid or middle-market papers (Newspaper Marketing Agency, 2009) and 
their use of statistics may only have allowed their more numerate readers to fully 
comprehend them.  Furthermore, although all types of newspapers referred to the issue of 
risky sexual behaviour following HPV vaccination it was not considered by all newspapers 
under review (some tabloid and middle market newspapers did not discuss the issue once).  
This descriptive finding is supported by the findings of Hilton et al. (2010) who also found 
tabloid newspapers to be less likely to mention the issue of risky sexual behaviour than 
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broadsheet newspapers, although middle-market papers were just as likely as broadsheet 
papers to address the issue.  Thus individuals from lower social classes and possibly the 
less educated are less likely to have been exposed to these normative beliefs and knowledge 
inequalities between social classes may widen.  Tichenor, Donohue and Olien (1970) call 
this the ‘knowledge gap hypothesis’ where the mass media offer more information to 
higher social classes leaving other groups less informed when arguably they have the most 
to gain from HPV vaccination (Quinn et al., 2001).  Future research should examine 
parental reactions to media representations of the HPV vaccine and adolescent risky sexual 
behaviours to objectively elucidate how current portrayals affect parents with a special 
consideration to socio-economic inequalities.  
 
As with all qualitative research the interpretation of the data in this present study is 
subjective.  The analysis was not performed blind and pre-existing perceptions of the 
analyst about particular newspapers or opinions about the HPV vaccination may have 
affected the results.  Qualitative methods cannot be validated or their reliability tested using 
quantitative techniques, instead qualitative warranting procedures must be employed to 
ensure that the interpretation of the data is appropriate.  Although there is no definitive 
approach to validating qualitative methods (Smith, 2002) this study did use warranting 
techniques that have been identified by other researchers as being appropriate for this task.  
Triangulation is the process by which multiple approaches are taken to enhance the 
completeness of the analysis.  This may be in the form of multiple researchers (investigator 
triangulation) or multiple methodologies (methodological triangulation; Tindall, 1998).  
Tindal (1998) recommends the use of multiple levels of triangulation to gain the most 
complete analysis of the data. 
 
The present study used investigator triangulation by conducting analysis in close discussion 
with colleagues working in the field of HPV vaccination.  Methodological triangulation 
was also achieved by the use of qualitative and descriptive quantitative methods and by 
bringing in findings from research that has used alternative methods.  The transparency of 
framework analysis in charting the data and the examples given in the results section 
allowed others to examine the interpretation of the data and also afforded independent audit 
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in the manner recommended by Yin (1989).  Contextual validity was assured in this 
discussion section as the findings of the present study were compared to other examinations 
of HPV in the media and similarities in the findings between studies assured the internal 
coherence of the present study (whether the interpretation made sense).  The setting of the 
study was ecologically valid as the newspapers articles were available already in the public 
domain with no interference from the analyst.  Finally the methods employed in this study 
were comparable to similar studies published after the present study was completed and 
similar findings tend to give support for the validity of the results in the present study.  
Hilton et al. (2010) made distinctions based on newspaper type and looked at the tone of 
included articles; Habel et al. (2009) and Abdelmutti et al. (2009) considered tone also.  
Many studies have used online databases to search for newspaper articles (Abdelmutti & 
Hoffman-Goetz, 2009; Anhang et al., 2004a; Calloway et al., 2006).  Other warranting 
procedures could have been used such as member validation and reflexive analysis (Smith, 
2002) in which the analysis is discussed or created in discussion with the individuals who 
provided the responses (the journalists).  However, it was not feasible to involve the 
journalists in the analysis of the present study as they were never aware of their 
involvement.  Furthermore the analysis was descriptive rather than interpretive so may not 
have benefited from such reflexive practices. 
 
This study provided the first systematic analysis of media coverage of risky sexual 
behaviour and HPV vaccination in the UK, examining a large number of news stories over 
an extended period of time.  The framework analysis was conducted rigorously and the 
newspaper search was thorough; the NexisUK database is as accurate as a hand search of 
papers (Wells et al., 2001).  By excluding articles in local/regional publications and 
examining national newspapers only, it became possible to focus on the types of 
discussions that large sections of the public were exposed to, regardless of geographical 
location.  To date only articles published in English language newspapers have been 
analysed so conclusions can only be drawn about the dominant Western media outlets.   
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Conclusions 
The study highlighted that the argument that girls will engage in risky sexual behaviour 
following vaccination has been regularly, but briefly discussed in most of the papers.  The 
articles covered both sides of the argument and allowed parents the opportunity to form 
opinions.  Arguments against the view that HPV vaccination will result in girls engaging in 
risky sexual behaviour were more varied and better elaborated than those supporting the 
argument, but may have a less emotive appeal.  Parents have been given the opportunity to 
hear about the experiences of others and this analysis indicated that most reports said that 
parents are not unduly concerned about adolescent risky sexual behaviour following 
vaccination.  Nonetheless, the idea that girls will increase their risky sexual behaviour 
following vaccination was consistently proposed in the national press and had the potential 
to negatively affect parents’ attitudes towards vaccination.  Now that it is established what 
media messages parents are being exposed to regarding HPV vaccination and risky sexual 
behaviour, it is necessary to measure the beliefs that parents themselves have about the 
vaccine and this issue.
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Chapter 5 - Mothers’ beliefs about HPV vaccination and risky sexual 
behaviour 
BACKGROUND10 
The literature review in Chapter 2 revealed that some parents are rejecting HPV vaccination 
because of concerns about girls engaging in risky sexual behaviour following vaccination.  
An analysis of newspaper articles in Chapter 4 showed that parents may regularly be 
exposed to the argument that HPV vaccination will impact on adolescent sexual behaviour 
and these articles have the potential to affect personal concerns about the vaccine.  The 
concerns expressed by parents fall into two groups: concern that girls will engage in more 
risky sexual behaviour and concern about implicitly encouraging sexual debut. 
 
The first type of concern expressed by parents is apprehension that girls will engage in 
more risky sexual behaviour following HPV vaccination because they believe that they 
have a reduced risk of catching an STI, for example increasingly engaging in unprotected 
sex, having sex more often, at an earlier age and with a greater number of partners.  A 
number of studies have reported that some parents do have these concerns and some have 
shown such concerns to be associated with intentions to allow a daughter to receive the 
HPV vaccine.  Olshen, Woods, Austin, Luskin and Bauchner (2005) conducted a 
qualitative study with 25 American parents finding some to report concern that HPV 
vaccination might cause girls to adopt unsafe sexual practices.  Marlow, Waller and Wardle 
(2007a), in a sample of 684 British mothers, found that those who believed that their 
daughter would be more likely to have unprotected sex after receiving the vaccine were less 
likely to intend to allow their daughter to have the HPV vaccine, but this result did not 
remain when other correlates of vaccination intention were adjusted for.  In the same study, 
Marlow et al. also found mothers to be apprehensive about their daughters being more 
                                            
10
 This study was completed in May 2008.  Literature available at this time which contributed to the rationale 
for this study is presented in the introduction.  Literature published after May 2008 is introduced in the 
discussion section.  This study was published as part of a two-study paper in the Journal of Adolescent Health 
(Appendix 9). 
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likely to have sex following HPV vaccination and again this was associated with intentions 
to decline the vaccine, but not in multi-variable tests.   
 
Constantine and Jerman (2007) reported that some American parents cited concern about 
girls being more likely to have sex after HPV vaccination as a reason for not intending to 
vaccinate a daughter before age 16 or not at all.  Davis, Dickman, Ferris and Dias (2004) 
found parents who were opposed to HPV vaccination after reading information about HPV 
were more likely than those not opposed to vaccination to cite this as a concern about the 
vaccine.  Woodhall, Verho, Huhtala and Hokkanen et al. (2007) found that when answering 
in the context of HPV vaccination, 42% of Finnish parents believed that an STI vaccine 
would lead to girls having sex earlier and this was associated with a lower intention to 
accept the HPV vaccine for a daughter in both univariate and multi-variable tests.  Ogilvie, 
Remple, Fawziah, McNeil and Monika et al. (2007) reported that Canadian parents who 
believed that the HPV vaccine would have a negative influence on sexual behaviour were 
less likely to intend to vaccinate their daughter in both univariate and multi-variable tests.  
Finally concerns about increased sexual promiscuity have been reported, but only in one 
study and by one parent (Lenselink et al., 2008). 
 
Some parents have also reported concern that HPV vaccination consent (implicitly) confers 
‘carte blanche’ consent for sexual activity in their daughters (Bair et al., 2008; Brabin et 
al., 2008; Constantine & Jerman, 2007; Toffolon-Weiss et al., 2008; Waller et al., 2006).  
One parent in a focus group study by Waller et al. (2006) explained this succinctly: ‘some 
kids would go “excellent, that means I can sleep with whoever I like” you know and it’s 
almost giving them carte blanche’.  This concern shall be explored in more detail in 
Chapter 6. 
 
It has clearly been established that some parents hold these concerns about the HPV 
vaccine, but there have not been further investigations into their nature.  Studies that have 
considered these concerns have explored them secondarily to acceptance of the vaccine, the 
prevalence of these concerns has not often been reported and the majority of existing 
studies have been conducted outside of the UK.  It is likely that cultural issues specific to 
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attitudes towards sexual behaviour in the UK will impact on mothers’ concerns and need to 
be considered.  Such concern relates to the principles behind Risk Compensation theory 
(Adams, 1985; Adams, 1988; Wilde, 1982).  Parents are worried that girls will perceive 
their risk of an STI to have lowered following vaccination and so be willing to engage in 
riskier sexual behaviour so that their optimal level of risk is restored. 
 
This study investigated the first type of concern that mothers’ have reported, concern that 
girls will engage in more risky sexual behaviour following HPV vaccination, focusing 
specifically on beliefs about sexual behaviour and was designed to achieve aim two of this 
thesis: to establish the degree of concern that parents feel about HPV vaccination and 
sexual behaviour.  The analysis in this chapter was conducted on an existing dataset 
collected before I became involved in HPV research.  This dataset came from a study in 
which mothers, recruited from across the UK, were asked to participate in a quantitative 
face-to-face structured interview conducted in their home.  Mothers were asked specifically 
about their beliefs about sexual behaviour in girls following HPV vaccination and the 
nature of these beliefs was explored in analysis.  The study was commissioned by 
GlaxoSmithKline (GSK) to validate an earlier internet-based international market research 
survey that GSK had designed and conducted in collaboration with the market research 
company TNS.  Three chapter-specific research questions were posed: 
 
1. Do mothers believe that risky sexual behaviour may increase following HPV 
vaccination? 
2. Do beliefs about risky sexual behaviour predict mothers’ willingness to consent to their 
daughters receiving the HPV vaccine? 
3. What predicts whether mothers believe that risky sexual behaviour may increase 
following HPV vaccination? 
 
Based on the findings of previous research it was hypothesised that a minority of mothers 
would believe that risky sexual behaviour may increase following vaccination and that 
these concerns would predict mothers’ willingness to consent to their daughters receiving 
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the HPV vaccine.  Previous research has not investigated the type of parent who is likely to 
hold views about increases in risky sexual behaviour following HPV vaccination so a 
hypothesis about this research question was not made. 
 
METHODS11 
Participants 
Mothers with daughters under the age of 16 were recruited through an omnibus survey 
conducted in two waves by the National Centre for Social Research (NatCen).  NatCen are 
an independent social research organisation who conducts large-scale research nationally.  
They conduct an omnibus survey six times a year and researchers can pay to have their 
questions included in the survey.  This method of recruitment benefited from sampling 
participants from across Great Britain using stratified random probability sampling, 
stratifying by Government Office Region (GOR) and then by area-level National Statistics 
Socioeconomic Classification (NS-SEC, a measure of employment type).  This method has 
previously been used for large surveys such as the Health Survey for England, 
commissioned by the Department of Health and the National Survey of Sexual Attitudes 
and Lifestyles funded jointly by the Wellcome Trust and Medical Research Council.  The 
method allowed data to be collected quickly, using a professional and experienced 
organisation and sampled a large number of participants.   
 
Participants were approached to take part after their address had been chosen from a 
postcode address file (PAF).  Great Britain is divided into 10,631 postcode sectors, and 122 
from mainland Great Britain were systematically selected with probability proportional to 
size.  At each wave 25 addresses were randomly selected from each postcode sector 
(N=3050 at each wave), were approached and an individual residing in that address over 
                                            
11
 This study was performed before I started my PhD and became involved in HPV vaccination research.  The 
study was conceived, designed and implemented by Professor Wardle, Dr Waller and another colleague Dr 
Laura Marlow.  The study was funded by GlaxoSmithKline.  I performed the analysis on this existing dataset 
with advice from our statistician Mr David Boniface and from Professor Wardle and Dr Waller.  Dr Marlow 
and I wrote the findings from this study and another study for a single publication with advice and input from 
Dr Waller and Professor Wardle.  I discussed the study extensively with staff from NatCen who conducted the 
research to ensure that the methods described are accurate and detailed. 
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the age of 16 was asked to participate in a computer-assisted face-to-face interview 
conducted in the home by a trained researcher.  Interviews could only be conducted with 
individuals living at the selected addresses.  As shown in Table 5.1, 2981 individuals 
completed the interview, with data being available for 2971.  Only women who identified 
themselves as having a daughter under the age of 16 were used in this analysis (n=341).  
Post-hoc power calculations showed that this sample size would have detected Pearson’s 
effect sizes of >.16 with over 80% power.  NatCen did not provide a response rate broken 
down by gender but a higher percentage of women than men completed the interview 
suggesting that the response rate for women would have been slightly higher than 53%.  
The research did not require formal ethical committee approval; however NatCen abides by 
the Social Research Association ethical guidelines. 
 
Table 5.1 - Response rates and reasons for non-interview 
 
 N % of original 
addresses 
% of eligible 
addresses 
% of productive 
interviews 
Issued addresses 6100 100   
Ineligible addresses 515 8.4   
Eligible addresses 5585 91.6 100  
Non-contacts 425  7.6  
Refusals 1839  32.9  
Other non-interview 248  4.4  
Unknown eligibility 92  1.6  
Productive interviews 2981 a  53.4  
Male respondent    46 
Female respondent    54 
a
 10 cases were removed by NatCen from the dataset due to incorrect selection procedures having been 
applied. 
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Measures 
Questions for the present study were imbedded within the larger omnibus survey; see 
Appendix 6 for the measures for the present study.   
 
Beliefs about risky sexual behaviour following HPV vaccination 
Beliefs about risky sexual behaviour following HPV vaccination were elicited using three 
statements: ‘having the HPV vaccination might make girls more likely to have sex’, ‘girls 
who had the HPV vaccination would be more likely to have unprotected sex’ and 
‘vaccinating young girls against HPV would encourage sexual promiscuity’.  Women were 
asked to respond on a five-point scale to these statements indicating the strength of their 
agreement with them (‘strongly disagree’ to ‘strongly agree’).  The items were developed to 
encompass a number of parents’ concerns about sexual behaviour following vaccination 
that have been expressed in previous studies (Constantine & Jerman, 2007; Lenselink et al., 
2008) and two were used by Marlow et al. (2007a). 
 
Willingness to consent to HPV vaccination 
Willingness to provide consent to HPV vaccination for their daughter was assessed with 
one item adapted from Gibbons, Gerrard, Cleveland, Wills and Brody (2004) that asked 
mothers to respond on a 10-point scale to the following question: ‘Please think about your 
daughter’s current situation.  How willing would you be to get her vaccinated with this 
vaccine for the prevention of infection with the HPV virus that causes cervical cancer?’ 
(1=not at all willing to 10=extremely willing).  Behavioural willingness was developed as 
an attempt to better predict behaviours that are unplanned, in place of behavioural 
intentions  (Gibbons et al., 1998).  It was designed to be used when measuring adolescents’ 
willingness to adopt risky behaviours that they may not have encountered before or could 
not imagine having the opportunity to engage in, such as recreational drug use.  At the time 
of the interviews the HPV vaccine was only recently developed and knowledge was 
established to be low (Klug et al., 2008); as a result it was anticipated that the respondents 
would not have previously planned whether they would accept HPV vaccination for their 
daughter and behavioural willingness was considered a suitable measure. 
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Perceived risk of cervical cancer 
Perceived risk of cervical cancer was assessed using a single item adapted from 
Diefenbach, Weinstein and O'Reilly (1993).  Women were asked to respond on a seven-
point scale to the question ‘what do you think your chances of getting cervical cancer in the 
future are?’ (1=no chance to 7=certain to happen).   
 
Perceived severity of cervical cancer 
Perceived severity of cervical cancer was measured by asking women to indicate on a 10-
point scale how serious they believed cervical cancer to be (1=not at all serious to 
10=extremely serious, with an option for not being aware of the condition).  This item was 
developed by GSK/TNS and was used to replicate the earlier GSK/TNS internet-based 
international market research survey. 
 
Cervical cancer screening attendance 
Women were asked to choose one of four possible statements that best described their 
previous cervical cancer screening attendance (‘I regularly have cervical cancer 
screening/smear tests and do not need reminding’ or ‘I regularly have cervical cancer 
screening/smear tests but do need reminding’ or ‘I do not have regular cervical cancer 
screening/smear tests in spite of reminders to do so’ or ‘I have never had a cervical cancer 
screening/smear test’).  Again this item had been developed by GSK/TNS and used to 
replicate their earlier survey. 
 
Demographic questions 
Demographic questions and responses came from a standard set used by NatCen.  Using 
predefined categories the women were asked to select their age, ethnicity, highest 
educational qualification, their own and partners’ income (both before and after any tax 
deductions) and employment type classified using NS-SEC 3 (National Office of Statistics, 
2007).  Respondents reported their previous awareness of HPV by responding to the 
question ‘before this interview, were you aware of HPV?’ (response: ‘yes’, ‘no’). 
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Procedure 
Participants were approached in November 2006 and February 2007.  Prior to a researcher 
approaching an address respondents were contacted by letter explaining that they had been 
selected to take part in research, detailing the nature of the research and reassuring 
confidentiality and anonymity.  Included with this letter was a packet of first class stamps 
given as an incentive to take part.  Interviewers attempted to make contact with an 
individual living at each address four times before an address was considered a ‘non-
contact’ (including at least one day at the weekend, and one weekday evening).   
 
The questions for the present study were only asked to women.  The first questions for the 
present study that were included in the interview schedule asked participants about their 
awareness of HPV and perceived risk of cervical cancer.  Following these questions, the 
women received brief information about HPV and the HPV vaccine (see Appendix 6).  
Information about HPV was provided to participants as at the time of interview the vaccine 
was only recently developed and knowledge of HPV reported prior to the development of 
the vaccine was low (Klug et al., 2008).  All other questions were then completed using 
computer-assisted interviewing (CASI).  The CASI programme routes the interviewer to 
each relevant question based on the respondent’s previous answers, removing participant 
and interviewer burden in having to decipher which next question is appropriate to 
answer/ask.  It also makes it harder for questions to be missed, reducing the amount of 
missing data.  CASI also benefits the researcher as the data is immediately entered into an 
electronic database ready for analysis.  As part of the omnibus survey other researchers 
independent to the HPV study included questions in the two waves of data collection.  In 
both waves participants also responded to questions about health and work, and reform of 
incapacity benefit.  In addition, in wave one questions about public transport, disability and 
public services, and active aging were included and in wave two questions were asked 
about child support and mental health. 
 
Analysis 
Data were analysed using SPSS 14 for Windows (SPSS Inc., 2005).  Household income 
was calculated by summing the mean income ((income with deductions + income without 
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deductions)/2) for both the respondent and any partner.  Too few participants identified 
themselves as belonging to some ethnic groups making group sizes too small for statistical 
comparisons to be made.  These groups were grouped together and labeled as ‘other’.  The 
creation of an ‘other ethnicity’ group meant that inferences could not be made about that 
group specifically, only comparisons made with it.  Too few participants had achieved 
certain educational qualifications so these groups were combined: postgraduate degree and 
first degree became ‘degree or higher’, higher education (below degree level) and A Level 
or equivalent became ‘A Level or higher education below degree’, O Level or equivalent 
and CSE or equivalent became ‘GCSE or equivalent’ and ‘don’t know’, foreign 
qualifications and other qualifications were classified as ‘missing’.  Cervical screening 
attendance was dichotomised due to small original group sizes by combining those who 
responded ‘I regularly have cervical cancer screening/smear tests and do not need 
reminding’ and ‘I regularly have cervical cancer screening/smear tests but do need 
reminding’ and combining those who responded ‘I do not have regular cervical cancer 
screening/smear tests in spite of reminders to do so’ or ‘I have never had a cervical cancer 
screening/smear test’.   
 
The three risky sexual behaviour statements were highly correlated (Cronbach’s α=.87) 
therefore a total risky sexual behaviour belief score was calculated by summing the 
respondents’ scores on these three questions (maximum score of 15, higher scores 
indicating stronger agreement that sexual behaviour would change).  There was no 
difference in the household income of participants of pensionable age (≥ 60 years old) and 
those younger than 60, therefore age was not adjusted for in analysis using income (p=.98, 
Appendix 7).  Five women over the age of 65 identified themselves as being mothers of 
daughters under the age of 16.  It was assumed that these women were the primary 
guardians of girls under the age of 16 and their data were included in analysis.  These 
women did not differ from the rest of the sample for any of the dependent variables (data 
not shown).  For the cervical screening analysis only women who were below the screening 
age were included (younger than 65).  In the UK women aged 65 and older who have 
received three consecutive negative cervical screening results are no longer included in the 
call and recall system.  In the present study a number of women who were still eligible for 
screening may have been excluded inappropriately however previous cervical screening 
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results were not recorded and the sample was not reduced considerably by excluding 
women aged 65 and older.  
 
On the whole the percentage of missing data from the original dataset was low (Table 5.2).  
The item ‘perceived severity of cervical cancer’ had a high percentage of missing responses 
which may have been due to unawareness of the condition resulting in a large number of 
participants using the response option ‘I have never heard of this condition’.  Household 
income also had a high percentage of missing responses which may be explained by 
participants preferring to keep such personal information private.  Missing data were dealt 
with using the expectation-maximisation (EM) algorithm of missing values analysis 
(MVA) on continuous variables.  EM is an iterative procedure that uses the known 
parameters in the data to estimate the unknown parameters.  These filled in data are then 
used to inform other missing parameters.  The algorithm adds some error to the parameters 
it is estimating until the solution becomes stable.  MVA computed two negative numbers 
for household income and these two cases were recoded as ‘missing’ from household 
income analysis. 
 
Preliminary analysis demonstrated that the data were not normally distributed; minor 
skewness and kurtosis for the main variables was apparent although the data looked 
normally distributed graphically (data not shown).  Skewness and kurtosis could not be 
resolved by transforming the data.  However as the data looked normally distributed when 
presented graphically and the sample size was large it was decided that parametric statistics 
were robust enough to deal with minor distribution problems in the dataset.  In cases where 
Levene’s tests showed the variance in the data to be heterogeneous non-parametric tests 
were run in addition to parametric tests.  The results of the parametric tests only were 
reported unless the two types of test differed in their findings.   
 
To test whether relationships existed between the independent variables Fisher’s chi-square 
statistic was used for analysis of two categorical variables and independent t-tests or 
ANOVAs to establish differences between categorical and continuous variables.  Cramer’s 
V was used as an effect size for chi-square analysis.  Associations between two continuous 
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variables were assessed using correlations.  Significant differences between these variables 
were adjusted for in subsequent analysis.  To test whether beliefs about risky sexual 
behaviour following HPV vaccination affected the mothers’ willingness to consent to HPV 
vaccination ANCOVAs, and two-tailed Pearson’s and partial correlations were used.  Post-
hoc comparisons were made using Bonferroni tests and H² for ANCOVAs were converted 
into Pearson’s r to determine the size of any effect.  Variables that had a p of <.05 were 
entered into a multiple linear regression to establish predictors of willingness to have a 
daughter vaccinated against HPV.  To test whether variables were associated with the 
mother’s beliefs about risky sexual behaviour following vaccination or whether groups 
differed in their strength of belief, ANCOVAs and Pearson’s and partial correlations were 
used.  Post-hoc comparisons were made using Bonferroni tests.  Variables with a p value 
<.05 were entered into a multiple linear regression to establish predictors of beliefs about 
risky sexual behaviour. 
 
 
Table 5.2 - Percentage of missing responses from original dataset 
 
 Percentage of cases missing 
Willing to have daughter vaccinated against HPV 1.49 
Having the HPV vaccination might make girls more likely to have sex 1.79 
Girls who had the HPV vaccination would be more likely to have 
unprotected sex 1.49 
Vaccinating young girls against HPV would encourage sexual 
promiscuity 1.19 
Perceived severity of cervical cancer 29.41 
Perceived risk of getting cervical cancer 5.25 
Household income 18.40 
Age 0.00 
NSSEC3 0.00 
Education 0.00 
Aware of HPV 0.30 
Cervical screening attendance 0.91 
Ethnicity 0.00 
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RESULTS 
Characteristics of the sample 
Mothers in this sample had an average age of 38 and 90% were White (Table 5.3).  The 
average household income was £27,446, the majority of respondents were in routine or 
manual professions (42%) and 41% had GCSE qualifications or equivalent.  Most regularly 
attended cervical cancer screening (88%).  The majority of respondents believed that 
cervical cancer was serious (mean=9.4 out of 10; Table 5.4) and most were not previously 
aware of HPV (77%).  Most mothers believed their perceived risk of getting cervical cancer 
to be moderate (mean=3.6 out of 7; Table 5.4). 
 
 
Table 5.3 – Demographic characteristics 
 
  n (%)/mean (sd) 
Ethnicity (n=341)  
White 306 (89.7) 
Other 35 (10.3) 
NS-SEC 3 (n=341)  
Managerial and professional occupations 94 (27.6) 
Intermediate occupations 83 (24.3) 
Routine and manual occupations 143 (41.9) 
Not classifiable 21 (6.2) 
Cervical screening attendance (n=335)  
Regular cervical screening 293 (87.5) 
Irregular cervical screening or non-attendees 40 (11.9) 
Education (n=339)  
None 62 (18.2) 
GCSE or equivalent 139 (40.8) 
A Level or higher education (below degree) 94 (27.6) 
Degree or higher 44 (12.9) 
Age (n=341) 38.17 (9.23) 
Household income (n=341) £27,446 (30,187) 
Note: Columns not equaling total are due to missing data 
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Table 5.4 – Psychological variables (n=341) 
 
  n (%)/mean (sd) 
Having the HPV vaccination might make girls more likely to have sex  
Disagree strongly 46 (13.5) 
Disagree 147  (43.1) 
Neither agree nor disagree 90 (26.4) 
Agree 53 (15.5) 
Agree strongly 5 (1.5) 
Girls who had the HPV vaccination would be more likely to have unprotected sex  
Disagree strongly 36 (10.6) 
Disagree 144 (42.2) 
Neither agree nor disagree 82 (24.0) 
Agree 64 (18.8) 
Agree strongly 15 (4.4) 
Vaccinating young girls against HPV would encourage sexual promiscuity  
Disagree strongly 42 (12.3) 
Disagree 143 (41.9) 
Neither agree nor disagree 94 (27.6) 
Agree 53 (15.5) 
Agree strongly 9 (2.6) 
Perceived severity of cervical cancer (range 1-10) 9.40 (1.23) 
Perceived risk of getting cervical cancer (range 1-7) 3.59 (1.05) 
Total risky sexual behaviour belief (range 0-15) 7.67 (2.67) 
Willing to have daughter vaccinated against HPV (range 1-10) 7.86 (3.06) 
Aware of HPV (n=340)  
Yes 80 (23.5) 
No 260 (76.5) 
Note: Columns not equaling total are due to missing data 
 
Do mothers believe that risky sexual behaviour may increase following HPV 
vaccination? 
Willingness to vaccinate a daughter was high (mean=7.9 out of 10, Table 5.4).  Most 
‘disagreed’ or ‘disagreed strongly’ that the HPV vaccine may cause girls to have more sex 
(57%; Table 5.4), unprotected sex (52%) or cause sexual promiscuity (54%).  However, 
17% ‘agreed’ or ‘agreed strongly’ that the HPV vaccine may cause girls to have more sex, 
23% ‘agreed’ or ‘agreed strongly’ that girls would have more unprotected sex and 18% 
‘agreed’ or ‘agreed strongly’ that the vaccine may cause sexual promiscuity.  Overall, most 
appeared neither to agree nor disagree that girls would engage in risky sexual behaviour 
following vaccination (total risky sexual behaviour belief mean score=7.7 out of 15; Table 
5.4). 
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Associations between independent variables 
Some of the independent variables to be used in the analysis were associated with each 
other; these relationships were controlled for in the main analysis.  NS-SEC3 differed by 
ethnicity (χ²(3)=11.21, p<.01, V=.21; see Appendix 7 for analysis tables and Appendix 8 
for graphs of all significant effects).  Graphically it appeared that White respondents were 
more likely to be in managerial/professional occupations, intermediate occupations or 
routine/manual occupations than respondents grouped as ‘Other’.  White respondents were 
more likely to be in managerial/professional occupations than in non-classifiable 
occupations.  NS-SEC3 also differed by HPV awareness (χ²(3)=15.99, p<.01, V=.22) with 
those in managerial/professional occupations appearing graphically to be more likely to be 
aware of HPV than those in routine/manual occupations and also less likely to be not aware 
of HPV than those in routine/manual occupations.  Education was associated with cervical 
screening attendance (χ²(3)=14.09, p<.01, V=.21), NS-SEC3 (χ²(9)=121.3, p<.01, V=.3), 
previous awareness of HPV (χ²(3)=30.9, p<.01, V=.3), education (χ²(9)=121.3, p<.01, 
V=.3) and age (F(3,335)=6.04, p<.01).  Graphically it appeared that mothers with no formal 
qualifications were older than those with GCSEs or equivalent and those with A Levels or 
equivalent or further educational qualifications (below degree level).  Finally, cervical 
screening attendance was also related to being aware of HPV (χ²(1)=6.85, p<.01, V=.14).  
Graphically it appeared that regular screening attendees were more likely to be aware of 
HPV than irregular/non-attendees and also less likely to be not aware of HPV than non-
attendees.  See Appendix 7 for the tables reporting these findings. 
 
Predictors of willingness to have daughter vaccinated 
Possible psychological and demographic predictors of mothers’ willingness to vaccinate 
their daughters against HPV were explored independently and then in multiple variable 
analysis.  Mothers who disagreed that girls would engage in more risky sexual behaviour 
were more willing to have their daughter vaccinated against HPV (girls more likely to have 
sex r=-.14, p=.01; more likely to have unprotected sex r=-.13, p=.02; would encourage 
sexual promiscuity r=-.11, p=.04; total risky sexual behaviour r=-.14, p=.01; see Table 5.5) 
as were mothers who had a higher perceived risk of cervical cancer (r=.22, p<.01).  See 
Table 5.5 and Table 5.6 for all other non-significant effects. 
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All dependent variables with a significance value of ≤.05 were entered into a multiple 
linear regression to establish predictors of willingness to vaccinate.  Total risky sexual 
behaviour was used to represent all of the risky sexual behaviour variables to avoid co-
linearity.  The only variable that remained significant in the model was perceived risk of 
cervical cancer (p<.01; Table 5.7).  Around 5% of the variance in willingness to vaccinate 
could be predicted by this model and for every 1 unit change in perceived risk of cervical 
cancer, willingness to vaccinate a daughter against HPV increased by .2 units. 
 
 
Table 5.5 – Associations with willingness to have daughter vaccinated against HPV 
 
N=341 Pearson/Partial Correlation p 
Age (adjusted for education) -.05 .41 
Household income -.06 .27 
Perceived risk of cervical cancer .22 <.01 
Having the HPV vaccination might make girls 
more likely to have sex -.14 .01 
Girls who had the HPV vaccination would be more 
likely to have unprotected sex -.13 .02 
Vaccinating young girls against HPV would 
encourage sexual promiscuity -.11 .04 
Total risky sexual behaviour belief -.14 .01 
Perceived severity of cervical cancer .03 .64 
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Table 5.6 – Group differences for willingness to have daughter vaccinated against HPV 
 
 n Adjusted Mean SE P 
Whether respondent attends cervical screening    .85 
Regular cervical screening 290 7.79 0.18  
Irregular cervical screening or non-attendees 40 7.90 0.50  
Ethnicity    .77 
White 306 7.86 0.18  
Other 35 7.83 0.52  
Aware of HPV   . .93 
Yes 80 7.80 0.35  
No 257 7.85 0.19  
NS-SEC3    .94 
Managerial and professional occupations 94 7.60 0.33  
Intermediate occupations 82 7.75 0.35  
Routine and manual occupations 143 8.05 0.27  
Not classifiable 19 7.80 0.76  
Education    .73 
None 56 7.48 0.50  
GCSE or equivalent 136 8.07 0.34  
A Level or higher education (below degree) 94 7.89 0.27  
Degree or higher 44 7.43 0.46  
 
 
 
Table 5.7 – Multiple regression examining predictors of willingness to vaccinate 
 
 B SE B β pa 
Constant 6.56 .86  <.01 
Perceived risk of getting cervical cancer 0.58 0.16 .20 <.01 
Total risky sexual behaviour belief score -0.10 0.06 -.09 .11 
a Adjusted R²=.05 (p<.01), N=341 
 
Predictors of risky sexual behaviour beliefs 
Potential psychological and demographic predictors of each risky sexual behaviour belief 
were considered independently.  Each risky sexual behaviour statement was first considered 
on its own to establish the predictors of the specific concern and they were then explored as 
a measure of general concern about this issue (summed total of the three statements).  
Predictors with a p value <.05 for any of the first analyses and for any of the three belief 
statements and the summed total risky sexual behaviour belief score were then considered 
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in a multi-variable test to establish predictors of beliefs about risky sexual behaviour using 
the summed score. 
 
Having the HPV vaccination might make girls more likely to have sex 
Respondents who perceived themselves to be at higher risk of cervical cancer were less 
likely to believe that having the HPV vaccination might make girls more likely to have sex 
(r=-.22, p<.01; Table 5.8).  Mothers who were previously aware of HPV were less likely to 
agree with this statement (F=17.94, p<.01, r=.22; Table 5.9).  Mothers who attended 
regularly for cervical screening were less likely to agree that girls might have more sex 
(F=9.21, p<.01, r=.52).  Finally, white mothers were more likely to believe that the HPV 
vaccination might make girls more likely to have sex (F=3.98, p=.05, r=.35; Table 5.9).  
See Table 5.8 and Table 5.9, which also includes non-significant effects. 
 
 
Table 5.8 – Associations with the belief that ‘having the HPV vaccination might make girls more likely 
to have sex’ 
 
N=341 Pearson/Partial Correlation p 
Age (adjusted for education) -.03 .57 
Perceived risk of cervical cancer -.22 <.01 
Household income -.09 .11 
Perceived severity of cervical cancer .04 .47 
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Table 5.9 – Group differences for ‘having the HPV vaccination might make girls more likely to have 
sex’ controlling for independent variable associations  
 
 n Adjusted Mean SE p 
Whether respondent attends cervical screening    <.01 
Regular cervical screening 290 2.42 0.05  
Irregular cervical screening or non-attendees 40 2.89 0.15  
Ethnicity    .05 
White 306 2.52 0.55  
Other 35 2.18 0.16  
Aware of HPV    <.01 
Yes 79 2.08 0.16  
No 251 2.60 0.06  
NS-SEC3    .20 
Managerial and professional occupations 93 2.66 0.11  
Intermediate occupations 82 2.51 0.10  
Routine and manual occupations 141 2.37 0.08  
Not classifiable 16 2.24 0.24  
Education    .22 
None 56 2.47 0.13  
GCSE or equivalent 136 2.61 0.08  
A Level or higher education (below degree) 94 2.36 0.10  
Degree or higher 44 2.35 0.15  
 
 
Girls who had the HPV vaccination would be more likely to have unprotected sex 
The independent tests showed that women who perceived themselves to be more at risk of 
cervical cancer were less likely to agree with the statement (r=-.25, p<.01; Table 5.10).  
Women who regularly attended for cervical screening were less likely to believe that the 
HPV vaccine might cause girls to have unprotected sex (F=4.13, p=.04, r=.11; Table 5.11).  
Finally, mothers who were aware of HPV were less likely to agree with the statement 
(F=10.47, p<.01, r=.17; Table 5.11).  See Table 5.10 and Table 5.11. 
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Table 5.10 – Associations with the belief that ‘girls who had the HPV vaccine would be more likely to 
have unprotected sex’ 
 
N=341 Pearson/Partial Correlation p 
Age (adjusted for education) -.07 .19 
Perceived risk of cervical cancer -.25 <.01 
Household income -.10 .08 
Perceived severity of cervical cancer .02 .66 
 
 
 
Table 5.11 - Group differences for ‘girls who had the HPV vaccine would be more likely to have 
unprotected sex’ controlling for independent variable associations 
 
 n Adjusted Mean SE p 
Whether respondent attends cervical screening    .04 
Regular cervical screening 290 2.61 0.06  
Irregular cervical screening or non-attendees 40 2.95 0.16  
Ethnicity    .94 
White 306 264 0.06  
Other 35 2.65 0.18  
Aware of HPV    <.01 
Yes 79 2.31 0.12  
No 251 2.76 0.07  
NS-SEC3    .93 
Managerial and professional occupations 94 2.70 0.11  
Intermediate occupations 82 2.63 0.11  
Routine and manual occupations 143 2.64 0.09  
Not classifiable 21 2.55 0.23  
Education    .41 
None 56 2.52 0.15  
GCSE or equivalent 136 2.79 0.13  
A Level or higher education (below degree) 94 2.65 0.13  
Degree or higher 44 2.70 0.17  
 
 
Vaccinating young girls against HPV would encourage sexual promiscuity 
Mothers who perceived themselves to be less at risk of cervical cancer were more likely to 
agree that vaccinating young girls against HPV would encourage sexual promiscuity (r=-
.26, p<.01; Table 5.12), as were women with a lower household income (r=-.2, p<.01; 
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Table 5.16).  Mothers who were aware of HPV were less likely to believe that vaccinating 
young girls against HPV would encourage sexual promiscuity (F=12.36, p<.01, r=.20; 
Table 5.13).  See Table 5.12 and Table 5.13. 
 
Table 5.12 – Associations with the belief that ‘vaccinating young girls against HPV would encourage 
sexual promiscuity’ 
 
N=341 Pearson/Partial Correlation p 
Age (adjusted for education) -.07 .19 
Perceived risk of cervical cancer -.26 <.01 
Household income -.20 <.01 
Perceived severity of cervical cancer <.01 .97 
 
 
Table 5.13 - Group differences for ‘vaccinating young girls against HPV would encourage sexual 
promiscuity’ controlling for independent variable associations 
 
 n Adjusted Mean SE p 
Whether respondent attends cervical screening    .19 
Regular cervical screening 290 2.52 0.06  
Irregular cervical screening or non-attendees 40 2.73 0.15  
Ethnicity    .27 
White 306 2.56 0.06  
Other 35 2.37 0.17  
Aware of HPV    <.01 
Yes 79 2.19 0.11  
No 251 2.65 0.06  
NS-SEC3    .75 
Managerial and professional occupations 94 2.57 0.10  
Intermediate occupations 82 2.61 0.11  
Routine and manual occupations 143 2.48 0.08  
Not classifiable 21 2.66 0.22  
Education    .31 
None 56 2.48 0.20  
GCSE or equivalent 136 2.84 0.15  
A Level or higher education (below degree) 94 2.57 0.18  
Degree or higher 44 2.54 0.22  
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Total risky sexual behaviour belief score 
When the three belief statements were summed into a total score, women with a higher 
household income were overall less likely to agree that sexual behaviour following HPV 
vaccination would change (r=-.14, p=.01; Table 5.14) as were women who perceived 
themselves to more be at risk of cervical cancer (r=-.27, p<.01; Table 5.14).  Mothers who 
regularly attended for cervical screening were less likely to agree that behaviour would 
change (F=5.67, p=.02, r=.11; Table 5.15) as were women who were aware of HPV 
(F=16.82, p<.01, r=.22; Table 5.15).  See Table 5.14 and Table 5.15. 
 
All independent variables with a significance value of ≤.05 for any of the three statements 
or the summed total risky sexual behaviour belief score were entered into a multiple 
regression to establish predictors of total risky sexual behaviour belief score.  The only 
variables that remained significant in the model were perceived risk of cervical cancer 
(p<.01), awareness of HPV (p<.01) and cervical screening attendance (p=.02; Table 5.16).  
Around 13% of the variance in risky sexual behaviour belief score could be predicted by 
this model.  The largest proportion of variance in total risky sexual behaviour belief was 
explained by perceived risk of cervical cancer; as perceived risk of cervical cancer 
increased, total risky sexual behaviour belief decreased. 
 
Table 5.14 – Associations with total risky sexual behaviour belief score 
 
N=341 Pearson/Partial Correlation p 
Age (adjusted for education) -.07 .23 
Perceived risk of cervical cancer -.27 <.01 
Household income -.14 .01 
Perceived severity of cervical cancer .02 .66 
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Table 5.15 – Group differences for total risky sexual behaviour belief score controlling for independent 
variable associations 
 
 n Adjusted Mean SE p 
Whether respondent attends cervical screening    .02 
Regular cervical screening 290 7.54 0.15  
Irregular cervical screening or non-attendees 40 8.59 0.41  
Ethnicity    .27 
White 306 7.72 0.15  
Other 35 7.20 0.45  
Aware of HPV    .01 
Yes 79 6.59 0.30  
No 251 8.01 0.16  
NS-SEC3    .80 
Managerial and professional occupations 94 7.88 0.27  
Intermediate occupations 82 7.74 0.29  
Routine and manual occupations 143 7.54 0.22  
Not classifiable 21 7.54 0.58  
Education    .28 
None 56 7.39 0.54  
GCSE or equivalent 136 8.47 0.40  
A Level or higher education (below degree) 94 7.86 0.47  
Degree or higher 44 7.55 0.58  
 
 
 
Table 5.16 – Multiple regression examining the predictors of total risky sexual behaviour score 
 
 B SE B β p a 
Constant 7.80 0.77   <.01 
Ethnicity -0.45 0.45 -.05 .32 
Screening attendance 1.27 0.42 .12 .02 
Aware of HPV 1.30 0.32 .21 <.01 
Perceived risk of getting cervical cancer -0.61 0.13 -.24 <.01 
Household income <0.00 <0.00 -.10 .07 
a
 Adjusted R²=.13 (p<.01), N=332 
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DISCUSSION 
This study aimed to examine mothers’ HPV vaccination intentions, beliefs about girls 
engaging in risky sexual behaviour following vaccination, whether willingness to receive 
the vaccine would be affected by holding such beliefs and predictors of these beliefs.  This 
was achieved in a study that used face-to-face structured interview methods to examine the 
beliefs of mothers of daughters under the age of 16. 
 
Despite low levels of awareness of HPV, mothers appeared extremely willing for their 
daughters to receive the HPV vaccine.  It is likely that awareness in mothers has increased 
substantially since this study was conducted given that the immunisation programme is 
now underway.  Encouragingly, most mothers did not believe that HPV vaccination might 
cause girls to have more sex, unprotected sex or encourage sexual promiscuity. 
 
However, a significant minority of mothers agreed that sexual behaviour may change 
following HPV vaccination and these beliefs on their own related to willingness to consent 
to their daughter receiving the HPV vaccine.  This finding accords with previous studies of 
mothers that found some concern about the effect that HPV vaccination may have on their 
daughters’ sexual behaviour because of a perceived reduction in susceptibility to STIs 
(Constantine & Jerman, 2007; Davis et al., 2004; Lenselink et al., 2008; Marlow et al., 
2007a; Ogilvie et al., 2007; Olshen et al., 2005; Woodhall et al., 2007). 
 
Since this study was conducted additional large studies have supported these findings.  For 
example, Bernat et al. (2009) found 13% of parents believed that the HPV vaccine would 
encourage more sexual activity in their daughters and in Wu, Porch, McWeeney, Ohman-
Strickland, and Levine’s (2010) study 56% of Hispanic mothers/vaccine-eligible women 
held this belief when asked directly.  Dahlstron et al. (2010) found 12% of Swedish parents 
to believe that the vaccine would encourage their daughters to have unprotected sex or 
more sexual partners and Stretch et al. (2008) reported that 4% of parents were ‘quite’ or 
‘very’ concerned that the vaccine might encourage their child to be more sexually active.  
Perkins, Pierre-Joseph, Marquez, Iloka and Clark et al. (2010), in study of low-income 
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minority women, found some mothers to believe that girls will start having sex earlier and 
will be less cautious in their sexual behaviour because they will perceive themselves as 
‘invincible’ after receiving the HPV vaccine.  Finally, Ferris, Cromwell, Waller and Horn 
(2010) found 6.4% of American parents of 9-17 year olds to believe that the HPV vaccine 
would encourage their child to have sex.  In accordance with the present study, Ferris et 
al.’s study did not report that there was an association between beliefs about risky sexual 
behaviour and mother’s age, income or education.  The authors did report that mothers 
were more likely to believe that vaccination would encourage girls to have sex if they had a 
higher number of daughters, if they had children aged 15-17 years, if they did not believe 
that vaccines are important, held moral or religious objections to vaccines generally and the 
HPV vaccine specifically, if they were concerned about the adverse effects of HPV 
vaccination and if they did not believe the HPV vaccine to be effective at preventing 
cervical cancer.  Other studies have reported that such concerns are held although their 
prevalence was found to be much lower (Morison et al., 2010; Reiter et al., 2010; 
Sanderson et al., 2009; Tozzi et al., 2009). 
 
The findings from the present study that these beliefs were associated with acceptance of 
the vaccine are further confirmed by Stretch et al. (2008), Marlow et al. (2007a), Ferris et 
al. (2010) and Bernat, Harpin, Eisenberg, Bearinger and Resnick (2009) who all found that 
these beliefs related to willingness to vaccinate a daughter against HPV in univariate 
analysis, although one small American study did not support these findings (Gerend et al., 
2009). 
 
In the present study the extent that mothers agreed that girls will engage in risky sexual 
behaviour following HPV vaccination could to some extent be explained by their 
demographic characteristics (household income and ethnicity) but also their previous 
awareness of HPV, previous attendance at cervical screening and risk perceptions.  Mothers 
with a higher perceived risk of cervical cancer were less likely to agree that sexual 
behaviour would change and such risk perceptions were the most important contributor to 
such beliefs.  It may be that mothers who have a high perceived risk of cervical cancer had 
a greater understanding of the reasoning behind the vaccine being administered prior to 
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sexual activity, although general awareness was not associated with perceived risk.  
Alternatively it may have been a result of cognitive dissonance, the psychological tension 
an individual experiences when they hold two conflicting cognitions (Festinger, 1957).  In 
the present study mothers with a high perceived risk of cervical cancer were more willing 
to vaccinate their daughter and so may have been less likely to agree with the statements to 
avoid such psychological tension or it may have been that mothers who were unwilling to 
vaccinate their daughters used concern about sexual behaviour as evidence to support their 
decision not to vaccinate (bolstering cognitions).  The implication of this interpretation is 
that addressing beliefs about risky sexual behaviour may not be the most effective way to 
increase vaccination uptake.  This interpretation is likely to only be true for mothers who 
were previously aware of HPV as perceived risk of cervical cancer was assessed before 
information about the vaccine was introduced to the respondents. 
 
Other factors that were related to mothers’ beliefs about adolescent sexual behaviour 
following vaccination included previous awareness of HPV, previous cervical screening 
attendance, household income and ethnicity.  The importance of HPV awareness suggests 
that agreement that risky sexual behaviour will increase following vaccination may have 
stemmed from a lack of understanding about HPV, and therefore by raising awareness of 
HPV vaccination, these issues might be less important for mothers.  The introduction of 
HPV into the childhood immunisation schedule since this study was conducted is likely to 
already have contributed to this.  The finding that mothers who did not attend for cervical 
screening were more likely to agree with the statements is probably related to awareness of 
HPV as those who engage with cervical cancer prevention services are likely to have been 
more knowledgeable than infrequent attendees.  The role of household income in 
influencing these beliefs was unlikely to have been related to the type of job the mother had 
(NS-SEC3) or her education, as relationships did not exist between these independent 
variables suggesting that most of the women’s income came from a partner.  Further 
examinations of how household income impacts on beliefs about the HPV vaccine should 
be conducted; for example it may have been that daily activities and social engagement 
related to household income impacted on beliefs about sexual behaviour following HPV 
vaccination (such as engaging with friends who live in the same area as them) or that the 
women were influenced by the beliefs of their partner that were reflective of their partners’ 
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income.  Finally, ethnicity was associated with beliefs about girls’ sexual behaviour.  White 
mothers were more likely to agree that the vaccine might cause girls to have more sex; 
these results cannot be expanded upon as the comparison group was not large enough to be 
sufficiently powered and combined all other ethnic groups.  These preliminary findings 
need to be replicated although their importance in explaining beliefs about risky sexual 
behaviour was minor as ethnicity did not remain significant in multiple regression analysis.  
Other research has not found a relationship between beliefs about risky sexual behaviour 
and mother’s ethnicity (Ferris et al., 2010). 
 
In multiple regression, beliefs about girls’ sexual behaviour following HPV vaccination no 
longer predicted willingness to vaccinate, and perceived risk of cervical cancer was more 
important.  This result replicated the finding of Marlow et al. (2007a) who reported that 
beliefs about girls being more likely to have sex generally and unprotected sex related to 
willingness to vaccinate a daughter in univariate but not multi-variable analysis (adjusted 
for religion, experience of cancer in the family, severity, susceptibility, social norms, 
normative beliefs, positive beliefs about HPV and general vaccination concerns).  This is in 
contrast to the findings of Bernat et al. (2009) in the USA who reported that mothers of 5-
18 year old daughters who believed that the vaccination would encourage girls to have 
more sex were less likely to have allowed their daughter to have the HPV vaccine in multi-
variable analysis; Dahlstrom et al. (2010) who reported similar findings for beliefs about 
unprotected sex and number of sexual partners in Swedish parents and Canadian parents 
who were more likely to believe that the vaccine would have some effect on sexual 
practices (Ogilvie et al., 2010).  These three studies had much larger sample sizes than the 
present study and Marlow et al.’s study so non-significant findings may have been due to 
lack of power or may have been due to cultural differences between the studies. 
 
If the findings of the present study are correct they are reassuring as although mothers may 
believe that girls will engage in more risky sexual behaviour after vaccination, other factors 
are more strongly associated with their decision to consent to vaccination for a daughter.  
The effect of perceived risk appears to be so strong that it overrides other factors that may 
have been associated with vaccination decisions.  As was detailed in Chapter 2, perceived 
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risk of cervical cancer has consistently been shown to be associated with HPV vaccination 
intentions (Marlow et al., 2007a; Natan et al., 2010; Ogilvie et al., 2007; Woodhall et al., 
2007) and actual refusal of the HPV vaccine (Gerend et al., 2009; Reiter et al., 2009).   
 
Qualitative investigations of vaccination-resistant groups have found risk to be an 
important rhetoric in their position against vaccination (Hobson-West, 2007).  Such groups 
claim that governments are not objective and use risk information to promote vaccination.  
The groups suggest that vaccination causes new health risks and these risks are largely 
unknown (scientific trials are inadequate and are too short in duration).  Further concern 
relates to their belief that vaccination risk is non-random and that certain individuals are 
more immunologically vulnerable than others (some reformist groups advocate testing all 
children’s immunity prior to vaccination receipt).  These groups do not claim that refusing 
vaccinations is the right answer and do not purport to fully understand the risks of non-
vaccination but in the same vein they believe that vaccination authorities do not know all 
the answers either.   
 
Perceived risk is also considered to be associated with behaviour in many social cognition 
models such as the Health Belief Model (Becker et al., 1977; Rosenstock, 1966), Protection 
Motivation Theory (Rogers, 1975; Rogers, 1983), Health Action Process Approach 
(Schwarzer, 1992; Schwarzer, 2001), all of which posit that perceived vulnerability or 
susceptibility to an illness relates to behavioural intentions.  It is also highlighted as 
important in general models of vaccination decision making in parents such as the parental 
immunisation decision making model proposed by Sturm, Mays and Zimet (2005).  This 
present study suggested that one’s own perceived risk can inform proxy decision making or 
alternatively it may have been that self-perceptions of risk informed assessments of others’ 
risk and it was this that influenced the mothers’ willingness to agree to vaccination. 
 
It makes theoretical sense that vaccination uptake could be maximized if mothers’ 
perceptions of risk were targeted.  For example, information materials could be tailored to 
focus on perceived risk, although it must first be determined whether it was the mothers’ 
own perceived risk of cervical cancer or their perceived risk for their daughter that was 
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related to their vaccination intentions, to ensure that the correct cognitions are targeted.  
Simply providing mothers with information about the prevalence of HPV and the chance of 
contracting the virus or cervical cancer may increase risk perceptions.  Additionally, 
framing information in specific ways has been found to increase risk perceptions, although 
this has been put to limited use in HPV vaccination to date. 
 
Framing originates from Prospect theory (Kahneman & Tversky, 1979) which proposed 
that individuals risk-seek when a message is framed as a loss, but are risk averse when 
messages are gain-framed.  Research has suggested that responses to such messages are 
dependent on the nature of the behaviour and that with low-frequency health-protective 
behaviours, such as one-off vaccination, the opposite is the case; individuals risk-seek when 
the behaviour is framed as a gain, but are risk-averse when the behaviour is loss-framed, 
due to the role of uncertainty (Rothman & Salovey, 1997).  Thus it may be efficacious to 
provide mothers with loss-framed risk perceptions messages.   
 
Gerend, Shepherd and Money (2008) provided support for this proposal finding that those 
with a low perceived risk of HPV were more likely to intend to receive the HPV vaccine if 
the HPV information they received was loss-framed and the vaccine was described as 
requiring only one dose.  Similarly, Gerend and Shepherd (2007) found that vaccination 
intentions were greater for individuals who received loss-framed HPV information (as 
opposed to gain-framed) in participants who were likely to find the vaccine personally 
relevant (those who performed more risky sexual behaviours) and those who were 
avoidance-motivated.  Additionally, decision aids have been used to facilitate medical 
decision making (O'Connor et al., 1999) and could be designed with a specific focus on 
perceived risk.  Decision aids are tools developed to help patients in their healthcare 
choices by providing information on options and possible outcomes (O'Connor et al., 1999) 
and can appear in various formats, such as videos or counselling sessions with healthcare 
professionals.  Although there are no established decisions aids for HPV vaccination 
(Sheinfeld-Gorin et al., 2006), they have been found to increase hepatitis B 
vaccination/screening uptake in physicians who originally intended use these services 
(Clancy et al., 1988) and poliovirus vaccine knowledge in parents of 2-3 month old infants 
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(Dunn et al., 1998).  However, they have had a variable effect in improving HPV 
knowledge generally  (Sheinfeld-Gorin et al., 2006).  Such devices and techniques may be 
beneficial in helping to increase vaccination uptake if they incorporate the theoretical 
concepts that research, such as the present study, identify as contributing to vaccination 
intentions.  One must consider the morality of increasing mothers’ risk perceptions of 
cervical cancer given that it is a rare disease and may result in undue anxiety among the 
‘worried well’.  Such psychological tools should only be used when they are justified and it 
could be considered that using them to increasing uptake of a vaccine that prevents a rare 
disease is not appropriate. 
 
In contrast to the assertions of social cognition models such as the Health Belief Model 
(Becker et al., 1977; Rosenstock, 1966), perceived severity of cervical cancer was not 
associated with HPV vaccination decisions.  Perceived severity of HPV and HPV-related 
disease has been found to be an important predictor of HPV vaccination intentions in some 
previous studies (de Visser & McDonnell, 2008; Kahn et al., 2008; Marlow et al., 2007a) 
but one earlier study has questioned its importance (Marlow et al., 2009) and of the three 
studies examining perceived severity and actual vaccination receipt detailed in Chapter 2, 
only one found a significant relationship (Ogilvie et al., 2010), whereas the others reported 
null findings for perceived severity of HPV-related disease and of cervical cancer (Conroy 
et al., 2009; Reiter et al., 2009).  These non-significant findings and the results from the 
present study could be due to ceiling effects.  In the present study the item ‘perceived 
severity of cervical cancer’ had a mean score of 9.4 out of 10 and so there may not have 
been enough variation in the data to distinguish differences between participants.  The 
differences in findings may also be due to the measurement of perceived severity as 
research has considered perceived severity of HPV-specifically, HPV-disease generally and 
of cervical cancer.  Alternatively, perceived severity may not be a useful construct to 
examine when considering HPV vaccination uptake, as was alluded to in Chapter 2. 
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Limitations 
The cross-sectional nature of this study meant that that causality could not be determined.  
It may have been that willingness to vaccinate a daughter was informing mothers’ risky 
sexual behaviour beliefs, rather than vice versa and this is a pragmatic interpretation of the 
results.  Vaccination intentions may not have reflected actual behaviour; a review across a 
range of health behaviours showed intentions to predict no more than one third of the 
variance in actual behaviour (Sheeran, 2002). 
 
All social cognition constructs (perceived risk, perceived severity and willingness to 
vaccinate) were measured using single items which may have resulted in measurement 
error and reduced the potential for variability in the data.  However, single item measures 
of HPV vaccine acceptability for a daughter have commonly been used in previous research 
(for example, de Visser & McDonnell, 2008; Kahn et al., 2009; Marlow et al., 2007a) and 
intention to vaccinate does map on to early reports of actual vaccination uptake; for 
example Brabin et al. (2006) found 81% of parents to intend for their daughter to receive 
the HPV vaccine and Marlow et al. (2007a) reported that 75% of mothers would accept 
vaccination for a daughter compared with 80.1% of eligible 12-13 year olds who had 
actually received all three doses of the vaccine between September 2008 and August 2009 
(Department of Health, 2010).  Single item measures of perceived risk are also acceptable if 
well chosen (Weinstein et al., 2007) and the item used in this study accorded with the 
recommendations asserted in this paper. 
 
In addition, a variety of response scales were used to measure the constructs.  This limits 
our ability to compare findings between constructs.  Such comparisons were made in this 
study and these may have been inappropriate.  Response scales with a greater number of 
response options allows for more variability in the data than response scales with fewer 
response options and means that there is greater likelihood that significant effects will be 
detected.  It is possible that significant results reported in this study were due to the choice 
of measurement tool; however, in all analyses the item with the greatest number of 
response options (perceived severity of cervical cancer) was not found to be significantly 
associated with the dependent variables. 
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Given that awareness of HPV was low the risky sexual behaviour statements may have 
asked mothers to respond about issues that they had not previously considered.  It would be 
beneficial to examine mothers’ beliefs about sexual behaviour and HPV now that the 
vaccination programme has started and mothers have had the opportunity to consider 
vaccination more carefully and formulate their own opinions. 
 
The variables assessed in the present study could predict only 5% of the variance in 
willingness to vaccinate a daughter against HPV.  Future research should attempt to 
identify other predictors of HPV vaccination acceptance in parents and could benefit from 
being informed by general models of parental immunisation decision making and social 
cognition models. 
 
As with all survey methods, the sample was restricted to individuals who were available 
and willing to take part in this study.  Only 53% of individuals originally contacted agreed 
to participate suggesting that the findings may not be entirely representative of British 
mothers with daughters who will be offered the vaccine.  Quota sampling would have 
increased the number of participants being available for interview, but would have masked 
the fact that the data was unlikely to be representative.  However, the proportion of White 
respondents and average household income of the participants was comparable with 
population estimates.  The 2001 census showed that 91% of the UK population were White 
versus 90% in the present study (Office for National Statistics, 2003) and average 
household income was £28,854 in 2007-08 reported by the Office for National Statistics 
versus £27,446 in the present study (Barnard, 2009).  The response rate provided could 
only be a guide to the actual response rate for women as gender-specific response rates 
were not available. 
 
The study did not explore the beliefs of fathers.  It is likely that fathers will play a role in 
their daughter’s healthcare decisions and this study did not provide insight into their 
attitudes regarding HPV vaccination.  In the UK the HPV information materials are being 
targeted at mothers only so it is likely that fathers are less aware of the immunisation 
programme.  Primarily, an exploration into the attitudes of the individuals most likely to be 
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involved in the HPV vaccination programme was most appropriate.  Although a number of 
the studies that have considered sexual behaviour and HPV vaccination have included 
mothers and fathers, the attitudes of fathers specifically have not been considered.  In East 
Asian countries it is recognised that fathers play a key role in decisions about their child’s 
healthcare, including HPV vaccination (Wong, 2009a), but the role of fathers in HPV 
vaccination decisions in the UK or Western world has not been examined.  This is 
especially intriguing given the sexual nature of HPV and that adolescents, especially girls, 
have been shown to feel more at ease discussing sex with their mothers (DiIoro et al., 
1999).  It would be interesting to explore fathers’ beliefs about their daughter’s sexual 
behaviour following HPV vaccination and how this impacts on their role in vaccination 
decisions. 
 
The study did not receive formal ethical approval.  This is potentially harmful both for the 
researcher and the participants as the risks of the study were not independently assessed and 
is not good research practice.  It was not possible to enforce ethical standards onto the 
external research company that collected the data, however NatCen do abide by the Social 
Research Association ethical guidelines. 
 
Conclusions 
This study highlighted the prevalence of mothers’ beliefs about risky sexual behaviour 
following HPV vaccination and found some mothers of daughters under the age of 16 to 
agree that behaviour may change.  However, the mothers’ perceived risk of cervical cancer 
was related to their willingness to consent to HPV vaccination to a greater extent than 
beliefs about sexual behaviour, suggesting that sexual behaviour concerns held by a 
minority will not be sufficient to cause mothers to refuse consent to vaccination.  
Vaccination programme information materials for mothers may improve HPV vaccination 
acceptance if they discuss cervical cancer risk and improvements in awareness of HPV may 
also reduce parents’ concern about their daughter’s sexual behaviour following HPV 
vaccination.  This study addressed one sexual behaviour concern that parents express about 
the HPV vaccination: apprehension that girls will engage in more risky sexual behaviour 
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following HPV vaccination because they believe that they have a reduced risk of catching 
an STI.  It will be important to establish whether this concern is appropriate and Chapter 7 
will consider whether girls have changed their sexual behaviour following HPV 
vaccination.  Before exploring this, the second concern that parents have reported must be 
investigated and this is the focus of Chapter 6.
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Chapter 6 - Girls’ beliefs about the meanings behind their parents’ HPV 
vaccination decisions 
BACKGROUND12 
Chapter 5 highlighted that a significant minority of parents have concern about the sexual 
behaviour of their daughters following HPV vaccination.  This study investigated the 
second type of sexual behaviour concern that parents have reported about the HPV vaccine, 
that consent to vaccination may be perceived as implicit approval (or ‘carte blanche’) for 
sexual activity and may encourage earlier sexual debut. 
 
A number of studies from the USA and UK have consistently found a minority of parents 
express this particular concern.  Waller et al. (2006) conducted focus groups with mothers 
of 8-14 year old daughters.  They found some mothers report concern that HPV vaccination 
consent might imply tacit approval for sexual activity in their daughters, although others 
were less concerned.  In another early study of Californian parents, Constantine and Jerman 
(2007) found some mothers report that they intended to refuse vaccination because consent 
would go against what they taught their daughter about not having sex before marriage.  
Brabin et al. (2008), in a feasibility study of the implementation of the HPV vaccination 
programme in the UK, asked parents to explain why they had refused to consent to 
vaccination for their daughter unprompted.  Of parents who responded (8.1% of all non-
consenters) 3% (n=4) refused the vaccine because of a concern that consent to HPV 
vaccination would condone sexual activity in their daughter.  A study of Alaskan mothers 
did not find this issue to be of concern, but the women did think it may be for other mothers 
(Toffolon-Weiss et al., 2008).  Finally, Bair et al. (2008) found 2 (out of 40) Latina mothers 
to report that concern about implicit encouragement of sexual activity would prevent them 
from vaccinating their daughter. 
 
                                            
12
 This study was completed in November 2008.  Literature available at this time which contributed to the 
rationale for this study is presented in the introduction.  Literature published after November 2008 is 
introduced in the discussion section.  This study was published in BJOG (Appendix 10). 
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As the review of the literature in Chapter 2 highlighted, a growing body of research has 
considered parental opinions of the HPV vaccine, however fewer studies have assessed 
girls’ attitudes and none have asked them about the sorts of inferences they would draw 
from their parents’ decision to consent to HPV vaccination or not.  Understanding these 
inferences could be important because they may affect post-vaccination sexual behaviour or 
allay parents’ concerns.  A few studies have shown some girls to have made inaccurate 
interpretations about HPV vaccination and sexual behaviour.  A systematic review of HPV 
knowledge conducted by Klug et al. (2008) reported that most people have a poor 
understanding of HPV, however, inaccurate knowledge was also evident.  Some studies 
reported that individuals confused HPV with other STIs suggesting that vaccination 
recipients may incorrectly believe that the HPV vaccine affords more protection than it 
actually does (although all of the studies were conducted before the announcement of the 
development of the HPV vaccine when knowledge was likely to be low).  A qualitative 
study of 13-27 year old women in Malaysia found that some were concerned about the 
message being given to others were they to decide to have the HPV vaccine: “People will 
think we are sexually active” (Wong, 2008). 
 
Most girls appear to be in favour of receiving the HPV vaccine.  Studies from the USA 
have reported that around 70% of girls intend to receive the HPV vaccine although early 
reports of actual vaccination receipt were much lower, with around 25% of 13-17 year olds 
being vaccinated (Caskey et al., 2008; Hoover et al., 2000; Jain et al., 2008; Kahn et al., 
2008).  One British study that investigated the feasibility of the HPV immunisation 
programme before the main programme was initiated reported that 70% of girls received 
the vaccine (Brabin et al., 2008). 
 
British and American studies have reported that mothers worry that their providing consent 
to HPV vaccination will be regarded by their daughters as implicit consent for them to be 
sexually active, but research has not considered whether daughters themselves are likely to 
take such messages.  It is possible that girls will interpret vaccination consent solely as their 
parents’ desire to protect them from cervical cancer and such an outcome may allay 
parents’ concerns.  Alternatively if parents are correct in their beliefs about how some girls 
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would interpret parental HPV vaccination consent, it is important to understand these 
interpretations and identify ways to dispel such beliefs.  This study was designed to achieve 
aim three of this thesis: to establish girls’ views on the HPV vaccine and sexual behaviour.  
Using questionnaires, this was investigated by exploring the beliefs that girls had about the 
messages behind their parents’ vaccination consent.   
 
 
Three study-specific research questions were posed: 
1. Do girls intend to have the HPV vaccine? 
2. Do girls believe their parents will consent to HPV vaccination? 
3. Would girls take implicit messages about sexual behaviour and other issues relating 
to HPV vaccination from their parent’s consent to HPV vaccination? 
 
In accordance with previous research it was hypothesised that girls would want to receive 
the HPV vaccine.  Given these positive intentions and the evidence from previous studies 
that most parents would consent to HPV vaccination, it was predicted that girls would 
believe that their parents would also consent to HPV vaccination.  Finally it was 
hypothesised that a minority of girls would take unintended messages from their parents’ 
consenting to HPV vaccination as some evidence suggests that some have inaccurate 
knowledge. 
 
METHODS 
Participants 
Adolescent girls in school year 10 (age 14 and 15) were recruited from a high-achieving, 
state-funded, single-sex secondary school in London.  This population was chosen as they 
were due to be involved in the HPV vaccination ‘catch-up’ programme.  The school was 
chosen as it had participated in research with the Health Behaviour Research Centre 
previously. 
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Procedure 
The head of year 10 was contacted via telephone and asked whether their students would be 
able to participate in a study about the cervical cancer vaccine.  They were provided with 
information about the study and after having an opportunity to consider the research, 
consented to researchers approaching their students during a tutorial lesson conducted in 
the school hall.  The session was facilitated by two researchers who were independent to 
the school but teachers were also present.  After reading the study information sheet, the 
girls read a leaflet that provided them with information about HPV, cervical cancer, the 
HPV vaccine, and cervical screening (see Appendix 11 for study information materials).  
The leaflet was developed following a series of interviews and focus groups (Marlow et al., 
2008).  As part of another study, participants were randomly assigned to receive the leaflet 
in one of two different graphical forms (the content of the leaflet was identical, see 
Appendix 11) to investigate whether the source of the leaflet (a pharmaceutical company or 
a university) affected participants’ responses.  Exactly half of the participants received one 
version of the leaflet and half received the other version.  Participants were given as much 
time as they needed to read the leaflet; they then completed the questionnaire (Appendix 
12).  Participants were given an opportunity to ask questions after completing the 
questionnaire.  Questionnaires were used as they were considered an effective way of 
quickly collecting information that could be elicited using multiple choice options.  
Collecting data in school was the most appropriate location for the research to be conducted 
as all girls of the age range under consideration should have been in full-time education, 
testing conditions could be monitored by the researcher and questionnaires would be 
returned immediately.  The study was approved by the UCL research ethics committee (see 
Appendix 13), the school provided proxy consent for parents and all participants provided 
informed consent. 
 
Measures 
The questionnaire assessed demographic characteristics (age, ethnicity, religion and 
whether they were practising that religion), HPV knowledge and two vaccine-related 
issues: HPV vaccination intentions and perceptions of the meanings behind parents’ HPV 
vaccination consent in terms of sexual behaviour and other issues relating to HPV 
vaccination.   
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Beliefs about the meanings behind parents’ HPV vaccination consent 
The items assessing adolescents’ perceptions of the meanings behind parents’ HPV 
vaccination consent were designed to find out what girls think of the beliefs that parents 
have been shown to hold about HPV vaccination in previous studies.  These items were 
developed based on parental beliefs about HPV vaccination elicited in focus groups and a 
quantitative survey (Marlow et al., 2007a; Waller et al., 2006).  The items developed in the 
present study isolated these beliefs and were piloted with a small opportunistic sample to 
ensure that they were easy to understand.  The items asked participants to respond to seven 
statements assessing what they thought it would mean if their parents allowed them to have 
the HPV vaccine (responding on a five-point scale from ‘strongly disagree’ to ‘strongly 
agree’).  An example statement was provided for participants to read before responding to 
the main statements to give them an opportunity to check they understood the type of 
question being asked.  Beliefs about sexual behaviour were examined in four statements 
(e.g. ‘If my parents let me have the HPV vaccine they would be concerned that I might 
have sex earlier’), and three statements examined beliefs about other issues relating to HPV 
vaccination (e.g. ‘If my parents let me have the HPV vaccine I would know that they 
agreed with vaccinations in general’).   
 
Vaccination intentions 
Vaccination intentions were assessed by asking participants to indicate their own intention 
to receive the HPV vaccine using a four-point scale (‘when you are invited to have the HPV 
vaccination, how likely would you be to have it?’, response 'very unlikely' to 'very likely'), 
that was adapted from the structure used by Orbell, Hodgkins and Sheeran (1997).  A 
forced-choice scale was used as it was predicted based on previous research that awareness 
of HPV would be low.  A review of HPV knowledge reported that on average 17% of 
children under the age of 18 had heard of HPV (Klug et al., 2008).  As a result, participants 
would have been likely to use the middle ‘not sure’ option.  To increase the variability in 
responses a middle option was not used.  Participants were also asked ‘do you think that 
your parents would let you have the HPV vaccine?’ (‘no’, ‘not sure’, ‘yes’). 
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Knowledge of HPV 
Knowledge of HPV was assessed by asking participants whether 18 statements about HPV 
and the vaccination were ‘true’ or ‘false’ (an option for ‘don’t know’ was provided here); a 
total knowledge score was derived by summing the number of correct responses.  The 
question items had been previously developed following a literature search of items that 
had been used to assess knowledge about HPV.  These items were categorised into broad 
themes and items from each theme were selected for use to assess knowledge of HPV in the 
present study.  The information leaflet provided to participants directly addressed 11 of the 
knowledge questions, indirectly addressed five of the questions and did not address two of 
the questions. 
 
Analysis 
Data were analysed using SPSS 14 for Windows and STATA SE 11.0 for Windows (SPSS 
Inc., 2005; StataCorp LP, 2009).  Too few participants identified themselves as belonging 
to some ethnic and religious groups to make statistical comparisons.  These groups were 
grouped together and labeled as ‘other’.  The creation of an ‘other ethnicity’ and ‘other 
religion’ group meant that inferences could not be made about these groups specifically, 
only comparisons made with them.  Age was treated dichotomously as only two responses 
were given in the year group participating in the study (age 14 and 15).  Analysis using the 
variable ‘practising a religion’ only included respondents who already identified themselves 
as having a religion in a previous question. 
 
Effect sizes reported in previous studies of adolescents’ beliefs about HPV vaccination 
were used to help establish the sample size necessary for the study, one of these studies was 
unpublished at the time of the present study (Kahn et al., 2008; Marlow et al., 2009).  Using 
the average significant effect reported in these studies (f²=.25), conventional alpha and 
power estimates (alpha=.05 and power=.8) and anticipating analysis using a maximum of 
three groups, it was determined using GPower that 159 participants would be needed to 
detect significant effects (Faul et al., 2007).  There were approximately 200 students 
registered in school year 10 at the school used to recruit the participants so it was 
appropriate to sample from one school only.  None of the potential participants refused to 
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complete the survey but 11 cases were excluded due to large amounts of missing data 
(>50%) leaving responses from 162 girls to be included in the analysis.  Additional missing 
values were dealt with by performing missing values analysis using the expectation-
maximisation algorithm on continuous variables as described in Chapter 5.  The 
percentages of missing responses computed for each variable have been presented in 
Appendix 14. 
 
Preliminary analysis demonstrated that the data was not normally distributed; skewness and 
kurtosis for the main variables were at unacceptable levels, this was resolved using log 
transformations.  The non-transformed data were presented for descriptive purposes to 
make the interpretation simpler but inferential statistics used the transformed scores.  In 
cases where Levene’s tests showed the variance in the data to be heterogeneous non-
parametric tests were run as well as parametric tests.  The results of the parametric tests 
were presented unless the two types of test differed in their results. 
 
To test whether relationships existed between the demographic and knowledge variables 
Fisher’s chi-square statistic was used for analysis of two categorical variables and 
independent t-tests or ANOVAs to establish differences between categorical and 
continuous variables.  Significant differences between these variables were adjusted for in 
subsequent analysis.  To test for differences and relationships between the girls’ own HPV 
vaccination intentions and the knowledge/demographic variables ANOVAs, independent t-
tests, two-way Pearson’s correlations and ANCOVAs were performed.  To test for 
differences between the girls’ beliefs about whether their parents would consent to HPV 
vaccination and the knowledge/demographic variables ANOVAs, Fisher’s chi-square 
statistic and ordinal regressions were performed.  To test for relationships between the 
girls’ beliefs about the meanings behind their parents’ vaccination consent and the 
knowledge, demographic and vaccination intention variables two-way Pearson’s 
correlations were performed for analysis of only continuous data and independent t-tests, 
ANOVAs or ANCOVAs were performed for analysis of continuous and categorical 
variables.  Cramer’s V was used as an effect size for Fisher’s chi-squared statistic and 
Pearson’s r for all other statistics.  As there were a large number of items assessing 
                                                                                            CHAPTER 6 – GIRLS’ BELIEFS 
 178 
perceptions of meaning behind parents’ HPV vaccination consent, analysis of these items 
required multiple comparisons to be made which could have resulted in type 1 errors being 
committed13.  To reduce the likelihood of this occurring, a significance level of p≤ .01 was 
accepted for analysis of these items.  Post-hoc effect size calculations demonstrated 80% 
power for Pearson effect sizes larger than .22.  There were no significant differences 
between groups based on which leaflet was read (data not presented) therefore all data were 
analysed together. 
 
My role in this study 
This study was conceived and designed by myself with Professor Wardle, Dr Waller and a 
colleague Mr Gareth Lloyd.  Mr Lloyd was conducting research on a related topic, 
developing HPV vaccine information and so the data collection for our studies were 
combined.  I developed the measures for the study in discussion with Dr Waller and Mr 
Lloyd.  I gained ethical approval for this study; including writing a detailed protocol, 
consent form and questionnaires for data collection.  Dr Marlow, Dr Waller and Mr Lloyd 
prepared the written information materials.  Mr Lloyd and I performed the data collection 
together.  I entered the majority of the data myself and analysed the data.  Mr Boniface and 
Dr Waller provided input on the analysis.  I wrote this study up for publication in 
collaboration with Dr Waller and Dr Marlow. 
 
RESULTS 
The girls had an average age of 14.6, most identified themselves as White and of a 
Christian religious denomination (Table 6.1).  Of those who reported a religion 63.9% were 
not practising it.  Knowledge of HPV was good (mean=12.0 out of 18; Table 6.2), although 
this is likely due to the girls receiving the information leaflet prior to completing the 
questionnaire rather than previous awareness. 
 
Differences and relationships between groups were found for the independent variables and 
these were adjusted for in subsequent analysis.  Ethnicity was related to religion 
                                            
13
 Acceptance of the alternative hypothesis when the null hypothesis should have been accepted. 
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(χ²(6)=82.12, p<.01, V=.61) and whether an individual reported that they were practicing a 
religion (χ²(2)=15.21, p<.01, V=.43).  Religion was related to whether an individual 
reported practicing that religion (χ²(2)=8.81, p=.01, V=.32).  See Appendix 14 for analysis 
tables showing tests of differences and relationships between the independent variables and 
Appendix 15 for bar graphs showing the direction of the significant differences. 
 
Table 6.1 – Demographic characteristics of the sample (n=162) 
 
 n (%) 
Age  
14 66 (40.7) 
15 96 (59.3) 
Ethnicity  
White 118 (72.8) 
Asian 18 (11.1) 
Other 17 (10.5) 
Missing 9 (5.6) 
Religion  
None 36 (22.2) 
Christian 74 (45.7) 
Muslim 15 (9.3) 
Other 8 (4.9) 
Missing 29 (17.9) 
Practising this religion  
Yes 26 (26.8) 
No 62 (63.9) 
Missing 9 (9.3) 
In general, do you think that your parents would let you have the HPV vaccine?  
Yes 116 (71.6) 
No 6 (3.7) 
Not Sure 24 (14.8) 
Missing 16 (9.9) 
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Table 6.2 – Vaccination intentions, knowledge of HPV and perceptions of the meanings behind parents’ 
HPV vaccination consent for untransformed data 
 
N=162 n (%) 
If you were invited to have HPV vaccination, how likely would you be to have it?  
Very unlikely 7 (4.3) 
Unlikely 8 (4.9) 
Likely 74 (45.7) 
Very likely 73 (45.1) 
Knowledge of HPV; mean (sd) 12.0 (3.8) 
If my parents let me have the HPV vaccine they would be concerned that I might have sex earlier  
Strongly disagree 37 (22.8) 
Slightly disagree 55 (34.0) 
Unsure 38 (23.5) 
Slightly agree 28 (17.3) 
Strongly agree 4 (2.5) 
If my parents let me have the HPV vaccine they would be concerned that I might have 
unprotected sex  
Strongly disagree 35 (21.6) 
Slightly disagree 65 (40.1) 
Unsure 30 (18.5) 
Slightly agree 27 (16.7) 
Strongly agree 5 (3.1) 
If my parents let me have the HPV vaccine it would mean that they think that I am old enough to 
have sex  
Strongly disagree 32 (19.8) 
Slightly disagree 71 (43.8) 
Unsure 47 (29.0) 
Slightly agree 9 (5.6) 
Strongly agree 3 (1.9) 
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Table 6.2 continued 
N=162 n (%) 
If my parents let me have the HPV vaccine I would know that they think it is ok for me to be 
sexually active   
Strongly disagree 23 (14.2) 
Slightly disagree 78 (48.1) 
Unsure 45 (27.8) 
Slightly agree 12 (7.4) 
Strongly agree 4 (2.5) 
If my parents let me have the HPV vaccine it would mean that they wanted to protect me against 
sexually transmitted infections   
Strongly disagree 2 (1.2) 
Slightly disagree 4 (2.5) 
Unsure 26 (16.0) 
Slightly agree 87 (53.7) 
Strongly agree 43 (26.5) 
If my parents let me have the HPV vaccine it would mean that they wanted to protect me from 
cervical cancer   
Strongly disagree 2 (1.2) 
Slightly disagree 3 (1.9) 
Unsure 14 (8.6) 
Slightly agree 92 (56.8) 
Strongly agree 51 (31.5) 
If my parents let me have the HPV vaccine I would know that they agreed with vaccinations in 
general   
Strongly disagree 3 (1.9) 
Slightly disagree 17 (10.5) 
Unsure 54 (33.3) 
Slightly agree 70 (43.2) 
Strongly agree 18 (11.1) 
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Intention to receive the HPV vaccine and beliefs about parents’ intentions to consent 
to HPV vaccination 
Intentions to receive the HPV vaccine were strong (see Table 6.2 and Table 6.3 for 
transformed scores).  Around 91% thought that it was likely or very likely that they would 
have the vaccine and 72% believed that their parents would let them have the vaccine 
(Table 6.2 and Table 6.3 for transformed scores).  Knowledge of HPV was related to the 
girls’ intentions with higher knowledge associated with stronger intentions to receive the 
vaccine (r=.31, p<.01).  No other independent variables were related to whether girls 
intended to have the HPV vaccine and no independent variables were associated with the 
girls’ beliefs about whether their parents would let them have the vaccine (see Appendix 14 
for all non-significant effects). 
 
Table 6.3 – Vaccination intentions, knowledge of HPV and perceptions of the meanings behind parents’ 
HPV vaccination consent for transformed data 
 
N=162 Transformed 
mean (sd) 
Knowledge (0-1.3) a 1.1 (0.23) 
If you were invited to have HPV vaccination, how likely would you be to have it? (0-.6) a 0.5 (0.13) 
If my parents let me have the HPV vaccine they would be concerned that I might have sex 
earlier (0-.7) a 
0.3 (0.22) 
If my parents let me have the HPV vaccine they would be concerned that I might have 
unprotected sex (0-.7) a 
0.3 (0.21) 
If my parents let me have the HPV vaccine it would mean that they think that I am old 
enough to have sex (0-.7) a 
0.3 (0.19) 
If my parents let me have the HPV vaccine I would know that they think it is ok for me to be 
sexually active (0-.7) a 
0.3 (0.18) 
If my parents let me have the HPV vaccine it would mean that they wanted to protect me 
against sexually transmitted infections (0-.7) a 
0.6 (0.11) 
If my parents let me have the HPV vaccine it would mean that they wanted to protect me 
from cervical cancer (0-.7) a 
0.6 (0.1) 
If my parents let me have the HPV vaccine I would know that they agreed with vaccinations 
in general (0-.7) a 
0.5 (0.13) 
a
 Information in brackets indicates the possible range for transformed scores 
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Perceptions of the meanings behind parents’ HPV vaccination consent 
A minority of participants slightly agreed or strongly agreed that parental consent to HPV 
vaccination implied that they were old enough to have sex (7%, Table 6.2 and Table 6.3 for 
transformed scores) and 10% slightly agreed or strongly agreed that it was okay for them to 
be sexually active.  A minority slightly agreed or strongly agreed that that if their parents 
consented to vaccination they would be concerned that their daughter might have 
unprotected sex (20%) or reach sexual debut earlier (20%).  However, most girls would 
take positive health messages from parental consent to HPV vaccination, seeing such 
consent as indicating general approval of vaccinations (54% slightly agreed or strongly 
agreed that this was the case) and a desire to protect their daughter against cervical cancer 
(88% slightly agreed or strongly agreed) and STIs (80% slightly agreed or strongly agreed). 
 
Girls with stronger intentions to receive the HPV vaccine were more likely to believe that 
consent to vaccination implied that they were old enough to have sex (r=.19, p=.01).  None 
of the items assessing perceptions of the meanings behind parents’ HPV vaccination 
consent were related to whether the girls believed their parents would consent to 
vaccination (see Appendix 14 for all non-significant effects). 
 
Girls with higher knowledge scores were more likely to believe that consent to vaccination 
implied that parents wanted to protect their daughters against cervical cancer (r=.27, p<.01) 
and STIs (r=.22, p<.01) and were less likely to believe that their parents would be 
concerned about unprotected sex (r=-.17, p=.03), although this finding was only 
approaching significance. 
 
Practising a religion was also related to the belief that parents who consent to HPV 
vaccination may be concerned about unprotected sex in their daughters (F=6.72, p=.01, 
adjusted r=.06; adjusted mean for those who were practising a religion .41 vs. .26 for those 
who were not) with girls who reported practising a religion being more likely to hold these 
beliefs.  Practising a religion was also related to the belief that parents who consent to HPV 
vaccination may be concerned that their daughter may have sex earlier (F=5.25, p=.03, 
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adjusted r=.07; adjusted mean for those who were practising a religion .41 vs. .29 for those 
who were not) with girls who reported practising a religion being more likely to hold these 
beliefs; again this effect was only approaching significance. 
 
No other statistically significant relationships or differences existed for comparisons with 
the independent variables (demographic characteristics, HPV knowledge, the girls’ own 
HPV vaccination intentions and whether they thought their parents would consent to HPV 
vaccination) and the dependent variables (perceptions of the meanings behind parents’ 
HPV vaccination consent; see Appendix 14 for non-significant results). 
 
DISCUSSION 
This questionnaire study explored girls’ HPV vaccine intentions, perceived parental 
attitudes, and beliefs about the meaning behind parents’ HPV vaccination consent.  The 
study was conducted following reports of parents being concerned that their consent to 
HPV vaccination would be perceived by their daughters as implicit approval to engage in 
sexual activity (Bair et al., 2008; Brabin et al., 2008; Constantine & Jerman, 2007; 
Toffolon-Weiss et al., 2008; Waller et al., 2006).  Since the present study was performed 
similar concerns have continued to be expressed in three American and two Malaysian 
studies.  Wong (2009b) conducted focus groups with Malaysian mothers, fathers and 
vaccine-eligible girls.  Participants considered it important that the HPV vaccine should not 
be labelled solely as an STI vaccine as it could put parents in the position of condoning 
premarital sex and Sam, Wong, Rampal, Leong and Pang et al. (2009) found 33% of 
Malaysian mothers who were unwilling to vaccinate their daughter reported that this was 
because of concern that the vaccination will encourage sexual activity in their daughter, but 
this was lower in an American study of largely Latino parents of daughters even when this 
was provided as a response option to explain why they had refused the HPV vaccine for 
their daughters (8%; Yeganeh et al., 2010).  However, this belief was higher in another 
American study of mothers of whom 15% expressed concern that HPV vaccination consent 
implies approval for sexual activity when they were given this response as an option for 
why they said they would refuse or had refused vaccination for their daughter (Podolsky et 
al., 2009).  One final American study found a few low-income minority mothers of 11-18 
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year old daughters report in a qualitative study that they were fearful that their daughters 
would ‘misinterpret [vaccination as] a green light to have sex, a form of permission’ 
(Perkins et al., 2010).  One mother even said that she would not fully inform her daughter 
about the HPV vaccine because of this reason. 
 
In the present study beliefs about vaccination decisions were broadly positive with most 
girls expressing strong intentions to receive the vaccine and believing that their parents 
would consent.  Most girls reported that they would infer positive messages about 
vaccination and other HPV vaccination-related issues if their parents consented to 
vaccination.  The statements that almost all girls agreed with were that being allowed the 
HPV vaccine meant that their parents wanted to protect them against cervical cancer and 
STIs.  Most girls did not believe that vaccination consent implied approval for them to be 
sexually active.  Parents concerned about negative changes in sexual behaviour following 
vaccination may be reassured by this, and feel happier about consenting to their daughters 
having the vaccine. 
 
However, a small number of girls would perceive implicit approval for sexual activity if 
they were allowed the vaccine.  These beliefs reinforced concerns previously expressed by 
parents and highlight the importance of parent-daughter communication about sex.  Of 
further concern was the finding that girls with stronger intentions to receive the vaccine 
were more likely to perceive that parental consent to vaccination implies that the recipient 
is old enough to have sex.   
 
Although other research has not considered the messages that adolescents may interpret 
from being allowed the HPV vaccine, research published after the present study was 
conducted has partially supported the validity of parents’ concerns as it also suggested that 
adolescents are holding a range of inaccurate beliefs about HPV vaccination and sexual 
behaviour.  A study from the USA found 13-18 year old girls misinformed about the 
protection offered by the HPV vaccine with around 43% believing the vaccine affords 
protection against chlamydia and gonorrhoea and 15% believed that it was not possible to 
be infected with an STI after receipt of the vaccine (Mathur et al., 2010).  Similar findings 
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were reported in an Australian qualitative study conducted after the initiation of a national 
immunisation programme with girls confusing HPV with other STIs and some believing 
that they were protected from STIs generally, pregnancy and completely protected from 
cervical cancer after receiving the vaccine (Robbins et al., 2010).   
 
Taken together, the findings from previous research and the current study are worrying and 
have implications for the sexual behaviour and future cervical screening practices of girls 
who may believe that they are now protected from STIs generally, HPV infection, cervical 
cancer and even pregnancy.  However, the present study was small and the pre-defined 
items may have primed the girls to agree with issues that they had not previously 
considered.  Even if the findings were genuine, they may have been due to the cross-
sectional nature of the data; it may be that girls who felt that they were ready to have sex 
were more likely to intend to have the vaccine.  Additionally, even if girls believe that they 
have been given ‘carte blanche’ to be sexually active, this does not mean that they will 
necessarily become sexually active.  Further study of girls’ response to these items in 
alternative settings and assessment of their freely recalled beliefs about the HPV vaccine is 
needed.  Some girls did appear to be confused about this vaccine and may benefit from 
talking to their parents or a healthcare professional about it.   
 
Practicing a religion appeared to be related to the belief that if parents consented to 
vaccination they may be concerned about unprotected sex and earlier sexual debut.  Girls 
who were practising a religion may have believed that the protection afforded by the HPV 
vaccine overrides/lessens the requirements of their religion regarding sexual behaviour.  It 
is likely that girls who are practising their religion have parents who are also practising and 
it appears that these girls believe their parents will be concerned about their daughter’s 
sexual behaviour for religious reasons.   
 
However, the finding that the statements of perceptions of the meanings behind parental 
HPV vaccination consent regarding sexual behaviour were not related to whether girls 
believed that their parents would consent to vaccination themselves is reassuring.  It 
appears that although parents who are practising a religion may be concerned about the 
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HPV vaccine relating to sexual behaviour, girls did not believe that this concern would be 
great enough for them to refuse vaccination for their daughters.  More detailed exploration 
of this issue is required.  Three of the four published studies that have considered religiosity 
have found more highly religious parents to be less likely to intend to consent to HPV 
vaccination (Barnack et al., 2001; Constantine & Jerman, 2007; Natan et al., 2010) 
although one large Canadian study reported null findings (Ogilvie et al., 2010).  It may be 
beneficial to consult religious community leaders when deciding how best to communicate 
information about the vaccine as it appears that issues relating to one’s religious beliefs are 
influencing vaccination beliefs, although not to an extent that warrants undue concern.   
 
Identifying oneself as having a religion was not related to girls’ beliefs about their parents’ 
concern about sexual behaviour.  This suggests that active participation in a religion as 
opposed to affiliating oneself with one’s parents’ religious beliefs or cultural upbringing is 
a better indicator of whether religion will influence beliefs and behaviour.  Alternatively it 
may have been that this analysis was inadequately powered to detect differences as there 
were too few participants in each religious group. 
 
Although the vaccination is being presented in the UK as a vaccination against cervical 
cancer, the sexually transmitted nature of the virus is referenced in information leaflets 
designed for girls and McRee et al. (2010) in a conference proceeding reported that 47% of 
parents who discussed the HPV vaccine with their daughter said that this led to a 
conversation about sex.  Parents may feel more confident that vaccination will not influence 
their daughter’s sexual behaviour if they were provided with guidance in how to have 
conversations about sex with their daughters and were helped to explain why the vaccine is 
being given.  Vaccination programme coordinators must ensure that information materials 
highlight both the reason that the vaccine is being given before the onset of sexual activity 
and that girls do not have to wait until they are ready to have sex before having the vaccine 
(as is the case in the current leaflet used by the NHS in Northern Ireland).   Discussions 
with daughters could be facilitated by engaging them in the decision making process about 
whether to receive the HPV vaccine and this is in line with Article 12 of the UN convention 
on the rights of the child which states that children have a right to be involved in decisions 
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that affect them (Office of the United Nations High Commissioner for Human Rights, 
1989).  There is evidence that parents are willing to do this or are doing so already (Brabin 
et al., 2007; Breitkopf et al., 2009; Mathur et al., 2010). 
 
As has been found in previous UK studies of vaccine acceptance (Marlow et al., 2009), 
girls’ own HPV vaccination intentions were strong and most believed their parents would 
let them have the vaccination.  This appears to be the case from initial reports of actual 
vaccination uptake in 12-13 year old girls (Department of Health, 2009).  Knowledge of 
HPV was good suggesting that girls’ awareness of HPV is improving from earlier 
assessments conducted after the development of the vaccine; previously Kahn et al (2008) 
found that girls assessed in 2006-07 could on average accurately respond to 40% of 
questions about HPV and Marlow et al. (2009) reported that only 6% of 16-19 year olds 
surveyed in 2007 had heard of HPV.  However, the improved knowledge scores shown in 
the present study may have just reflected the fact that information was provided to 
respondents before they completed the knowledge measure.  Positive associations reported 
between willingness to receive the vaccine and knowledge, and relationships between 
beliefs about the meaning behind parents’ vaccination decisions and knowledge, might 
have been a result of greater engagement in the study rather than higher knowledge per se.  
Girls who read the leaflet more carefully are likely to have gained a greater knowledge and 
consequently more clearly recognise the benefits of HPV vaccination and have attitudes 
that reflect this. 
 
Similarly to previous studies examining girls’ intentions to receive the vaccine (Kahn et al., 
2008; Marlow et al., 2007a; Ogilvie et al., 2007; Woodhall et al., 2007), knowledge of HPV 
was associated with intentions to receive the vaccine and girls with higher knowledge were 
more likely to take positive messages about the vaccine from being allowed it.  These 
findings suggest that by increasing knowledge girls could be more likely to intend to 
receive the vaccine which could increase vaccination uptake.  The findings are mixed 
regarding changes in vaccination acceptance following the provision of HPV information; 
such intervention studies have not been performed with girls and even in adults have looked 
at intentions to consent to vaccination rather than actual vaccination rates.  Chan, Cheung, 
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Lo and Chung (2007) found improved acceptance and self-perceived knowledge in parents 
after they received a pamphlet about the vaccine, and although not reporting changes in 
knowledge, Gillespie, Banas, Tang, Worley and Rome (2008) improved acceptance of the 
vaccine in previously undecided parents after they received an HPV information sheet.  
Similarly, Davis, Dickman, Ferris and Dias (2004) found an educational fact sheet to 
improve acceptance rates in parents who were originally opposed to or undecided about 
vaccination, but they did not find knowledge to be associated with acceptance.  Dempsey, 
Zimet, Davis and Koutsky (2005) did not find parents’ vaccine acceptability to relate to 
whether they received an HPV information sheet or not, although knowledge was higher in 
those who received the information sheet. 
 
In contrast to the findings of the literature review in this thesis ethnicity was not related to 
intentions to receive the vaccine.  However, this may because group sizes were too small 
for difference to be detected and the study was not powered to explore ethnicity.  It would 
be worthwhile to examine demographic predictors of vaccination acceptance in a larger 
sample.  In concordance with the findings of the literature review in Chapter 2, religion, 
whether the girls were actively practising a religion and age were not significantly 
associated with girls’ intentions to receive the HPV vaccine 
 
The girls in the present study were slightly older than the cohort receiving the vaccine as 
part of the standard immunisation programme; however this age group have been included 
in the ‘catch-up’ series.  Girls in this older age group are more likely to have begun 
engaging in sexual relationships than 12-13 year olds in the main immunisation programme 
(26% of girls have sex before age 16, Wellings et al., 1990) and it could be argued that girls 
who are already sexually active are more liable to change their sexual behaviour following 
HPV vaccination.  Thus this study examined and improved understanding of issues relating 
to sexual behaviour in an appropriate age group.  Additionally, girls who receive the 
vaccine as part of the routine immunisation programme will grow up knowing that they are 
protected against HPV and it is important to understand how recipients of the vaccine 
interpret HPV vaccination in older adolescence (even if they did receive it a few years 
previously). 
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Limitations 
The participants of this study attended a high-achieving, secondary school, the majority 
were White and only 9% of pupils were entitled to free school meals which is below the 
average (13.6%) for England (Department for Education and Skills, 2006).  This may limit 
how representative the results are for British girls in general.  The rest of the population 
may have lower vaccination intentions given that parents in high SES groups tend to be 
more likely to consent to HPV vaccination (Brabin et al., 2008; Chao et al., 2009a; Chao et 
al., 2009b).  The study was inadequately powered to detect between-group differences 
smaller than r=.22 which will have increased the possibility that significant results may 
have been missed.  The measures assessing girls’ perceptions of meanings behind their 
parents’ HPV vaccination consent were not formally validated and the girls may have been 
confused with the conditional – ‘if X then Y’ – nature of the questions (e.g. having to 
imagine their parents’ beliefs whilst imagining that their parents would allow them to have 
the vaccine) although an example question was provided to participants before they 
responded to the items.  Future research must assess how reliable these statements are over 
time.  The girls’ intentions were assessed hypothetically in the present study and may not 
reflect vaccination behaviour.  Additionally, girls may have had inaccurate beliefs about 
their parents’ vaccination intentions, although the findings of this study are comparable to 
other British studies assessing parental vaccination intentions (Brabin et al., 2006; de 
Visser & McDonnell, 2008; Marlow et al., 2007b; Marlow et al., 2007a; Marlow et al., 
2008).  The present findings must only be used as a guide to prepare immunisation 
programme coordinators for potential issues that may arise.   
 
Information provided to participants prior to completing the questionnaire provided 
answers to the majority of the knowledge questions and the mean knowledge score 
reflected this.  However, the full range of possible knowledge scores were found during 
analysis and there remained enough variability in the knowledge scores for knowledge of 
HPV to be associated with beliefs about the meaning behind parents’ HPV vaccination 
decisions and girls’ own intentions to receive the HPV vaccine. 
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Conclusions 
This study provided an insight into the beliefs of adolescent girls who were due to receive 
the HPV vaccine as part of the ‘catch-up’ programme.  The majority of the girls intended to 
be vaccinated, and would infer positive messages if their parents consented to them having 
the vaccination.  A minority of the girls would infer negative messages about their sexual 
behaviour from being allowed the vaccine.  Accordingly it is necessary to investigate 
adolescent sexual behaviour following HPV vaccination to explore whether mothers’ 
concerns described in this chapter, their concerns shown in Chapter 5 and girls’ own beliefs 
are reflected in girls’ behaviour and this was the focus of Chapter 7.  Education may 
improve acceptance of the vaccine by girls and counter inaccurate beliefs that some girls 
hold.  It may be beneficial for religious groups to be involved in the design of such 
programmes.
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Chapter 7 – The impact of HPV vaccination on risk perceptions, sexual 
behaviour, communication about sex with parents and intentions to 
attend for cervical screening in the future 
BACKGROUND14 
It has been proposed in this thesis that some mothers report concern about HPV vaccination 
and the influence it may have on their daughters’ sexual behaviour.  Until now, in the UK 
at least, because of the novelty of the HPV immunisation programme it has not yet been 
possible to investigate whether girls are likely to change their behaviour following HPV 
vaccination.  The two studies reported in this chapter were the first to explore the impact of 
HPV vaccination on girls’ behaviour. 
 
The impact of risky sexual behaviour 
Were girls’ sexual behaviour to change, mothers would be right to be concerned as it is 
widely recognised that sexual behaviours influence STI acquisition and pregnancy.  In 2005 
it was estimated that over 50,000 young women under the age of 20 in England had 
children (Department for Children Schools and Families, 2007), although rates of 
conception in both under-16s and under-18s are falling (Department for Children Schools 
and Families, 2010b).  Teenage mothers and their children suffer poorer physical and 
mental health, well-being and economic status, although this is confounded by teenage 
mothers being most likely to come from deprived backgrounds (Department for Children 
Schools and Families, 2007).  The UK government recognises that having a baby when a 
girl is young can represent a positive time in her life but has also published a formal 
strategy to reduce incidence of teenage pregnancy (Department for Children Schools and 
Families, 2010a).   
 
                                            
14
 The studies reported in this chapter were conceived and designed in September 2008.  Data collection 
occurred in March 2009, September-November 2009 and March 2010.  Data analysis was completed in June 
2010. 
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STIs, as their name indicates, are primarily transmitted via sexual contact.  They can be 
caused by bacterial infections (such as chlamydia and gonorrhoea), virus infections (such as 
genital herpes and HPV) or parasites (for example vaginal trichomoniasis).  STIs are the 
leading cause of preventable infertility and can lead to complications in pregnancy (World 
Health Organisation, 2010).  Some infections result in long-term illness or untimely death 
(HPV, HIV), whilst others cause less severe but undesirable symptoms (for example 
blistering and pain in the case of genital herpes and itching and pain in genital warts).  
There was an increase in the number of most STIs diagnosed at genitourinary medicine 
clinics in the UK from 1998 to 2008, although this figure may reflect increased awareness 
of access to clinics in the population, greater clinic availability and enhanced sensitivity of 
tests rather than an overall increase in STI incidence.  Diagnosis is most common in 16-24 
year olds with chlamydia being most frequently diagnosed (Health Protection Agency, 
2008). 
 
A number of sexual behaviours can help reduced the likelihood of STI acquisition and 
unplanned pregnancy, as recognised by the National Institute for Health and Clinical 
Excellence (NICE, 2007), and the two studies reported in this chapter considered four 
behaviours and how they related to HPV vaccination receipt: consistent condom use, 
minimising the number of sexual partners, delaying sexual debut15 and abstinence.  Parent-
daughter communication about sex and cervical cancer screening attendance intentions 
were also considered in the context of HPV vaccination. 
 
The influence of psychosocial factors on sexual behaviour and parent-child 
communication about sex 
Some of the psychosocial factors that influence sexual behaviour in young people have 
been identified.  A systematic review of the American literature by Buhi and Goodson 
(2007) identified consistent correlates of early sexual debut, ever having had sex, being 
currently sexually active, number of sexual partners, intercourse frequency and heterosocial 
                                            
15
 There is evidence that earlier sexual debut impacts on future sexual health outcomes, for example girls who 
reach sexual debut before age 16 are more likely to be mothers or to have an abortion before age 18 (Wellings 
et al., 2001). 
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risk (engaging in an increasing number of risky sexual behaviours).  Intention was the most 
stable predictor of sexual behaviour and was associated with sexual debut, being currently 
sexually active and heterosocial risk.  The amount of time adolescents reported being left 
home alone (or alone with a member of the opposite sex) reliably related to having ever had 
sex and earlier sexual debut.  Perceived norms were also influential with perceptions of 
parental disapproval of engaging in sexual intercourse correlating with lower frequency of 
intercourse, higher chance of abstinence and fewer heterosocial risks.  Finally, adolescents 
who perceived that their peers were not in favour of adolescent sexual activity were less 
likely to intend to have sex, were more likely abstinent and to delay sexual debut.  
However, the studies in this review were often cross-sectional, relied on convenience 
samples and employed simplistic analytical strategies that did not explore the complex 
nature of adolescent sexual behaviour.   
 
Qualitative research has supported some of the findings of Buhi et al. and has introduced 
new concepts for consideration.  Marston and King (2006), in a systematic review of 
qualitative research identified the key themes that are important when conceptualising 
adolescent sexual behaviour.  Firstly, young people weigh up the risks of engaging in 
sexual relations with an individual based on how ‘clean’ they perceive they are and this 
also has an influence on their decision to use condoms.  For women, carrying a condom can 
be stigmatising, indicating that she is expecting sex, and a woman can be seen as not 
trusting her partner or believing him to be unclean if she were to propose that condoms be 
used.  There are gender stereotypes and norms associated with sexual behaviour.  Women 
are expected to not be highly sexually active.  There are rewards and penalties for 
complying with these norms and young people highly value their reputations linked to these 
norms regarding their sexual behaviour.  It may be the case that in some cultures a woman 
can be stigmatised for having ‘too many’ sexual partners or reaching sexual debut ‘too 
early’ and others may feel that they receive the reward of group membership by remaining 
abstinent.  These expectations, norms, rewards and penalties impede communication about 
sex, making it difficult for girls to suggest that a condom is used or that sexual debut is 
postponed.  Finally, the attitudes and behaviours of sexual partners are highly influential in 
affecting sexual behaviour.  Sexual pleasure will also likely have a significant impact 
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(Marston & King, 2006), although this qualitative research has not considered sexual 
pleasure. 
 
In addition to what systematic reviews have concluded are influential in informing 
adolescent sexual behaviour, it may also be beneficial to consider parent-child 
communication about sex.  HPV vaccination may provide a ‘teachable moment’ for parents 
to talk to their daughters about sex (Askelson et al., 2010).  Parent-child communication 
about sex has shown to reduce the likelihood of children engaging in risky sexual 
behaviour.  DiIorio, Pluhar and Belcher (2003) in a systematic review found mother-
daughter communication about sex tended to be associated with increased condom use.  
Similarly, communication about HIV/AIDS risk behaviours (such as multiple partners or 
condom use for the prevention of HIV specifically) was associated with adolescents 
engaging in fewer HIV-risk behaviours.  The findings were inconclusive regarding parent-
child communication about sex and delayed sexual debut and, similarly to Buhi et al.’s 
review there was no clear evidence for the order of events as data were cross-sectional.  A 
more recent review of longitudinal studies found that parents’ communication about sexual 
values was associated with delayed sexual debut until age 16 or later but that these findings 
may not generalise to all populations (Zimmer-Gembeck & Helfand, 2008).  It may also be 
that the kind of families that talk about sex are different from those who do not, and that 
these other factors explain sexual debut.  There is also evidence that communication style 
contributes to whether these behaviours are engaged in (Diiorio et al., 2003), and the 
content of the communication and when or how frequently it occurs are also important to 
consider. 
 
The impact of HPV vaccination on sexual behaviour 
The two studies reported in this chapter were designed to address the fourth aim of this 
thesis - to examine the effect of participation in the HPV immunisation programme on 
sexual behaviour.  Risk perceptions, communication about sex with parents and cervical 
cancer screening attendance intentions for the future were also considered.  Participants 
were older girls participating in the HPV ‘catch-up’ programme.  The findings of these 
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studies may have implications for STI acquisition and unplanned pregnancy16 and aimed to 
provide a response to parents’ concerns about changes in their daughters’ sexual behaviour 
following HPV vaccination.  These were the first such studies as there was no existing 
evidence of behaviour or attitudinal change following HPV vaccination.  As a result it was 
deemed beneficial to consider what has been reported about the potential effect of the 
vaccine on sexual behaviour in the context of what is already known to influence 
adolescent sexual behaviour, or theorised as influencing their sexual behaviour. 
 
As explained in Chapter 3, risk compensation theory and psychological behaviour-
motivation and risk-reappraisal theories would suggest that changes in perceptions of risk 
may result in adolescents engaging in increasingly risky sexual behaviour following HPV 
vaccination.  As detailed in Chapter 3 there is evidence of risk perceptions reducing 
following the adoption of risk reduction interventions.  Brewer, Cuite, Herrington and 
Weinstein (2007b) in their Lyme disease vaccination study found perceptions of risk 
lowered in the vaccinated group (below the levels of the unvaccinated group) and 
individuals who had been vaccinated were found to perform two of five Lyme disease 
protective behaviours less often than before their vaccination (using tick repellent and 
wearing light-coloured clothing).  There is currently no prospective data considering risk 
perceptions predicting HPV vaccination receipt or change in risk perceptions following 
HPV vaccination and the subsequent impact on behaviour.  A cross-sectional study 
conducted in the USA reported that there was no association between being sexually active 
and completion of the HPV vaccination series and a prospective American study found no 
relationship between age of sexual debut and receipt of the HPV vaccine or number of 
sexual partners and vaccination receipt  (Conroy et al., 2009; Neubrand et al., 2009).  One 
other study of vaccination intentions found that sexually active American girls who were on 
average 15 years old were 2.2 times more likely to intend to receive the HPV vaccine than 
girls who had not reached sexual debut (Read et al., 2010).  However these studies tell us 
nothing about causation due to their cross-sectional nature nor do they inform us about 
                                            
16
 Unplanned pregnancy as a result of condoms not being used rather than due to non-use of other 
contraception devices, failure of contraception (including condoms) and planned pregnancy. 
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changes in behaviour, for example Conroy et al. did not control for average number of 
sexual partners in vaccinated girls before they were vaccinated. 
 
It was concluded in Chapter 3 that behaviour change would only be feasible in accordance 
with the theory if certain conditions were present: if the vaccine is perceived effective, if 
the vaccine is visible to the girls, if girls are motivated to change, if girls have control over 
their current behaviour (Hedlund’s four criteria), if the girls misinterpret the protection 
afforded by the vaccine to include all STIs, and will more likely cause girls who are already 
sexually active prior to vaccination to reduce their condom usage or increase their number 
of sexual partners (rather than virgins initiating sexual relationships). 
 
There is some evidence from a Swedish questionnaire study that some individuals may feel 
an increased sense of security if they received the HPV vaccine (Gottvall et al., 2009).  The 
15-16 year old male and female high-school students in this study believed that they would 
have reduced intentions to use condoms with a new partner if they received the HPV 
vaccine.  Brabin, Stretch, Roberts, Elton and Baxter et al. (2010) spoke to 553 12-13 year 
old British girls from a number of schools who had been offered vaccination (94% had 
received the vaccine).  Prior to being offered the vaccine the girls watched an educational 
film about cervical cancer and HPV vaccination and were questioned six months later.  The 
girls lacked knowledge about HPV and the vaccine and some held inaccurate beliefs.   
Around 13% believed that they might take more risks because they were protected against 
HPV, and none of the girls could recall information given to them about the uncertain 
protective effect of condoms on HPV acquisition.  In contrast, Short et al. (2010) found that 
some older adult women believe they would engage in safer sexual behaviour following 
HPV vaccination because it would act as a reminder about the dangers associated with 
sexual behaviour. 
 
In addition to research suggesting directly that risk perceptions and intentions may change 
following HPV vaccination there is evidence that misconceptions are held about the 
vaccine which may lead girls to believe their risk of STIs or pregnancy has reduced, as was 
alluded to in Chapter 6.  Vaccinated adolescents have been shown more likely than 
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unvaccinated individuals to believe that the HPV vaccine is more effective than it actually 
is.  Around 63% of 13-18 year old American high-school girls who had received the HPV 
vaccine (n=59) believed that they were protected against gonorrhoea, 63% believed the 
vaccine protected against chlamydia and this was higher than non-vaccinated students, 
although all vaccinated students thought that they could still contract some STIs following 
vaccination (Mathur et al., 2010).  Similarly an Australian qualitative study conducted after 
the initiation of a national immunisation programme reported that girls confused HPV with 
other STIs and some believed they were protected from STIs generally, some from 
pregnancy, and some believed they were completely protected from cervical cancer after 
receiving the vaccine (Robbins et al., 2010).  Finally adolescents report that they do not 
know why vaccines are given and confuse vaccination with diagnosis (Benin et al., 2010), 
suggesting that some may believe that HPV vaccination is akin to a sexual health check-up.  
Adolescents may be highly motivated to believe that their risk of infection or pregnancy has 
been reduced due to the social barriers that exist that hamper communication about sex.  
Believing oneself at a reduced risk may be the ‘excuse’ needed to put-off talking to a 
partner about using condoms. 
 
HPV vaccination may also affect the factors that qualitative studies have highlighted as 
influencing adolescent sexual behaviour.  Although most of the vaccinated young Danish 
women in a focus group study by Mortensen (2010) reported that they would still used 
condoms to prevent pregnancy and other STIs, those who were in a steady relationship felt 
that HPV vaccination was a chance for a ‘clean slate’ and possibly an opportunity to cease 
using condoms in that particular relationship.  It also appears that social expectations for 
sex may alter following HPV vaccination as Brabin et al.’s (2010) study also showed that 
19% of the girls surveyed believed that their boyfriends might expect them to take more 
risks because they had received the vaccine.  Finally, Marston et al.’s (2006) findings 
suggest that behaviour will not change because girls do not have absolute control over their 
sexual behaviour as they are bound by social expectations, norms and the penalties that 
accompany deviation from acceptable standards. 
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Some of the factors that are associated with sexual behaviour have not been investigated in 
relation to HPV vaccination, for example the effect of HPV vaccination on intentions to 
have sex, peer’s normative beliefs about sex, time spent at home alone or pleasure gained 
through sexual activities, although HPV vaccination is unlikely to influence sexual pleasure 
or parents’ decisions to leave a child at home alone.  However, Chapter 6 did allude to 
adolescents believing that HPV vaccination decisions reflect parental norms towards sex.  
Research has also not reported how effective girls believe the HPV vaccine to be so it is 
unknown whether efficacy beliefs will likely affect risk perceptions nor has research 
considered whether girls are fully cognisant of their vaccination status when engaging in 
sexual behaviours (two of Hedlund’s four criteria).  
 
The impact of HPV vaccination on parent-daughter communication about sex 
There is evidence that HPV vaccination is associated with the likelihood that parents 
engage their daughters in conversations about sex.  Roberts, Gerrard, Reimer and Gibbons 
(2010) in a cross-sectional study found vaccinated college students (age 18-25) more likely 
to have received the vaccine if they had spoken to their mother about sex and the values of 
sex.  However, given the correlational nature of the data it may have been that discussions 
between mothers and daughters about whether to receive the HPV vaccine naturally led to 
discussions about sex and the mothers’ sexual values, or that the type of parent who 
discusses sex with their daughter is more likely to encourage vaccination. 
 
The impact of HPV vaccination on cervical cancer screening attendance intentions 
In addition to concern expressed by parents about changes in sexual behaviour, concern has 
been raised in the academic literature about reductions in cervical cancer screening 
attendance in girls who receive the HPV vaccine because they falsely believe that screening 
is unnecessary after vaccination (Crosbie & Brabin, 2010).  There is evidence from a 
Danish focus group study of 16-26 year old women that some vaccinated individuals feel a 
sense of increased security after receiving the HPV vaccine and do not plan to attend for 
cervical cancer screening as regularly as recommended (Mortensen, 2010).  These young 
women were not aware that the virus could remain undetected for many years and believed 
their first cervical cancer screening appointment would be sufficient to confirm that they 
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were not at risk of cervical cancer.  Only around 9% of adult women in a Belgian study 
believed that cervical cancer screening was unnecessary if the HPV vaccination were 
received (Donders et al., 2008) but younger women (<25 years) more likely believed that it 
would no longer be required.  There is no evidence suggesting that girls are motivated to 
not attend (or to attend) for cervical cancer screening, or that they do or do not feel they 
have control over whether they attend for cervical cancer screening (two of Hedlund’s four 
criteria). 
 
THE PRESENT STUDIES 
The majority of the research presented considering behaviour change following HPV 
vaccination was conducted in Europe, in comparison to the wealth of literature on HPV 
vaccination acceptability generally that has been conducted in the United States.  This 
suggested that behaviour change issues are more on the radar of researchers in Europe than 
elsewhere in the world and that it is a pertinent research topic to consider in a British 
sample.   
 
However, none of the existing literature used prospective methodologies, meaning that 
causality could not be assigned to HPV vaccination per se, nor could pre-existing beliefs 
and past behaviours be controlled for in analysis.  The studies also have not been able to 
account for the effect of the immunisation programmes themselves.  These programmes 
have accompanied significant educational and advertising campaigns that unvaccinated 
girls will have been exposed to as well as those who opted to receive the vaccine.  The two 
studies presented in this chapter sought to overcome these issues and were designed to 
address aim four of this thesis: to examine the effect of participation in the HPV 
immunisation programme on sexual behaviour in older girls participating in the ‘catch-up’ 
programme.  Based on the existing literature, it was also deemed important to consider risk 
perceptions, cervical screening intentions and parent-daughter communication about sex. 
 
The first study was a prospective study and explored differences in changes in risk 
perceptions, sexual behaviour, parental communication about sex and intentions to attend 
for cervical cancer screening between vaccinated girls and girls who had opted not to 
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receive the vaccine.  The study design meant that baseline differences between the two 
groups could be controlled for. 
 
Were differences in change present in this study they could have been due to exposure to 
the immunisation programme itself (for example the advertising campaign accompanying 
the programme), rather than due to receipt of the HPV vaccine and the prospective study 
was not able to consider this.  It is important to understand whether it is the programme 
itself that affects adolescents rather than the receipt of HPV immunisation.  The second 
study overcame this issue by comparing girls who had not been offered the HPV vaccine 
with girls who had received the HPV vaccine and was a quasi cross-sectional study.  This 
quasi cross-sectional study could be compared to a wait-list control study in the sense that 
one group of girls who had received the vaccine were compared to girls who had not yet 
been offered the vaccine.  Because the HPV ‘catch-up’ programme was implemented so 
quickly it was not possible to concurrently recruit these two groups and for this reason the 
study was a quasi cross-sectional study (the girls who had not been offered the vaccine 
were studied one whole year before those who had received the vaccine, which would not 
be the case with a traditional wait-list control study).  The methodologies and results of 
these two studies have been presented separately, but the findings are discussed together. 
 
STUDY 1 – A PROSPECTIVE STUDY 
The existing literature described in this chapter and theory outlined in Chapter 3 allowed a 
number of hypotheses to be drawn for this prospective study. 
1. Girls who believed themselves at greater risk of HPV infection, cervical cancer and 
other STIs prior to HPV vaccination will be more likely to have received the HPV 
vaccine. 
2. Girls who receive the HPV vaccine will have greater reductions in their perceptions 
of risk for HPV infection, cervical cancer and other STIs after receiving the vaccine 
than girls who did not take up the offer of vaccination. 
3. Girls who have received the HPV vaccine will have changed their sexual behaviour 
relative to those who did not take up the offer of 
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4. Girls who have received the HPV vaccine will have increased the amount that they 
speak to their parents about sex relative to those who did not take up the offer of 
vaccination. 
5. Girls who have received the HPV vaccine will have decreased their intentions to 
attend for cervical cancer screening in the future relative to those who did not take 
up the offer of vaccination. 
 
Methods 
Design 
Study 1 was prospective in design, tracking risk perceptions, sexual behaviours, 
communication about sex with parents and intentions to attend for cervical cancer screening 
in the future in girls in school year 12 and 13 (aged 16-18 years) over a six month period.  
The analysis compared whether there were differences in changes in the dependent 
variables between girls who received the vaccine and those who did not take up the offer.  
Data collection occurred before (baseline) and after (follow-up) the offer of HPV 
vaccination (see Figure 7.1).  The analysis controlled for the risk perceptions, sexual 
behaviours, communication about sex with parents and intentions to attend for cervical 
cancer screening reported at baseline.  The term ‘declined vaccination’ was used in the 
figures and tables to denote not taking up the offer of HPV vaccination although it is 
acknowledged that non-receipt may not have been an active decision.  Detailed inclusion 
criteria are presented in Table 7.1. 
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Figure 7.1 – Timeline for data collection 
 
 
 
 
 
 
Table 7.1 – Inclusion criteria for each group 
 
Declined vaccination Vaccinated 
Had not received the HPV vaccine at follow-up 
Had not received the HPV vaccine at baseline 
Participated at both baseline and follow-up 
≤ 18 years old a 
Had received the HPV vaccine at follow-up 
Had not received the HPV vaccine at baseline 
Participated at both baseline and follow-up 
≤ 18 years old 
a Respondents who were over the age of 18 were excluded as they were not entitled to receive the HPV 
vaccine as part of the national immunisation programme (n=25 of all participants). 
 
 
 
Participants 
Adolescent girls in school year 12 and 13 (usually aged 16-18 years) were recruited in 
September-November 2009 from eight further education and sixth form colleges in London 
and the South East of England.  This cohort of girls was tracked for six months and asked 
to participate twice in total (completing a baseline and follow-up questionnaire). 
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It was calculated that a sample of 788 participants was required to examine between-group 
differences in behaviour.  Based on risk perception theory and logical arguments set out in 
the introduction to this chapter (supposing that it was not expected that sexual behaviour 
would change or that effects would be small) the following assumptions were made when 
determining sample size: alpha=.05, power=.8, number of groups=2, effect size (r) =.117.  
Experience of other researchers adopting similar methods found attrition of up to 50% 
(10% of students did not complete the academic year or were absent on the day of data 
collection and 40% were not compliant in providing accurate information allowing them to 
be tracked prospectively).  It was also anticipated that not every college would complete the 
study due to unforeseeable events.  As a result ~1700 participants were needed to be 
recruited at baseline. 
 
The colleges were chosen based on ease of travel; it was anticipated that data collection 
would commence before 9am in some colleges and so each college needed to be within 1.5 
hours of London to avoid overnight stays for researchers.  Colleges that met this criterion 
were recruited opportunistically until the sample size was fulfilled.  Initially the head of 
sixth form/FE college was contacted by telephone to give them brief information about the 
project and this was followed up with an information pack sent via email.  The information 
pack included an explanation of the study, a copy of the questionnaire, information sheet 
and consent form (see Appendix 16 and 17).  Contact was made with 10 colleges and eight 
agreed to participate, two of which had previously completed research with the Health 
Behaviour Research Centre, but none of whose data were included in this thesis (see Table 
7.2 for details of the included colleges).  These were a combination of small and medium 
sized sixth form colleges and two large further education colleges.  It was decided to recruit 
from colleges as just over 63% of 16-18 year olds remain in further education and so the 
majority of girls who were eligible for vaccination were accessible (Office for National 
Statistics, 2008).  Education establishments also provide an existing structure for data to be 
collected in a systematic format (students sitting at desks) and data collection could be 
observed and controlled by the researcher.  It was requested that the colleges make all 
                                            
17
 This sample size was used with caution as complex samples models were planned to be run which would 
reduce power.  Post-hoc power calculations were reported in the results section to ensure transparency of 
actual power achieved, even if the desired sample size was met. 
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female students available to participate in the research.  All colleges except College 7 
provided access to all female students in the college.  College 7 provided access to female 
students participating in vocational ‘Health and Social Care’ courses.  This resulted in a 
lower response rate for this college but did allow students with a lower educational 
attainment to be included in the sample.  Such students were not accessible in all of the 
other colleges as some of the smaller colleges offered a narrower range of subjects for 
students to study. 
 
Table 7.2 – College demographic characteristics 
 
 College  
 1 2 3 4 5 6 7 8 Total  
Location Surrey Brent London 
Brent 
London Surrey 
Camden 
London 
Westminster 
London 
Tower 
Hamlets 
London 
Hackney 
London - 
Type FE 
college Sixth form 
Sixth 
form 
FE 
college 
Sixth 
form Sixth form 
Sixth 
form 
Sixth 
form - 
Single sex No No No No No No Yes Yes - 
Location 
that 
vaccine 
was 
offered 
GP School School GP School GP/pharmacy School School  
Response rate 
Denominator= number attending session       
Baseline  
N (%) 
589 
(90.0) 31 (100) 
63 
(100) 19 (100) 
100 
(98.0) 189 (96.4) 
 31 
(100) 
97 
(98.5) 
1119 
(97.9) 
Follow-up  
N (%) 
542 
(98.0) 
No 
participants 
16 
(100) 
Not 
recruited 
39 
(100) 142 (91.0) 
29 
(100) 
68 
(98.6) 
836 
(97.9)a 
Total  
N (%) 
1131 
(94.0) 31 (100) 
79 
(100) 19 (100) 
139 
(99.0) 331 (93.7) 
60 
(100) 
165 
(98.6) 
1955 
(98.2)b 
Response rate 
Denominator= number registered in college       
Baseline  
N (%) 
589 
(75.0) 31 (45.6) 
63 
(73.3) 19 (3.3) 
100 
(56.5) 189 (86.7) 31 (8.7) 
97 
(85.7) 
1119 
(54.4) 
Follow-up 
N (%) 
542 
(76.3) 
No 
participants 
16 
(12.3) 
Not 
recruited 
39 
(22.0) 142 (65.1) 29 (8.1) 
68 
(88.3) 
836 
(45.4)a 
Total 
N (%) 
1131 
(75.7) 31 (45.6) 
79 
(42.8) 19 (3.3) 
139 
(39.3) 331 (75.9) 60 (8.4) 
165 
(87.0) 
1955 
(42.3)b 
a Total excludes the follow-up response rates for College 2 and College 4. 
b Total includes the response rates for College 2 and College 4. 
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Procedure 
Choice of data collection method 
Questionnaires were chosen as the most suitable format for data collection.  It was 
considered most appropriate that the questionnaires be completed during college hours so 
that they could be collected immediately by researchers and also reduced the possibility 
that questionnaires would be misplaced by participants leaving their sensitive responses 
vulnerable to be seen.  It was believed that questionnaire responses provided anonymously 
to the researcher would be more honest than if this information was determined in face-to-
face interviews. 
 
Pilot work 
The questionnaire was piloted using cognitive interviewing with three girls in the 
appropriate age group.  The questionnaire was also completed by other individuals to gauge 
how long it would take to complete. 
 
Baseline assessment 
In September-November 2009 all year 12 and 13 female students attending tutorial sessions 
were invited to take part18.  The study was completed in classrooms in Colleges 1, 4 and 7 
and in an assembly hall in Colleges 2, 3, 5, 6 and 8.  All respondents completed the 
questionnaire during a tutorial period.  Given the sensitive nature of the information asked 
in the questionnaires special considerations were made to reassure participants that their 
responses would be anonymous and confidential.  It was hoped that these measures would 
maximise the honesty of the answers provided and reduce the amount of missing data.  
Methods used by Testa and Coleman (2006) were followed and adapted.  Presumed consent 
was adopted based on the participants’ completion of the questionnaire so participants did 
not have to ever disclose their name.  The questionnaires were printed A5 size so that 
responses could easily be concealed from other students.  Dependant on space constraints, 
participants were asked to ensure that they did not have anyone sitting next to them when 
                                            
18
 In College 1, year 12 boys (n=216) completed a similar questionnaire at the same time as the girls.  The 
college requested that the boys participated in the research.  The boys’ results were not discussed in this 
thesis. 
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they answered the questionnaires to maximise the privacy of their responses.  Finally a 
word-search was provided at the end of the questionnaire to keep respondents occupied 
when they had completed the questionnaire while others were still finishing.  This helped to 
ensure that finished participants did not disturb others and made respondents who were still 
completing the questionnaire feel reassured that no one was looking at their answers.  
Fieldworkers from the Health Behaviour Research Centre at UCL helped administer the 
questionnaires and in every college the session was run by an individual independent to the 
college; completed questionnaires were collected by the researcher only and were never 
touched by the participants’ teachers.  This method has been shown to result in more 
accurate responses than asking the students’ teachers to administer the sessions (Testa & 
Coleman, 2006).  Fieldworkers received training prior to administrating the questionnaires 
and documented the number of students attending the session and the number of students 
refusing to participate.  The study received a favourable ethical opinion from the UCL 
research ethics committee (Appendix 18). 
 
Follow-up 
In March 2010 these girls were approached again using the same procedures and asked to 
participate in a follow-up questionnaire (Appendix 17). 
 
Vaccination receipt 
Between baseline and follow-up the girls were offered the HPV vaccine as part of the 
‘catch-up’ immunisation programme.  This study had no influence on whether girls were 
offered the vaccine or whether they chose to receive the vaccine or not.  Some primary care 
trusts offered the vaccine to girls in their colleges whereas others offered the vaccine 
through the girls’ GPs or pharmacies (Table 7.2). 
 
Measures 
The dependent variables of perceived risk, sexual behaviours, communication about sex 
with parents and intentions to attend for cervical cancer screening in the future were 
assessed along with the main independent variable, vaccination receipt and factors that 
were established to be associated with the dependent variables (see Table 7.3).  Other 
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variables were assessed in the questionnaire but were not considered for the analyses in this 
chapter. 
 
Table 7.3: Factors established to be associated with each dependent variable that were adjusted for in 
the second model run for each dependent variable 
 
Factors established to be associated with the 
dependent variable Reference 
Sexual debut Having ever had a boyfriend 
 
Drug use  
Subjective norm for my parents think I should have 
sex this year 
Subjective norm for my friends think I should have 
sex this year 
Kaestle et al. (2002) 
Marin et al. (2006)  
Donnelly et al. (2001) 
Buhi et al. (2007) 
 
Buhi et al. (2007) 
Age of sexual debut Subjective norm for my friends think I should have 
sex this year 
Being a smoker 
 
Having ever had a boyfriend 
Buhi et al. (2007) 
 
Donnelly et al. (2001) 
Tucker, et al. (2006) 
Kaestle et al. (2002) 
Marin et al. (2006)   
Condom use Oral contraceptive use 
Subjective norm for my parents think I should use a 
condom when I next have sexual intercourse 
Subjective norm for my friends think I should use a 
condom when I next have sexual intercourse 
Woods et al. (2006) 
Buhi et al. (2007) 
 
Buhi et al. (2007) 
 
Dependent variables 
Risk perceptions 
Risk perceptions were assessed because the theory described in Chapter 3 and in the 
introduction to this chapter suggested that changes in sexual behaviour and intentions to 
attend for cervical cancer screening in the future following HPV vaccination would be the 
result of altered risk perceptions.  To measure perceived susceptibility to HPV, cervical 
cancer and STIs two dimensions of the construct were measured: perceived likelihood and 
feelings of risk.  Both of these dimensions were measured using single items to reduce the 
length of the questionnaire and avoid repetitive questions.  Single item measures of 
perceived risk are acceptable if well chosen (Weinstein et al., 2007).  In accordance with 
recommendations for measuring perceived risk (Brewer et al., 2004) the items specified the 
person, threat, time period and considerations of future behaviour. 
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Likelihood of illness/infection 
There is no agreed gold standard for measuring perceived likelihood (Weinstein et al., 
2007) and previous assessments in the context of cervical cancer have employed both 
absolute measures (e.g. Gerend & Magloire, 2008; Ingledue et al., 2004; Kahn et al., 2001; 
Marteau et al., 2002) and comparative measures (e.g. Marteau et al., 2002; Price et al., 
1996).  Absolute and comparative measures of susceptibility can result in different 
perceptions of risk.  Lipkus et al. (2000) found that women overestimated their risk of 
breast cancer when asked using an absolute measure and underestimated their risk when 
asked using a comparative measure.  As it was hypothesised that perceived likelihood of 
cervical cancer, HPV and STIs would reduce in young women once they had received the 
HPV vaccine an absolute measure was chosen.  Using a comparative measure of perceived 
likelihood may have resulted in floor effects at baseline measurement and have not allowed 
for possible reductions in risk perception to be visible. 
 
Numerical risk probabilities can be difficult for lay populations to understand (Black et al., 
1995; Lipkus et al., 2001; Schwartz et al., 1997; Yamagishi, 1997) and verbal scales have 
been found more reliable, valid and easier to use (particularly 7-point scales; Diefenbach et 
al., 1993; Woloshin et al., 2000). 
 
Consequently, an absolute-risk measure of perceived likelihood of being diagnosed with 
cervical cancer and being infected with HPV or STIs was chosen using the 7-point verbal 
linear scale as used by Diefenbach et al. (1993).  For example, ‘If I never have the HPV 
vaccine, my chance of getting infected with an STI in the future is…’, response: no chance, 
very unlikely, unlikely, moderate chance, likely, very likely, certain to happen’.  The prefix 
‘If I never have the HPV vaccine’ was removed for assessment at follow-up when the 
participants could have received the HPV vaccine and information about HPV was 
provided prior to the questions about HPV (see Box 7.1). 
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Feeling at risk  
A dimension of perceived risk that has been gaining interest is ‘feelings of risk’.  The 
concept has been found to produce stronger correlations with actual behaviour than 
reported perceived likelihood (Weinstein et al., 2007).  Although its superiority is 
becoming established, because of its novelty it is unknown whether measurement is likely 
to result in participants giving unrealistically optimistic (Weinstein, 1980) responses in the 
context of cervical cancer, HPV or STIs and creating an undesirable floor effect.  
Consequently it was deemed appropriate to measure both dimensions of perceived risk.  
Feelings of risk were assessed with an item used by Weinstein et al. (2007), ‘If I never have 
the HPV vaccine, I would feel very vulnerable to HPV in the future’, response: strongly 
disagree, disagree, not sure, agree, strongly agree.  The prefix ‘If I never have the HPV 
vaccine’ was removed for assessment at follow-up. 
a Varied by time point 
 
Box 7.1 – Information provided to participants before sexual behaviour, HPV and cervical 
cancer screening questions 
 
Sexual behaviour information 
The next questions are about people you have had sexual intercourse with.  Please include every 
person you have ever had sexual intercourse with whether it was just once or a few times or a 
regular partner.  By sexual intercourse we mean vaginal sex. 
 
HPV information 
Human papillomavirus (HPV) is a very common infection involved in most cervical cancers.  It is 
transmitted via skin-to-skin contact, most commonly during sexual activity.  A vaccine has been 
developed that protects against this infection.  This school year/next school year you are 
being/will be offered the HPV vaccine a. 
 
Cervical cancer screening information 
Women aged 25-64 years are offered cervical screening (also known as a smear test) every 3-5 
years.   
Cervical screening checks the health of the cervix (neck of the womb), and allows doctors to find 
changes in the cervix before they can develop into cancer.   
During the cervical screening test the doctor or nurse will ask you to lie down on a couch.  They 
will then gently put a small instrument, called a speculum, into your vagina to hold it open. Then 
they will wipe a small spatula or a brush-like device over the cervix to pick up some cells.   
They will transfer these cells into a small container of liquid, and send it away for the cells to be 
examined under a microscope.  The test takes just a few minutes. 
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Sexual behaviour 
Questions assessing age of sexual debut, number of sexual partners with definitions 
provided to participants (see Box 7.1) were adapted from the National Surveys of Sexual 
Attitudes and Lifestyles (NATSAL) 2000 (‘how many people have you ever had sexual 
intercourse with?’ and ‘how old were you when you first had sexual intercourse?’; ‘I have 
never had sex’ was provided as an option).  The survey was originally completed by 11,161 
16-44 year old males and females, and has been used to measure changes in sexual 
behaviour over time (Fenton et al., 2001b; Johnson et al., 2001; Wellings et al., 2001).  It 
underwent considerable acceptability and reliability testing during its development 
(Wellings et al., 1990).  The variable ‘having ever had sex’ was determined using 
participants’ responses to these questions (coded: ‘had sex’, ‘never had sex’). 
 
Questions assessing previous barrier contraceptive use were from the RIPPLE study 
(Stephenson et al., 2004; 'when you have sexual intercourse how often do you use a 
condom?'  Response: Never, hardly at all, less than half the time, about half of the time, 
most times, every time or I have never had sex').  The study questions from RIPPLE were 
originally used with 13-16 year olds to evaluate the effectiveness of a peer-led sex 
education intervention. 
 
It was not feasible in the current study to validate sexual behaviour self-reports, however 
other researchers have made attempts to do so.  Bhave et al. (1995) examined STI incidence 
(HIV, hepatitis B and syphilis) as well as self-reported sexual behaviour.  Similarly, 
Hobfoll et al. (1994), in addition to asking for self-reported behaviour, gave study 
participants a credit card to obtain free condoms from a pharmacy.  The pharmacy then 
provided details of the number of women who used this service.  In both of these studies 
analyses that were significant for self-reported behaviour were also significant for objective 
measures of behaviour and in the same direction, for example self reported use of condoms 
for vaginal sex increased as did the number of condoms obtained from the pharmacy.  This 
suggests that self-report measures of sexual behaviour are as reliable as objective measures. 
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Parental communication about sex 
Previous communication about sex with parents was assessed by asking whether 
respondents had ever spoken to their parents about six sex-related topics.  Five of the topics 
formed a highly reliable scale developed by Hutchinson, Jemmott, Jemmott, Braverman, 
and Fong (2003); HPV vaccination was added to this scale for the present study and gave 
acceptable Cronbach’s alpha levels.  The Cronbach’s α for baseline=.70 and for follow-
up=.75. 
 
Intention to attend for cervical cancer screening in the future 
Intentions to attend cervical cancer screening when older were measured using the average 
of two items that followed the structure used by Sheeran and Abraham (2003): ‘when I am 
older and am invited to go for a smear test, I intend to go’ and ‘when I am older and am 
invited to go for a smear test, I will try to go’; response: strongly disagree, disagree, not 
sure, agree, strongly agree.  The two items measuring intention to attend cervical cancer 
screening were highly reliable.  The Cronbach’s α for baseline=.86 and for follow-up=.86.  
Information about cervical cancer screening was provided to participants before they 
answered these questions (see Box 7.1). 
 
Independent variable 
Vaccination receipt 
Girls were asked to indicate their vaccination status using the following options ‘I have 
received all three doses of the HPV vaccine’ or ‘I have received 1 or 2 doses of the HPV 
vaccine and will complete the course of injections’ or ‘I have received 1 or 2 doses of the 
HPV vaccine and will not complete the course of injections’ or ‘I have been offered the 
HPV vaccine but I haven’t yet had it’ or ‘I have been offered the HPV vaccine but have 
decided not to have it’ or ‘I have not been offered the HPV vaccine’.  Those who had 
received any dose of the HPV vaccine were classified as having had the HPV vaccine and 
those who had not received at least one dose of the HPV vaccine were classified as having 
not had the HPV vaccine.  These items were developed for the present study. 
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Potential confounding variables known to be associated with sexual behaviour 
Subjective norms 
A subjective norm is the extent that an individual believes that others think they should 
perform a certain behaviour coupled with how motivated the individual is to behave as 
others think they should.  Subjective norms have consistently been shown associated with 
condom use, having ever had sex and age of sexual debut (Buhi & Goodson, 2007).  
Normative beliefs for sexual behaviour (beliefs about parents’ and friends’ beliefs about 
whether the participant should have sex this year and should use a condom next time the 
participant has sexual intercourse) were assessed along with two items tapping general 
motivation to comply with the individuals described (parents and friends).  The format of 
these questions followed the structure described by Armitage and Conner (1999), for 
example, ‘my parents think I should use a condom when I next have sexual intercourse’ and 
‘in general, I want to do what my friends think I should do’, response for both types of 
question: strongly disagree, disagree, not sure, agree, strongly agree.  Subjective norm 
scores were calculated following the procedure recommended by Trafimow (2008; 
normative belief x motivation to comply). 
 
Smoking 
Current smoking status was assessed as it is associated with an earlier sexual debut (e.g. 
Donnelly et al., 2001; Tucker et al., 2006).  Girls responded to a question adapted from 
Clemens, Jotangia, Lynch, Nicholson and Pigott (2008); ‘do you smoke?’ with either ‘yes’ 
or ‘no’ as a response option. 
 
Oral contraceptive use 
Oral contraceptive use was assessed as it appears that participants who adopt alternative 
methods of contraception to condoms are less likely to be consistently using condoms at 
sexual intercourse (Woods et al., 2006).  In this study the authors reported that 26% of 14-
17 year old girls were solely using oral contraceptives at coitus.  Girls may be especially 
less likely to use barrier contraceptives in addition to an oral contraceptive if both partners 
were virgins prior to engaging in sexual activities together and so considered their risk of 
STIs to be minimal.  In 2008/2009 in Great Britain oral contraceptives were the second 
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most common contraceptive method used by 16-19 year old girls after male condoms 
(Office for National Statistics, 2009); in respondents who were using at least one form of 
contraception, 65% were using the male condom and 54% were using the contraceptive 
pill.  Other methods of contraception were rarely used by 16-19 year olds, for example the 
next most common contraceptive method used was emergency contraception (7%).  The 
girls responded to the question ‘do you take the pill (oral contraceptives)?’, response: yes, 
no.  This question was developed for the present study as I was unable to locate another 
study that had asked solely about oral contraceptive use.  Previous studies had included 
other methods of contraception. 
 
Illicit drug consumption 
Illicit drug consumption was assessed as it is associated with having had sexual intercourse 
(Donnelly et al., 2001).  It was assessed using a question from a government commissioned 
national survey of smoking, drinking and drug use among young people (11-15 year olds) 
in England (Clemens et al., 2008).  ‘How often do you usually take drugs that you did not 
get from your doctor or chemist (illegal drugs)?’, response: never, only a few times a year, 
about once a month, about once a fortnight, about once a week, about twice a week, every 
day or almost every day. 
 
Relationship status 
Having a partner is a predictor of sexual activity in adolescence and the effect appears 
present at a range of ages suggesting that age of sexual debut is also affected by 
relationship status (Kaestle et al., 2002; Marin et al., 2006).  Relationship status was 
assessed using a measure developed for the present study by asking respondents: ‘Have you 
had a boyfriend or girlfriend at all since starting secondary school?’, response: yes, no.  The 
measure was comparable to those used by Marin et al. (2006) and Carlson et al. (1990). 
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Demographic questions 
Ethnicity 
Ethnicity was assessed using classifications from the UK 2001 census (Office for National 
Statistics, 2001). 
 
Religion 
Religion was assessed using classifications from the UK 2001 census (Office for National 
Statistics, 2001).  Respondents who identified themselves as having a religion were asked 
to indicate if they were practising that religion; ‘Would you say that you are practising this 
religion?’, response: yes, practising or no, not practising.  An option was provided for ‘I do 
not have a religion’. 
 
Socioeconomic status 
Receipt of educational maintenance allowance (EMA) and amount received was used as a 
crude measure of socioeconomic status.  EMA is a term time payment given to 16-18 year 
old students who remain in education after the end of compulsorily studies.  The amount 
received is calculated using household income (income of <£20,817 per year earns £30 per 
week, £20,818-£25,521 per year earns £20 per week, £25,522-£30,810 per year earns £10 
per week, students with a household income >£30,810 per year have no entitlement to 
EMA).  The girls were asked ‘how much EMA (educational maintenance allowance) are 
you normally entitled to receive per week?’; response: £30, £20, £10 or ‘I am not entitled to 
EMA’. 
 
Matching data between time points 
To anonymously match the participants’ responses between baseline and follow-up, the 
girls were asked to provide their postcode and date of birth.  The participants were not 
immediately identifiable in person by the researchers knowing this information but it was 
likely to remain stable between time points.  The colleges were never permitted to see the 
questionnaires and so were not able to match this participant information to their students.  
It was not possible to contact any participant who was absent at follow-up and so their data 
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was missing.  Occasionally at follow-up participants provided incomplete matching data, 
where possible or appropriate, attempts were made to match their questionnaire with 
participants from baseline using other information that was deemed to be stable (for 
example, ethnicity).  Participants were matched in this way on 25 occasions.  Three 
participants could not be matched as they had the same date of birth, postcode and ethnicity 
so they were entered as new participants. 
 
Analysis 
Response rate 
Two response rates were calculated.  In the first response rate the denominator was the 
number of female students registered in the colleges.  Anecdotally, colleges reported that 
around 10% of students registered at the beginning of the school year do not complete their 
courses and the colleges were unable to provide up-to-date records of the number of 
students attending the college at the time of data collection.  This first response rate was 
likely to be an overly conservative estimate of participation.  The denominator of the 
second response rate was the number of students attending the tutorial session when data 
collection took place.  It was anticipated that the true response rate would be between these 
two estimates. 
 
Missing data 
At baseline 14 cases had >50% data missing so were excluded from the analysis and 11 
cases were excluded for this reason in March 2010.  On rare occasions, participants 
reported what was considered to be an implausible response (very high number of sexual 
partners, low age of sexual debut); these responses were considered outliers and were coded 
as missing.  Similarly, on a small number of occasions respondents provided a response at 
follow-up that was incongruent with their response at baseline (for example they reported 
having fewer lifetime sexual partners at follow-up than they did at baseline).  These 
responses were labelled as missing for follow-up (number of sexual partners n=7; 
communication about sex n =135; had sex n=38, age of sexual debut n=11, vaccine receipt 
n=3).  The high number of incongruent responses for parental communication about sex 
raises questions about the reliability of this measure. 
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Missing values were retained in the dataset for analysis and were not imputed.  It was 
deemed inappropriate to impute the main variables under consideration for this study 
(whether the girl had received the HPV vaccine and her sexual behaviour).  The analysis for 
the present study was intended to explore the variation in the dependent variables that was 
not explained by factors that are already known to predict it.  Expectation maximisation 
methods would have used the factors that are already known to predict the dependent 
variable to impute the dependent variable (for example imputing number of sexual partners 
using parental normative beliefs).  This would have been undesirable because it would 
generate values for the dependent variables that were explained by the factors that would 
have been adjusted for in analysis.  Replacing missing values with mean scores would have 
reduced the variance in the data resulting in reduced effect sizes.  Given that effect sizes 
were hypothesised to be small or even non-significant, mean imputations were also 
considered unsuitable.  There were a small number of missing values for the variables 
(average 3.25%, see Appendix 19) so non-imputed data were used.  Although generally 
missing data were rare, two of the questions about sexual behaviour were unanswered by a 
larger proportion of participants (number of sexual partners – follow-up measure: 12.0% 
missing, age of sexual debut – follow-up measure: 9.6% missing).  These questions were 
likely to have been considered too sensitive to disclose in a questionnaire and this was 
unsurprising.  However, it was unfortunate that a higher percentage of participants did not 
answer these questions.  Procedures described in the methods section were adopted to 
reassure participants of confidentiality and participants have previously reported a 
preference for self-completion questionnaires over face-to-face interviews when disclosing 
sensitive information (Tourangeau & Smith, 1996). 
 
When summing the number of topics about sex discussed with parents the final score was 
coded as missing if any value was missing from the items contributing to the summed 
score.  Too few participants identified themselves as belonging to some ethnic and religious 
groups making group sizes too small for statistical comparisons to be made.  These groups 
were grouped together and labeled as ‘other’.  The creation of an ‘other ethnicity’ and an 
‘other religion’ group meant that inferences could not made about that group specifically, 
only comparisons made with it. 
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Statistical analysis 
Statistical analysis was performed using SPSS version 14 (SPSS Inc., 2005).  A number of 
the dependent variables showed statistically significant skewness and kurtosis.  As the 
values for these variables were meaningful it was decided not to transform this data (for 
example the actual number of sexual partners would be more informative than a 
transformed score) and to dichotomise non-normally distributed dependent variables.  A 
median split was used for number of sexual partners (dichotomised into number of sexual 
partners at or below the median versus number of sexual partners above the median; 
median=0 for both analysis), number of topics about sex discussed with parents 
(dichotomised into number at or above the median – ‘high communication about sex’ 
versus number below the median – ‘low communication about sex’; median=4, range:0-5) 
and intention to attend for cervical cancer screening in the future (dichotomised into 
intention below the median – ‘low intention’ versus intention at or above the median – 
‘high intention’; median=3, range:0-4).  Condom use was dichotomised into ‘always uses 
condoms’ versus all other responses as this was considered most meaningful (inconsistent 
condom use of any kind increases risk of pregnancy/STI infection). 
 
The first analysis run was designed to help choose the best measure of perceived risk to be 
used in the rest of the analysis.  Complex samples univariate logistic regression models 
were performed as the sampling design meant that the data were clustered.  An inherent 
assumption of statistical analysis is that samples are random.  This was not the case for the 
present study as participants were recruited from colleges and not randomly sampled from 
the population.  As a result the participants were clustered by college.  Complex samples 
analysis overcomes violated assumptions of independence by taking the cluster into 
account (in this case the cluster was ‘college’) and usually produces a more conservative 
alpha statistic than simple analysis.  SPSS was a suitable programme for performing 
complex samples analysis however it did not provide some of the desired output statistics 
that are produced by non-cluster adjusted analytical techniques; in these cases non-
clustered statistics were reported so long as they were not dependent on the alpha or its 
confidence intervals (for example effect sizes).  For the logistic regression Nagelkerke’s 
pseudo R² was reported and odds ratios (OR) with 95% confidence intervals (CI).  I 
examined standardised residuals from non-clustered models (again because SPSS did not 
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provide these statistics) to look at how well the model fit the data.  Cook’s distance and 
DFBetas from non-clustered models were examined to check for outliers.  I also ran 
complex samples univariate logistic regression to examine whether perceived risk at 
baseline predicted vaccination status at follow-up. 
 
I next intended to look at whether any changes in the dependent variables between baseline 
and follow up were different between those who were vaccinated and those who opted not 
to receive the vaccine.  The dependent variables I considered were risk perceptions, sexual 
debut, age of sexual debut, number of sexual partners, condom use, intention to attend for 
cervical cancer screening and communication about sex with parents.  When the dependent 
variable was continuous I ran complex samples analysis of co-variance (ANCOVAs) run as 
general linear models (GLM) using Wald’s F.  I determined the appropriateness of each 
model by examining interaction effects although I decided a priori to not to consider 
interactions for the analysis.  I used Partial H² as an effect size, and power that were derived 
from non-clustered models as SPSS did not provide effect sizes or power estimations for 
complex samples analysis.  When the dependent variable was dichotomous I ran complex 
samples logistic regressions using the statistics reported above for the perceived risk 
analysis.   
 
For both types of test I ran two models.  The first included vaccination status and the 
baseline version of the dependent variable.  The second model also adjusted for factors that 
are established in the literature to be associated with the dependent variable and included 
just demographic characteristics for the cervical cancer screening intentions and the 
communication about sex analysis (see Table 7.3).  I would have liked to have included 
demographic characteristics in all of the second models, but their inclusion in the models 
cause instability due to small numbers in certain groups.  As a consequence, demographic 
characteristics were only considered for the two dependent variables that have not shown 
consistent associations with other factors.  Unadjusted change scores have been presented 
for descriptive purposes but they were not used for analysis.  The methods that were used 
for analysis have been considered better as they are unaffected by baseline imbalances 
between groups, unlike change score analysis (Vickers & Altman, 2001). 
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It was not possible to run analysis comparing differences in changes in sexual debut, 
change in age of sexual debut or change in number of sexual partners for the whole sample.  
For the sexual debut analysis, participants were unable to have reached sexual debut at 
baseline but to have not reached sexual debut at follow-up causing some cells in the 
analysis to be empty and making it impossible for these models to be run.  For the age of 
sexual debut analysis it was not possible for a participant to have changed their age of 
sexual debut and so this analysis was not appropriate.  For the analysis looking at number 
of sexual partners, splitting the sample at the median (0) meant that this analysis would 
again attempt to look at changes in having ever had sex and so could not be performed.  
Instead, this analysis was performed with only girls who had ever had sex at baseline. 
 
My role in this study 
I conceived and designed this study with advice from Professor Wardle and Dr Waller.  I 
developed or decided upon the measures for the study myself.  I gained ethical approval for 
the study, including writing a detailed protocol, designed the information materials, consent 
form and questionnaire.  I recruited the colleges, managed the study generally and prepared 
for data collection on my own.  Colleagues from the Cancer Research UK Health 
Behaviour Research Centre helped with data collection and I provided them with a briefing 
them about procedures and organised when and where they were needed in the colleges.  I 
was present at each data collection time point and site.  I entered the data and received help 
from three data entry workers for entering the data from the follow-up questionnaire.  I 
made random checks to ensure accuracy.  I conducted data analysis with supervision from 
Mr Boniface and Dr Waller. 
 
Results 
Response rate 
At baseline, College 4 was unable to accommodate the research in the manner described in 
the procedure section.  Due to timetabling difficulties the coordinator in the college asked 
students to come to a quiet room to complete the questionnaire when they were not in 
lessons.  This resulted in very few girls choosing to come to the session (19 students 
completed the questionnaire over three eight-hour day sessions) and also meant that these 
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girls would complete the research under different conditions from the rest of the sample.  It 
was decided not to recruit from College 4 at follow-up.  At follow-up in College 2 
attendance at tutorial session was not mandatory for the students as they were in a revision 
period, the coordinator in the college failed to tell the girls to come to the session and so no 
participants turned up.  The coordinator was unable to reschedule the data collection 
session for a later date because of exams.  As a result there was no data for College 2 at 
follow-up.  No participants from these two colleges were used in the main analysis. 
 
At baseline 1119 completed the questionnaire and this was 836 at follow-up (Table 7.2).  
Data from 407 girls were included in the analysis (n=259 who declined vaccination and 
n=148 vaccinated)19.  Of the girls who were registered in the colleges, 54.4% completed the 
questionnaire at baseline and 45.4% participated at follow-up, giving an overall response 
rate of 42.3%, excluding the response rates for College 2 and College 4.  Of the girls who 
were present in the data collection sessions 97.9% participated at baseline and 97.9% 
participated at follow-up.  Overall, excluding the response rates for College 2 and College 
4, 98.2% of girls present in the sessions completed the questionnaire.  As described in the 
methods section the denominators for the number of girls registered in the colleges was 
unlikely to be accurate, as a consequence it was concluded that the overall response rate for 
the study was between 42.3% and 98.2%. 
 
Description of the colleges 
Statistical comparisons between colleges were not possible due to small group sizes and the 
variation between colleges being too great to combine colleges; however, a descriptive 
analysis of the colleges is provided below.  For the baseline assessment the number of 
participants recruited from each college ranged from 19 to 589 and at follow-up it was from 
16 to 542 (Table 7.2).  At each time point the majority of participants came from College 1 
(Table 7.4).  The majority of participants from Colleges 3, 7 and 8 were from ethnic 
minority groups (Table 7.4).  The majority of participants from Colleges 5, 7 and 8 were 
receiving EMA (Table 7.3).  Two of the colleges only admitted girls and the rest were co-
                                            
19
 The reduced sample size was the result of the inclusion criteria prescribing that participants must have 
responded at baseline and follow-up for the 1st analysis, and to have detailed their vaccination status. 
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educational (Table 7.2).  Two of the colleges were further education establishments (not 
linked to a school) and the other six were sixth form colleges.  The majority of the girls 
were offered the vaccine in school but girls from three colleges had to visit their GP or 
local pharmacist in order to receive the vaccine (Table 7.2).  Uptake of the vaccine ranged 
from 15.8% to 100% (mean for all colleges=52%, Table 7.4).  Only in College 8 did the 
proportion of girls who had received the HPV vaccine match the proportion of eligible girls 
receiving at least one dose of the HPV vaccine in their primary care trust (PCT, Table 7.4).  
Out of the remaining five colleges, two colleges had a greater proportion of girls vaccinated 
than their PCT average and three colleges had a lower proportion of girls vaccinated than 
their PCT average.  Generally, across the colleges a smaller proportion of the girls were 
vaccinated compared with the average for England.  However, the PCT data were for the 
previous academic year. 
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Table 7.4: College demographics and regional statistics. 
 
  
College  
N (%) 
 1 3 5 6 7 8 
Average 
for 
England 
Total  223 (54.8) 6 (1.5) 21 (5.2) 
101 
(24.8) 12 (2.9) 44 (10.8)  
Declined vaccination 134 (60.1) 0 (0) 9 (42.9) 85 (84.2) 5 (41.7) 26 (59.1)  
Vaccinated 89 (39.9) 6 (100) 12 (57.1) 16 (15.8) 7 (58.3) 18 (40.9)  
Percent of girls receiving 
≥ 1 HPV vaccine dose in 
the PCT that the college 
resided in a 
49.1 77.1 23.2 65.2 71.5 40.4 62.2 
Demographic 
characteristics of each 
college 
       
From an ethnic 
minority 43 (19.3) 5 (83.3) 10 (47.6) 41 (40.6) 12 (100) 34 (77.3) 
9.1%  
(London: 
28.4%) 
Receiving EMA 64 (28.7) 2 (33.3) 19 (90.5) 41 (40.6) 12 (100) 37 (84.1)  
Note: Number of cases included for the ‘from an ethnic minority’ and ‘receiving EMA’ rows are lower than 
the total rows due to participants not reporting their ethnicity or EMA entitlement.   
a
 http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh 
_111676.pdf (Department of Health, 2010).  Percentages were for girls born between 01/09/1995-31/08/1999 
whereas the study participants were from the following year of the ‘catch-up’ programme. 
 
 
Description of the sample 
Most of the girls were white (62.8%), were not entitled to EMA (56.9%) and were on 
average 17.5 years old.  Around 40% of the sample was Muslim and of those who reported 
a having a religion 51% were practising that religion (Table 7.5). 
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Table 7.5: Demographic characteristics 
N=407 n (%) 
Ethnicity  
White 250 (62.8) 
Black  33 (8.3) 
Asian  75 (18.8) 
Other 40 (10.1) 
EMA receipt  
£30 146 (36.0) 
£20 15 (3.7) 
£10 14 (3.4) 
No entitlement 231 (56.9) 
Religion  
None 142 (35.6) 
Christian 70 (17.5) 
Muslim 160 (40.1) 
Other 27 (6.8) 
Practising a religion a  
Yes 126 (51.0) 
No 121 (49.0) 
Age (mean (se) 17.51 (.02) 
Note: Total columns not equalling the total for sample are due to missing data, percentages not equalling 
100% are due to missing data. 
a
 Of those who reported a having a religion 
 
 
Best method for measuring risk 
The first analysis investigated which method of measuring risk was most appropriate to use 
as measures of both ‘perceived likelihood’ and ‘feelings of risk’ had been taken.  Data from 
any participant who responded in March 2010 were used to establish whether ‘feelings of 
risk’ or ‘perceived likelihood’ had the highest association with having the vaccination.  As 
can be seen from Table 7.6 only the ‘feelings of risk’ item for HPV infection was 
associated with vaccination receipt, with those who had been vaccinated against HPV 
having lower perceptions of personal risk of HPV infection as would be predicted.  
‘Feelings of risk’ for cervical cancer approached significance.  Given that ‘feelings of risk’ 
was most highly associated with vaccination receipt, this measure of risk perceptions was 
used for all other analysis. 
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Table 7.6: Univariate logistic regression exploring predictors of vaccination receipt in March 2010 
 
  
Mean 
(se) 
Vaccinated 
mean (se) 
Unvaccinated 
mean (se) B SE B 
OR  
(95% CI)a p 
Perceived likelihood of 
HPV b (n=763) 
2.36 
(.04) 
2.30  
(05) 
2.42 
(.05) -0.12 0.07 
0.89 
(.77-1.03) .12 
Feelings of risk for 
HPV c (n=763) 
1.51 
(.03) 
1.44  
(.03) 
1.58 
(.04) -0.26 0.10 
0.77 
(.64-.94) <.01 
Perceived likelihood of 
cervical cancer (n=760) 
2.47 
(.03) 
2.45  
(.03) 
2.49 
(.05) -0.06 0.08 
0.95 
(.80-1.11) .50 
Feelings of risk for 
cervical cancer (n=762) 
1.60 
(.03) 
1.56  
(.04) 
1.65  
(.04) -0.17 0.10 
0.85 
(.07-1.02) .09 
a 
 Odds ratio for vaccinated versus unvaccinated 
b
 Perceived likelihood range 0-6 
c
 Feelings of risk range (0-4) 
 
Does perceived risk predict vaccination status? 
It was next considered whether perceived risk prior to vaccination could predict vaccination 
status.  Feelings of risk for HPV, cervical cancer and STIs at baseline were moderate: HPV 
mean=2.22, se=.10; cervical cancer mean=2.24, se=.09; STIs mean=2.03, se=.07 (possible 
range 0-4).  As can be seen from Table 7.7 feelings of risk for HPV infection and cervical 
cancer at baseline predicted whether girls received the vaccine at follow-up.  Girls with 
higher feelings of risk were more likely to receive the vaccine.  Model 1 and Model 2 could 
explain 3% and 4 % of the variance in vaccination receipt.  Feelings of risk for STIs at 
baseline did not predicted vaccination receipt at follow-up.  It was not possible to generate 
residuals for the complex samples logistic regression; in the absence of these cluster-
adjusted residuals a non-clustered logistic regression was run.  Fewer than 5% of the 
standardised residuals for all of the non-clustered logistic regressions were greater than 2 
and no more than 1% were above 2.5 suggesting that the models fit the data well.  No 
Cook’s distance or DFBeta was greater than 1 indicating that no case was influencing the 
models over and above any other case. 
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Table 7.7: Can feelings of risk at baseline predict vaccination status at follow-up? 
 
Declined 
vaccination Vaccinated 
 mean (se) mean (se) 
R² 
Model 1: Feelings of risk of HPV at baseline (n=405) 2.12 (.08) 2.41 (.12) .03* 
Model 2: Feelings of risk of cervical cancer at baseline (n=404) 2.12 (.08) 2.45 (.09) .04** 
Model 3: Feelings of risk of STIs at baseline (n=398) 1.97 (.09) 2.12 (.05) .01 
p≤ .01, **p≤ .05 
 
 
Did perceived risk of HPV, cervical cancer and STIs change following the receipt of HPV 
vaccination to a greater extent than girls who did not take up the offer of vaccination? 
First, it was considered whether vaccinated girls had changed their feelings of risk of HPV, 
cervical cancer and STIs following HPV vaccination compared with girls who had not 
taken up the offer of vaccination.  At follow-up feelings of risk for HPV, cervical cancer 
and STIs were low generally for the whole sample: HPV mean=1.57, se=.08; cervical 
cancer mean=1.66, se=.08; STIs mean=1.53, se=.09.  As can be seen from Table 7.8 there 
was no greater change in feelings of risk of HPV infection in vaccinated girls than girls 
who had not taken up the offer of vaccination from baseline to follow-up although the 
vaccination receipt analyses were not powered to detect a significant effect (F(1,5)=4.76, 
p=.08, partial H²=.01, power 44%).  There was a significant difference in the change in 
feelings of risk of cervical cancer between baseline and follow-up (F(1,5)=12.00, p=.02, 
partial H²=.02, power 69%; Table 7.8).  Vaccinated girls had lowered their feelings of risk 
to a greater extent than girls who had not taken up the offer of vaccination.  An interaction 
effect was found suggesting that regression slopes were not homogeneous and that the 
model was only true of one group.  When this was explored graphically, it was evident that 
only those who received the vaccine changed their feelings of risk of cervical cancer.  
Regardless of original levels of feelings of risk, vaccinated individuals reduced their 
perceived risk to the same level, whereas girls who had not taken up the offer of 
vaccination did not change their feelings of risk.  There was no greater change in feelings 
of risk of STIs in vaccinated girls than in girls who had not taken up the offer of 
vaccination from baseline to follow-up but this analysis was not sufficiently powered 
(F(1,5)=6.21, p=.06, partial H²=.04, power 49%; Table 7.8). 
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Table 7.8: Feelings of risk for vaccinated girls and girls who had not taken up the offer of vaccination 
 
Feelings of risk for HPV 
mean (se) 
Feelings of risk for cervical cancer 
mean (se) 
Feelings of risk for STIs 
mean (se) 
 Baseline Follow-
up 
Change 
score 
P a Baseline Follow-
up 
Change 
score 
P b Baseline Follow-
up 
Change 
score 
P c 
Vaccination status    .08    .02    .06 
Vaccinated  2.41 (.12) 1.48 (.10) .93 (.08)  2.45 (.09) 1.58 (.07) .88 (.05)  2.12 
(.05) 
1.58 
(.16) 
.55  
(.15) 
 
Declined 
vaccination 
2.12 (.08) 1.63 (.08) .49 (.04)  2.12 (.08) 1.71 (.09) .41 (.03)  1.97 
(.09) 
1.50 
(.07) 
.48  
(.08) 
 
a R²=.16, n=399.  Difference in follow-up scores between vaccinated girls and those who declined vaccination, adjusted for baseline feelings of risk for HPV. 
b R²=.13, n=399.  Difference in follow-up scores between vaccinated girls and those who declined vaccination, adjusted for baseline feelings of risk for cervical cancer 
c R²=.07, n=397.  Difference in follow-up scores between vaccinated girls and those who declined vaccination, adjusted for baseline feelings of risk for STIs 
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Did sexual behaviour change following the receipt of HPV vaccination to a greater extent 
than girls who did not take up the offer of vaccination? 
It was then considered whether vaccinated girls had changed their sexual behaviour 
following HPV vaccination to a greater extent than girls who had not taken up the offer of 
vaccination.  Sexual debut, age of sexual debut, number of sexual partners and condom use 
were measured.  It was not possible to perform this analysis for sexual debut, age of sexual 
debut and number of sexual partners for the whole sample but the descriptive statistics for 
these variables have been presented. 
 
Sexual debut and age of sexual debut 
For the whole sample 45.7% had reached sexual debut at follow-up.  As can be seen from 
Table 7.9, at baseline 29.6% of the girls who remained unvaccinated at follow-up had 
reached sexual debut compared with 34.5% of vaccinated girls.  At follow-up 42.0% of 
girls who did not take up the offer of vaccination had reached sexual debut compared with 
47.6% of vaccinated girls.  The average age of sexual debut among sexually active girls 
was 15.7 years. 
 
 
 
Table 7.9: Vaccination receipt by whether the participant had reached sexual debut at baseline and 
follow-up (n=395) 
 
  
  
Reached sexual debut at baseline 
n (%) 
Reached sexual debut at follow-up 
n (%) 
Declined vaccination 74 (29.6) 105 (42.0) 
Vaccinated 50 (34.5) 69 (47.6) 
 
 
Did the girls’ number of sexual partners change following receipt of the vaccination to a 
greater extent than girls who did not take up the offer of vaccination? 
As most girls had not reached sexual debut, the median number of sexual partners was 0.  
As the sample was split at the median the analysis comparing differences in changes in 
number of sexual partners using the whole sample would in essence be the same as 
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exploring changes in having reached sexual debut (which itself could not be performed for 
reasons described in the analysis section).  Instead it was decided to explore changes in 
number of sexual partners in participants who were already above the median number of 
sexual partners at baseline (i.e. were sexually active).  The rationale for this analysis was 
the theoretical suggestion that behaviour change may only occur in girls who were already 
engaging in sexual activities prior to HPV vaccination.  This analysis was not possible 
using the dichotomous variable and so a complex samples GLM was run using original 
data, although caution must be taken as the data used were not normally distributed.   
 
At follow-up, vaccinated girls (who were sexually active at baseline) had an average of 
2.64 sexual partners and unvaccinated girls had an average of 2.49 sexual partners.  There 
was no greater change in the number of sexual partners in vaccinated girls than in girls who 
had not taken up the offer of HPV vaccination from baseline to follow-up (Table 7.10; 
F(1,3)=1.32, p=.33, partial H²<.01, power 24.5%).  There was no interaction between 
baseline number of sexual partners and vaccination receipt at follow-up suggesting that the 
regression slopes in the model were homogeneous. 
 
 
Table 7.10: Difference in number of sexual partners at follow-up for vaccinated girls and girls who had 
not taken up the offer of HPV vaccination, in girls who were sexually active at baseline. 
 
 
Number of sexual partners 
mean (se) 
 Baseline Follow-up Change score p a 
    .33 
Declined vaccination 1.97 (.13) 2.49 (.17) -.51 (.03)  
Vaccinated 2.23 (.14) 2.64 (.24) -.40 (.12)  
a
 R²=.82, n=117.  Difference in number of sexual partners between vaccinated girls and those who declined 
vaccination, adjusted for baseline number of sexual partners. 
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Did condom use change following the receipt of HPV vaccination to a greater extent than 
girls who did not take up the offer of vaccination? 
Of the girls who had ever had sex (n=174) 6.5% never used condoms and 35.9% used 
condoms every time they had sexual intercourse (38.5% of those who reported ever using 
condoms).  Of those who had inconsistent condom use at follow-up 67% had received the 
vaccine and this was 62% of those who had opted not to receive the vaccine (Table 7.11).  
Vaccinated girls were no more likely to have changed their condom use than girls who had 
not taken up the offer of HPV vaccination (F(1,3)=.47, p=.54, partial H²<.01, power 6.5%).  
This result remained true when adjusting for factors that are known to affect condom use.  
It was not possible to generate residuals for the complex samples logistic regression; in the 
absence of these cluster-adjusted residuals a non-clustered logistic regression was run.  Of 
the standardised residuals for the non-clustered logistic regression 6.9% were greater than 2 
suggesting that the model may not have been the best fit to the data.  One case had a Cook’s 
distance of >1 and a DFBeta >1 indicating that this case was influencing the model more 
than any other case, the results of this analysis did not differ if this case was removed so it 
was retained in the analysis (data not reported). 
 
Given the non-significant findings for condom use in the whole sample, I then explored 
whether condom use changed in those who were already engaging in unprotected sex at 
baseline (n=116).  Again, due to non-normally distributed data I ran parametric tests on 
non-parametric data (ANCOVAs).  Table 7.12 shows that among girls who were using 
condoms inconsistently at baseline, those who received the vaccine were no more likely to 
have changed their condom use than girls who had not taken up the offer of HPV 
vaccination.  This result remained true when adjusting for factors that are known to affect 
condom use.  Interaction effects were not significant indicating that regression slopes were 
homogenous. 
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Table 7.11: Condom use at follow-up for vaccinated girls and girls who had not taken up the offer of 
HPV vaccination. 
 
 
Inconsistent 
condom use 
n (%) 
Uses condoms 
every time 
n (%) 
Change 
score a 
mean (se) 
OR b 
(95% CI) 
OR c 
(95% CI) 
Declined 
vaccination 62 (62.0) 38 (38.0) .42 (.12) Reference Reference 
Vaccinated 45 (67.2) 22 (32.8) .56 (.20) 1.14 (.76-1.72) 1.10 (.68-1.77) 
a
 Unadjusted, for continuous data 
b
 Odds ratio for being in the high versus low condom use group.  Adjusted for baseline condom use 
c Odds ratio for being in the high versus low condom use group.  Adjusted for baseline condom use and 
follow-up measurement of pill use, parental subjective norms for condoms and friend subjective norm for 
condoms.  Nagelkerke’s pseudo R²=.49, n=130. 
 
 
 
Table 7.12: Condom use at follow-up for vaccinated girls and girls who had not taken up the offer of 
HPV vaccination, using girls who were engaging in unprotected sex at baseline. 
 
 
Condom use 
mean (se) 
 Baseline Follow-up Change score a P b P c 
    .54 .47 
Declined 
vaccination 2.92 (.28) 2.87 (.13) .06 (.16) - - 
Vaccinated 2.27 (.15) 2.24 (.03) .03 (.13) - - 
a
 Unadjusted  
b
 Differences in condom use at follow-up between vaccinated girls and those who declined vaccination, 
adjusted for baseline condom use 
c Differences in condom use at follow-up between vaccinated girls and those who declined vaccination, 
adjusted for baseline condom use and follow-up measurement of pill use, parental subjective norms for 
condoms and friend subjective norm for condoms 
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Did communication about sex with parents change after the receipt of HPV vaccination to 
a greater extent than girls who did not take up the offer of vaccination? 
The girls had discussed a median of 4 topics about sex with their parents at follow-up 
(possible range: 0-5).  Of the girls who had low communication about sex with their parents 
(below the median) 57.4% were vaccinated and this figure was 52.3% of those who opted 
not to receive the vaccine (Table 7.13).  There was no difference in change in 
communication about sex with parents between girls who were vaccinated or girls who did 
not take up the offer of HPV vaccination and this remained the case when demographic 
characteristics were controlled for (p>.05).  Change scores indicated that both groups 
increased their communication about sex with their parents over the study period.  It was 
not possible to generate residuals for the complex samples logistic regression; in the 
absence of these cluster-adjusted residuals a non-clustered logistic regression was run.  
Fewer than 5% of the standardised residuals for the non-clustered logistic regression were 
greater than 2 and <1% were above 2.5 suggesting that the model was a good fit to the data.  
One of the DFBeta scores was >1 indicating that this case was influencing the model more 
than others.  Removing this case did not change the results (data not shown) so it was 
retained in the model.  None of the Cook’s distance scores were >1. 
 
 
Table 7.13: Communication about sex with parents at follow-up for vaccinated girls and girls who had 
not taken up the offer of HPV vaccination. 
 
 
Low 
communication 
n (%) 
High 
communication 
n (%) 
Change 
score a 
mean (se) 
OR b 
(95% CI) 
OR c 
(95% CI) 
Declined 
vaccination 134 (52.3) 122 (47.7) -.15 (.06) 
Reference Reference 
Vaccinated 81 (57.4) 60 (42.6) -.32 (.05) 1.15 (.82-1.61) 1.43 (.80-2.53) 
a
 Unadjusted, for continuous data 
b
 Odds ratio for being in the low versus high communication group.  Adjusted for baseline communication 
about sex. 
c Odds ratio for being in the low versus high communication group.  Adjusted for baseline communication 
about sex, ethnicity, religion, whether the participant was practising that religion, EMA receipt and age.  
Nagelkerke’s pseudo R²=.49, n=368. 
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Did intentions to attend cervical cancer screening in the future change following the 
receipt of HPV vaccination to a greater extent than girls who did not take up the offer of 
vaccination? 
The girls had a median intention to attend for cervical cancer screening in the future of 3 at 
follow-up (possible range 0-4).  Around 17% of girls who were below the median in their 
intention to attend for cervical cancer screening (low intention) had received the HPV 
vaccine compared with 18% of those who opted not to receive the vaccine (Table 7.14).  
There was no change in cervical cancer screening attendance intentions in vaccinated girls 
(or girls who did not take up the offer of HPV vaccination) and this finding remained true 
when adjusting for demographic factors.  It was not possible to generate residuals for the 
complex samples logistic regression; in the absence of these cluster-adjusted residuals a 
non-clustered logistic regression was run.  Fewer than 5% of the standardised residuals for 
the non-clustered logistic regression were greater than 2 and less than 1% were above 2.5 
suggesting that the model was a good fit to the data.  One of the Cook’s distance scores and 
seven DFBeta scores were >1 indicating that these cases were influencing the model more 
than others, removing these cases caused the model to become unstable (certain cells 
became empty) meaning that the models could not be run.  As a result these cases were 
retained in the model but it was acknowledged that they could be significantly influencing 
the results. 
 
Table 7.14: Intentions to attend for cervical cancer screening in the future at follow-up for vaccinated 
girls and girls who had not taken up the offer of HPV vaccination. 
 
 
Low intention  
n (%) 
High intention  
n (%) 
Change 
score a 
mean (se) 
OR b 
(95% CI) 
OR c 
(95% CI) 
Declined 
vaccination 
46 (18.0) 210 (82.0) -.07 (.04) Reference Reference 
Vaccinated 25 (17.0) 122 (83.0) .01 (.08) 1.04 (.49-2.22) 1.48 (.63-3.51) 
a
 Unadjusted, for continuous data 
b
 Odds ratio for having a low versus high intention.  Adjusted for baseline intentions. 
c Odds ratio for having a low versus high intention.  Adjusted for baseline intentions, ethnicity, religion, 
whether the participant was practising that religion, EMA receipt and age.  Nagelkerke’s pseudo R²=.31, 
n=373. 
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Summary of findings for the prospective study 
This study followed a group of girls aged 16-18 years old over time.  All girls were 
unvaccinated at baseline.  Between baseline and follow-up the girls were offered the HPV 
vaccine as part of the childhood immunisation schedule (‘catch-up programme’) and, as a 
result, at follow-up assessment had either received the HPV vaccine or opted not to do so.  
The study was designed to explore whether receipt of the HPV vaccine was associated with 
adolescent girls’ sexual behaviour and attitudes.  Vaccinated girls showed reduced risk 
perceptions of cervical cancer following HPV vaccination.  There was no difference in 
change in the number of sexual partners a girl had for girls who were already sexually 
active at baseline or difference in change in condom use for the whole sample or those who 
were inconsistently using condoms before vaccination.  There was also no difference in 
change in parental communication about sex or intentions to attend for cervical cancer 
screening in the future following HPV vaccination. 
 
STUDY 2 – A QUASI CROSS-SECTIONAL STUDY 
Study 2 was a quasi cross-sectional study and was designed to explore the effect of HPV 
vaccination receipt, accounting for the effect of the immunisation programme generally.  
This had not been possible in the prospective study.  The immunisation programme has 
been accompanied by significant educational and advertising campaigns that unvaccinated 
girls will have been exposed to as well as those who opted to receive the vaccine, so it is 
important to understand whether it is the programme itself that affects adolescents rather 
than the receipt of HPV immunisation.  As described in Chapter 1, the HPV ‘catch-up’ 
programme was rolled out quickly which made impossible to concurrently recruit one 
group who had been offered the vaccine and one group who had not.  Another important 
consideration was that age was controlled for, as normal levels of sexual behaviour are 
likely to differ at varying ages, especially in adolescent girls. 
 
In order to overcome these problems a group of year 12 girls (usually aged 16-17) were 
recruited and completed questionnaires in March 2009 before the HPV vaccine was 
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available to them as part of the ‘catch-up’ programme20.  This group was use as a ‘control 
cohort’.  They were compared with the group of girls who participated at follow-up in 
Study 1 (the prospective study), who were vaccinated and of the same age as the control 
cohort (also in school-year 12).  The data from the vaccinated girls was collected exactly 
one year later than when the control cohort participated (March 2010) so that normal levels 
of sexual behaviour could be controlled for.  This quasi cross-sectional study looked at 
whether there were any differences in risk perceptions, sexual behaviours, communication 
about sex with parents and intentions to attend for cervical cancer screening in the future 
between vaccinated girls and the equivalent control cohort of unvaccinated girls. 
 
Hypothesis 
The existing literature described in this chapter and theory outlined in Chapter 3 allowed a 
number of hypotheses to be drawn for the present study. 
1. Girls who receive the HPV vaccine will have lower perceived risk of HPV, cervical 
cancer and other STIs than girls who have not been offered the HPV vaccine. 
2. Girls who have received the HPV vaccine will be engaging in different sexual 
behaviour than girls who have not been offered the HPV vaccine. 
3. Girls who have received the HPV vaccine will speak to their parents about sex more 
than girls who have not been offered the HPV vaccine. 
4. Girls who have received the HPV vaccine will be less likely to intend to attend for 
cervical cancer screening in the future than girls who have not been offered the 
HPV vaccine. 
 
Methods 
Participants, procedures and measures 
The recruitment of the vaccinated group was detailed in the methods section of the 
prospective study reported earlier in this chapter.  In brief, girls were selected for analysis 
in this quasi cross sectional study (Study 2) if they participated at follow-up in the 
                                            
20
 At this time the HPV immunisation programme was underway, however the vaccine was not yet being 
offered to these girls.  Accordingly these girls were unvaccinated, unless they had received the vaccine 
privately.  Girls who reported they had received the vaccine privately were excluded. 
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prospective study, had indicated that they had received the HPV vaccine and were in school 
year 12 (see Table 7.15 for detailed inclusion criteria).  The responses to the follow-up 
questionnaire detailed in the prospective study were used for analysis.  My role in this 
study was identical to that described for the prospective study. 
 
In March 2009, the control cohort was recruited from the same eight colleges used in the 
prospective study (Study 1).  The procedures adopted at baseline in the prospective study 
were also adopted for this quasi cross-sectional study.  Most measures comprising the 
control cohort questionnaire were identical to those used for the baseline questionnaire in 
the prospective study (see Appendix 17 for control cohort questionnaire).  Vaccination 
receipt was measured differently from baseline: the control cohort was asked to respond to 
a yes/no question asking whether they had received the HPV vaccine.  A simple 
dichotomous response was used as the vaccine was not yet available to these girls as part of 
the NHS programme and it was anticipated that very few girls would have received the 
vaccine privately.  This item was developed for the present study. 
 
For the communication about sex scale the Cronbach’s α for the control cohort=.79 and for 
the vaccinated cohort=.79 and for the variable assessing intentions to attend for cervical 
screening the Cronbach’s α for the control cohort=1.0 and for the vaccinated cohort =.90. 
 
 
 
Table 7.15 – Inclusion criteria for each group 
 
Pre-vaccination programme control cohort Vaccinated 
Recruited in March 2009 
In school year 12 
≤ 18 years old a 
Had not been offered or received the HPV vaccine 
Recruited at follow-up (March 2010) 
In school year 12 
≤ 18 years old  
Had received at least one dose of the HPV vaccine at 
follow-up 
a
 Respondents who were over the age of 18 were excluded as they were not entitled to receive the HPV 
vaccine as part of the national immunisation programme (n=25 of all participants). 
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Analysis 
Sample size calculations, response rate calculations and procedures for handling missing 
data were identical to those used in the prospective study.  The proportion of missing data 
for the vaccinated group has been detailed in the methods for the prospective study.  For the 
control cohort, 2 cases had >50% data missing so were excluded.  The percentage of 
missing data for the control group for each variable can be found in Appendix 19. 
 
Statistical analysis 
Statistical analysis was performed using SPSS version 14 (SPSS Inc., 2005).  The 
dependent variables were identical to those used for the prospective study: risk perceptions, 
sexual behaviour, communication about sex with parents and intentions to attend cervical 
screening in the future.  A number of the dependent variables showed statistically 
significant skewness and kurtosis.  As the values for these variables were meaningful it was 
decided not to transform this data and to dichotomise non-normally distributed dependent 
variables.  As with the variables in the prospective study, a median split was used for 
number of sexual partners (dichotomised into number of sexual partners at or below the 
median versus number of sexual partners above the median; median=0), number of topics 
about sex discussed with parents (dichotomised into number at or above the median – ‘high 
communication about sex’ versus number below the median – ‘low communication about 
sex’; median=3, range 0-5) and intention to attend for cervical cancer screening in the 
future (dichotomised into intention below the median – ‘low intention’ versus intention at 
or above the median – ‘high intention’; median=3, range 0-5).  Condom use was 
dichotomised into ‘always uses condoms’ versus all other responses as this was considered 
most meaningful (inconsistent condom use of any kind increases risk of pregnancy/STI 
infection). 
 
In order to examine whether there were differences between vaccinated girls and the 
equivalent pre-vaccination programme control cohort I ran complex samples analysis of 
variance (ANOVAs) or ANCOVAs as general linear models for continuous dependent 
variables and complex sample logistic regression models for dichotomous dependent 
variables (I used the same statistics as the ones run for the prospective study for both 
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analytical methods).  I ran two models. In the first I included just vaccination receipt as an 
independent variable.  In the second model I also included factors that were established in 
the literature to be related to the dependent variable and included just demographic 
characteristics for the analysis exploring cervical cancer screening intentions and 
communication about sex with parents (detailed in the methods section of the prospective 
study).  It was not possible to run analysis comparing differences in number of sexual 
partners for the whole sample as splitting the sample at the median (0) meant that this 
analysis would again attempt to look at differences in whether respondents had reached 
sexual debut and so could not be performed. 
 
Results 
Response rate 
Data collected at follow-up have been described in the results for the prospective study.  
665 girls completed the control group questionnaire.  Data from 811 girls were included in 
the analysis (n=592 from the control cohort and n=219 vaccinated girls from the follow-up 
cohort21).  For the control group assessment the number of participants recruited from each 
college ranged from 17 to 302, the range at follow-up was from 16 to 542 (Table 7.16).  For 
both groups, the majority of participants came from College 1 (Table 7.16). 
 
Of the girls who were registered in the colleges, 49% completed the questionnaire when the 
control cohort were recruited and 45.4% participated at follow-up, giving an overall 
response rate of 46.9%, inclusive of the response rates for College 2 and College 4 (which 
did not provide participants for follow-up assessment).  Of the girls who were present in the 
data collection sessions 95.0% participated when the control group were recruited and 
97.9% participated at follow-up.  Overall, including the response rates for College 2 and 
College 4, 96.7% of girls present in the sessions completed the questionnaire.  As described 
in the methods section for the prospective study, the denominators for the number of girls 
                                            
21
 The reduction in sample size for the number of girls recruited at follow-up to the number included in the 
analysis is due to the analysis requiring that the girls were both vaccinated and in school year 12 (usually aged 
16-17). 
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registered in the colleges was unlikely to be accurate, as a consequence it was concluded 
that the overall response rate for the study was between 46.9% and 96.7%. 
 
 
Table 7.16 – College response rates 
 
 College 
 1 2 3 4 5 6 7 8 Total  
Response rate 
Denominator= number attending session       
Control group 
N (%) 
302 
(94.2) 29 (100) 
29 
(82.9) 101 (100) 
61 
(91.0) 
87 
(91.6) 
17 
(100) 
39 
(100) 
665 
(95.0) 
Follow-up 
N (%) 
542 
(98.0) 
No 
participants 
16 
(100) 
Not 
recruited 
39 
(100) 
142 
(91.0) 
29 
(100) 
68 
(98.6) 
836 
(97.9)  
Total  
N (%) 
844 
(96.1) 29 (100) 
45 
(91.5) 101 (100) 
100 
(95.5) 
229 
(91.3) 
46 
(100) 
107 
(99.3) 
1501 
(96.7)a 
Response rate 
Denominator= number registered in college       
Control group 
N (%) 
302 
(62.9) 29 (56.8) 
29 
(30.2) 101 (28.7) 
61 
(55.5) 
87 
(79.1) 
17 
(9.1) 
39 
(69.6) 
665 
(49.0) 
Follow-up 
N (%) 
542 
(76.3) 
No 
participants 
16 
(12.3) 
Not 
recruited 
39 
(22.0) 
142 
(65.1) 
29 
(8.1) 
68 
(88.3) 
836 
(45.4)  
Total 
N (%) 
844 
(69.6) 29 (56.8) 
45 
(21.3) 101 (28.7) 
100 
(38.8) 
229 
(72.1) 
46 
(8.6) 
107 
(79.0) 
1501 
(46.9)a 
a Total includes the response rate for College 2 and College 4. 
 
 
Description of the sample 
Most participants were white (62%), 55% were not entitled to EMA, the average age was 
17.3 years, 40% were Muslim and 46% were practising a religion (Table 7.17). 
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Table 7.17: Demographic characteristics  
 
n=811 n (%) 
Ethnicity  
White 486 (62.0) 
Black  82 (10.5) 
Asian  136  (17.3) 
Other 80 (10.2) 
EMA receipt  
£30 156 (20.0) 
£20 37 (4.7) 
£10 157 (20.1) 
No entitlement 431 (55.2) 
Religion  
None 293 (37.3) 
Christian 106 (13.5) 
Muslim 311 (39.6) 
Other 75 (9.6) 
Practising a religion a  
Yes 216 (46.2) 
No 252 (53.8) 
Age (mean (se) 17.3 (.05) 
Note: Total columns not equalling the total for sample are due to missing data, percentages not equalling 
100% are due to missing data. 
a
 Of those who reported a having a religion 
 
 
 
Do vaccinated girls’ perceptions of risk differ from the pre-vaccination programme control 
cohort? 
First it was considered whether vaccinated girls differed from the pre-vaccination 
programme control cohort in their perceived risk of HPV, cervical cancer and STIs.  The 
‘feelings of risk’ measurement of perceived risk was used for this analysis.  For the whole 
sample feelings of risk were low: HPV mean=2.03, se=.03; cervical cancer mean=2.05, 
se=.03; STIs mean=1.92, se=.03 (possible range 0-4).  Feelings of risk for HPV were lower 
in vaccinated individuals than in the control cohort (F(1,7)=333.0, p<.01, partial H²=.14, 
power 100%; Table 7.18), as were feelings of risk for cervical cancer (F(1,7)= 201.23, 
p<.01, partial H²=.10, power 100%; Table 7.18) and feelings of risk for STIs (F(1,7)=67.83, 
p<.01, partial H²=.02, power 99.4%; Table 7.18).  The R² statistic showed that vaccination 
status alone could explain 14% of the variance in feelings of risk of HPV infection, 10% for 
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cervical cancer feelings of risk and 2% of the variance in feelings of risk of STIs.  It was 
not possible to report whether homogeneity of variance had been violated in the complex 
samples analysis as this was not an option in the statistical package used for analysis and 
exploring homogeneity of variance using a simple ANOVA would not have taken the 
clustering into account.  This was the case for all GLM analysis performed. 
 
 
Table 7.18: Differences in feelings of risk between vaccinated girls and the pre-vaccination programme 
control cohort. 
 
 
Feelings of risk for 
HPV  
Mean (se) 
Feelings of risk for 
cervical cancer 
mean (se) 
Feelings of risk for 
STIs 
mean (se) 
    
Vaccinated  1.47 (.05)* a 1.59 (.06)* b 2.00 (.00)* c 
Pre-vaccination programme cohort 2.23 (.07) 2.22 (.06) 2.09 (.05) 
* Difference between vaccinated girls and the pre-vaccination programme cohort p<.01 
a
 R²=.14, n=800 
b
 R²=.10, n=799 
c
 R²=.02, n=794 
 
Does vaccinated girls’ sexual behaviour differ from the pre-vaccination programme 
control cohort? 
It was then considered whether there were differences between vaccinated girls and the pre-
vaccination programme control cohort in terms of their sexual behaviour.  Sexual debut, 
age of sexual debut and condom use was examined.  Number of sexual partners was not 
examined as the median number of sexual partners was 0 and so this analysis would have 
been a replication of the sexual debut analysis. 
 
Do vaccinated girls’ differ from the pre-vaccination programme control cohort in whether 
they have reached sexual debut? 
For the whole sample 58.1% of girls had not reached sexual debut.  Of the control cohort, 
42.5% had reached sexual debut compared with 40.9% of vaccinated girls.  In the 
unadjusted model vaccinated girls were no more likely to have reached sexual debut than 
the control cohort (OR: .94, CI: .71-1.24; Table 7.19).  This remained the case when 
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adjusting for factors that are known to affect sexual debut.  For the full model, 
Nagelkerke’s pseudo R² indicated that 34% of the variance in sexual debut could be 
explained.  Fewer than 5% of the standardised residuals for the non-clustered logistic 
regression were greater than 2 and no more than 1% were above 2.5 suggesting that the 
model was a good fit to the data.  Two of the Cook’s distance scores were greater than 1 
indicating that these cases were influencing the model over and above any other case so 
these cases were removed from the analysis.  None of the DFBeta scores were greater than 
1. 
 
 
Table 7.19: Differences in whether participants had reached sexual debut between vaccinated girls and 
the pre-vaccination programme control cohort. 
 
 Reached sexual debut?   
 
No 
n (%) 
Yes 
n (%) 
OR a 
(95% CI) 
OR b 
(95% CI) 
Pre-vaccination programme cohort 333 (57.5) 246 (42.5) Reference Reference 
Vaccinated 123 (59.1) 85 (40.9) 
.94  
(.71-1.24) 
.77  
(.57-1.04) 
a
 Odds ratio for yes versus no  
b Odds ratio for yes versus no.  Adjusted for having ever had a boyfriend, drug use, parental subjective norms 
for sex and friend subjective norm for sex.  Nagelkerke’s pseudo R²=.34, n=747. 
 
 
 
 
Do vaccinated girls differ from the pre-vaccination programme control cohort in their age 
of sexual debut? 
In girls who had reached sexual debut, the average age of sexual debut was 15.4 years.  The 
mean age of sexual debut for vaccinated girls was 15.44 and this was similar for the control 
cohort (15.43; Table 7.20).  Age of sexual debut was not associated with vaccination 
receipt (F(1,6)=.01, p=.92, partial H² <.01, power 5.0%) and this continued to be the case 
when controlling for factors known to be associated with age of sexual debut (F(1,6)=.20, 
p=.67 partial H² <.01, power 5.3%).  However the number of participants in each group was 
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not large enough to be sufficiently powered to detect the reported effect size were it 
genuinely correct. 
 
 
Table 7.20: Differences in age of sexual debut between vaccinated girls and the pre-vaccination 
programme control cohort. 
 
 
Age of sexual debut  
Mean (se) 
p a p b 
Vaccination status  .92 .67 
Pre-vaccination programme cohort 15.43 (.07)   
Vaccinated 15.44 (.02)   
a
 Unadjusted 
b Adjusted for smoking status and whether respondent had ever had a boyfriend.  R²=.10, n=329. 
 
 
 
Do vaccinated girls differ from the pre-vaccination programme control cohort in their 
condom use? 
Of the girls who had ever had sex (n=331) 6.3% never used condoms when they had sexual 
intercourse and 37.4% used condoms every time (39.9% of those who reported ever using 
condoms).  Around 70% of girls who had inconsistent condom use were vaccinated, 
compared with 62% of those in the control cohort (Table 7.21).  Vaccinated girls were 
marginally more likely to have inconsistent condom use than the control cohort (p=.05, OR: 
1.42, CI: 1.01-1.99), but this result did not remain true when adjusting for factors that are 
known to affect condom use.  Greater than 5% of the standardised residuals for the non-
clustered logistic regression were greater than 2 and 3.7% were above 2.5 suggesting that 
the model may not have been the best fit to the data.  None of the Cook’s distance scores 
nor the DFBeta scores were >1 indicating that no case was influencing the model more than 
any other. 
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Table 7.21: Differences in condom use between vaccinated girls and the pre-vaccination programme 
control cohort. 
 
 
Inconsistent 
condom use 
n (%) 
Uses condoms 
every time 
n (%) 
OR a 
(95% CI) 
OR b 
(95% CI) 
Pre-vaccination programme cohort 150 (62.0) 92 (38.0) Reference Reference 
Vaccinated 60 (69.8) 26 (30.2) 
1.42* 
(1.01-1.99) 
1.57 
(.97-1.57) 
a
 Unadjusted odds ratio for low versus high condom use 
b
 Odds ratio for low versus high condom use, adjusted for pill use, parental subjective norms for condom use 
and friend subjective norm for condom use.  Nagelkerke’s pseudo R²=.19, n=317. 
* p=.05 
 
Do vaccinated girls differ from the pre-vaccination programme control cohort in their 
communication about sex with their parents? 
The next analysis considered whether vaccinated girls differed from the control cohort in 
the extent that they had communicated about sex with their parents.  For the whole sample, 
the girls had discussed a median of 3 topics about sex with their parents (possible range 0-
5).  Of the girls who had low communication about sex with their parents 37.0% were 
vaccinated against HPV, compared with 44.1% of those in the control cohort (Table 7.22).  
Vaccination status could not predict whether girls had high communication about sex with 
their parents and this remained the case when demographic characteristics were controlled 
for (p>.05).  Fewer than 5% of the standardised residuals for the non-clustered logistic 
regression were greater than 2 but 3.7% were above 2.5 suggesting that the model may not 
have been the best fit to the data.  One of the Cook’s distance scores and four DFBeta 
scores were >1 indicating that these cases were influencing the model more than others, 
removing these cases caused the model to become unstable (certain cells became empty) 
meaning that the models could not be run.  As a result these cases were retained in the 
model but it was acknowledged that they could be significantly influencing the results. 
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Table 7.22: Differences in communication about sex with parents between vaccinated girls and the pre-
vaccination programme control cohort. 
 
 
Low 
communication 
n (%) 
High 
communication 
n (%) 
OR a 
(95% CI) 
OR a 
(95% CI) 
Pre-vaccination programme cohort 258 (44.1) 327 (55.9) Reference Reference 
Vaccinated 81 (37.0) 132 (60.3) 
.78 
(.54-1.12) 
.87 
(.61-1.23) 
a Unadjusted odds ratio for low versus high communication. 
b Odds ratio for low versus high communication adjusted for ethnicity, religion, whether the respondent is 
practising that religion, EMA entitlement and age.  Nagelkerke’s pseudo R²=.17, n=534. 
 
 
 
Do vaccinated girls differ from the pre-vaccination programme control cohort in their 
intention to attend cervical cancer screening in the future? 
Finally it was considered whether there were differences between vaccinated girls and the 
pre-vaccination programme control cohort in their intentions to attend for cervical cancer 
screening in the future.  For the whole sample the girls had a median intention to attend for 
cervical cancer screening in the future of 3 (possible range 0-4).  Of the girls who had low 
intentions 38% were vaccinated, compared with 44.4% of those in the control cohort (Table 
7.23).  Vaccinated girls were less likely to have low intentions to attend for cervical cancer 
screening than the pre-vaccination programme control cohort (p=.03, OR: .71, CI: .54-.95).  
This relationship did not remain significant when demographic characteristics were 
adjusted for.  Fewer than 5% of the standardised residuals for the non-clustered logistic 
regression were greater than 2 and none were above 2.5 suggesting that the model was a 
good fit to the data.  None of the Cook’s distance scores were >1 however four DFBeta 
scores were >1 indicating that these cases were influencing the model more than others, 
removing these cases caused the model to become unstable (certain cells became empty) 
meaning that the models could not be run.  As a result these cases were retained in the 
model but it was acknowledged that they could be significantly influencing the results. 
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Table 7.23: Differences in intention to attend for cervical cancer screening between vaccinated girls and 
the pre-vaccination programme control cohort. 
 
 
Low intention 
n (%) 
High intention 
n (%) 
OR a 
(95% CI) 
OR b 
(95% CI) 
Pre-vaccination programme cohort 135 (23.2) 448 (76.8) Reference Reference 
Vaccinated 38 (17.7) 177 (82.3) 
.71 
(.54-.95)* 
.95 
(.77-1.18) 
a Unadjusted odds ratio for low versus high intention. 
b Odds ratio for low versus high intention adjusted for ethnicity, religion, whether the respondent is practising 
that religion, EMA entitlement and age.  Nagelkerke’s pseudo R²=.08, n=534.  
* p=.03 
 
 
 
Summary of the findings for the quasi cross-sectional study (Study 2) 
This quasi cross-sectional study explored whether vaccinated girls differed from a pre-
vaccination programme control cohort of girls recruited before they had been offered the 
HPV vaccine.  The girls were of the same age (school year 12) but were recruited exactly 
one year apart; in March 2009 for the control cohort and in March 2010 (follow-up) for the 
vaccinated group.  The study was designed to examine whether receipt of the HPV vaccine 
had any effect on adolescent girls’ behaviour and attitudes, accounting for the effect of the 
HPV immunisation programme itself.  Vaccinated girls were found to have lower feelings 
of risk for HPV, cervical cancer and of STIs than the pre-vaccination programme control 
cohort.  There was no difference between vaccinated girls and control cohort in age of 
sexual debut or whether they had reached sexual debut and there was no difference in 
condom use when factors known to affect condom use were taken into account.  Similarly, 
there was no difference in communication about sex with parents.  Vaccinated girls were 
less likely to have low intentions to attend for cervical cancer screening in the future than 
the control cohort in univariate analysis. 
 
DISCUSSION 
In this chapter I have presented two studies that explored the effect of HPV vaccination, on 
the sexual behaviour of 16-18 year old girls.  The studies also examined the effect of 
vaccination on girls’ communication about sex with their parents and on their intentions to 
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attend for cervical cancer screening in the future.  Girls from eight colleges across London 
and the South East of England participated in a prospective study, which informed us about 
the effect of vaccination and a quasi cross-sectional study which could account for the 
effect of the programme itself.  The prospective study showed that uptake of the vaccine 
was generally below optimal levels across the colleges.  The quasi cross-sectional study 
found that vaccinated girls showed lowered perceptions of risk for cervical cancer and 
thought that they were less likely to be infected with HPV or with other STIs than an 
equivalent pre-vaccination programme control cohort of girls.  The findings from both 
studies showed that there was no negative effect of vaccination, even when accounting for 
the effect of the immunisation programme itself, on sexual behaviour, even in the most ‘at 
risk’ groups, and no negative effect on cervical cancer screening intentions.  The studies 
also showed that vaccination was not being used by parents as a ‘teachable moment’ to 
discuss sex with their daughters. 
 
In the quasi cross-sectional study vaccinated girls were no more likely than the control 
cohort to have reached sexual debut.  This was contrary to the hypothesis outlined in this 
chapter and to Read et al’s (2010) finding that intentions to receive the vaccine were 2.2 
times higher in sexually active girls who were mainly from minority ethnic groups in the 
USA.  However, Neubrand et al. (2009) have also found no association between being 
sexually active and completion of the HPV vaccination series.  Age of sexual debut did not 
differ between vaccinated girls and the control cohort, in discordance with the hypothesis 
stated in the introduction to this chapter.  However, a prospective study conducted with 13-
26 year old American girls also reported null findings (Conroy et al., 2009).  Around 43% 
of girls in the prospective study and 42% of girls in the quasi cross-sectional study had 
reached sexual debut and the median number of sexual partners was 0 for both studies.  The 
prospective study showed that there was no difference in change in number of sexual 
partners in vaccinated girls relative to girls who had opted not to receive the vaccine for 
girls who were sexually active at baseline, contrary to as was hypothesised. 
 
Of concern was that most sexually active girls were inconsistently using condoms or not 
using them at all.  However, the prospective study showed that vaccinated girls were no 
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more likely to have changed their condom use following HPV vaccination than 
unvaccinated girls (not hypothesised) and this was also the case when considering only 
girls who at baseline were inconsistently using condoms, contrary to as was hypothesised.  
The quasi cross-sectional study showed that there was no difference between vaccinated 
girls and the control cohort in condom use when factors known to affect condom use were 
taken into account, in disagreement with the hypothesis.  In 2008/2009 a government 
commissioned national survey in the UK found 70% of women aged 16-24 who said that 
they used condoms reported using them every time they had sex (Office for National 
Statistics, 2009), compared with 38.5-39.9% in the current samples, suggesting that 
consistent condom use in these studies was considerably lower than in the general 
population.  If these samples were engaging in more instances of unprotected sex than the 
general population, in accordance with the hypothesis outlined in the introduction, these 
more ‘at risk’ girls should have been more likely to have further reduced their condom use 
following vaccination, but this was not found in the prospective study.  Although the 
figures for the national sample may not be directly comparable to the present studies as 
they refer to a wider age group. 
 
If the results of these two studies are correct, they are reassuring as it appears that neither 
HPV vaccination nor the programme itself have negatively affected girls’ sexual behaviour 
and may go some way to alleviate parents’ concerns about girls’ sexual behaviour 
following HPV vaccination that have been described throughout this thesis: concern about 
providing implicit approval for sexual activity (for example, Waller et al., 2006) and 
concern about disinhibition because girls perceived their risk of STIs to have reduced (for 
example, Ogilvie et al., 2010).  The findings contradict girls’ and adult women’s beliefs 
about changes in their own or others’ sexual behaviour following HPV vaccination (Brabin 
et al., 2010; Gottvall et al., 2009; Short et al., 2010).  Vaccinated girls have not started to 
engage in sexual activities because they perceive that the HPV vaccine being available to 
them implies that they should be sexually active (no difference in number of girls who had 
reached sexual debut between vaccinated girls and the control cohort in the quasi cross-
sectional study) nor have they become more risky in their sexual behaviours (no difference 
in change in condom use or number of sexual partners in the prospective study) or are any 
different from the those who had not been offered vaccination in the risky sexual 
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behaviours that they do engage in (no difference in consistency of condom use, age of 
sexual debut or whether they had ever had sex).  The results also suggest that vaccinated 
girls who were already engaging in risky sexual behaviour are no more likely to have 
changed their sexual behaviour than girls who opted not to receive the vaccine as was 
concluded as a possible occurrence in Chapter 3. 
 
When measuring perceived risk, the prospective study found ‘feelings of risk’ to be a better 
predictor of behaviour than ‘perceived likelihood’, which concurs with the findings of 
Weinstein et al. (2007).  None of the ‘perceived likelihood’ variables were related to 
vaccination receipt whereas ‘feelings of risk’ for HPV was associated and ‘feelings of risk’ 
for cervical cancer showed a similar trend.  This finding has important implications for the 
measurement of perceived risk.  It is essential that measurement tools are as accurate as 
possible to ensure that error and the resulting bias in findings is minimised.  It appears that 
‘feelings of risk’ is the most appropriate measure of risk perceptions of HPV when 
exploring subsequent preventive behaviour related to those perceptions. 
 
The prospective study also found, as was partly hypothesised in the introduction and in 
support of behaviour motivation theories, that risk perceptions of HPV and cervical cancer 
predicted vaccination receipt.  The R² for these analyses were small suggesting that other 
factors contributed to vaccination receipt also.  Perceptions of risk for STIs did not predict 
vaccination receipt suggesting that the girls understood the reason that the HPV vaccine is 
being given.  This appears in opposition to the existing literature that has suggested that 
adolescents are confused about what the HPV vaccine protects against (Mathur et al., 2010; 
Robbins et al., 2010).  This finding makes sense in the context of the UK HPV 
immunisation programme as the bivalent vaccine is being used that does not protect against 
genital warts.  Girls who are offered the quadrivalent vaccine may be more likely to 
become confused about the protection provided by the vaccine as the issue of STIs is 
raised. 
 
In partial accordance with the hypothesis outlined in the introduction and risk compensation 
theory, the prospective study showed that vaccinated girls lowered their perceived risk of 
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cervical cancer, whereas those who declined the vaccine did not change their perceived 
risk.  This finding supported the notion of risk-reappraisal (changes in risk perceptions 
following a risk altering intervention) and replicates Brewer et al.’s (2007b) Lyme disease 
vaccination study in which vaccinated individuals lowered their perceptions of risk.  
Brewer and colleagues used a ‘perceived likelihood’ measure of perceived risk, unlike the 
present study which assessed ‘feelings of risk’, suggesting that the existence of risk-
reappraisal does not seem to be measurement-type dependent.  There was no difference in 
change in perceived risk of HPV or STIs although neither of these analyses was powered to 
detect differences.  The observed effect size for HPV was comparable to the effect size for 
cervical cancer suggesting that with greater power significant effects may have been 
reported for perceived risk of HPV.  It is positive that perceived risk of STIs did not change 
in vaccinated girls relative to girls who declined vaccination, as this provided additional 
support for the theory that vaccinated girls are aware of the protection provided and not 
provided by the HPV vaccine. 
 
The quasi cross-sectional study showed that those who were vaccinated had lower risk 
perceptions for HPV, cervical cancer and STIs than those who had not been offered 
vaccination.  In accordance with the hypothesis outlined previously and risk compensation 
theory the adoption of a risk reducing intervention resulted in those adopting the 
intervention to have lower perceptions of risk than the pre-vaccination programme control 
cohort.  Again this finding reflects Brewer et al.’s results in which they reported that those 
individuals vaccinated against Lyme disease had lower risk perceptions for Lyme disease 
than unvaccinated individuals (Brewer et al., 2007b).  It is possible that the finding for 
perceived risk of cervical cancer was the result of the immunisation programme itself rather 
than receipt of the immunisation.  It is likely that those in the vaccinated group (surveyed at 
follow-up – March 2010) had a greater understanding of the likelihood of cervical cancer 
diagnosis as the vaccination programme had been underway for one year longer than when 
the pre-vaccination programme control cohort were surveyed (March 2009) and these girls 
had been exposed to the promotional campaign that accompanied the roll out of the 
programme.  As a result they may have better understood the rarity of cervical cancer and 
so have lower risk perceptions because of greater knowledge.  However, this does not 
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explain the lower perceptions of risk for HPV as it is a common infection.  It seems likely 
that this finding was due to vaccination receipt. 
 
These explanations do not clarify the lower perceptions of risk for STIs.  The questions 
assessing perceived risk of STIs did not specify that the STIs to be considered should not 
include HPV.  It is possible that some participants may have recognised HPV as an STI and 
so responded to this question considering HPV also, which may have contributed to the 
significant findings for lower perceived risk of STIs in vaccinated girls than in the pre-
vaccination programme control cohort.  Alternatively it may be that the vaccinated girls 
misunderstood the protection afforded by the HPV vaccine to include other STIs which is 
concerning, although positively girls do not appear to be changing their sexual behaviour as 
a result of these possible misconceptions.  Misconceptions about the protection provided by 
the HPV vaccine have been reported elsewhere and have included the belief that the 
vaccine protects against chlamydia, STIs generally, pregnancy and provides complete 
protection against cervical cancer (Mathur et al., 2010; Robbins et al., 2010).  Although 
previous analysis in the prospective study exploring predictors of vaccination receipt and 
changes in risk perceptions following vaccination suggested that girls are not confused 
about what the HPV vaccine provides protection from, the quasi cross-sectional study 
appears to show that they are.  Visually, the pre-vaccination programme cohort had much 
higher feelings of risk for HPV, cervical cancer and STIs than either the vaccinated group 
in both the prospective study and the quasi cross-sectional study or those who declined 
vaccination in the prospective study, suggesting that being involved in the programme 
(receiving or refusing vaccination) causes perceptions of risk to lower.  It appears that low 
perceptions of risk of STIs are not a result of HPV vaccination receipt, but may be due to 
exposure to the programme.  Vaccination co-ordinators should continue to ensure that 
information materials provided to girls draw attention to the fact that the vaccine does not 
prevent all cases of cervical cancer nor does it protect recipients from other STIs. 
 
It appears then that there is partial support for risk-reappraisal theories in the context of 
HPV vaccination in that an intervention has caused a change in perceived risk.  There was 
also evidence for part of risk compensation theory as the quasi cross-sectional study 
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showed that vaccinated girls had lower perceptions of risk than the pre-vaccination 
programme control cohort (Adams, 1985; Adams, 1988; Wilde, 1982) and evidence for 
behaviour-motivation theories as risk perceptions predicted vaccination receipt in the 
prospective study.  However, there was no evidence that these reductions/differences in 
perceived risk influenced subsequent behaviour in the prospective study, as risk 
compensation theory would suggest.  As a result there was also no evidence of original 
levels of actual risk being restored, in accordance with risk compensation theory.  This 
finding appears to invalidate adolescents’ assertions that they may engage in more risky 
sexual behaviour following HPV vaccination (Brabin et al., 2009; Gottvall et al., 2009); 
girls may have believed that they might change their behaviour but they have not acted on 
these beliefs. 
 
It has been suggested that the perceived efficacy of the intervention should be considered 
when comparing differences in changes in perceived risk (Brewer et al., 2007a) as altered 
risk perceptions may be more apparent in individuals who hold high efficacy beliefs.  It has 
not been proposed how perceived efficacy in risk perception analysis should be considered 
and given that the risk perception findings for the present study were as hypothesised, 
efficacy beliefs were not interpreted (although they were measured as part of the larger 
questionnaire).  Similarly, behaviour motivation theories would suggest that if behaviour 
had changed it could have been explained by risk perceptions.  As behaviour did not change 
the role of risk perceptions was not explored.  This meant that this aspect of behaviour 
motivation was not tested. 
 
Most girls in both studies were having conversations about sex with their parents.  
However, neither vaccination receipt, nor the immunisation programme itself were being 
used as a ‘teachable moment’ by parents to talk about other issues relating to sex as has 
been recommended by the World Health Organisation (2006): the prospective study 
showed that vaccinated girls did not increase their communication about sex relative to 
girls who opted not to receive the vaccine and the quasi cross-sectional study found that 
vaccinated girls had not spoken to their parents about sex any more than girls who had not 
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been offered vaccination.  As around half of the sample had not yet reached sexual debut, 
such conversations appear still relevant with girls in this age group. 
 
Askelson et al. (2010) reported that American parents are willing to use HPV vaccination 
as an opportunity to discuss sex and contraception with their daughter if they hold 
favourable opinions about discussing sex with their daughters and believe that people who 
are important to them think that is would be a good idea.  It is unknown whether British 
parents are willing to do this, but it appears that even if they do intend to do so they are not 
acting on these intentions.  Parents’ concerns about sexual behaviour following HPV 
vaccination may have resulted in parents being reluctant to discuss sex with their daughters 
in the context of HPV vaccination so that implicit messages of approval for sexual activity 
are not conveyed.  Educational interventions have been developed to help parents 
communicate with their children about sex (O'Donnell et al., 2007) and their use should be 
considered, as children who do not talk to their parents about sex are at an increased risk of 
earlier sexual debut and of adopting STI-risk behaviours, such as multiple partners and 
inconsistent condom use (Diiorio et al., 2003; Zimmer-Gembeck & Helfand, 2008).  The 
offer of HPV vaccination, regardless of vaccination status may have facilitated 
communication about sex as the change scores in the prospective study indicated that both 
groups increased their communication with their parents over the study period, although the 
increase may have reflected the fact that follow-up measures were taken six months after 
baseline.  This interpretation is also questionable as there was no difference in 
communication between vaccinated girls and those who had not been offered the vaccine.  
The three-dose vaccination schedule provides multiple opportunities for the discussion 
about sex to be continued, rather than the talk about the ‘birds and the bees’ being a one-off 
conversation and these opportunities may not be being used. 
 
Intentions to attend for cervical cancer screening in the future were high generally.  The 
prospective study found that vaccinated girls did not change their intentions following 
vaccination (relative to girls who opted not to receive the vaccine) and the quasi cross-
sectional study showed that vaccinated girls were less likely to have low intentions to 
attend for cervical screening than the pre-vaccination programme control cohort in 
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univariate analysis.  These findings appear to conflict with the findings of Mortensen 
(2010) who found vaccinated 16-26 year old Danish girls to report in focus groups that they 
did not think they would consistently attend for cervical cancer screening in the future and 
Donders et al.’s (2008) findings who showed that younger Belgian women were more 
likely to believe that cervical cancer screening was no longer necessary following 
vaccination, although this study did not consider girls who had received the vaccine.  The 
contrast in findings from the present studies to the previous studies may be due to 
differences in the information materials supplied alongside the immunisation programmes 
in the various countries.  It may be the case that the literature given to girls about the HPV 
vaccine by British immunisation coordinators was more comprehensive and appropriate 
and immunisation programmes in countries outside of the UK may benefit from adopting 
the materials provided to girls in the UK.  It may also have been the case that the control 
cohort, who would not have been exposed to these information materials, were less 
informed about the necessity of cervical screening generally. 
 
Limitations 
The inclusion criteria for the various analysis in each study, such as having to have 
participated at both baseline and follow-up for the prospective study and the choice of 
complex sampling for analysis, meant that sample sizes were reduced considerably.  In 
addition, two of the colleges did not complete the study meaning that their data could not 
be used for the prospective study, further reducing the sample size.  Testa et al. (2006) in 
their study exploring sexual behaviour in young people also reported a school drop-out rate 
of 25%, and it was anticipated during recruitment that not all of the colleges would 
participate at each time point.  1617 girls completed a questionnaire at least once but only 
407 girls were included in the prospective study analysis and 811 girls were included in the 
quasi cross-sectional study analysis.  The inclusion criteria that caused the sample size to 
reduce were essential to the analysis to remove possible confounding variables that would 
have influenced the results and the analytical strategy was necessary to overcome violated 
assumptions of independence, but both meant that combined with small effect sizes that 
were detected, the analysis was not powered to find significant effect sizes of smaller than 
r=.16 (alpha=.05, power=.80, df=3, based on the lowest df reported in both studies, n=2 
groups).  For the lowest effect to have been detect
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would have been required (alpha=.05, power=.80, df=7, based on the highest df reported, 
n=2 groups, r=.1).  Using the experience of recruitment in the prospective study (only 
~25% of recruited participants were included in the analysis) around 5772 participants 
would have had to complete the questionnaires and up to 13,645 girls approached to 
participate (based on the lowest response rate).  As effects were expected to be small the 
lack of power may not have affected the results, but we cannot be completely confident that 
HPV vaccination receipt does not negatively affect behaviour and attitudes.  However, 
given that the effect sizes that were reported were so small it could be suggested that even 
if significant changes or differences did occur they would have been too small to be 
clinically meaningful and so not of concern on a population level. 
 
The reduced sample size also affected the stability of the models.  On a number of 
occasions models were run that were not the best fit to the data and included cases that it 
would have been optimal to remove had enough cases made all responses possible (for 
example some cells were empty meaning that models could not be run).   The complex 
samples analysis used more sophisticated statistical methods than regular general linear 
models and logistic regression meaning that they were stricter in adhering to the 
assumptions necessary to perform the models.  Had simpler statistical methods been used 
more of the models may have been possible to have been performed but this could have 
masked the fact that the data were not appropriate for these models.  Because of the 
reduced sample size demographic characteristics were not included in the sexual behaviour 
models as the large number of categories meant that many cells were empty so analysis 
could not be run.  Given a larger sample size it would be interesting to consider the effect 
of demographic characteristics. 
 
Participants in the present studies were in post-compulsory (post-16) education and 
consequently were likely more academically qualified than other 16-18 year olds who are 
not in education.  The most up-to-date figures show that 62.5% of 16-18 year old girls were 
in full-time education in England in 2007 (Office for National Statistics, 2008) suggesting 
that the findings of these studies should not be extrapolated to girls who are not in 
education (those who are working, unemployed or on government training schemes).  The 
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participants recruited from the colleges were highly heterogeneous; the proportion of 
participants from ethnic minorities generally did not reflect the English average but were 
closer in characteristics to the London average.  Most girls were not entitled to EMA 
suggesting that the samples were reasonably affluent.  Finally the participants were all 
attending colleges located in the South East of England and London and girls from 
elsewhere in England were not investigated.  As a result of these demographic deviations 
from the English average and based on the response rates that used the number of 
participants registered in the colleges the generalisability of these results must be 
considered when interpreting the findings of these studies. 
 
The Cronbach’s alphas for the communication about sex scale were not as high as desired 
and there was likely between 21% to 30% error in measurement.  Caution should be taken 
regarding non-significant findings which may have been significant had measurement been 
more accurate.  Kline (1999) asserted that an alpha of greater than .7 is appropriate when 
interpreting Cronbach’s alphas for internal reliability, however, this does not take into 
account the number of items included in the scale.  When there are fewer items in a scale, 
such as in the scale for the present studies, it is less likely that the alpha will be high 
regardless of the actual internal reliability (Grayson, 2004) and this may have been the case 
for the communication about sex scale. 
 
In these studies sexual behaviour was measured by self-report.  It was not possible to have 
an objective measure of sexual intercourse meaning that the chosen method of assessing 
sexual behaviour was not perfect due to the potential for inaccurate memory recall and 
social desirability bias.  During data collection comments from the girls, particularly girls 
from Colleges 3, 7 and 8, made it apparent that girls from some cultures were not expected 
to have sex before marriage.  For these girls to admit, even in an anonymous questionnaire, 
that they had reached sexual debut may be socially stigmatising and not worth their honesty 
in a questionnaire administered by a relative stranger who they have no reason to risk their 
reputation for.  Even if abstinence before marriage is not encouraged, socially derived 
norms of girls being chaste are socially rewarding and impact on personal reputations 
(Marston & King, 2006).  Consequently, girls may have been reluctant to be entirely honest 
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about their age of sexual debut or number of sexual partners.  It is possible that the number 
of girls who had reached sexual debut was actually greater than the number who reported 
being sexually active, that the average age of sexual debut was younger than reported and 
that the average number of sexual partners was higher than reported.  To further confuse 
this there is evidence that individuals who fail to respond to questions about sexual 
behaviour are less sexually experienced than non-responders which could mean that the 
average number of sexual partners was inflated (Fenton et al., 2001a).  Unfortunately these 
are issues associated with the assessment of sensitive personal information and are 
applicable to research in other health domains (Wellings et al., 1990); however because of 
this uncertainty it may be more appropriate in the present studies to pay attention to the 
confidence intervals reported for significant effects rather than specific effect sizes. 
 
Non-significant results reported in the present studies may have been due to such 
limitations in measurement of the dependent variables.  However, all of the dependent 
variables had been used previously in published research, they showed high test-retest 
reliability as baseline and follow-up assessments were highly related and they were 
associated with factors that one would expect the dependent variable to be associated with 
(data not reported).  For example, oral contraceptive use related to condom use and having 
ever had a boyfriend was associated with age of sexual debut. 
 
The condom use analysis focused on heterosexual sexual risk behaviours and did not 
account for women who engage in sexual activities with other women.  Analysis of the 
NATSAL survey conducted in 2000 estimated that 3.9% of 16-44 year old women from 
Greater London had a female sexual partner in the last five years and this was 2.4% of 
women for the rest of the UK (Johnson et al., 2001).  The condom use analysis may not 
have been appropriate for a small proportion of the sample.  It is possible that such 
participants would not have deemed the condom use question relevant to them and may 
have not responded to this question. 
 
It could be argued that the follow-up period in the prospective study was not sufficient in 
duration for behaviour change to have been detected.  However, a longer follow-up 
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duration would have increased the number of potential confounding variables affecting the 
likelihood that effects were due to HPV vaccination receipt only.  Vaccinated girls are 
likely to have received their first dose of the HPV vaccine at least four months prior to 
follow-up assessment, giving girls who were already in relationships plenty of time to adapt 
their sexual behaviour and there was no evidence of behaviour change in the most at risk 
groups.  It may not have been enough time for girls who were never sexually active to 
initiate a sexual relationship, however this reinforces the fact that there are other more 
influential factors than HPV vaccination in determining sexual activity. 
 
Finally, the vaccinated cohort, were a self-selected group.  Their decision to receive the 
vaccine may have been a result of inherent characteristics of this group that existed prior to 
vaccination.  However, the study designs were as close as was possible to address aim four 
reliably.  The study designs allowed for prospective observations as well as cross-sectional 
analysis.  It would have been most desirable for the quasi cross-sectional study to have 
studied participants concurrently.  However, as the HPV vaccination ‘catch-up’ programme 
was rolled out so quickly, it was not possible to study girls of the same age who had and 
had not been offered the vaccine at the same time.  It was important to study girls of the 
same age to account for normal levels of sexual behaviour.  The chosen study design for the 
quasi cross-sectional study was the closest possible that could reliability explore the impact 
of HPV immunisation on adolescents, accounting for the effect of the immunisation 
programme itself. 
 
Conclusions 
HPV vaccination receipt appeared to have no negative effect on the sexual behaviour of the 
16-18 year old girls who took part in these studies.  Vaccinated girls were no more likely to 
have inconsistent condom use or to have reached sexual debut than a pre-vaccination 
programme control cohort, or have an earlier sexual debut.  Vaccinated girls did not use 
condoms more inconsistently after vaccination relative to girls who had opted not to receive 
the vaccine and vaccinated girls who were already engaging in risky sexual behaviours did 
not increase their number of sexual partners or use condoms any more inconsistently.  This 
may go someway to alleviate parents’ concerns about their daughters engaging in more 
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risky sexual behaviour following HPV vaccination.  It is likely that girls who have 
participated in the HPV immunisation programme have acquired an appropriate 
understanding of their risk of cervical cancer and have adjusted their perceptions of risk 
accordingly.  It appears that the information provided to girls in the UK immunisation 
programme is sufficiently informing them about the continued need for safe sexual 
behaviour and attendance at cervical cancer screening in the future.  Immunisation 
programmes in other countries may benefit from adopting the educational literature used in 
the UK.  Vaccinated girls’ intentions to attend for cervical cancer screening in the future 
were more positive than the unvaccinated control cohort of girls and their intentions did not 
alter following vaccination relative to girls who opted not to receive the vaccine.  Parents 
are missing out on the opportunity to use HPV vaccination as a chance to discuss issues 
surrounding sex and contraception with their daughters.  The programme itself, rather than 
vaccination receipt, may be influencing girls’ perceptions of risk.  This study provided 
evidence for risk-reappraisal theory but failed to provide complete support for risk 
compensation theory.  Recommendations for future analysis and best practise for 
measurement were made including the adoption of ‘feelings of risk’ for the measurement of 
perceived risk and the necessity of substantial sample sizes.
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Chapter 8 - Discussion 
The development of a vaccine to prevent infection with HPV types established to cause 
most cases of cervical cancer and the introduction of this vaccine into childhood 
immunisation schedules worldwide has prompted a proliferation of research into this area.  
Acceptability of HPV vaccination has been considered often and numerous factors have 
shown associations with parents’ intentions to consent to HPV vaccination for a daughter, 
or whether they have actually consented for their daughter to receive the vaccine.   
 
It was highlighted in the review of the literature in Chapter 2 that parents’ concern about 
their daughters’ sexual behaviour following HPV vaccination was one factor that 
consistently related to HPV vaccination acceptance and was novel to HPV vaccination, 
rather than all childhood vaccines.  Mothers’ concerns fell into two groups.  Firstly they 
were apprehensive that girls will engage in more risky sexual behaviour following 
vaccination because they believe themselves to be at a reduced risk of catching an STI 
(Marlow et al., 2007a; Olshen et al., 2005).  Secondly, some mothers worried that their 
consent to vaccination would implicitly confer ‘carte blanche’ approval for sexual activity 
(Constantine & Jerman, 2007; Waller et al., 2006).   
 
Previous experience had shown the media to be hugely influential regarding vaccination 
uptake (Hackett, 2008) and there was evidence that the HPV vaccination was already being 
discussed in the UK and international press.  These discussions were not always in positive 
contexts and often contained inaccuracies (Anhang et al., 2004b; Greene & Davies, 2008). 
 
Two American studies had shown no association between sexual behaviour and receipt of 
the vaccine, although neither study was designed to demonstrate behaviour change or 
causation of relationships (Conroy et al., 2009; Neubrand et al., 2009).  Hypothetically, 
adolescents had reported that they might change their behaviour and misconceptions were 
held about the protection afforded by the vaccine (Brabin et al., 2010; Conroy et al., 2009; 
Mathur et al., 2010; Robbins et al., 2010). 
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These issues had not been explored in detail in the literature and this thesis aimed to 
investigate their different facets.  Risk compensation theory appeared to be an appropriate 
model to use to explore behaviour change following vaccination.  It was hoped that with a 
greater understanding of parents’ concern about these issues and knowledge of whether 
sexual behaviour will likely alter following vaccination, parents’ anxieties could be 
challenged, with the intention of reducing resistance to HPV vaccination associated with 
concern about sexual behaviour.  Accordingly, the objective of this thesis was to explore 
parents’ concerns about sexual behaviour in their daughters following HPV vaccination, in 
the context of the UK HPV immunisation programme and examine whether these concerns 
would likely be realised. 
 
This objective was addressed in five studies.  The first study attempted to establish the 
extent that the issue of risky sexual behaviour following HPV vaccination was being 
addressed in the UK national press, in order to clarify what arguments parents have been 
exposed to.  The second study investigated the degree of concern that mothers have about 
their daughters’ sexual behaviour following HPV vaccination and the third study explored 
adolescent girls’ beliefs about the meanings that they would interpret from their parents 
consenting to them receiving the HPV vaccine.  The final two studies investigated the 
impact of participating in the HPV immunisation programme by examining risk 
perceptions, sexual behaviour, communication about sex with parents and intentions to 
attend for cervical screening in the future in older adolescent girls who were offered HPV 
vaccination as part of the UK HPV immunisation ‘catch up’ programme. 
 
SUMMARY OF FINDINGS 
Four specific aims were set to help achieve the thesis objective.  Aims one to three were 
taken in turn and addressed by the studies reported in Chapters 4, 5 and 6.  Aim four was 
addressed by the two studies reported in Chapter 7. 
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Aim 1: To explore whether the issue of girls engaging in increased risky sexual 
behaviour following HPV vaccination is being addressed in the UK national press. 
My first study reported in Chapter 4, was the first systematic longitudinal examination of 
media coverage of the HPV vaccine in the UK.  I used an electronic database of newspaper 
articles to retrospectively search the most highly read daily and Sunday newspapers in the 
UK over five years to identify articles that had considered the HPV vaccine and risky 
sexual behaviour following HPV vaccination.  These articles were analysed qualitatively 
using Framework Analysis and content analysis.  I explored the debates that parents have 
been exposed to about risky sexual behaviour and the vaccine by considering categories 
arising in these discussions, the content of the text within each category, when the 
categories occurred, their context and frequency of occurrence.  The qualitative analysis 
was subjective in nature, meaning that researcher bias could have affected the interpretation 
of the articles.  However, a number of warranting techniques were employed to ensure that 
the analysis was appropriate. 
 
Just under half of the articles that mentioned the HPV vaccine also referred to risky sexual 
behaviour following HPV vaccination and 92 articles were included in the qualitative 
analysis.  Media coverage of the vaccine was found to have grown since the development 
of the HPV vaccine, and the issue of adolescents engaging in risky sexual behaviours 
following vaccination was a minor, but consistently discussed theme.  An increase in media 
coverage about the HPV vaccine has also been reported in studies exploring news reporting 
in the USA (for example, Kelly et al., 2009) and other research has found risky sexual 
behaviour in relation to the HPV vaccine to be discussed to a similar extent in newspaper 
articles (for example, Abdelmutti & Hoffman-Goetz, 2009).  Arguments proposing that 
sexual behaviour would change were usually covered briefly and when they were endorsed 
this was often based on the opinion of unspecified opposition groups.  On a number of 
occasions, articles that included arguments proposing that the HPV vaccination will not 
impact on girls’ sexual behaviour quoted scientists, but their use may have a less emotive 
appeal than the messages that used fear-based discourse that were put forward by those who 
opposed HPV vaccination. 
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Both sides of the argument were covered in the articles and this will have allowed parents 
the opportunity to form their own opinions.  The opposing arguments were frequently cited 
within the same article and this was reflected in the fact that most articles were deemed 
neutral in tone.  However, neutrality of reporting adhered to by journalists may not provide 
adequate perspective to parents about how serious the issue really is.  Vaccination 
programme managers must remain aware of how they can use the media to influence public 
opinion and be prepared to ensure that anti-vaccination sentiments represented in the press 
are countered if they continue to be represented. 
 
The articles allowed readers to hear about the experiences of others and provided them with 
normative beliefs.  Most of the parents quoted in the articles said that they were not unduly 
concerned about adolescent risky sexual behaviour following vaccination and this may 
have reassured parents reading the articles.  However, most of these particular articles were 
published in broadsheet newspapers, whose readers are more likely from higher social 
classes, meaning that only certain groups may have been exposed to such normative beliefs.  
This has the potential to further increase knowledge inequalities (Tichenor et al., 1970). 
 
Most newspaper-reading parents will at some point have read about opposition towards 
vaccinating girls and to the idea that the HPV vaccine could encourage risky sexual 
behaviour and this may have affected their opinions and future vaccination decisions.  It 
would be interesting to consider how this issue has been reported by the media since the 
introduction of the HPV vaccination into the childhood immunisation schedule. 
 
Aim 2: To establish the degree of concern that parents feel about HPV vaccination and 
sexual behaviour. 
My first study reported in Chapter 4 showed that parents have regularly been exposed to the 
argument that HPV vaccination will impact on adolescents’ sexual behaviour and these 
articles had the potential to affect parents’ personal concerns about the vaccine.  It had been 
reported in the literature that some parents were apprehensive about vaccinating their 
daughters against HPV because of concern that girls will engage in more risky sexual 
behaviour following vaccination due to a false belief that they have a reduced risk of 
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catching an STI.  A number of studies had shown such concern to be associated with 
intentions to allow a daughter to receive the HPV vaccine (for example, Marlow et al., 
2007a; Ogilvie et al., 2007).  However, such concerns had not been explored in detail and 
Study 2 addressed this gap.  Using an existing dataset of 341 mothers of daughters recruited 
in a national survey, I explored participants’ beliefs about sexual behaviour following HPV 
vaccination, whether such beliefs predicted vaccination acceptance for a daughter and what 
predicted the extent to which mothers were concerned about this issue. 
 
Most mothers were willing to vaccinate their daughters against HPV, indicating, in 
accordance with previous studies that acceptance of the vaccine was likely to be high when 
it became available.  These strong intentions to vaccinate have been reflected in high 
uptake of the HPV vaccine in 12-13 year old girls offered the vaccine as part of the UK 
childhood immunisation programme (Department of Health, 2010).  However, some agreed 
that their daughter may have more sex, more unprotected sex, and would become more 
promiscuous after having the vaccine.  Independently these beliefs were associated with 
willingness to accept the vaccine for a daughter, with mothers who agreed to a greater 
extent that sexual behaviour would change less willing to consent to HPV vaccination for 
their daughter.  Risk perceptions were important when exploring mothers’ beliefs about 
risky sexual behaviour following HPV vaccination, with mothers who believed that they 
were more at risk of cervical cancer less likely to believe that sexual behaviour would 
change.  This was likely due to mothers attempting to avoid cognitive dissonance: in the 
present study mothers with a high perceived risk of cervical cancer were more willing to 
vaccinate their daughter and so may have been less likely to agree with the belief 
statements to avoid such psychological tension or mothers who were unwilling to vaccinate 
their daughters using concern about sexual behaviour as evidence to support their decision 
not to vaccinate.  As a result, although beliefs about risky sexual behaviour appear 
associated with acceptance, addressing these beliefs with mothers may not be the most 
effective way to increase vaccination uptake. 
 
In multi-variable tests, mothers’ sexual behaviour beliefs were no longer related to 
willingness to consent to HPV vaccination when mothers’ own perceived risk of cervical 
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cancer was included in the model.  This finding contrasted with three published studies 
(Bernat et al., 2009; Dahlstrom et al., 2010; Ogilvie et al., 2010).  It was possible that 
differences between these studies were due to lack of power in the present study and 
cultural differences (the three other studies were conducted outside of the UK).  If the 
present study was correct in its findings the results were reassuring as although mothers 
may have believed that girls will engage in more risky sexual behaviour after vaccination, 
other factors were more strongly associated with their decision to consent to vaccination for 
a daughter.  The effect of perceived risk appeared so strong that it overrode other factors 
that were also associated with vaccination decisions.  Vaccination uptake may be improved 
by using framing to manipulate perceived risk in information materials or considering 
perceived risk when developing decision aids to support HPV vaccination decision making. 
 
Aim 3: To establish girls’ views on HPV vaccination and sexual behaviour 
In addition to parents being apprehensive that girls will engage in more risky sexual 
behaviour following HPV vaccination, parents have also expressed concern that their 
consent to vaccination may be misinterpreted by girls as implicit approval for sexual 
activity.  Similarly to the first parental concern about sexual behaviour investigated in my 
second study, reported in Chapter 5, this particular anxiety had not been considered in 
detail in the academic literature and my third study, reported in Chapter 6, sought to 
provide some initial insight into whether girls would equate parental consent to vaccination 
as consent to start having sex.  Adolescent girls recruited in school completed a 
questionnaire asking them to respond to a series of statements about what parental consent 
to HPV vaccination would mean to them in terms of sexual behaviour and other issues 
relating to HPV vaccination.  Their intentions to receive the vaccine were also assessed 
along with whether they believed their parents would provide consent to their receiving the 
vaccine. 
 
Most girls expressed strong intentions to receive the vaccine and believed that their parents 
would consent.  The majority would infer positive messages about vaccination and other 
HPV vaccination-related issues if their parents consented to vaccination with most girls 
believing that consent would mean that their parents wanted to protect them against 
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cervical cancer and STIs.  Most girls did not believe that vaccination consent implied 
approval for them to be sexually active.  Parents concerned about negative changes in 
sexual behaviour following vaccination may be reassured by this, and feel happier about 
consenting to their daughters having the vaccine.  However, some girls believed that 
consent implied that they were old enough to have sex (8%), or that it was okay for them to 
be sexually active (10%) but these beliefs were not related to whether they believed their 
parents would provide consent.  Of further concern was the finding that girls with strong 
intentions to receive the vaccine were more likely to perceive that parental consent to 
vaccination implies that the recipient is old enough to have sex.  A range of misconceptions 
held by adolescents about the HPV vaccination have been reported in the literature and 
together with the findings of the study reported in Chapter 6, have implications for the 
future sexual behaviour of girls.  It may be beneficial for some girls to talk to their parents 
or a healthcare professional about the HPV vaccine to address such misconceptions.  
However, the findings may have been due to the cross-sectional nature of the data; it may 
have been that girls who felt ready to have sex were more likely to intend to have the 
vaccine.  Additionally, even if girls believe they have been given ‘carte blanche’ to be 
sexually active, this does not mean that they will necessarily become sexually active. 
 
Aim 4: To examine the effect of participation in the HPV immunisation programme on 
sexual behaviour in older girls participating in the ‘catch-up’ programme. 
 
The conclusions drawn in Chapters 5 and 6 suggested that some parents show concern 
about their daughters’ sexual behaviour following HPV vaccination and some girls would 
misinterpret their parents’ consent to HPV vaccination as implicit approval for sexual 
activity.  However, it had not been explored whether parents’ concerns were valid and 
whether girls’ confusions about HPV vaccination would result in negative behaviour 
change or negative changes in intentions.  There was some evidence to suggest that cervical 
screening attendance may not be optimal in vaccinated girls and also that HPV vaccination 
may conveniently be used as a ‘cue to action’ for parents to talk with their daughters about 
sex.  Two studies were reported in Chapter 7.  The first was prospective in design tracking 
a cohort of girls recruited from eight further education colleges and sixth forms over six 
months.  The second study was a quasi cross-sectional study comparing differences 
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between girls who had been not been offered the HPV vaccine and girls who had received 
at least one dose of the HPV vaccine.  The two groups were recruited one-year apart.  
Separate analysis exploring risk perceptions was also performed.  A number of the analyses 
were underpowered meaning that we must question the certainty of non-significant findings 
and were the research to be conducted again I would consider measuring some of the 
dependent variables differently (for example, provide more detailed definitions of sexual 
behaviour). 
 
The quasi cross-sectional study found that vaccinated girls were no more likely to have 
reached sexual debut than unvaccinated girls, and did not differ from the pre-programme 
control cohort in terms of their age of sexual debut or condom use.  The prospective study 
showed that vaccinated girls had not changed their condom use relative to girls who opted 
not to receive the vaccine and neither had vaccinated girls who were already inconsistently 
using condoms prior to vaccination.  In girls who before vaccination had a greater than 
average number of sexual partners, vaccinated girls had also not increased their number of 
sexual partners relative to girls who opted not to receive the vaccine.  Such findings are 
positive, suggesting that HPV vaccination has not negatively affected girls’ sexual 
behaviour and may go some way to alleviate parents’ concern about the impact of HPV 
vaccination on the sexual behaviour of their daughters. 
 
The prospective study found that vaccinated girls lowered their perceived risk of cervical 
cancer to a greater extent than girls who opted not to receive the vaccine, but did not 
change their perceived risk of HPV infection or STIs.  The quasi cross-sectional study 
showed that vaccinated girls had lower risk perceptions for cervical cancer, HPV and STIs 
than girls in the pre-programme control cohort.  The lower risk perceptions for cervical 
cancer and HPV were appropriate and the findings for STI risk perceptions may have been 
due to inappropriate definitions being provided to participants or misconceptions held by 
vaccinated girls about what the vaccine provides protection from.  The differences in 
findings between the two studies were likely due to exposure to the HPV immunisation 
programme.  In the prospective study risk perceptions of HPV and cervical cancer (but not 
of STIs) predicted vaccination receipt suggesting that girls understood the reason that the 
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HPV vaccine is being given.  The results provided partial support for risk-reappraisal 
theories in the context of HPV vaccination in that an intervention caused a change in 
perceived risk.  There was also evidence for part of risk compensation theory as in the quasi 
cross-sectional study the vaccinated girls had lower perceptions of risk than the 
unvaccinated girls (Adams, 1985; Adams, 1988; Wilde, 1982) and partial support for 
behaviour-motivation theories as in the prospective study perceived risk predicted 
vaccination receipt.  However, there was no evidence that these reductions/differences in 
perceived risk influenced subsequent behaviour, as behaviour-motivation and risk 
compensation theory would suggest.  As a result there was also no evidence of original 
levels of actual risk being restored, in accordance with risk compensation theory 
(compensatory action taken to restore levels of risk back to desired levels).  This finding 
suggested that although girls may have believed that they might change their behaviour, as 
reported by Brabin et al. (2009) and Gottvall et al. (2009), they have not actually done so. 
 
Most girls did appear to have had conversations with their parents about sex previously, 
although HPV vaccination receipt was not being used by parents as an opportunity to 
discuss sex with their daughters.  This may be to the detriment of some girls as children 
who do not talk to their parents about sex are at an increased risk of earlier sexual debut and 
of adopting STI-risk behaviours, such as having multiple partners and inconsistent condom 
use (Diiorio et al., 2003; Zimmer-Gembeck & Helfand, 2008).  Educational interventions 
that already exist should be employed to help parents effectively use the three-dose 
vaccination schedule as an opportunity to discuss sex with their daughters and go some way 
to ensure that conversations about sex are a series of conversations rather than a one-off 
chat. 
 
Reassuringly, in the prospective study vaccinated girls did not change their intentions to 
attend for cervical cancer screening in the future relative to girls who opted not to receive 
the vaccine, and in the quasi cross-sectional study they held more positive intentions than 
the control cohort.  This was contrary to a previous study of Danish young women who 
reported that they did not think they would consistently attend for cervical cancer screening 
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in the future (Mortensen, 2010).  It will be important to monitor whether the findings of the 
present study are reflected when these girls start being invited for screening. 
 
Misconceptions about the vaccine reported in Chapter 6, apparent in Chapter 7 also and 
shown in previous research (for example, Mathur et al., 2010; Robbins et al., 2010), could 
have impacted on the sexual behaviour and intentions to attend for screening, but this 
appears not to be the case.  Vaccination programme coordinators should ensure that HPV 
information materials continue to draw attention to the fact that the vaccine does not protect 
against other STIs and coordinators in countries outside of the UK should consider using 
the information materials given to girls as part of the UK immunisation programme as they 
appear effective. 
 
Overview of findings 
Before these studies were conducted we knew that mothers were concerned about the effect 
that HPV vaccination may have on girls’ sexual behaviour and would not provide consent 
to vaccination for this reason.  Mothers’ concerns included apprehension about girls 
engaging in more risky sexual behaviour because of perceived protection from STIs and 
concern that their providing consent to vaccination implicitly conferred consent for sexual 
activity.  The HPV vaccine had received coverage in the UK and international press and 
this coverage was not always positive or accurate.  Research had not explored discussions 
of the HPV vaccination and sexual behaviour in the news media.  Although research had 
yet to consider whether receipt of the HPV vaccination would impact on the sexual 
behaviour of adolescent girls, some girls had reported that they would change their 
behaviour and many held misconceptions about the protection afforded by the vaccine.  
Risk compensation theory was deemed unlikely to be applicable on a population level to 
HPV vaccination, but it was plausible that it would be relevant if certain conditions were 
fulfilled.  Additionally it was considered an appropriate model to help investigate whether 
sexual behaviour would change. 
 
The studies in this thesis continued to show that some mothers report concern about the 
impact of HPV vaccination on the sexual behaviour of their daughters, and these concerns 
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have been raised in the national press.  The concerns have also been countered in the media 
and parents have had the opportunity to hear about positive normative beliefs reported by 
other parents regarding vaccination and sexual behaviour.  Parents’ concerns include worry 
about girls having more sex, more unprotected sex, and becoming more promiscuous after 
having the vaccine and they are apprehensive that girls will take vaccination consent to be 
equivalent to approval for sexual activity.  However, these concerns appear not related to 
willingness to allow a daughter to receive the vaccine and mothers’ own perceived 
susceptibility to cervical cancer appears more pertinent in mothers’ decisions to allow girls 
to have the vaccine. 
 
Parents’ concerns about implicit messages interpreted from vaccination consent may have 
been appropriate to some extent as some adolescents would infer implicit consent to sexual 
activity were their parents to allow them to receive the vaccine.  Girls would also take 
positive messages about HPV-vaccine related issues however and the extent that the girls 
thought their parents would be concerned about their sexual behaviour following HPV 
vaccination was not related to whether girls thought their parents would provide consent to 
vaccination. 
 
In reality the information materials and education accompanying the HPV immunisation 
programme appears to be informing girls sufficiently to ensure that sexual behaviour and 
cervical screening intentions do not become more negative following HPV vaccination, 
even though perceptions of risk have lowered following vaccination compared with those 
who did not take up the offer of vaccination.  Vaccinated girls have not started using 
condoms more inconsistently relative to girls who opted not to receive the vaccine.  These 
findings were also true of girls who were at most risk of changing their behaviour and these 
girls have also not increased their number of sexual partners.  Vaccinated girls have not had 
an earlier sexual debut, do not use condoms any less consistently than a pre-programme 
control cohort of girls and are no more likely to have reached sexual debut.  Parents’ 
concerns about sexual behaviour following HPV vaccination may have resulted in them 
being reluctant to discuss sex with their daughters in the context of HPV vaccination so that 
implicit messages of approval for sexual activity are not conveyed. 
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STRENGTHS AND LIMITATIONS 
As the two studies reported in Chapter 7 found no change in behaviour and found no 
difference between vaccinated and unvaccinated girls, it is important to critique the study 
methodologies to consider whether null findings were the result of poor study design.  This 
is especially important considering that this issue was deemed worthy of attention 
academically and publicly when this thesis was initiated.  In a similar vein, the rational for 
the final two studies was based in part on the findings of the studies reported in Chapters 4, 
5 and 6.  This rational may have been inappropriate if these previous studies had inadequate 
methodologies.  Accordingly, the strengths and limitations of this thesis are discussed 
below. 
 
Participants 
The choice of participants and where they were recruited from will likely have influenced 
the results reported in this thesis.  Accordingly it is important that the samples are 
representative of the populations that the findings will be extrapolated to.  It is likely that 
the participants recruited for the studies in Chapters 5, 6 and 7 may not have been wholly 
representative of the general British population, meaning that the results may not be 
generalisable beyond the specific populations that were studied. 
 
In the study reported in Chapter 5, only just over half of participants who were approached 
agreed to participate.  Research suggests that non-responders are more likely to have a 
lower SES, be older, male and less engaged with the topic under investigation (Porter & 
Whitcomb, 2005), meaning that the attitudes of these groups will less likely have been 
included in the analysis (excluding males).  Extensive measures were in place to maximise 
response rates for this study, including providing incentives and attempting to contact the 
address at least four times (including one weekday evening and weekend).  Despite this 
33% of individuals who were contactable refused to participate.  Were the study to be 
conducted again it may be useful to use additional methods to improve response rates such 
as entering responders into a prize draw.  However, the strength of the sample was 
enhanced by participants being recruited nationally and using random probability sampling. 
 
                                                                                                  CHAPTER 8 – DISCUSSION 
 272 
The findings in Chapter 6 were based solely on the responses of girls recruited from one 
secondary school in the South East of England whose students were less likely than the 
national average to be entitled to free school meals (a means tested benefit).  It will be 
important to replicate this study in a larger, more heterogeneous sample.  Participants must 
be recruited from more economically diverse schools, which could be identified using 
census area-level data (assuming the girls attend schools that are near to where they live) 
and recruited from across the UK, although this would make such research more expensive 
to run.   
 
The participants in the studies reported in Chapter 7 were recruited from eight sixth form 
and further education colleges and the refusal rates were low, however the final samples did 
not include 16-18 year olds who were not in full-time education, were more ethnically 
diverse than the English average and were reasonably affluent.  Girls who are unemployed, 
on government training schemes or who are in employment are all equally entitled to 
receive the HPV vaccine, but it is likely that their experience of vaccination will differ from 
those who are in education, especially in primary care trusts where the vaccine is provided 
in schools to those in education.  For girls who are employed it may be more difficult for 
them to take time off work to visit their GP and girls who are unemployed may equally 
have competing priorities that are barriers to vaccination. 
 
The response rate for the number of girls present in each testing session was very high.  The 
questionnaires were completed during tutorial sessions.  Attendance at these sessions is 
mandatory (and essential if the student is to qualify for EMA) but the sessions are not vital 
to ensure that students pass their subject exams.  Participants attending the tutorial sessions 
are likely to represent the more motivated and conscientious students.  It will be beneficial 
for future research to make efforts to recruit populations that are representative of the 
British population to ensure that the results are meaningful and useful. 
 
Study design 
In addition to the participants used in research, the design of the study is integral to its 
findings and inappropriate study design can cause misleading results.  Cross sectional data 
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were used for the studies in Chapters 5 and 6 meaning that inferences could not be made 
about causation.  However, a strength of the first study reported in Chapter 7 was its 
prospective design that allowed for more definitive conclusions to be drawn about the 
results.  The quasi cross-sectional study reported in Chapter 7 recruited a de facto control 
group which allowed for normal levels of sexual behaviour to be controlled for.  This type 
of work is time consuming; however, the increasing certainty of the results is highly valued 
when such research is uncommon.  A mixture of qualitative and quantitative research has 
been reported in this thesis.  This triangulation of methods will have increased the validity 
of the general findings and conclusions. 
 
Power 
It is essential that studies are sufficiently powered to detect significant effects and, in 
accordance with convention, 80% power was deemed an appropriate level in this thesis.  
The studies reported in Chapters 5, 6 and 7 were not powered to detect small effect sizes 
(smaller than r=.16 for Chapter 5, smaller than r=.22 for Chapter 6 and smaller than r=.16 
for Chapter 7).  Effect sizes were reported that were smaller than this in all of these studies, 
meaning that non-significant findings that were coupled with small effect sizes should be 
treated with caution as they may not have been powered sufficiently.  However, given that 
these effect sizes were so small, they would likely have been too small to be clinically 
meaningful and effectively non-significant on a population level. 
 
Theoretical approach 
A key strength of this thesis is the use of theory to explore issues that were lacking in 
evidence.  The two studies in Chapter 7 were only the second application of risk-
compensation theory to an inherently health-related context.  They improved upon previous 
limited assessments of risk-compensation theory by measuring risk perceptions directly, 
which would have allowed more definitive conclusions about the cause of changes in 
behaviour were they to have been present. 
 
Social cognition models of health psychology proved a useful structure to focus a review of 
vaccination refusal in Chapter 2 and numerous concepts were deemed influential.  The 
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factors identified as being influential in vaccination refusal fitted neatly within social 
cognition models of health psychology, highlighting the importance of theory in study 
design and interpretation.  Although multi-variable findings were not considered in the 
review, social cognition models of health psychology detailed the pathways through which 
the univariate findings could be influencing vaccination refusal and allowed a model of 
vaccination refusal to be outlined.  Criticism has been directed at HPV vaccination research 
for its lack of theory in study design (Zimet et al., 2006) and this thesis will help go 
towards a stronger body of HPV vaccination literature. 
 
Focus on females 
HPV vaccination has been criticised for continuing to place the responsibility for sexual 
health with females.  Not only are girls the focus of HPV vaccination programmes 
worldwide, but discussions about including males in these programmes talk about the 
protection that their inclusion would provide to females, in addition to the limited 
oncological protection provided to boys themselves (Thompson, 2010).  It was identified in 
Chapter 2 that fathers only have not been the focus of any research exploring vaccination 
receipt.   Mothers may traditionally be the primary caregiver for children and so have been 
most likely to have brought their child to clinics for vaccination, where recruitment for 
studies often occurred.  However, these studies have neglected that fathers will likely be 
involved in the vaccination decision making process and their opinions need considering.  
This thesis has further contributed to this bias in sexual healthcare.  Mothers, and not 
fathers were studied in Chapter 5, and girls only were considered in Chapters 6 and 7.  
Given that research in this area was limited when this PhD was initiated, it was appropriate 
for preliminary research to consider populations who were going to most proximally be 
affected by the programme.  However, future research must explore the attitudes of fathers, 
and the attitudes of boys who are likely to have sexual relationships with vaccinated 
females at some point. 
 
Confounding factors 
Like all research that is conducted with ‘real people’ in the ‘real world’ the studies 
conducted for this thesis were not unaffected by current affairs that impacted on 
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participants and the pertinence of certain issues.  When this PhD was instigated, concern 
about sexual behaviour following vaccination was considered an important issue that was 
going to have to be addressed for the vaccination programme to be successful.  However, as 
the programme was implemented, current affairs demanded that other issues became more 
of a concern.  As described in Chapter 1, a television personality who was popular with 
young women, died from cervical cancer in 2009 and a Coventry school girl also died that 
year after she had received the HPV vaccine (although it was later confirmed that her death 
was not related to her vaccination receipt).  Both of these events occurred whilst the studies 
reported in Chapter 7 were ongoing and will likely have both raised awareness of cervical 
cancer and its severity and increased concern about HPV vaccination.  The fact that issues 
regarding sexual behaviour became less pressing does not make the research presented in 
this thesis any less important.  The findings will be relevant when other STI vaccines are 
introduced and this thesis has highlighted that such issues are relevant to a significant 
minority of individuals who are affected by HPV vaccination. 
 
Other protection afforded by HPV vaccination 
In addition to cervical cancer, HPV types covered by the bivalent and quadrivalent vaccines 
are established to cause genital warts, cancer of the anus and some penis and oral cancers 
(Palefsky, 2006; Palefsky, 2010).  This thesis considered only the protection offered by 
HPV vaccination against cervical cancer as this is the focus of the UK HPV immunisation 
programme and the vaccine providing protection against genital warts is not offered free at 
the point of receipt to British girls.  It is likely that parents would show greater concern 
about vaccinating their daughters against an STI were the quadrivalent vaccine offered to 
girls in the UK because of its more immediate focus on a widely recognised STI, genital 
warts.  If the quadrivalent vaccine was offered in the UK or either vaccine made available 
for males, it will be important to understand parents’ attitudes towards vaccinating against 
these diseases and infections. 
 
Research and researcher effects 
It is possible that participants in the present study were affected by participation in the 
research, and this may have affected the results.  Given the novelty of the HPV vaccine, 
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respondents in the studies reported in Chapter 5 and 6 particularly may not have considered 
the HPV vaccine in detail previously.  The discussion of risk and the information provided 
to the participants may have been a cue to action for mothers to increase their concern 
about HPV vaccination and sexual behaviour or for girls to become more cautious about 
their sexual behaviour.  The results may have been the consequence of a first reaction to the 
information, rather than a deliberated response which will likely happen when parents and 
girls are actually making decisions about whether to accept the HPV vaccine.  
Alternatively, the results may have been due to the participants reflecting more over the 
information than they would for a routine vaccine.  It may be useful to repeat these studies 
now that the HPV immunisation programme is underway and awareness is likely higher 
than when the studies were first conducted (2007 and 2008). 
 
In a similar vein, the researcher may have affected the results herself.  As is the case with 
all qualitative analysis, the qualitative analysis of newspaper articles in Chapter 4 was 
subjective and is likely to have been influenced by my pre-existing perceptions about 
particular newspapers or opinions about the HPV vaccination. 
 
Reliability and validity of measures 
The reliability and validity of the measures used will impact on the findings of research.  It 
is important that the measures used ensure that the results would be reproducible and 
consistent if the study were conducted a number of times.  I calculated Cronbach’s alphas 
for all of the scales used in the studies reported in Chapter 7 so that the reliability of the 
measures was transparent.  All scales had at least a good reliability estimate.  Two 
constructs of perceived risk were measured in these studies to ensure that the most 
appropriate measurement tool was employed. 
 
Vaccination receipt was determined by self-report which could be subject to bias.  
However, respondents had no obvious reason to deceive the researchers about their 
vaccination receipt and vaccination receipt would have been within the previous six months 
so was unlikely to have been subject to recall bias.  Furthermore, objective measures of 
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immunisation receipt have been shown to be imperfect (Harrington et al., 1995; Jefferies et 
al., 1991; Salmon et al., 2005; Wei et al., 2009). 
 
If an item does not measure what it is designed to measure, conclusions that are drawn 
about the results are likely to be inappropriate.  One could question whether the measures 
used to assess the girls’ beliefs about the meaning behind their parents’ consent to HPV 
vaccination in Chapter 6 were valid.  Although these measures were developed based on 
existing literature, were piloted and participants were given an example question prior to 
completing the items, the questions were complex and the girls may have been confused by 
them.  In Chapter 6 it was suggested that future research should consider girls’ beliefs about 
the meaning behind their parents’ vaccination consent in varying contexts, using alternative 
methodologies and for the study to be repeated. 
 
Inconsistent condom use was defined in these studies as a risky sexual behaviour, however 
this did not acknowledge the possibility that some participants may have been in sexual 
relationships where condoms were not essential to reduce risk of STI transmission or 
pregnancy (participants may have been using an oral contraceptive in a relationship in 
which both individuals were virgins or had both received negative STI screening results).  
In these circumstances reporting that condoms were never used during sexual intercourse 
would not have been a risky behaviour.  Oral contraceptive use22 was adjusted for in the 
final condom use models and this adjustment did not cause vaccination to become 
associated with condom use in the prospective study and stopped any associations in the 
quasi cross-sectional study. 
 
Finally, in Chapter 7, there may have been variation in the girls’ interpretation of ‘sexual 
intercourse’.  Although it was stated in the questionnaire that sexual intercourse was 
defined as ‘vaginal sex’, anecdotal conversations with girls during data collection 
highlighted that the girls’ definitions of what ‘counted’ as sexual intercourse differed.  For 
                                            
22
 In 2008/2009 in Great Britain oral contraceptives were the second most common contraceptive method 
used by 16-19 year old women after male condoms (Office for National Statistics, 2009). 
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example, for a number of girls it was the event of male ejaculation that signified sexual 
intercourse rather than the act of vaginal intercourse itself.  Similar issues were reported in 
the NATSAL survey (Wellings et al., 1990).  This has implications for safe sex as girls may 
feel that some acts of intercourse do not require a condom and may also have impacted on 
how the girls responded to the question about their frequency of condom use during 
intercourse. 
 
IMPLICATIONS OF FINDINGS 
Implications for theory 
As a whole, the results presented in this thesis have implications for theory in health 
psychology.  Constructs from the health belief model, protection-motivation theory and 
theory of planned behaviour were all shown related to vaccination refusal in the review of 
the literature in Chapter 2, particularly barriers/benefits, normative beliefs and perceived 
susceptibility.  Throughout this thesis, perceptions of risk were shown important in the 
context of HPV vaccine acceptability and when considering HPV vaccination receipt.  It is 
essential that theories that acknowledge the importance of perceived vulnerability are 
applied to future research in this context. 
 
The combined results of the studies reported in Chapter 7 only provided support for some 
of the pathways highlighted in risk-compensation theory, suggesting that it is not relevant 
to HPV vaccination.  The theory did provide a useful framework with which to investigate 
behaviour change.  There was also some evidence for behaviour-motivation theories as 
perceptions of risk predicted vaccination receipt, suggesting that behaviour-motivation may 
be evident following HPV vaccination.  There was evidence for risk-reappraisal theory as 
vaccination did cause risk perceptions to change.  These findings help contribute to the 
body of evidence supporting/opposing these theories and will assist in the modification of 
these theories. 
 
In accordance with Weinstein et al. (2007) ‘feelings of risk’ was deemed a better predictor 
of behaviour than ‘perceived likelihood’.  None of the ‘perceived likelihood’ variables were 
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related to vaccination receipt whereas ‘feelings of risk’ for HPV was associated and 
‘feelings of risk’ for cervical cancer showed a similar trend.  This finding can help 
strengthen the literature considering the measurement of perceived risk.  It is essential that 
measurement tools reduce error and the resulting bias as much as possible; using ‘feelings 
of risk’ may be the appropriate way to do this when investigating HPV risk perceptions and 
subsequent preventive behaviour related to those perceptions. 
 
Implications for policy and practice 
The findings of this thesis will also impact on HPV vaccination and cervical cancer 
screening policy and practice.  Reassuringly girls do not appear to be changing their 
behaviour following HPV vaccination and it appears that current information materials 
provided to girls when they are offered the vaccine are sufficient to ensure that this 
continues to be the case.  Misconceptions held by girls before they have been invited for 
vaccination (identified in Chapter 6 and Chapter 7) could be addressed earlier than they are 
presently (when girls are first offered the vaccine), for example as part of personal, social 
and health education classes to ensure that beliefs do not have time to become ingrained 
and more difficult to change.  Nurses administering the vaccine need to be aware of how to 
address adolescents’ misconceptions about the vaccine, and training must be provided to 
ensure that nurses are equipped with the skills to do so.  Although parents will likely feel 
reassured by the findings of the two studies reported in Chapter 7, any concerns that they 
continue to have could further be addressed by ensuring that adolescent girls are fully 
informed about the vaccine early on.  School nurses may also be appropriate individuals to 
engage with parents who are reluctant to consent to vaccination and they must also feel 
they have the necessary knowledge to do so.  It may be appropriate for perceived risk to be 
raised, as mothers with a high perceived risk of cervical cancer held more positive 
intentions to vaccinate their daughters in spite of negative beliefs about sexual behaviour 
following HPV vaccination.  However, providing mothers with the true likelihood of 
cervical cancer may also reduce risk perceptions due to the rarity of the disease.  
Vaccination programme coordinators in countries outside of the UK, who have also 
decided to used the bivalent vaccine, may benefit from adopting the information materials 
provided as part of the UK immunisation programme as they have shown successful. 
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Vaccination programme coordinators in the UK and their press offices need to remain 
aware of the influence the media has in affecting parents’ vaccination decisions as has been 
evident with the MMR vaccine and has the potential to occur with HPV vaccination.  They 
must be prepared to counter negative arguments that have shown to be present in the UK 
press.  The main finding of the studies reported in Chapter 7, that HPV vaccination does 
not negatively affect the sexual behaviour of girls, would be an ideal ‘positive’ story that 
could be disseminated to parents via the media. 
 
Despite high intentions to attend for cervical screening in the future reported in the two 
studies in Chapter 7 and vaccinated girls being more likely to intend to attend for cervical 
cancer screening than those not yet involved in the programme, it will be important to 
ensure that information materials that accompany screening invitations are adapted to 
highlight the necessity of screening despite HPV vaccination receipt, as this is not the case 
with the information materials currently provided (NHS Cancer Screening Programmes, 
2010).  It will be especially important to ensure that vaccinated girls’ intentions to attend 
for cervical screening are acted upon when they are first invited for screening, as 25-29 
year olds in England are the least likely age group to attend (The Information Centre, 
2010b). 
 
FUTURE RESEARCH 
 
Monitoring of cervical screening attendance in vaccinated populations 
Cervical cancer screening recommendations are unlikely to be adapted for girls who receive 
the HPV vaccine as part of the ‘catch-up’ programme, but updated screening intervals will 
likely be developed for girls receiving HPV vaccines as part of the main programme 
(Franceschi, 2009).  Cervical cancer screening in some form will still be necessary for all 
vaccine recipients as current HPV vaccines provide protection against HPV types that cause 
70% of cervical cancers.  Furthermore, because HPV vaccination will reduce the number of 
abnormal cytology results, cytologists may find it increasingly difficult to maintain the 
concentration needed to spot abnormal cell changes (Franceschi, 2009).  With the increased 
likelihood of false negatives, regular screening may be even more important.  The two 
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studies reported in Chapter 7 showed that girls’ intentions to attend for cervical cancer 
screening in the future were not affected by HPV vaccination, however, it will be important 
to monitor screening attendance to ensure that vaccinated women do continue to be 
screened.  In England, the oldest girls in the catch-up group will not be invited for 
screening until 2015 when the girls will be 25 years old.  All other countries in the UK start 
screening at age 20 so it will be important to consider the attendance of these girls from 
September 2010 onwards. 
 
Future HPV and STI vaccines 
Second generation HPV vaccines are in development and have the potential to improve 
HPV vaccination delivery in developing countries, reduce the burden on recipients in terms 
of the vaccination schedule, reduce cost and inconvenience (Franceschi, 2009).  Efforts are 
being made in developing lyophilised (freeze dried) vaccine preparations, which would 
reduce the need for a cold chain and make vaccination in developing countries increasingly 
more feasible.  Mucosal delivery approaches via a nebuliser have shown similar antibody 
responses to those delivered by intramuscular injection (Nardelli-Haefliger et al., 2005) and 
would reduce resistance to vaccination due to fear of needles.  Girls in both developing and 
developed countries may be helped by the manufacturing of single dose HPV vaccines that 
would mean reductions in cost (currently the HPV vaccine retails at around $125 per dose, 
$375 for the full series, Centers for disease control, 2010).  The reduction in doses would 
mean fewer opportunities for HPV vaccination to be used as a ‘cue to action’ for related 
educational interventions.  The current schedule creates a six month period in which girls 
can be educated about HPV vaccination, the importance of screening and related sex 
education which one-off vaccination would not allow.  It will be important to ensure that if 
HPV vaccination is to be used as a ‘cue to action’ that interventions are concise and 
appropriate to be delivered alongside a single vaccination event. 
 
The development of HPV vaccines that provide protection from other oncogenic HPV types 
is underway and the manufacturers of Gardasil® are currently trialling a nine virus-like 
particle HPV vaccine.  Girls receiving multivalent vaccinations will likely have even 
greater reduction in perceived risk of cervical cancer than were seen in the prospective 
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study reported in Chapter 7.  Vaccines that are seen to offer more protection further have 
the potential to create misunderstanding about the protection afforded by HPV 
vaccinations, although as Chapter 7 showed this will likely be resolved through education.  
The potential for such confusions should be explored.  Parents are likely to be wary of 
vaccines that afford protection from multiple virus types due to an existing fear seen in 
some parents of combination vaccines; a fear that was further amplified by the MMR 
vaccine controversy when Andrew Wakefield claimed that they overload children’s 
immune systems (Offit, 2008).  Alternatively, people may construct HPV vaccination as a 
single entity.  It will be important to assess parental attitudes to the acceptability of these 
second generation HPV vaccines to ensure that appropriate steps are taken to maintain high 
uptake in the UK. 
 
In addition to hepatitis B and HPV vaccination which are already available, a number of 
vaccines are in development to prevent other STIs, for example chlamydia, gonorrhoea, 
genital herpes and HIV.  A small minority of parents have shown concern about 
vaccinating their daughters against HPV because of its sexually transmitted nature, even 
though, in the UK at least, it is being marketed as a vaccine against cervical cancer.  It is 
likely that parents will show greater concern about vaccinating their children against 
infections that are recognised as sexually transmitted.  Some effort has already been put 
into understanding the acceptability of STI vaccines and parents have been the focus of 
some of this research (Mays et al., 2004; Zimet et al., 1997; Zimet et al., 2005; Zimet et al., 
2007).  On the whole this research has been conducted with American parents and has been 
unable to investigate the attitudes of parents who are actually in the process of deciding 
whether to vaccinate a child with an STI vaccine as the vaccines are still only in 
development.  Once these vaccines become available parental attitudes must be explored.  
Furthermore, it will be important to monitor the sexual behaviour of STI vaccine recipients, 
as is currently the case in HIV vaccine trials, to ensure that the protection afforded by these 
vaccines is not negated by an increase in risky sexual behaviour. 
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Use of theory in research exploring vaccination refusal 
The review in Chapter 2 found that certain constructs considered important in social 
cognition models of health psychology have been understudied, which has resulted in there 
being insufficient evidence for their role in vaccination receipt, even though social 
cognition models would assert that they are likely to be influential, for example, self-
efficacy from protection-motivation theory (Rogers, 1975; 1983) and the closely associated 
construct of perceived behavioural control from the theory of planned behaviour (Ajzen, 
1985; Ajzen, 1988; Ajzen, 1991).  It will be important to ensure that future vaccination 
refusal research is grounded in theory and that the theory is applied correctly and 
completely, as current research may be missing important findings that could be applied to 
interventions to improve vaccination uptake. 
 
FINAL REMARKS 
The development and introduction of a vaccine that protects against a sexually transmitted 
infection associated with cervical cancer has caused some parents to express concern about 
the impact that this vaccine may have on the sexual behaviour of their daughters and these 
concerns have been reported and also countered in the national press.  A minority of parents 
have expressed concern about girls having more sex, more unprotected sex, and becoming 
more promiscuous after having the vaccine and other research has shown parents to be 
concerned that girls will take vaccination consent to be equivalent to approval for sexual 
activity.  Some girls would believe HPV vaccination consent to give them carte blanche for 
sexual activity, but girls would also take positive messages about HPV-vaccine related 
issues.  Parents’ concerns do not appear great enough for mothers to refuse HPV 
vaccination for their daughters and girls believe that this will be the case also. In reality 
though, the introduction of HPV vaccination into the childhood immunisation schedule in 
the UK has not affected girls’ sexual behaviour or cervical screening intentions, even 
though perceptions of risk of cervical cancer have lowered and this is likely in part due to 
the information materials and education efforts that have accompanied the programme.  
Parents’ concerns about sexual behaviour following HPV vaccination may have resulted in 
parents being reluctant to discuss sex with their daughters in the context of HPV 
vaccination so that implicit approval of sexual activity is not conveyed.  Risk perceptions 
are pertinent in HPV vaccination acceptability and when exploring changes in behaviour 
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following vaccination receipt.  This thesis tells a ‘good news’ story and may go someway 
to alleviate the concerns of a minority of parents who are anxious about girls’ sexual 
behaviour following HPV vaccination.
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2. exp patient attitude/ 
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4. exp health care utilization/ 
5. 4 or 1 or 3 or 2 
6. exp immunization/ 
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8. 6 or 7 
9. exp adolescent/ 
10. exp infant/ 
11. exp newborn/ 
12. exp child/ 
13. *girl/ 
14. *boy/ 
15. *daughter/ 
16. son.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer name] 
17. exp child/ 
18. *childhood/ 
19. exp socioeconomics/ 
20. exp income/ 
21. exp ethnic group/ 
22. exp education/ 
23. *correlation analysis/ 
24. *predictor variable/ 
25. exp attitude/ or exp attitude to health/ or exp attitude to illness/ or exp patient 
attitude/ or exp student attitude/ 
26. exp health/ 
27. 25 or 21 or 26 or 20 or 22 or 24 or 19 or 23 
28. 11 or 9 or 17 or 12 or 15 or 14 or 18 or 10 or 13 or 16 
29. 27 and 8 and 28 and 5 
30. from 29 keep 1-407 
31. limit 30 to (english and yr="2004 -Current" and (article or journal or "review")) 
MedLine 537 1. exp intention/ 
2. exp "Patient Acceptance of Health Care"/ 
3. exp patient compliance/ or exp treatment refusal/ 
4. exp Patient Compliance/ 
5. 4 or 1 or 3 or 2 
6. exp adolescent/ or exp child/ or exp infant/ or exp parents/ 
7. exp Nuclear Family/ 
8. 6 or 7 
9. exp immunization programs/ or exp mass immunization/ 
10. exp Immunization/ 
11. exp Vaccines/ 
12. 11 or 10 or 9 
13. exp socioeconomic factors/ 
14. exp Ethnic Groups/ 
15. exp attitude/ or exp attitude to health/ 
16. (correlat* or predict* or determinant*).mp. [mp=title, original title, abstract, name 
of substance word, subject heading word] 
17. 16 or 13 or 15 or 14 
18. 8 and 17 and 12 and 5 
19. limit 18 to (english language and english) 
20. limit 19 to (yr="2004 -Current" and english and (introductory journal article or 
journal article or meta analysis or "review")) 
PsychInfo 2 1. exp Intention/ 
2. exp Health Care Utilization/ 
3. exp Treatment Compliance/ 
4. 1 or 3 or 2 
5. *immunization/ 
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8. exp "income (economic)"/ or exp income level/ 
9. attitudes/ or exp adolescent attitudes/ or exp health attitudes/ or exp parental 
attitudes/ 
10. exp Health Knowledge/ 
11. adult attitudes/ 
12. exp educational attainment level/ 
13. 8 or 6 or 11 or 7 or 10 or 9 or 12 
14. *adolescent attitudes/ 
15. exp parents/ or exp fathers/ or exp mothers/ 
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17. *sons/ 
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19. 17 or 18 or 15 or 16 or 14 
20. 4 and 19 and 13 and 5 
21. limit 20 to ("0110 peer-reviewed journal" and english and yr="2004 -Current") 
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Management 
Information 
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0 1. exp patient compliance/ 
2. exp patient cooperation/ 
3. exp health service utilisation/ 
4. exp young people/ 
5. exp neonates/ 
6. exp children/ 
7. exp pre school children/ 
8. exp girls/ 
9. exp boys/ 
10. exp daughters/ 
11. 1 or 3 or 2 
12. 8 or 6 or 4 or 7 or 10 or 9 or 5 
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IMMUNISATION SERVICES/ 
14. exp vaccines/ 
15. 13 or 14 
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17. exp income/ 
18. exp ethnic groups/ 
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S47 S38 and S39 and S45    
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S44 TX (determinant*) or (predict*) or (correlat*)    
S43 (MM "Risk Factors+")    
S42 (MM "Health Knowledge")    
S41 (MM "Attitude+")    
S40 (MM "Socioeconomic Factors+")    
S39 S35 or S36 or S37    
S38 S30 or S31 or S32 or S33 or S34    
S37 (MM "Vaccines+")    
S36 (MM "Immunization Programs")    
S35 (MM "Immunization+")    
S34 (MM "Sons")    
S33 (MM "Daughters")    
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S32 (MM "Child+")    
S31 (MM "Infant")    
S30 (MM "Adolescence")    
S29 S25 or S26 or S27 or S28    
S28 (MM "Patient Compliance+")    
S27 (MM "Health Resource Utilization")    
S26 (MM "Treatment Refusal")    
S25 (MM "Intention")    
S24 S14 and S15 and S21    
S23 S14 and S15 and S21    
S22 S5 and S14 and S15 and S21    
S21 S16 or S17 or S18 or S19 or S20    
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S18 (MM "Health Knowledge")    
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S14 S6 or S7 or S8 or S9 or S10    
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S12 (MM "Immunization Programs")    
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S10 (MM "Sons")    
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S1 (MM "Intention")    
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science 
173 # 6 #5 AND Language=(English) AND Document Type=(Article OR Review)  
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S Timespan=2004-2009 
# 5 #4 AND #3 AND #2 AND #1  
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S Timespan=2004-2009 
# 4 Topic=((Adolescent*) or (infant*) or (newborn*) or (child*) or (girl*) or 
(boy*) or (daughter*) or (son*) or (pre?school))  
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S Timespan=2004-2009 
# 3 Topic=((immuni?ation*) or (vaccine*) or (immuni?ation rate*) or 
(immuni?ation program*))  
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S Timespan=2004-2009 
# 2 Topic=((Behavio?r) or (patient attitude) or (treatment refusal) or 
(health?care utili?ation) or (intention) or (patient acceptance of health?care) or (patient 
compliance) or (treatment refusal) or (treatment compliance) or (patient cooperation) 
or (health service utili?ation) or (health resource utili?ation) or (adherence))  
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S Timespan=2004-2009 
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or (education status) or (correlation analysis) or (predictor variable*) or (attitude*) or 
(attitude* to health) or (attitude* to illness) or (patient attitude*) or (student attitude*) 
or (health) or (correlate*) or (predict*) or (determinant*) or (risk factor*) or 
(knowledge) or (health knowledge))  
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S Timespan=2004-2009 
Cochrane 
Database of 
Systematic 
Reviews 
0 # 6 #5 AND Language=(English) AND Document Type=(Article OR Review)  
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S Timespan=2004-2009 
# 5 #4 AND #3 AND #2 AND #1  
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S Timespan=2004-2009 
# 4 Topic=((Adolescent*) or (infant*) or (newborn*) or (child*) or (girl*) or 
(boy*) or (daughter*) or (son*) or (pre?school))  
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S Timespan=2004-2009 
# 3 Topic=((immuni?ation*) or (vaccine*) or (immuni?ation rate*) or 
(immuni?ation program*))  
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S Timespan=2004-2009 
# 2 Topic=((Behavio?r) or (patient attitude) or (treatment refusal) or 
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Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S Timespan=2004-2009 
# 1 Topic=((Socio?economic*) or (income*) or (ethnic group*) or (education*) 
or (education status) or (correlation analysis) or (predictor variable*) or (attitude*) or 
(attitude* to health) or (attitude* to illness) or (patient attitude*) or (student attitude*) 
or (health) or (correlate*) or (predict*) or (determinant*) or (risk factor*) or 
(knowledge) or (health knowledge))  
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S Timespan=2004-2009 
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APPENDIX 3- EXAMPLE EXTRACTION FORM (CONTINUED FOR ID 3 ON FOLLOWING PAGE) 
General Methods 
      Design   Measures 
ID Author and 
title 
Year Definition of 
non-receipt 
Vaccine 
of interest 
Powered 
to detect 
effect size 
Prospective 
study? 
Validated 
measure 
used 
Measure of 
vaccination 
receipt 
Piloted 
measure 
Measure of 
intention 
Qualitative 
quality 
assessment 
      small, 
medium, 
large 
Y/N Some, all, 
none/not 
reported 
 Y/N   
3 Allison et al. 
School-based 
health centers: 
Improving 
access and 
quality of care 
for low-
income 
adolescents 
2007 If tetanus 
booster 
needed, 
receipt = 
booster during 
study period 
Tetanus Small N None Chart review N N/A N/A 
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Example extraction form continued… 
Population 
Gender Average age of 
child/adolescent 
Parent or adolescent N Recruitment 
site 
>50% 
response 
rate 
Country Mean SES Most 
common 
ethnic 
group 
M/F/Both  P(mother/father)/A/Both   Y/N    
Both 14-17 year olds A 1715 Attended a 
health service in 
Denver in 20 
months before 
study period and 
registered in 
school 
Not reported USA Not 
reported 
Latino 
 
Example extraction form continued… 
 Results       Quality 
score 
Factors examined Univariate associations with 
non-receipt/non-intention 
Non-significant findings 
reported 
Qualitative reasons for receipt/intention  
Attendance at a school based 
clinic or other clinic 
Attendance at a non-school 
based clinic 
  2 
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APPENDIX 4 – ANALYSIS FROM CHAPTER 4 
EXAMPLE OF THE FRAMEWORK ANALYSIS 
 
 
OTHER THEMES AND SUB-THEMES FROM FRAMEWORK ANALYSIS 
Sex education 
 The curriculum 
Vaccination education 
Effects of sex education 
Concerns about age 
 Why young people are being vaccinated: sex at a young age 
Why young people are being vaccinated: puberty at a young age 
Why young people are being vaccinated: HPV infection levels and age 
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Decisions about what age to vaccinate 
Too young to vaccinate 
Benefits 
 Physical benefits 
 How long before benefits will be seen 
Psychological benefits 
Children 
 Responsibility for decisions 
Discussions with friends 
Parents broaching the topic of vaccination with children 
Dislike of injections 
Consent 
 Compulsory vaccination 
Parental consent 
How the vaccine is labelled 
 Sex 
Cancer 
General protection 
Parents’ vaccination decisions 
 Concerns 
 Vaccination discussions 
 Emotional responses 
Critics of the vaccine 
 Who the critics are 
 Critics are unaware of the realities of bringing up children 
 Irresponsible to be a critic 
Concerns 
 Side effects 
 Vaccines generally 
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Sex in society 
 Behaviours relating to sex 
Societal norms 
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APPENDIX 5 - PUBLICATION FROM CHAPTER 4 
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APPENDIX 6- MEASURES FOR CHAPTER 5 
Q1. Before this interview were you aware of HPV (human papillomavirus)? 
Yes 
No  
 
Q2. What do you think your chances of getting cervical cancer in the future are? 
No chance 
Very unlikely 
Unlikely 
Moderate chance 
Likely 
Very likely  
Certain to happen 
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Participant information about HPV 
Info card 1 - General HPV information 
Cervical cancer kills 250,000 women every year worldwide.  The total number of women worldwide who 
currently have cervical cancer is greater than 1.4 million. 500,000 women are diagnosed with cervical cancer 
each year. 
It has recently been established that cervical cancer is caused by certain types (high risk types) of the HPV 
virus (human papillomavirus). 
Most of the time, no symptoms are felt, but, in certain cases (3%), infection becomes persistent and leads to 
precancerous lesions, which can in turn develop into cervical cancer if not detected and treated on time. 
Cervical cancer can take a long time to develop, i.e. up to 15 – 20 years.   
Detection of precancerous changes in the cervix which could lead to cervical cancer is currently carried out by 
means of smear tests in doctor’s surgeries and that is why regular examinations are important.  However, 
smear testing is not a perfect means of detection.  
In addition to high risk HPV types, low risk HPV types also exist. These low risk HPV types do not lead to 
cervical cancer but are responsible for genital warts. Although genital warts are not life threatening, they can 
cause physical and psychological burden.  
At some point in time throughout her life, one woman in two gets exposed to the virus.   The virus is 
generally transmitted via skin-to-skin contact, most commonly during sexual activity. The risk starts right 
from the first sexual encounter.  Condoms do not completely protect against the HPV virus, as it is possible 
for the virus to be transmitted by sexual contact without intercourse.   
An HPV test looks for the presence of HPV infection in the cervical cells.  In the future, HPV testing may be 
used alongside smear tests. 
There is a vaccine to prevent cervical cancer, which is caused by HPV.  The vaccine prevents 70% of cervical 
cancers.  The vaccine can be given to girls and women aged between 10 and 55 years old.  The vaccine is 
given in 3 doses over a 6 month period: dose 1, then dose 2 one month later and dose 3 five months after the 
second.  The vaccine is given in the arm, like most vaccines.  Side effects, such as redness and swelling at the 
site of the injection, are comparable to all widely used vaccines, i.e. mild and temporary. 
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Q3. How much do you agree or disagree with this statement?: Having the HPV vaccination might make girls 
more likely to have sex. 
 
Strongly disagree 
Disagree 
Neither agree nor disagree 
Agree 
Strongly agree 
 
Q4. How much do you agree or disagree with this statement?: Girls who had the HPV vaccination would be 
more likely to have unprotected sex.  
 
Strongly disagree 
Disagree 
Neither agree nor disagree 
Agree 
Strongly agree 
 
Q5. How much do you agree or disagree with this statement?: Vaccinating young girls against HPV would 
encourage sexual promiscuity. 
 
Strongly disagree 
Disagree 
Neither agree nor disagree 
Agree 
Strongly agree 
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Q6. I am now going to read out a series of different conditions and I want you to tell me in general, how 
serious you consider each of the conditions to be.  Please answer on this scale from 1 to 10 where 1 means not 
at all serious and 10 means extremely serious.  If you haven’t heard of the condition just say so and we’ll 
move on to the next one.   
 
First, HPV (human papillomavirus)? 
1  Not at all serious 
2 
3 
4 
5 
6 
7 
8 
9  
10  Extremely serious 
Or ‘I have not heard of this condition’ 
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Q7. Please think about your daughter’s current situation. How willing would you be to get her vaccinated with 
this vaccine for the prevention of infection with the HPV virus that causes cervical cancer?  Please answer on 
this scale from 1 to 10 where 1 means not at all willing and 10 means extremely willing. 
 
1 Not at all willing 
2 
3 
4 
5 
6 
7 
8 
9 
10 Extremely willing 
 
Q8.  Thinking about cervical cancer screening/smear tests, which ONE of the following statements is closest 
to your situation? 
 
I regularly have cervical cancer screening/smear tests and do not need reminding 
I regularly have cervical cancer screening/smear tests but do need reminding 
I do not have regular cervical cancer screening/smear tests in spite of reminders to do so 
I have never had a cervical cancer screening/smear test  
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Q9. From this card, to which of these ethnic groups do you consider you belong? 
  
 1 White - British    
 2 White - Irish    
 3 White - Any other White background (please specify)    
 4 Mixed - White and Black Caribbean    
 5 Mixed - White and Black African    
 6 Mixed - White and Asian    
 7 Mixed - Any other mixed background (please specify)    
 8 Asian or Asian British - Indian    
 9 Asian or Asian British - Pakistani    
 10 Asian or Asian British - Bangladeshi    
 11 Asian or Asian British - Any other Asian background (please specify)    
 12 Black or Black British - Caribbean    
 13 Black or Black British - African    
 14 Black or Black British - Any other Black background (please specify)    
 15 Chinese    
 95 Any other (please specify) 
 
Q10. Will you please look at this card (card 1) and tell me which group represents your total income from all 
sources, before deductions for income tax, National Insurance etc. 
 
Q11. Will you please look at this card (card 1) and tell me which group represents your partner’s total income 
from all sources, before deductions for income tax, National Insurance etc.   
 
Q12.  Could you please look at the next card (card 1) and give your total income as an annual amount from 
this card?  
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Q13. Could you please look at the next card (card 1) and give your partner’s total income as an annual amount 
from this card?  If the participant or participants’ partner’s income was in group 38 they were asked to 
identify their income on card 2 also. 
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Card 1 
WEEKLY 
1  Up to £9 
2  £10 up to £19 
3  £20 up to £29 
4  £30 up to £39 
5  £40 up to £49 
6  £50 up to £59 
7  £60 up to £69 
8 £70 up to £79 
9  £80 up to £89 
10  £90 up to £99 
11  £100 up to £119 
12  £120 up to £139 
13  £140 up to £159 
14  £160 up to £179 
15  £180 up to £199 
16  £200 up to £219 
17  £220 up to £239 
18 £240 up to £259 
19  £260 up to £279 
20  £280 up to £299 
21  £300 up to £319 
22  £320 up to £339 
23  £340 up to £359 
24  £360 up to £379 
25  £380 up to £399 
26  £400 up to £449 
27  £450 up to £499 
28  £500 up to £549 
29  £550 up to £599 
MONTHLY 
Up to £42 
£43 up to £85 
£86 up to £129 
£130 up to £172 
£173 up to £216 
£217 up to £259 
£260 up to £302 
£303 up to £346 
£347 up to £389 
£390 up to £432 
£433 up to £519 
£520 up to £606 
£607 up to £692 
£693 up to £779 
£780 up to £866 
£867 up to £952 
£953 up to £1,039 
£1,040 up to £1,126 
£1,127 up to £1,212 
£1,213 up to £1,299 
£1,300 up to £1,386 
£1,387 up to £1,472 
£1,473 up to £1,559 
£1,560 up to £1,646 
£1,647 up to £1,732 
£1,733 up to £1,949 
£1,950 up to £2,166 
£2,167 up to £2,382 
£2,383 up to £2,599 
ANNUAL 
Up to £519 
£520 up to £1,039 
£1,040 up to £1,559 
£1,560 up to £2,079 
£2,080 up to £2,599 
£2,600 up to £3,119 
£3,120 up to £3,639 
£3,640 up to £4,159 
£4,160 up to £4,679 
£4,680 up to £5,199 
£5,200 up to £6,239 
£6,240 up to £7,279 
£7,280 up to £8,319 
£8,320 up to £9,359 
£9,360 up to £10,399 
£10,400 up to £11,439 
£11,440 up to £12,479 
£12,480 up to £13,519 
£13,520 up to £14,559 
£14,560 up to £15,599 
£15,600 up to £16,639 
£16,640 up to £17,679 
£17,680 up to £18,719 
£18,720 up to £19,759 
£19,760 up to £20,799 
£20,800 up to £23,399 
£23,400 up to £25,999 
£26,000 up to £28,599 
£28,600 up to £31,199 
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30  £600 up to £649 
31  £650 up to £699 
32  £700 up to £749 
33  £750 up to £799 
34  £800 up to £849 
35  £850 up to £899 
36  £900 up to £949 
37  £950 up to £999 
38  £1000 or more 
£2,600 up to £2,816 
£2,817 up to £3,032 
£3,033 up to £3,249 
£3,250 up to £3,466 
£3,467 up to £3,685 
£3,686 up to £3,899 
£3,900 up to £4,116 
£4,117 up to £4,332 
£4,333 or more 
£31,200 up to £33,799 
£33,800 up to £36,399 
£36,400 up to £38,999 
£39,000 up to £41,599 
£41,600 up to £44,199 
£44,200 up to £46,799 
£46,800 up to £49,399 
£49,400 up to £51,999 
£52,000 or more 
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Card 2 
1 £52,000 up to £53,999 
2 £54,000 up to £55,999 
3 £56,000 up to £57,999 
4 £58,000 up to £59,999 
5 £60,000 up to £64,999 
6 £65,000 up to £69,999 
7 £70,000 up to £74,999 
8 £75,000 up to £79,999 
9 £80,000 up to £84,999 
10 £85,000 up to £89,999 
11 £90,000 up to £94,999 
12 £95,000 up to £99,999 
13 £100,000 up to £104,999 
14 £105,000 up to £109,999 
15 £110,000 up to £114,999 
16 £115,000 up to £119,999 
17 £120,000 up to £124,999 
18 £125,000 up to £129,999 
19 £130,000 up to £134,999 
20 £135,000 up to £139,999 
21            £140,000 up to £144,999 
22 £145,000 up to £149,999 
23 £150,000 up to £154,999 
24 £155,000 up to £159,999 
25 £160,000 up to £164,999 
26 £165,000 up to £169,999 
27 £170,000 up to £174,999 
28 £175,000 up to £179,999 
29 £180,000 up to £184,999 
30 £185,000 up to £189,999 
31 £190,000 up to £194,999 
32 £195,000 up to £199,999 
33 £200,000 up to £209,999 
34 £210,000 up to £219,999 
35 £220,000 up to £229,999 
36 £230,000 up to £239,999 
37 £240,000 up to £249,999 
38 £250,000 up to £259,999 
39 £260,000 up to £269,999 
40 £270,000 up to £279,999 
41 £280,000 up to £289,999 
42 £290,000 up to £299,999 
43 £300,000 up to £319,999 
44 £320,000 up to £339,999 
45 £340,000 up to £359,999 
46 £360,000 up to £379,999 
47 £380,000 up to £399,999 
48            £400,000 or more 
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Q14: Have you passed any of the examinations on this card? 
SECTION 1:  
GCSE Grades D-G/Short course 
GCSE/Vocational GCSE 
CSE Grades 2-5 
O-level grades D-E or 7-9 
Scottish SCE Ordinary Bands D-E 
Scottish Standard Grades 4-7 
SCOTVEC/SQA National Certificate modules 
Scottish School Leaving Certificate –  
(no grade) 
Scottish Access 1-3 
Scottish Intermediate 1 
SECTION 2: 
GCSE Grades A*-C 
CSE Grade 1 
O-level Grades A-C or 1-6 
School Certificate/Matriculation 
Scottish SCE Ordinary Bands A-C or Pass 
Scottish Standard Grades 1-3 or Pass 
Scottish School Leaving Certificate Lower Grade 
Scottish Intermediate 2 
SUPE Ordinary 
Northern Ireland Junior Certificate 
SECTION 3: 
A-level, S-level, A2-level, AS-level 
International Baccalaureate 
Vocational A-level (AVCE) 
Scottish Higher 
Scottish SCE/SLC/SUPE at Higher Grade 
Scottish Higher School Certificate 
Certificate of Sixth Year Studies/ Advanced 
Higher Grades 
Northern Ireland Senior Certificate 
SECTION 4: 
Overseas school leaving exam or certificate 
SECTION 5: 
University or CNAA first degree, e.g. BA, BSc 
University or CNAA diploma or Foundation 
Degree 
Postgraduate degree, e.g. MA, MSc, MPhil, 
DPhil, PhD 
Teacher Training qualification 
SECTION 6: 
Foundation/Advanced (modern) apprenticeship 
completed 
Other recognised trade apprenticeship completed 
OCR/RSA 
Other clerical or commercial qualification 
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Nursing qualification 
 
City and Guilds Certificate  
BEC/TEC First Certificate/ First or General Diploma 
BTEC/ (General/ Ordinary) National Certificate (ONC) 
or Diploma(OND) 
Higher National Certificate (HNC) or Diploma (HND)  
NVQ/SVQ/GNVQ/GSVQ 
SECTION 7: 
Other recognised academic or vocational 
qualifications 
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APPENDIX 7 - FINDINGS FOR CHAPTER 5 
Exploring difference in household income in those of pensionable age and those of working age 
 
 n Mean SD t 
Age    t(339)=-.02, p=.98 
<60 333 27451 30489.06  
>60 8 27235 13065.21  
 
 
 
 
 
Testing relationships between continuous independent variables – Age 
 
N=341 Pearson Correlation Sig. (2-tailed) 
Household income .05 .41 
Perceived severity of cervical cancer -.85 .16 
Perceived risk of getting cervical cancer -.06 .25 
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Testing relationships between continuous and categorical independent variables – Age 
 
 n Mean SD F (ANOVA) 
NS-SEC3    F(3,337)= 1.65, p=.18 
Managerial and professional occupations 94 3.00 .75  
Intermediate occupations 83 2.78 .73  
Routine and manual occupations 143 2.77 1.0  
Not classifiable 21 3.05 1.6  
Total 341 2.85 .93  
Education    <.01 
None 62 42.23 14.9  
GCSE or equivalent 139 36.50 7.11  
A Level or higher education (below 
degree) 94 37.52 7.33  
Degree or higher 44 39.11 6.68  
 
 
 
 
 
 
Testing relationships between continuous and binary categorical independent variables – Age 
 
 n Mean SD t 
Whether respondent attends cervical screening    t(331)=.04, p=.97 
Regular cervical screening 293 37.55 7.32  
Irregular cervical screening or non-attendees 40 37.50 9.13  
Ethnicity    t(339)=-.14, p=.89 
White 306 38.15 9.06  
Other 35 38.37 10.7  
Aware of HPV    t(338)=-.27, p=.79 
Yes 80 37.90 6.87  
No 260 38.22 9.85  
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Testing relationships between continuous independent variables – Household income 
 
N=341 Pearson Correlation Sig. (2-tailed) 
Perceived severity of cervical cancer .06 .26 
Perceived risk of getting cervical cancer .05 .39 
 
 
 
 
 
Testing relationships between continuous and categorical independent variables – Household income  
 
 n Mean SD F (ANOVA) 
NS-SEC3    F(3,337)=.91, p=.44 
Managerial and professional 
occupations 94 30605.12 46719.56  
Intermediate occupations 83 24503.84 17756.39  
Routine and manual occupations 143 26271.79 21490.59  
Not classifiable 21 32936.91 25398.1  
Total 341 27446.45 30186.52  
Education    F(3,335)=2.56, p=.06 
None 62 29647.34 27585.01  
GCSE or equivalent 139 26150.97 26723.82  
A Level or higher education (below 
degree) 94 22808.47 17518.10  
Degree or higher 44 37388.25 54490.63  
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Testing relationships between continuous and binary categorical independent variables – Household 
income 
 
 n Mean SD t 
Whether respondent attends cervical 
screening    
t(331)=1.20, 
p=.23 
Regular cervical screening 293 28122.66 317898.99  
Irregular cervical screening or non-
attendees 40 21966.98 16131.30  
Ethnicity    t(339)=-.1, p=.92 
White 306 27390.17 30895.27  
Other 35 27938.48 23439.12  
Aware of HPV    t(338)=1.3, p=.19 
Yes 80 31290.59 42208.58  
No 260 26254.20 25431.82  
 
 
 
Testing relationships between continuous independent variables – Perceived severity of cervical cancer 
 
N=341 Pearson Correlation Sig. (2-tailed) 
Perceived risk of getting cervical cancer -.01 .87 
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Testing relationships between continuous and categorical independent variables – Perceived severity of 
cervical cancer 
 
 n Mean SD F (ANOVA) 
NS-SEC3    F(3,337)=.26, p=.85 
Managerial and professional 
occupations 94 9.43 1.07  
Intermediate occupations 83 9.30 1.18  
Routine and manual occupations 143 9.43 1.38  
Not classifiable 21 9.33 1.06  
Total 341 9.40 1.23  
Education    F(3,335)=1.32, p=.27 
None 62 9.66 .75  
GCSE or equivalent 139 9.32 1.31  
A Level or higher education (below 
degree) 94 9.31 1.50  
Degree or higher 44 9.45 .79  
 
 
 
 
 
 
Testing relationships between continuous and binary categorical independent variables – Perceived 
severity of cervical cancer 
 
 n Mean SD t 
Whether respondent attends cervical 
screening    
t(331)=.76, 
p=.45 
Regular cervical screening 293 9.88 2.17  
Irregular cervical screening or non-
attendees 40 9.60 2.41  
Ethnicity    t(339)=.12, p=.90 
White 306 9.40 1.25  
Other 35 9.37 1.09  
Aware of HPV    t(338)=.1, p=.92 
Yes 80 9.41 1.11  
No 260 9.40 1.26  
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Testing relationships between continuous and categorical independent variables – Perceived risk of 
cervical cancer 
 
 n Mean SD F (ANOVA) 
NS-SEC3    F(3,337)=1.2 p=.35 
Managerial and professional 
occupations 94 3.60 1.04  
Intermediate occupations 83 3.42 .96  
Routine and manual occupations 143 3.68 1.15  
Not classifiable 21 3.67 .58  
Total 341 3.59 1.05  
Education    F(3,335)=.58, p=.63 
None 62 3.65 1.23  
GCSE or equivalent 139 3.50 1.09  
A Level or higher education (below 
degree) 94 3.63 .96  
Degree or higher 44 3.70 .82  
 
 
 
Testing relationships between continuous independent variables – Perceived risk of cervical cancer 
 
 n Mean SD t 
Whether respondent attends cervical 
screening    
t(331)=.39, 
p=.70 
Regular cervical screening 293 3.62 1.02  
Irregular cervical screening or non-
attendees 40 3.55 1.13  
Ethnicity    t(339)=-.9, p=.37 
White 306 3.58 1.07  
Other 35 3.74 .82  
Aware of HPV    t(338)=1.18, p=.24 
Yes 80 3.71 .97  
No 260 3.55 1.07  
 
 
                                                                                                                APPENDICES 
 355 
 Testing relationships between categorical independent variables – NS-SEC3 
 
 
Managerial/ 
professional 
occupations 
n (%) 
Intermediate 
occupations 
n (%) 
Routine/ 
manual 
occupations 
n (%) 
Not 
classifiable 
n (%) 
Total 
n (%) χ² 
Whether respondent 
has smear tests      
χ² (3)= 
3.33 
p=.3 
Has regular 
cervical screening 84 (90.3) 76 (91.6) 118 (84.3) 15 (88.2) 
293 
(88.0)  
Has irregular 
cervical screening 
or non-attendee 
9 (9.7) 7 (8.4) 22 (15.7) 2 (11.8) 40 (12.0)  
Total 93 (100) 83 (100) 140 (100) 17 (100) 333 (100)  
Ethnicity      
χ²(3)=1
1.21, 
p<.01, 
V=.21 
White 86 (91.5) 73 (88) 133 (93) 14 (66.7) 306 (89.7)  
Other 8 (8.5) 10 (12.0) 10 (7.0) 7 (33.3) 35 (10.3)  
Total 94 (100) 83 (100) 143 (100) 21 (100) 341 (100)  
Aware of HPV      
χ² (3)= 
15.99, 
p<.01, 
V=.22 
Yes 34 (36.2) 22 (26.8) 22 (15.4) 2 (9.5) 80  (23. 5)  
No 60 (63.8) 60 (73.2) 121 (84.6) 19 (90. 5) 260  (76. 5)  
Total  94 (100) 82 (100) 143 (100) 21 (100) 340 (100)  
 
 
 
 
 
Testing relationships between categorical independent variables – Ethnicity 
 
 
White 
n (%) 
Other  
n (%) 
Total 
n (%) χ² 
Aware of HPV    χ²(1)=.88, p=.41 
Yes 74 (24.3) 6 (17.1) 80 (23.5)  
No 231 (75.7) 29 (82.9) 260 (76.5)  
Total  305 (100) 35 (100) 340 (100)  
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Testing relationships between categorical independent variables – Education 
 
 
None 
n (%) 
GCSE or 
equivalent  
n (%) 
A 
Level/Higher 
education 
(below 
degree) 
n (%) 
Degree or 
higher 
n (%) 
Total 
n (%) χ² 
Ethnicity      χ²(3)=6.1, p=1 
White 53 (85.5) 131 (94.2) 81 (86.2) 39 (88.6) 304 (89.7)  
Other 9 (14.5) 8 (5.8) 13 (13.8) 5 (11.4) 35 (10.3)  
Total  62 (100) 139 (100) 94 (100) 44 (100) 339 (100)  
Whether 
respondent 
attends cervical 
screening 
     <.01 
Has regular 
cervical 
screening 
41 (73.2) 126 (92) 85 (90.4) 39 (88.6) 291 (87.9)  
Has irregular 
cervical 
screening or 
non-attendee 
15 (26.8) 11 (8) 9 (9.6) 5 (11.4) 40 (12.1)  
Total  56 (100) 137 (100) 94 (100) 44 (100) 331 (100)  
Aware of HPV      χ²(3)=30.9, p<.01, V=.3 
Yes 5 (8.1) 21 (15.2) 35 (37.2) 18 (40.9) 79 (23.4)  
No 57 (91.9) 117 (84.8) 59 (62.8) 26 (59.1) 259 (76.6)  
Total 62 (100) 138 (100) 94 (100) 44 (100) 338 (100)  
NSSEC      χ²(9)=121.3, p<.01, V=.3 
Managerial/ 
professional 
occupations 
1 (1.6) 22 (15.8) 43 (45.7) 28 (63.6) 94 (27.7)  
Intermediate 
occupations 
7 (11.3) 37 (26.6) 26 (27.7) 13 (29.5) 83 (24.5)  
Routine/ 
manual 
occupations 
42 (67.7) 75(54) 23 (24.5) 3 (6.8) 143 (42.2)  
Not 
classifiable 
12 (19.4) 5 (3.6) 2 (2.1) 0 (0) 19 (5.6)  
Total 62 (100) 139 (100) 94 (100) 44 (100) 339 (100)  
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Testing relationships between categorical independent variables – Whether respondent attends for 
cervical screening 
 
 
Has regular cervical 
screening 
Has irregular 
cervical screening 
or non-attendee 
Total 
n (%) χ² 
Ethnicity    χ²(1)=2.93, p=.09 
White 267 (91.1) 33 (82.5) 304 (89.9)  
Other 26 (8.9) 7(17.5) 34 (10.1)  
Total 293 (100) 40 (100) 333 (100)  
Aware of HPV    χ²(1)=6.85, p<.01, V=.14 
Yes 77 (26.1) 3 (7.1) 80 (24.1)  
No 215 (85.3) 37 (14.7) 252 (75.9)  
Total  292 (100) 40 (100) 332 (100)  
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APPENDIX 8 - GRAPHS FOR CHAPTER 5 
Bar graph for whether the respondent attends cervical screening grouped by whether they were 
aware of HPV 
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Bar graph for NS-SEC3 grouped by ethnicity 
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Bar graph for NS-SEC3 grouped by whether the respondent was aware of HPV 
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Bar graph for education grouped by whether the respondent was aware of HPV 
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Bar graph for education grouped by whether the respondent attends cervical screening 
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Bar graph for education grouped by NS-SEC3 
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Bar graph for mean age of respondents in each education group 
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APPENDIX 9 - PUBLICATION FROM CHAPTER 5 
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APPENDIX 10 - PUBLICATION FROM CHAPTER 6 
CHAPTER XX  
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APPENDIX 11- INFORMATION MATERIALS FOR CHAPTER 6 
Information Sheet  
You can keep this information sheet. 
Title of Project:   Adolescent attitudes to HPV information   
This study has been approved by the UCL 
Research Ethics Committee [Project ID 
Number]: 1399/001 
Name, Address and Contact Details of 
Investigators: 
 
 
Professor Jane Wardle, Laura Marlow 
and Gareth Lloyd, Alice Forster 
Department of Epidemiology & Public 
Health, UCL, Brook House, 2-16 
Torrington Place, WC1E 6BT 
 
We would like to invite you to participate in this research project. You should only participate 
if you want to; choosing not to take part will not disadvantage you in any way. Before you 
decide whether you want to take part, it is important for you to read the following information 
carefully and discuss it with others if you wish. Ask us if there is anything that is not clear or 
you would like more information.  
 
Details of Study 
 
In this study, we are attempting to examine adolescents’ reactions to health information.  
The session will last no longer than 45 minutes.   
 
You will then be asked to read through an information leaflet and then answer some 
questions about your attitudes to what you have read.  We will then give you the opportunity 
to ask any questions that you have about the information you have read.   
 
At the end of the study we will give you a debriefing pack which will give you more details 
about the aim of the study.  If you have any further questions or issues to discuss, feel free 
to ask the researcher at any time during the session. 
 
It is up to you to decide whether or not to take part. If you choose not to participate it will 
involve no penalty or loss of benefits to which you are otherwise entitled. If you decide to 
take part you will be given this information sheet to keep and be asked to sign a consent 
form. If you decide to take part you are still free to withdraw at any time and without giving a 
reason.  All the answers you give us will be anonymous (your name will not be on the 
questionnaires) and all data will be collected and stored in accordance with the Data 
Protection Act 1998. 
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Informed Consent Form  
Title of 
Project:     
Adolescent attitudes to HPV information   
This study has been approved by the UCL 
Research Ethics Committee [Project ID Number]: 1399/001 
 
 
Participant’s Statement 
I  ……………………………………...................................... 
agree that I  
 
 have read the information sheet and the project has been explained to me orally; 
 have had the opportunity to ask questions and discuss the study; 
 have received satisfactory answers to all my questions or have been advised of 
an individual to contact for answers to my questions about the research; 
 have been told that the answers I give will be anonymous and confidential and it 
will not be possible to identify me from any reports that the researchers write. 
 
I understand that I am free to withdraw from the study without penalty if I so wish and I 
consent to the processing of my personal information for the purposes of this study only and 
that it will not be used for any other purpose. I understand that such information will be 
treated as strictly confidential and handled in accordance with the provisions of the Data 
Protection Act 1998. 
 
 Signed: 
 
Date: 
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APPENDIX 12 – MEASURES FOR CHAPTER 6 
 
 
 
This booklet contains some questions about: 
 
Your views about HPV 
Your parents’ views about HPV 
You 
 
It should take about 30 minutes to complete. 
 
When the entire group has finished the researcher will collect the questionnaires.  
 
 
 
 
 
 
 
 
 
  
Questionnaire booklet 
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Please answer the following questions about HPV.  Don’t worry if you are not sure 
about the answers or the terms used!  Just answer to the best of your ability. 
 
Your knowledge of HPV 
Please read each of the statements about HPV and indicate whether they are true or 
false by ticking () the appropriate box. 
 
True False Not Sure 
HPV often has no visible signs or symptoms    
Having many sexual partners increases the risk of getting HPV    
HPV always causes genital warts    
HPV is related to the AIDS virus    
HPV can be transmitted during sexual intercourse    
HPV can be treated with antibiotics    
HPV is very rare    
HPV can cause cervical cancer (cancer of the neck of the 
womb)    
HPV usually goes away without needing any treatment    
Most sexually active people will get HPV at some point in their 
lives    
A person always knows if they have HPV    
A person could have HPV for many years without knowing it    
Men cannot get HPV    
If you receive the HPV vaccine you no longer have to go to 
have a smear test    
The HPV vaccine is most effective if given to girls before they 
first have sex    
The HPV vaccine will be available on the NHS for 12-13 year 
old girls    
The HPV vaccine protects against all types of cancer    
Some HPV vaccines protect against genital warts    
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In the future girls aged 12-18 years will be offered a vaccination to prevent HPV 
infection.  
 
When you are invited to have the HPV vaccination, how likely would you be to have 
it? 
Very unlikely Unlikely Likely Very likely 
    
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About your parents …. 
Imagine you are offered the HPV vaccine this year.  
 
How much do you agree with the following statements? 
EXAMPLE 
Strongly 
disagree 
Slightly 
disagree 
Neither 
disagree 
nor 
agree 
Slightly 
agree 
Strongly 
agree 
If my parents let me have the HPV 
vaccine they would be 
acknowledging that I will have sex 
one day 
     
      
 Strongly 
disagree 
Slightly 
disagree 
Neither 
disagree 
nor 
agree 
Slightly 
agree 
Strongly 
agree 
If my parents let me have the HPV 
vaccine they would be concerned 
that I might have sex earlier 
     
If my parents let me have the HPV 
vaccine they would be concerned 
that I might have unprotected sex 
     
If my parents let me have the HPV 
vaccine it would mean that they 
wanted to protect me against 
sexually transmitted infections 
     
If my parents let me have the HPV 
vaccine it would mean that they 
wanted to protect me from 
cervical cancer 
     
If my parents let me have the HPV 
vaccine it would mean that they 
think that I am old enough to have 
sex 
     
If my parents let me have the HPV 
vaccine I would know that they 
agreed with vaccinations in 
general 
     
If my parents let me have the HPV 
vaccine I would know that they 
think it is ok for me to be sexually 
active 
     
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In general, do you think that your parents would let you have the HPV vaccine? 
 
Yes 
 
 
No 
 
Not Sure 
   
Ethnic group (please tick one box): 
  White (British or other)   Asian or Asian British (Pakistani) 
  Black or Black British (African)   Asian or Asian British (Other) 
  Black or Black British (Caribbean)   Chinese 
  Black or Black British (Other)  
 
  Mixed (please state) 
...……………………….. 
   Asian or Asian British (Indian)   Other (please state) 
………………………….. 
   Asian or Asian British (Bangladeshi)   Do not wish to answer 
What religion are you? (Please state)   ……………………….  
Would you say you are practicing this religion?       Yes               No   
And a few questions about you …. 
      
What is your age today?  ……….. 
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APPENDIX 13- ETHICAL APPROVAL FOR CHAPTER 6 
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APPENDIX 14 – FINDINGS FOR CHAPTER 6 
 
Percentage of missing responses from original dataset 
 
 Percentage of missing responses 
Age 7.4 
Knowledge  11.7 
If you were invited to have the HPV vaccination, how likely 
would you be to have it? 5.6 
Beliefs about sexual behaviour  
If my parents let me have the HPV vaccine they would be 
concerned that I might have sex earlier  6.8 
If my parents let me have the HPV vaccine they would be 
concerned that I might have unprotected sex  6.8 
If my parents let me have the HPV vaccine it would mean 
that they think that I am old enough to have sex  7.4 
If my parents let me have the HPV vaccine I would know 
that they think it is ok for me to be sexually active  8.0 
Beliefs about other issues relating to HPV vaccination  
If my parents let me have the HPV vaccine it would mean 
that they wanted to protect me against sexually transmitted 
infections  
8.6 
If my parents let me have the HPV vaccine it would mean 
that they wanted to protect me from cervical cancer  8.6 
If my parents let me have the HPV vaccine I would know 
that they agreed with vaccinations in general  8.0 
 
 
Testing relationships between continuous and categorical independent variables – Age 
 
  n Mean SD t 
Knowledge 14 66 1.06 0.27 
 15 96 1.09 0.19 
t(160)=-.79, p=.43 
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Testing differences between categorical independent variables – Age 
 
 
14  
n (%) 
15  
n (%) 
Total  
n (%) χ² 
Ethnicity    
White 53 (82.8) 65 (73.0) 118 (77.1) 
Asian 6 (9.4) 12 (13.5) 18 (11.8) 
Other 5 (7.8) 12 (13.5) 17 (11.1) 
Total 64 (100) 89 (100) 153 (100) 
χ² (2)=1.98, 
p=.38 
Religion    
None 40 (22) 19 (22.9) 41 (29.7) 
Christian 26 (47.3)  48 (57.8) 74 (53.6) 
Muslim 4 (7.3)  11 (13.3) 15 (10.9) 
Other 3 (5.5) 5 (6.0) 8 (5.8) 
Total 55 (100) 100 (83) 138 (100) 
χ² (2)=1.98, 
p=.38 
Would you say that you are practicing 
this religion?    
Yes 7 (23.3) 19 (32.8) 26 (29.5) 
No 23 (76.7) 39 (67.2) 62 (70.5) 
Total 30 (100) 58 (100) 88 (100) 
χ² (1)=.83, 
p=.36 
 
 
 
Testing differences between categorical and continuous independent variables – Ethnicity 
 
   n Mean SD F(ANOVA) 
Knowledge White 118 1.07 .23 
  Asian 18 1.12 .08 
  Other 17 1.01 .31 
  Total 153 1.07 .23 
F(2,150)=1.06, 
p=.35 
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Significant differences between categorical independent variables – ethnicity 
 
 
White  
n (%) 
Asian  
n (%) 
Other  
n (%) 
Total  
n (%) p 
Religion     <.01 
None 38 (36.5) 1 (6.7) 0 (0) 39 (29.3)  
Christian 65 (62.5) 0 (0) 8 (57.1) 73 (54.9)  
Muslim 0 (0) 8 (53.3) 5 (35.7) 13 (9.8)  
Other 1 (1.0) 6 (40.0) 1 (7.1) 8 (6.0)  
Total 104 (100) 15 (100) 14 (100) 133 (100)  
Would you say you 
are practicing this 
religion? 
    <.01 
Yes 10 (16.9) 8 (57.1) 8 (61.5) 26 (30.2)  
No 49 (83.1) 6 (42.9) 5 (38.5) 60 (69.8)  
Total 59 (100) 14 (100) 13 (100) 86 (100)  
 
 
Table 6.6 – Significant differences between categorical independent variables – religion 
 
 
None  
n (%) 
Christi
an n 
(%) 
Muslim 
n (%) 
Other 
 n (%) 
Total  
n (%) p 
Would you say you are practicing 
this religion?      .01 
Yes  - 14 (21.2) 7 (50.0) 5 (62.5) 
26 
(29.5)  
No - 52 (78.8) 7 (50.0) 3 (37.5) 
62 
(70.5)  
Total - 66 (100) 
14 
(100) 8 (100) 
88 
(100)  
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Testing differences between categorical and continuous independent variables – Knowledge 
 
 n Mean SD F(ANOVA) 
Religion    
None 41 1.11 .14 
Christian 74 1.06 .25 
Muslim 15 1.04 .31 
Other 8 1.07 .12 
F(3,134)=.69, 
p=.56 
Would you say that you are practicing 
that religion    
Yes 26 1.01 .32 
No 62 1.08 .19 
F(1,86)=1.82, 
p=.18 
  
 
 
Testing differences between the girls’ own intention to receive the HPV vaccine and whether 
they believed their parents would let them have the vaccine. 
 
 n Mean SD F (ANOVA) 
In general, do you think that your 
parents would let you have the HPV 
vaccine? 
   
Yes 116 0.51 0.12 
No 6 0.48 0.15 
Not sure 24 0.52 0.14 
F(2,143)=.32, 
p=.72 
 
 
Testing differences between the girls’ own intention to receive the HPV vaccine and ethnicity, 
religion and practicing a religion 
 
 n Mean SE F (ANCOVA) 
Ethnicity    F=.52, p=.6 
White 59 0.47 0.06  
Asian 14 0.47 0.04  
Other 13 0.48 0.05  
Religion    F=.91, p=.41 
Christian 65 0.49 0.03  
Muslim 13 0.44 0.05  
Other 8 0.5 0.07  
Practicing this religion    F=2.5, p=.12 
Yes 26 0.45 0.04  
No 60 0.51 0.04  
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Testing differences between the girls’ own intention to receive the HPV vaccine and age 
 
 Age n Mean SD t 
Vaccine intention 14 66 0.52 0.10 
  15 96 0.49 0.15 
t(160)=1.61, 
p=1.1 
 
 
 
Testing differences between the girls’ beliefs about whether their parents will let them have the 
HPV vaccine and religion 
 
 
None 
n (%) 
Christian 
n (%) 
Muslim 
n (%) 
Other 
n (%) 
Total 
n (%) χ² 
In general, do 
you think your 
parents will let 
you have the 
HPV vaccine? 
     
χ²(6)=9.26, 
p=.10 
Yes 35 (87.5)  58 (84.1) 6 (60) 5 (62.5)  104 (81.9)  
No 0 (0) 3 (4.3) 1 (10) 1 (2.5) 5 (3.9)  
Not sure 5 (12.5) 8 (11.6) 3 (30) 2 (25) 18 (14.2)  
Total 40 (100) 69 (100) 10 (100) 8 (100) 127 (100)  
 
 
Testing differences between the girls’ beliefs about whether their parents will let them have the 
HPV vaccine and categorical independent variables 
 
 Odds ratio 
95% 
confidence 
interval 
P value for 
within variable 
comparisons 
P value for 
contribution to 
the model a 
Religion    .47 
None - - -  
Christian  3.83 .33-44.55 .28  
Muslim .91 .13-6.56 .93  
Other - - -  
Ethnicity    .77 
White - - -  
Asian 1.08 .08-13.76 .95  
Other .57 .07-4.31 .58  
Practicing a religion    .47 
Yes - - -  
No 1.65 .44-6.27 .74  
Not religious 5.50 .33-91.61 1.19  
a Pseudo R2=.06, N=118
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Testing differences between the girls’ beliefs about whether their parents will let them have the 
HPV vaccine and age 
 
14  
n (%) 
15  
n (%) 
Total  
n (%) χ² 
Will your parents let you have the 
vaccine?       
Yes 48 (76.2) 68 (81.9) 116 (79.5) 
No 2 (3.2) 4 (4.8) 6 (4.1) 
Not Sure 13 (20.6) 11 (13.3) 24 (16.4) 
Total 63 (100) 83 (100) 146 (100) 
χ²(2)=.32, 
p=1.0 
 
 
 
Testing differences between the girls’ beliefs about whether their parents will let them have the 
HPV vaccine and knowledge 
 
 n Mean SD F (ANOVA) 
In general, do you think that your 
parents would let you have the HPV 
vaccine? 
   
Yes 116 1.09 0.19 
No 6 0.99 0.17 
Not sure 24 1.09 0.25 
F(2,143)=.61, 
p=.54 
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Differences between the statements about the girls’ perceptions of the meanings behind their 
parents’ vaccination consent and age 
 
Age  n Mean SD t 
If my parents let me have the HPV vaccine they 
would be concerned that I might have sex earlier 
14 66 0.30 0.23 
 15 96 0.36 0.21 
t(160)=-1.69, 
p=.09 
If my parents let me have the HPV vaccine they 
would be concerned that I might have unprotected sex 
14 66 0.31 0.22 
 15 96 0.35 0.20 
t(160)=-1.22, 
p=.22 
If my parents let me have the HPV vaccine it would 
mean that they wanted to protect me against sexually 
transmitted infections 
14 66 0.59 0.11 
 15 96 0.59 0.11 
t(160)=-.22, 
p=.83 
If my parents let me have the HPV vaccine it would 
mean that they wanted to protect me from cervical 
cancer 
14 66 0.61 0.08 
 15 96 0.61 0.11 
t(160)=.57, 
p=.57 
If my parents let me have the HPV vaccine it would 
mean that they think that I am old enough to have sex 
14 66 0.32 0.19 
 15 96 0.31 0.19 
t(160)=.26, 
p=.8 
If my parents let me have the HPV vaccine I would 
know that they agreed with vaccinations in general 
14 66 0.55 0.12 
 15 96 0.52 0.14 
t(160)=1.41, 
p=.16 
If my parents let me have the HPV vaccine I would 
know that they think it is ok for me to be sexually 
active 
14 66 0.33 0.19 t(160)=-.72, 
p=.47 
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Relationships between the statements about the girls’ perceptions of the meanings behind their 
parents’ vaccination consent and knowledge 
 
(N=162) Pearson Correlation Sig. (2-tailed) 
If my parents let me have the HPV vaccine they would be 
concerned that I might have sex earlier 
-.12 0.11 
If my parents let me have the HPV vaccine it would mean 
that they think that I am old enough to have sex 
-.13 0.09 
If my parents let me have the HPV vaccine I would know 
that they agreed with vaccinations in general 
.05 0.49 
If my parents let me have the HPV vaccine I would know 
that they think it is ok for me to be sexually active 
-.11 0.16 
 
 
 
Relationships between the statements about the girls’ perceptions of the meanings behind their 
parents’ vaccination consent and the girls’ own HPV vaccination intentions 
 
(N=162) Pearson Correlation Sig. (2-tailed) 
If my parents let me have the HPV vaccine they would be 
concerned that I might have sex earlier 
-.11 0.16 
If my parents let me have the HPV vaccine they would be 
concerned that I might have unprotected sex 
-.06 0.44 
If my parents let me have the HPV vaccine it would mean 
that they wanted to protect me from cervical cancer 
.09 0.26 
If my parents let me have the HPV vaccine I would know 
that they agreed with vaccinations in general 
.13 0.11 
If my parents let me have the HPV vaccine I would know 
that they think it is ok for me to be sexually active 
.16 0.05 
If my parents let me have the HPV vaccine it would mean 
that they wanted to protect me against sexually transmitted 
infections 
-.14 0.07 
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Differences between the statements about the girls’ perceptions of the meanings behind their 
parents’ vaccination consent and ethnicity 
 
Ethnicity n Adjusted 
mean 
SE F (ANCOVA) 
If my parents let me have the HPV 
vaccine they would be concerned that I 
might have sex earlier 
   F=.59, p=.39 
White 59 .29 .03  
Asian 14 .40 .09  
Other 13 .39 .06  
If my parents let me have the HPV 
vaccine they would be concerned that I 
might have unprotected sex 
   F=.23, p=.79 
White 59 .3 .03  
Asian 14 .29 .09  
Other 13 .34 .06  
If my parents let me have the HPV 
vaccine it would mean that they wanted 
to protect me against sexually transmitted 
infections 
   F=.09, p=.91 
White 59 .59 .02  
Asian 14 .57 .04  
Other 13 .59 .03  
If my parents let me have the HPV 
vaccine it would mean that they wanted 
to protect me against cervical cancer 
   F=.19, p=.82 
White 59 .61 .02  
Asian 14 .59 .04  
Other 13 .59 .03  
If my parents let me have the HPV 
vaccine it would mean that they think that 
I am old enough to have sex 
   F=.2, p=.82 
White 59 .32 .03  
Asian 14 .31 .08  
Other 13 .35 .06  
If my parents let me have the HPV 
vaccine I would know that they agreed 
with vaccinations in general 
   F=.4, p=.67 
White 59 .5 .02  
Asian 14 .51 .06  
Other 13 .54 .04  
If my parents let me have the HPV 
vaccine I would know that they think it is 
ok for me to be sexually active 
   F=.61, p=.54 
White 59 .34 .03  
Asian 14 .36 .07  
Other 13 .4 .05  
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Differences between the statements about the girls’ perceptions of the meanings behind their 
parents’ vaccination consent and religion 
 
Religion n Adjusted 
mean 
SE F (ANCOVA) 
If my parents let me have the HPV 
vaccine they would be concerned that I 
might have sex earlier 
   F=.42, p=.65 
Christian 65 .34 .03  
Muslim 13 .3 .07  
Other 8 .27 .08  
If my parents let me have the HPV 
vaccine they would be concerned that I 
might have unprotected sex 
   F=1.28, p=.28 
Christian 65 .33 .03  
Muslim 13 .22 .07  
Other 8 .23 .08  
If my parents let me have the HPV 
vaccine it would mean that they wanted 
to protect me against sexually transmitted 
infections 
   F=1.22, p=.3 
Christian 65 .6 .01  
Muslim 13 .58 .04  
Other 8 .53 .04  
If my parents let me have the HPV 
vaccine it would mean that they wanted 
to protect me against cervical cancer 
   F<.01, p=1.0 
Christian 65 .61 .01  
Muslim 13 .61 .03  
Other 8 .61 .04  
If my parents let me have the HPV 
vaccine it would mean that they think that 
I am old enough to have sex 
   F=.22, p=.8 
Christian 65 .33 .03  
Muslim 13 .3 .06  
Other 8 .28 .07  
If my parents let me have the HPV 
vaccine I would know that they agreed 
with vaccinations in general 
   F=1.42, p=.25 
Christian 65 .52 .02  
Muslim 13 .53 .04  
Other 8 .44 .05  
If my parents let me have the HPV 
vaccine I would know that they think it is 
ok for me to be sexually active 
   F=.89, p=.42 
Christian 65 .35 .02  
Muslim 13 .37 .06  
Other 8 .28 .06  
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Differences between the statements about the girls’ perceptions of the meanings behind their 
parents’ vaccination consent and practicing a religion 
 
Practicing a religion n Adjusted 
mean 
SE F (ANCOVA) 
If my parents let me have the HPV vaccine it 
would mean that they wanted to protect me 
against sexually transmitted infections 
   F<.01, p=.94 
Yes 26 .59 .02  
No 60 .59 .01  
If my parents let me have the HPV vaccine it 
would mean that they wanted to protect me 
against cervical cancer 
   F=.16, p=.69 
Yes 26 .6 .02  
No 60 .61 .01  
If my parents let me have the HPV vaccine it 
would mean that they think that I am old 
enough to have sex 
   F=1.68, p=.2 
Yes 26 .37 .04  
No 60 .3 .03  
If my parents let me have the HPV vaccine I 
would know that they agreed with 
vaccinations in general 
   F=.04, p=.85 
Yes 26 .52 .03  
No 60 .51 .02  
If my parents let me have the HPV vaccine I 
would know that they think it is ok for me to 
be sexually active 
   F=.05, p=.83 
Yes 26 .34 .04  
No 60 .35 .02  
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Differences between the statements about the girls’ perceptions of the meanings behind their 
parents’ vaccination consent and the girls’ beliefs about whether their parents would consent to 
HPV vaccination 
 
 n Mean SD F (ANOVA) 
If my parents let me have the HPV vaccine they 
would be concerned that I might have sex earlier    
F(2,143)=.03, 
p=.98 
No 6 0.34 0.19  
Not sure 24 0.33 0.26  
Yes 116 0.32 0.21  
If my parents let me have the HPV vaccine they 
would be concerned that I might have unprotected 
sex 
   
F(2,143)=.68, 
p=.51 
No 6 0.35 0.23  
Not sure 24 0.38 0.24  
Yes 116 0.32 0.21  
If my parents let me have the HPV vaccine it would 
mean that they wanted to protect me against sexually 
transmitted infections 
   
F(2,143)=1.59, 
p=.21 
No 6 0.60 0.07  
Not sure 24 0.61 0.06  
Yes 116 0.59 0.12  
If my parents let me have the HPV vaccine it would 
mean that they wanted to protect me against cervical 
cancer 
   
F(2,143)=2.21, 
p=.11 
No 6 0.53 0.27  
Not sure 24 0.62 0.07  
Yes 116 0.61 0.08  
If my parents let me have the HPV vaccine it would 
mean that they think that I am old enough to have sex    
F(2,143)=.74, 
p=.48 
No 6 0.28 0.25  
Not sure 24 0.28 0.18  
Yes 116 0.32 0.18  
If my parents let me have the HPV vaccine I would 
know that they agreed with vaccinations in general    
F(2,143)=.59, 
p=.56 
No 6 0.48 0.16  
Not sure 24 0.53 0.11  
Yes 116 0.53 0.13  
If my parents let me have the HPV vaccine I would 
know that they think it is ok for me to be sexually 
active 
   
F(2,143)=2.97, 
p=.06 
No 6 0.44 0.12  
Not sure 24 0.27 0.20  
Yes 116 0.35 0.18  
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APPENDIX 15 - GRAPHS FOR CHAPTER 6 
 
Bar graph for practicing a religion grouped by ethnicity 
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Bar graph for practicing a religion grouped by religion 
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APPENDIX 16 – CHAPTER 7 INFORMATION SHEET AND CONSENT FORM 
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APPENDIX 17 – QUESTIONNAIRES USED AT EACH TIME POINT 
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APPENDIX 18 - ETHICAL APPROVAL FOR CHAPTER 7 
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APPENDIX 19 – MISSING DATA FOR THE PROSPECTIVE STUDY AND QUASI 
CROSS-SECTIONAL STUDY IN CHAPTER 7 
Variable Missing 
n (%) 
PROSPECTIVE STUDY  
Choosing an appropriate measure of risk – Follow-up measures  
I feel very vulnerable to HPV in the future 12 (1.5) 
I feel very vulnerable to cervical cancer in the future  13 (1.7) 
I feel very vulnerable to STIs in the future 17 (2.2) 
My chance of getting infected with HPV in the future is … 13 (1.7) 
My chance of getting infected with cervical cancer in the future is … 16 (2.0) 
My chance of getting infected with an STI in the future is … 17 (2.2) 
Vaccination receipt  16 (2.0) 
Comparing differences in changes in the dependent variables  
Follow-up measures  
Vaccination receipt 4 (1.0) 
I feel very vulnerable to cervical cancer in the future  6 (1.5) 
I feel very vulnerable to HPV in the future  6 (1.5) 
I feel very vulnerable to STIs in the future 11 (2.7) 
Communication about sex with parents  11 (2.7) 
Number of sexual partners  49 (12.0) 
Age of sexual debut  41 (9.6) 
Condom use 26 (6.4) 
Had sex?  12 (3.0) 
Subjective norm for my parents think I should only have sex this year  19 (4.7) 
Subjective norm for my friends think I should only have sex this year  18 (4.4) 
Subjective norm for my parents think I should use a condom when I next have sexual 
intercourse  25 (6.1) 
Subjective norm for my friends think I should use a condom when I next have sexual 
intercourse  19 (4.7) 
Ethnicity  10 (2.5) 
Religion  8 (2.0) 
Are you practicing that religion?  18 (4.4) 
EMA 1 (0.3) 
Oral contraceptive use  16 (3.9) 
Age 0 (0.0) 
Intention to attend cervical cancer screening  4 (1.0) 
Drug use  21 (5.2) 
Ever had a boyfriend  4 (1.0) 
Do you smoke? 12 (3.0) 
Baseline measures  
If I never have the HPV vaccine, I would feel very vulnerable to STIs in the future  10 (2.5) 
If I never have the HPV vaccine, I would feel very vulnerable to cervical cancer in the future 4 (1.0) 
If I never have the HPV vaccine, I would feel very vulnerable to HPV in the future 3 (0.7) 
Number of sexual partners  29 (7.1) 
Condom use  26 (6.4) 
Communication about sex with parents 6 (1.5) 
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Variable Missing 
n (%) 
Had sex?  12 (3.0) 
Age of sexual debut  32 (7.9) 
Intention to attend cervical cancer screening 5 (1.2) 
QUASI CROSS-SECTIONAL STUDY  
Vaccination receipt 0 (0) 
Intention to attend cervical cancer screening  11 (2.2) 
Condom use  17 (7.1) 
Number of sexual partner  22 (4.5) 
Communication about sex with parents 8 (1.6) 
Subjective norm for my friends think I should use a condom when I next have sexual 
intercourse 11 (2.2) 
Subjective norm for my parents think I should use a condom when I next have sexual 
intercourse 19 (3.9) 
Subjective norm for my friends think I should only have sex this year 8 (1.6) 
Subjective norm for my parents think I should only have sex this year 10 (2.0) 
Drug use 13 (2.6) 
Ever had a boyfriend  7 (1.4) 
Do you smoke? 10 (2.0) 
Feeling of risk for HPV 8 (1.6) 
Feeling of risk for cervical cancer  9 (1.8) 
Feeling of risk for STIs 11 (2.2) 
Had sex?  18 (3.5) 
Age of sexual debut  28 (5.7) 
Ethnicity  12 (2.4) 
Religion  11 (2.2) 
Are you practicing that religion?  22 (4.5) 
EMA 12 (2.4) 
Oral contraceptive use  22 (4.5) 
Age 31 (6.3) 
